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SUMMARY 
 
Tension-type headache (TTH) is the commonest type of headache in the general 
population. Its exact aetiology and pathophysiology are however unclear. 
Pharmacotherapy is the most widely used treatment for symptomatic relief of TTH. 
However, it is associated with medication-over use headache and serious adverse-effects. 
 
Chinese medicine (CM) has a long history of treating headaches. Acupuncture, as a 
treatment modality of CM, is recommended as a prophylactic treatment of chronic TTH in 
the Guidelines developed by the National Institute for Health and Clinical Excellence of the 
United Kingdom. The latest Cochrane review also concluded acupuncture could be a 
valuable non-pharmacological treatment for people with frequent episodic or chronic TTH. 
The fact that the optimal acupuncture treatment remains unknown hinders the routine use 
of this intervention for TTH. 
 
CM treatment of headaches is guided by the systematic analysis and classifications of 
symptoms and signs, known as pattern identification or syndrome differentiation. In the 
case for TTH, the existing CM classification is mainly based on expert opinion, and there 
are no validated criteria for such classification. In the Western medicine context, the 
International Classification of Headache Disorders, second edition (ICHD-II) classified TTH 
into three subtypes based on headache days per month. This method has been criticised 
for its simplicity and a lack of understanding of the clinical features of chronic TTH. 
 
The aims of this thesis project were to use evidence-based approaches to develop and 
validate the Chinese Medicine Headache Questionnaire (CMHQ) for TTH; and to explore 
CM patterns of TTH and understand TTH associated signs and symptoms by administering 
CMHQ to the clinical population. 
 
The specific objectives were: 1) to identify the factors contributed to the conflicting 
outcomes among efficacy studies of acupuncture for TTH through systematically reviewing 
randomised controlled trials; 2) to develop and validate the CMHQ to assist CM pattern 
identification; 3) to understand TTH associated symptoms and signs, and identify CM 
patterns using factor analysis and cluster analysis; and 4) to further differentiate TTH 
patterns and better understand their differences in the perceived level of stress, disability 
and comorbidity. 
 
The methodology and key findings that have been used to address the objectives of this 
thesis are outlined below: 
 
I. A systematic review of acupuncture for TTH 
The systematic review followed the methods in the Cochrane Handbook for Systematic 
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Reviews of Interventions. Meta-analysis and subgroup analysis were employed. The 
review identified that electro-acupuncture stimulation, longer needle retention and twice a 
week treatment, were the three key factors associated with better outcomes than manual 
acupuncture, no or shorter needle retention and weekly treatment, respectively. In 
addition, the lack of standards of CM pattern identification for TTH was another weakness 
of the included trials.  
 
II. Development and validation of the Chinese Medicine Headache 
Questionnaire (CMHQ) 
The CMHQ was developed and validated to gather headache and non-headache symptoms 
and signs for identifying TTH patterns using the gold standard methods over three phases.  
 
In Phases One, literature search, face-to-face interviews of patients (n=20) and expert 
consultations were undertaken for item generation (CMHQ-1). In Phase Two, a pilot study 
(n=87) was conducted to determine the face validity and content validity of CMHQ 
(CMHQ-2). In Phase Three, an international, multi-site investigation (n=171) was 
conducted to further evaluate the questionnaire. The revised CMHQ (CMHQ-3) was found 
to have excellent face validity, considerable content validity, high internal consistency 
validity, high test-retest reliability and adequate construct validity. 
 
III. Identification of TTH patterns using explorative statistical analytic 
methods 
Headache features and non-headache symptoms and signs were found using the validated 
CMHQ. The most common TTH accompanying symptoms were fatigue (71.3%), neck 
stiffness (70%) and neck pain (60%). Headache was mostly aggravated by overwork 
(74.1%), stress (73.6%), mental strain (70%), and when tired (68.1%) whereas relieved 
by sleeping (77.6%) and rest (68.8%). 
 
These findings were consistent with the findings from other contemporary studies. CM 
patterns were identified using factor analysis and cluster analysis of the CMHQ data. Four 
clusters were identified. Evaluated by CM experts, three of them were relevant to CM 
patterns, and were diagnosed as Ascendant hyperactivity of Liver-Yang (Cluster 1), Dual 
deficiency of Qi and Blood (Cluster 2), and Liver depression forming Fire (Cluster 3). The 
remaining one was a nonspecific cluster (Cluster 4) due to its insufficient symptoms and 
signs. The three clusters/patterns were clinically relevant as they represent common 
clinical presentations of TTH, and were in sharp contrast with the 11 patterns in the 
current literature.   
 
IV. Exploration of correlations between CM patterns and other instruments 
The four clusters identified (listed above) not only differed in clinical presentation, but also 
in headache frequency, level of disability and stress. Among them, Cluster 1 had a 
moderate level of headache intensity and disability, and performed the best in perceived 
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coping ability of stress among the four clusters. Cluster 2 had the most severe headache 
and the highest disability level, whereas Cluster 4 had the mildest headache intensity, 
moderate disability and was free from mental comorbidity. 
 
Conclusions 
 
This PhD project employed rigorous evidence-based methods for the development, 
validation and implementation of the CMHQ to ensure reliable and consistent clinical 
decision making for practice and future clinical research.  
 
The findings of this study expand the current understanding of the symptoms and signs of 
TTH. The CMHQ can be used in combination with the ICHD-II TTH subtype classification to 
enhance the research design of the future studies. Scientific methods employed in this 
project will guide evidence-based future development of the questionnaire. 
 
The main limitation of this project is the relatively small sample size during the validation 
process. Future studies need to use a larger sample size in different ethnics groups to 
further validate the CMHQ.  
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CHAPTER 1  General introduction  
 
Contents  
 
1.1  Background   
 
1.2  Aims and Objectives   
 
1.3  Organisation of the thesis   
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1.1  Background  
Tension-type Headache (TTH) is the most prevalent type of headache disorder with a 
global lifetime prevalence of 69% [1]. It is a significant cause of distress and disruption to 
life [2], resulting in marked reductions in quality of life and engagement in social and 
family activities [3]. The exact aetiology and pathophysiology of TTH remain unclear [4], 
therefore the treatment strategies for TTH remain unspecific [5]. Pharmacotherapy is the 
most widely used management strategy of TTH, which is largely for symptomatic relief. It 
is however associated with medication-over use headache and significant side-effects [6]. 
 
Chinese medicine (CM) has a long history of treating headaches. Acupuncture, as a 
treatment modality of CM, has been reported to be effective for pain management [7, 8]. 
Included in the National Institute for Health and Clinical Excellence (NICE) clinical 
guideline, acupuncture is the only physical intervention recommended for prophylactic 
treatment of Chronic Tension-Type Headache (CTTH) [9]. The latest Cochrane systematic 
review for TTH concludes that acupuncture is a valuable non-pharmacological option for 
patients suffering from frequent episodic or chronic TTH [10]. 
 
Some issues related to the use acupuncture for TTH, however, remain to be addressed to 
enable this intervention to be effectively incorporated into routine healthcare. Firstly, 
considerable variations in efficacy were reported in clinical trials comparing real 
acupuncture with sham interventions. Some supported the efficacy of acupuncture, 
whereas others found no difference between real and sham acupuncture. 
 
Secondly, the optimal acupuncture protocol for TTH is unknown. Since conflicting findings 
exist as outlined above, understanding of potential factors associated with the optimal 
treatment protocol is critical. Determination of such factors might improve quality of 
acupuncture trials for TTH. 
 
Thirdly, there is a lack of CM criteria for TTH patterns. Those patterns are important as 
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they guide the determination of the optimal acupuncture protocol. CM theory emphasises 
the importance of individualisation and hence, individuals with the same disorders may be 
treated with different therapeutic strategies due to pattern identifications. This is known 
as “Tong Bing Yi Zhi” (同病异治). For instance, a patient suffers from common cold, based 
on the clinical symptoms and signs, they can be sub-divided into Heat-dominating and 
Cold-dominating patterns. Hence, the treatment strategies will be different accordingly. 
This is followed by using cooling herbs for the Heat-dominating whereas warming herbs for 
the Cold-dominating patterns [11]. This illustrates the complex nature of CM diagnosis 
and its impact on clinical practice [12]. However, the current TTH pattern identification is 
mainly based on expert opinions, without an evidence-based and validated instrument to 
ensure reproducibility. 
 
Randomised controlled trials (RCTs), as the gold standard, have been used in CM clinical 
research [13, 14]. RCTs need to incorporate the CM theory to enable translatability of 
findings into practice. To do so, differential pattern diagnosis must be included in trial 
design. Among the 11 studies included in the Cochrane review [10], although 8 studies 
(Endres 2007; Jena 2008; Karst 2001; Melchart 2005; Söderberg 2006; Tovola 1992; 
White 2000; and, Wylie 1997) stated individualised acupoint selection for treatments, only 
one (Endres 2007) of them defined CM patterns of TTH in detail. However, the criteria 
used were mostly based on textbook information and expert opinions. As a result, a lack 
of reliable classification of pattern identification might have contributed to equivocal 
results in acupuncture studies. 
 
To address this methodological challenge in acupuncture research for TTH, validation in 
pattern identification is critical. Standards of pattern identification should be clinically and 
empirically supported [13, 14]. More importantly, objective and reliable tools that fulfil the 
scientific research requirements as well as reflecting the CM theories are necessary to be 
developed through scientifically sound methods [14-17]. 
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Such a development may also be complementary to Western medicine classification for 
TTH. For instance, the Headache Classification Subcommittee of the International 
Headache Society (IHS) divided TTH into three subtypes based upon frequency alone [18]. 
This method has been considered inadequate because minor differences in its associated 
features are defined for its chronic subtype [19]. Since the criteria were initially 
established to differ TTH from migraine, the current TTH subtypes may limit the 
development of targeted treatment strategies. 
 
This present project addressed this gap for clinical practice and research through the 
development, validation and implementation of the Chinese Medicine Headache 
Questionnaire (CMHQ). 
 
 
1.2  Aims and Objectives 
The aims of this thesis project were to use evidence-based approaches to develop and 
validate the Chinese Medicine Headache Questionnaire (CMHQ) for TTH; and to explore 
CM patterns of TTH and understand TTH associated signs and symptoms by administering 
CMHQ to the clinical population. 
 
Specific objectives were: 
 
Objective 1: to identify the factors contributed to the conflicting outcomes among 
efficacy studies of acupuncture for TTH through systematically reviewing randomised 
controlled trials 
 
Objective 2: to develop and validate the CMHQ to assist CM pattern identification 
 
Objective 3: to understand TTH associated symptoms and signs, and identify CM 
patterns using factor analysis and cluster analysis 
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Objective 4: to further differentiate TTH patterns and better understand their differences 
in the perceived level of stress, disability and comorbidity 
 
 
1.3  Organisation of the thesis 
This thesis consists of 10 chapters. The overview of each chapter is as follows: 
 
Chapter 1 briefly introduces the background and purpose of the present thesis project. It 
provides the overall structure and organisation of the thesis. 
 
Chapter 2 presents a literature review on TTH with respect to its definition, classification, 
diagnosis, epidemiology, mechanism, current management and measurement in WM 
perspective. It also describes the CM understandings of TTH, in terms of its theory, 
definition, aetiology, classification, and treatments modalities. 
 
Chapter 3 is a systematic review on acupuncture for TTH. It aimed to evaluate the 
effectiveness of acupuncture treatment for TTH and identify factors contributing to the 
treatment outcomes. It systematically reports the search strategies, selection criteria, 
assessment of methodological quality, data extraction, and data analysis. In addition, 
statistical method of subgroup analyses were used to assess the role of various factors 
that may contribute to inconsistent results of acupuncture treatment outcomes, and used 
for subgroup comparisons. 
 
Chapter 4 is the “Methods” chapter, and describes the methodology of questionnaire 
development. It introduces the fundamental information about questionnaire design and 
development processes. 
 
Chapter 5 details the methodology for the design and development of the CMHQ, 
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including steps of development and evaluation strategies that were applied to the 
validation of the CMHQ. Three phases were carried out to develop and validate CMHQ. 
Chapters 6-8 outline the three-phase development. 
 
Chapter 6 explains the process of CMHQ initial development. It details the item 
generation of and construction of CMHQ. Literature review and face-to-face interviews 
were applied at this stage. 
 
Chapter 7 presents the results of a pilot study. It addresses the methods used for the pilot 
study and the process of CMHQ pre-test and amendment. 
 
Chapter 8 reports the results of the full-scale survey and discusses the survey findings. It 
details the methodology of the survey, describes the survey implementation, and 
evaluates the reliability and validity of CMHQ. Information collected from TTH participants 
from Australia and China was analysed with explorative statistical analytic methods to 
identify CM patterns of TTH. Chapters 8 reports the survey results on symptomatic 
features of TTH whereas Chapter 9 explores CM patterns. 
 
Chapter 9 exams and discusses the different characteristics among the four patterns. 
 
Chapter 10 summarises the research findings, discusses the research methods, draws 
conclusion, makes recommendations and acknowledges the limitations of the thesis. 
 
The main structure of this study is shown in Figure 1:  
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2.1  Introduction 
Headache is one of the most common complaints in primary care [20] and is also the 
leading reason for neurological consultation [21, 22]. Almost everyone experiences 
headache in his or her life. It affects nearly half of adults worldwide [23].  
 
Tension-type headache (TTH) is the most prevalent form of headache disorder in the 
general population [1, 24-27]. This chapter reviews literature on its classification, 
diagnosis, epidemiology, mechanisms, and management and assessment from the 
Western medicine (WM) perspective. Also included in this chapter is CM understanding of 
headache and TTH in the aspects of aetiology, pathogenesis, pattern identification and 
acupuncture treatment.  
 
 
2.2  Definition and classification  
2.2.1  Definition of TTH 
TTH is characteristically described as a dull, pressing or tight quality without specific 
features in quality [28]. The pain is nonpulsatile, i.e., seldom or never experience 
throbbing or pulsating sensation. The headache is mild to moderate in intensity, and the 
pain is generally markedly persistent. It varies in frequency, duration and intensity. TTH is 
usually bilateral. Its location might not be fixed but changeable. It is frequently attributed 
to stress and can be caused by anxiety, depression, fatigue, or repressed hostility [1, 29]. 
TTH could be associated with pericranial tenderness, sensitivity to light or sensitivity to 
noise [23]. It is occasionally associated with mild nausea, but not aggravated by physical 
activity [23].  
 
TTH is formerly called muscle contraction headache, as it was thought to be resulted from 
muscle contraction and muscle tension of the head, neck, face or scalp muscle [4]. Some 
other terminologies refer to TTH were tension headache, psychomyogenic headache, 
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stress headache, ordinary headache, essential headache, idiopathic headache and 
psychogenic headache [18].  
 
Episodic tension-type headache (ETTH), the commonest form of TTH, is usually not related 
to organic disease and considered to be a “normal” headache [30, 31]. Because of its mild 
intensity and being resolved with simple analgesics, majority of patients usually do not 
seek medical consultation for such headache [32, 33].  
 
2.2.2  A brief history of headache classification 
2.2.2.1  The 1962 Ad hoc Committee’s criteria 
In 1962, a set of diagnostic criteria of 15 categories of headache syndromes were brought 
out by an Ad hoc Committee of the National Institutes of Health in the United States of 
America (USA) [34]. The Ad hoc classification was an important contemporary 
contribution to the classification of headache disorder (Table 1).  
 
Table 1. 1962 Ad hoc classification of headache: table of contents 
 
Categories Type of headaches 
1 Vascular Headache of Migraine Type  
A “Classic” Migraine  
B. “Common” Migraine 
C. “Cluster" Headache 
D. “Hemiplegic" and "Ophthalmoplegic" Migraine 
E. “Lower-Half" Headache 
2 Muscle-Contraction Headache 
3 Combined Headache: Vascular and Muscle-Contraction. 
4 Headache of Nasal Vasomotor Reaction 
5 Headache of Delusional, Conversion, or Hypochondriacal 
States 
6 Nonmigrainous Vascular Headaches 
7 Traction Headache 
8 Headache Due to Overt Cranial Inflammation 
9-13 
 
Headache Due to Disease of Ocular, Aural, Nasal and Sinusal, 
Dental, or Other Cranial or Neck Structures. 
14 Cranial Neuritides 
15 Cranial Neuralgias 
Source: adapted from “Headache Classification Subcommittee of the International Headache 
Society. Classification and diagnostic criteria for headache disorders, cranial neuralgias and 
facial pain. Cephalalgia, 1988. 8 Suppl 7: p. 1-96.” 
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However, the system was not well accepted internationally as only a limited number of 
headache disorders were identified, and glossary definitions were ambiguous and  
requiring subjective interpretation on different headache disorders [35]. Some adjectives 
like „commonly‟ or „sometimes‟ were used to qualify the definitions, which makes it difficult 
to apply when the patterns of headache vary, or several types of headache are mixed and 
coexist [36]. TTH, for example, was defined as “ache or sensations of tightness, pressure, 
or constriction, widely varied of tightness, pressure, or constriction, widely varied in 
intensity, frequency, and duration, sometimes long-lasting, and commonly suboccipital” 
[37]. Furthermore, lacking of operationalised criteria in quantifying frequency, severity, 
and duration limited its application in distinguishing different types of headaches [38].  
 
Although the Ad hoc committee‟s classification system was controversial as solid 
diagnostic criteria were not provided [35], it was a useful start to the study of headache. 
It was a step forward to a consensus-based classification and diagnosis for headache 
disorder [35, 39]. It also contributed to the development of the operational diagnostic 
criteria and the further headache classification.  
 
2.2.2.2  The 1988 international classification of headache disorders  
The first internationally accepted classification of headache disorders was published by the 
IHS [40]. In 1988, the IHS introduced diagnostic criteria for headache disorders, cranial 
neuralgias, and facial pain [36]. This international classification of headache disorders 
(ICHD-I) divided headache syndromes into 13 main categories with 66 subcategories. 
Primary (i.e., idiopathic) headache and secondary (i.e., symptomatic) headache as two 
important subgroups of headache syndromes were categorised [35]. Major categories of 
ICHD-I are listed in Table 2.  
 
Compared with the Ad hoc Committee system, its taxonomy of headache disorders was 
changed remarkably. Old terms such as “common migraine” and “classical migraine” were 
replaced with “Migraine with aura” and “migraine without aura”, respectively. The term 
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“tension-type headache” was designated to replace previously called “tension headache”, 
“muscle contraction headache”, “psychomyogenic headache”, or “stress headache” [5]. 
Furthermore, diagnostic criteria for  episodic and chronic types were introduced for 
headache subtype identification [41]. 
 
Table 2. Summary of ICHD-I outline 
 
Categories Type of headaches 
1 Migraine 
2 Tension-type headache 
3 Cluster headache and chronic paroxysmal hemicrania 
4 Miscellaneous headache unassimilated with structural lesions 
5 Headache associated with head trauma 
6 Headache associated with vascular disorders 
7 Headache associated with nonvascular intracranial disorder 
8 Headache associated with substances or their withdrawal  
9 Headache associated with noncephalic infection 
10 Headache associated with metabolic disorder 
11 Headache or facial pain associated with disorder of cranium, 
neck, eyes, ears, nose, sinuses, teeth, mouth, or other facial 
or cranial structures 
12 Cranial neuralgias, nerve truck pain, and deafferentation pain 
13 Headache not classifiable 
Source: adapted from “Headache Classification Subcommittee of the International Headache 
Society. Classification and diagnostic criteria for headache disorders, cranial neuralgias and 
facial pain. Cephalalgia, 1988. 8 Suppl 7: p. 1-96.” 
 
More importantly, ICHD-I provided a clear distinction between primary and secondary 
headache, and four digits IHS codes, which provided great advantages/convenience to 
clinical practice, epidemiological studies and clinical trials many years after its publication.  
 
The greatest achievement of the ICHD-I classification was its definitive standards for 
diagnosis. All of the included headache disorders were drew up with explicit descriptions 
and contains operational diagnostic criteria [42]. Headache as a clinical entity was 
classified, and its description of the headache features enables precise diagnosis rather 
than an etiological classification. Furthermore, based on its operationalised criteria, a 
headache sufferer can thus have more than one headache diagnosis [43].  
 
ICHD was the first ever classification gained international acceptance in the field of 
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headache classification system. It was rapidly extensively adopted worldwide, and its 
main principles were accepted by the World Health Organisation (WHO) in the 
International Classification of Diseases 10th version (ICD-10). Also, it has been translated 
into 22 languages includes German, French, Italian, Spanish, Portuguese, Japanese, 
Chinese, Russian and some other languages of the world [44].  
 
2.2.2.3  The 2004 international classification of headache disorders 
Subsequently in January, 2004, fifteen (15) years after its first edition published, ICHD-I 
was revised becoming ICHD-II. ICHD-II classify headaches into categories of primary 
headaches, secondary headaches and cranial neuralgias, facial pain (cranial neuralgias, 
central or primary facial pain and other headaches) (Table 3) [18]. Among them, fourteen 
(14) groups of headache syndromes and over 170 types of headache were classified.  
 
Compared with ICHD-I, terminologies, subtypes and diagnostic criteria were made based 
on the previous version. TTH, for example, was divided into ETTH, CTTH and others in its 
previous classification; whereas in ICHD-II, new subclassification of TTH made TTH 
classified into 4 categories, i.e., infrequent ETTH and probable TTH were introduced to 
replace “other TTH”. Other changes in ICHD-II includes that chronic migraine as a disorder 
has been acknowledged, some new rare idiopathic headaches are more clearly defined, 
trigeminal autonomic cephalalgias entered as a new terminology, an appendix has been 
added [45].   
 
The diagnostic criteria in ICHD-I were called „operational diagnostic criteria‟ whereas the 
term „explicit‟ is dedicated to ICHD-II, which means „unambiguous, precise and with as 
little room for interpretation as possible‟ [18]. With the release of ICHD-II and its 
predecessor, explicit diagnostic criteria with accurate definition were constructed. It 
enables a precise diagnosis for not only researchers and clinician but also neurologists and 
general practitioners. A uniformed terminology and consistent diagnostic criteria for the 
field of headache disorders was established [46]. 
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Table 3. Summary of the ICHD-II outline 
 
Categories Type of headaches 
Part 1: 
Primary 
headaches 
1 Migraine  
2 Tension-type headache 
3 
 
Cluster headache and other trigeminal autonomic 
cephalalgias  
4 Other primary headaches 
Part 2: 
Secondary 
headaches 
5 Headache attributed to head and/or neck trauma 
6 Headache attributed to cranial or cervical vascular 
disorder 
7 Headache attributed to non-vascular intracranial 
disorder 
8 Headache attributed to a substance or its withdrawal 
9 Headache attributed to infection 
10 Headache attributed to disorder of homoeostasis 
11 Headache or facial pain attributed to disorder of 
cranium, neck, eyes, ears, nose sinuses, teeth, mouth 
or other facial or cranial structures 
12 Headache attributed to psychiatric disorder 
Part 3: 
Neuralgias and 
other 
headaches 
13 Cranial neuralgias and central causes of facial pain  
14 Other headache, cranial neuralgia, central or primary 
facial pain 
Source: adapted from Headache Classification Subcommittee of the International Headache 
Society. The International Classification of Headache Disorders (2nd edition). Cephalalgia 
2004; 24 (suppl 1): 1-160. 
 
In ICHD-II, the first part of primary headaches involve extensive subtypes for migraine, 
TTH, cluster and other trigeminal autonomic cephalalgias, as well as other primary 
headaches. The criteria for primary headaches are mostly described based on headache 
features and exclusion of other disorders. The second part of is about secondary 
headaches, with the description of and classification on the basis of aetiology. In this part, 
eight subgroups are categorised, headache attributable to trauma, vascular disorder, 
infection, intracranial disorders were included. The third part is concerned about the 
headache associated with cranial neuralgias, facial pain, and trigeminal neuralgia. 
 
2.2.3  Classification of TTH subtypes 
Based upon frequency of attacks, ICHD-II classifies TTH into episodic and chronic varieties. 
ETTH is characterised with a frequency of less than 15 headache days each month with the 
duration from 30 minutes to 7 days, whereas CTTH is of high frequency (> 15 headache 
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days per month) for more than 3 months. Both varieties must have at least two of the 
following features: 
 
1. Bilateral location 
2. A pressing or tight (nonpulsating) quality 
3. Mild or moderate intensity 
4. Not aggravated by routine physical activity and not accompanied by nausea and 
vomiting. Photophobia or phonophobia may be present, but not both. 
 
A further subgrouping of TTH was introduced in ICHD-II on the basis of epidemiological 
studies [47]. For pathophysiological purposes, ETTH has been subdivided into forms of 
infrequent episodic and frequent episodic, namely infrequent ETTH and frequent ETTH 
[48]. The difference between the two is that the frequent ETTH occurs 1 to 14 days per 
month whereas the infrequent form has one day or less per average month (less than 12 
episodic per year) [49]. A comparison of the three types of TTH is listed in Table 4. 
 
Despite of the pain increases with frequency, the three subtypes of Frequent ETTH, 
Infrequent ETTH and CTTH are believed to be varieties of the same disorder and share 
similar clinical features [50]. However, minor differences in the associated features are 
listed for its chronic variety [51]. In addition, among all three subtypes, TTH can be 
differentiated with and without pericranial tenderness in ICHD-II. Nevertheless, it is doubt 
that any of these distinctions have any clinical importance [52]. 
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Table 4. ICHD-II diagnostic criteria for TTH 
 
 
Infrequent ETTH Frequent ETTH 
CTTH 
 
A)  
Frequency 
At least 10 episodes occurring on 
<1 day a month on average (<12 
days a year) and fulfilling criteria 
B-D  
at least 10 episodes occurring on ≥1 but 
<15 days per month for at least three 
months (≥12 and <180 days per year) 
and fulfilling criteria B-D 
Headache occurring on ≥15 days per month  (180 
days/year or more) for >3 months and fulfilling 
criteria B-D 
 
B)  
Duration 
Headache lasting from 30 minutes to 7 days  Headache lasts hours or may be continuous  
C)  
Criteria 
Headache has at least two of the following characteristics: 
1. bilateral location 
2. pressing/tightening (non-pulsating) quality 
3. mild or moderate intensity 
4. not aggravated by routine physical activity  
Headache has at least two of the following 
characteristics: 
1. bilateral location 
2. pressing/tightening (non-pulsating) quality 
3. mild or moderate intensity 
4. not aggravated by routine physical activity  
D)  
Associated 
symptom 
Both of the following: 
1. no nausea or vomiting (anorexia may occur) 
2. no more than one of photophobia or phonophobia 
Both of the following: 
1. not ＞1 of photophobia, phonophobia or mild 
nausea 
2. neither moderate or severe nausea nor vomiting 
E)  
Others 
Not attributed to another disorder 
Notes  Episodic Tension-type headache mayor may not be associated with 
increased pericranial tenderness on manual palpation. 
 Chronic Tension-type headache mayor may not 
be associated with increased pericranial 
tenderness on manual palpation. 
Source: adapted from “Headache Classification Subcommittee of the International Headache Society. The International Classification of Headache Disorders (2nd 
edition). Cephalalgia 2004; 24 (suppl 1): 1-160.“ 
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2.3  Diagnosis, clinical features and comorbidity 
2.3.1  Diagnosis of TTH 
Diagnostic pitfall 
TTH was regarded as a featureless headache, as most TTH sufferers have no associated 
symptoms when compared with other type of headaches. Due to its nonspecific and 
lacking of specific and distinguishing feature [5], diagnosis of TTH is largely based on 
negative features [5, 53] and by excluding other primary or secondary headache mimic 
symptoms, syndromes and organ diseases [51].  
 
As listed in the ICHD-II criteria, a diagnosis of TTH must meet at least two of the following 
criteria: 1). Bilateral location, 2). Nonpulsating quality, 3). Mild or moderate intensity, and 
4). Unaffected by routine activity [18]. The diagnosis of TTH also requires the exclusive of 
nausea or vomiting or both light and noise sensitivity. Although the latter two criteria are 
mandatory for making a diagnosis, one has to fulfil only two of the four criteria to finalise 
the diagnosis [48]. However, such criteria have been always questioned by physicians and 
patients since TTH is defined more by noting the absence of associated features and then 
by what it is present [48]. Due to the absence of positive specific symptoms of TTH, 
exclusion of other organic disease are usually performed in its diagnosis and 
supplementary investigations are more frequently applied than in other types of 
headaches, such as migraine or cluster headache [5]. It is also argued that a definitive 
diagnosis criteria provided by the ICHD-II are always given over “a probable diagnosis” 
[51], which indicates headaches that meet all but one of a set of criteria, without fulfilling 
those of another headache disorder [54]. Although such headaches, for example, 
migraine without aura, cervicogenic headache, and probable migraine, present similarity, 
they respond to different treatment strategies.  
  
Diagnostic difficulties 
In clinical practice, TTH is often comorbid with other headaches [51]. Diagnostic 
difficulties may arise as TTH may be mistaken with other primary headaches such as 
migraine without aura, cervicogenic headache, and probable migraine [51]. As most daily 
headache sufferers may mimic migraine, TTH, some overuse of analgesics and migraine 
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headache-specific drugs at the same time at their initial consultations [5], it could be 
difficult to give a precise diagnosis for most patients with daily headaches at their initial 
consultation due to TTH may mimic other headaches and share symptomatology with 
other primary and secondary headache disorders [5, 51]. For example, when TTH 
sufferers presents their headache being bilateral like, having a non-throbbing character, 
and not associated with photophobia and phonophobia or nausea, it could be 
misdiagnosed for migraine without aura, which especially when they complaint triggers 
typically regarded as specific for migraine [51].  
 
Importance of accurate diagnosis 
The importance of an operational diagnostic criterion for headache in clinical practice is 
evident. However, reliable and useful paraclinical tests on CTTH, medication overuse 
headache (MOH), and migraine are lacking [5], an accurate diagnosis for TTH is 
imperative not only for a better understanding of its nature but also for the most 
appropriate treatment [55]. Differential diagnosis could therefore be a substantial 
challenge when clinicians attempting to acquire an accurate diagnosis. For example, the 
ICHD-II mandate both infrequent and frequent ETTH cannot be associated with nausea or 
vomiting and no more than one of photophobia or phonophobia, whereas epidemiologic 
studies observed 10% of patients with ETTH reported mild photophobia and 7% reported 
mild phonophobia [29, 56]. It is likely that the diagnosis of TTH can be approached in a 
logical manner as many facets of the headache is measurable based on IHS diagnostic 
criteria. In addition, a careful history includes inquiring about family history, trigger 
factors, and other features that to uncover the coexisting depression, anxiety, and other 
disorders are also imperative to be taken towards to a more accurate diagnosis [51, 
57-59].  
 
2.3.2  Clinical features  
2.3.2.1  Sensation and quality  
The 1962 Ad hoc headache classification described quality of TH as tightness, pressure, or 
constriction [37]. In addition, other sensations of dull, aching, “drawing”, and “soreness”, 
including the feeling as if their head is squeezed in a vise, wearing a “headband”, or like a 
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“belt” even “band” encircling the head were identified in a detailed analysis of 1420 cases 
[51, 60, 61]. Latter studies have observed some other sensations such as stabbing, dull, 
nonthrobbing ache, heaviness, pressure [29]. In addition, patients with TTH usually 
reported weight on the head rather than pain and may extend like a band around the head 
in clinical practice [36]. The ICHD-II defines that the pain of TTH is often bilateral pressing 
or tightening, and the sensation of TTH pain is similar to myofascial pain elicited from 
other parts of the body [61]. However, other sensations listed above are not included.  
 
2.3.2.2  Intensity  
According to the ICHD-II criteria for TTH, the headache is in mild or moderately intensity 
and it is neither defined as severe nor disabling. More than 80% TTH sufferers report they 
"seldom" or "never" experience pulsating pain [1, 25]. However, the severity of pain may 
found to increase to moderate or severe when the attack frequency increases [29, 51, 62, 
63]. 
 
2.3.2.3  Duration  
As defined in ICHD-II, duration of TTH may last from 30 minutes to several days. The 
headache often occurs later in the day. Onset of ETTH is often gradually, and it may also 
occur in the middle of the day. In CTTH, however, its onset occurs and disappears over a 
prolonged period [36]. 
 
2.3.2.4  Location and site 
The pain is often bilateral in almost 90% of the population-based analysis of TTH [29]. 
However, TTH sufferers also experience pain that often changes locations during the 
attacks [64]. It may also affects the front or top of the head and also involve the posterior 
neck and shoulders [51]. Location of its long-lasting pain are also commonly occipital and 
associated with sustained contraction of skeletal muscles [65]. 
 
2.3.2.5  Trigger factors and accompanying symptoms 
Understanding of triggers factors for TTH largely rely on patients‟ self-report, but have not 
been tested systematically [47]. Stress (mental or physical), irregular or inappropriate 
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meals, high intake of coffee and other caffeine-containing drinks, dehydration, sleep 
disorders, too much or too little sleep, reduced or inappropriate physical exercise, 
psychological problems, as well as variations during the female menstrual cycle and 
hormonal substitution are most commonly self-reported triggers [56, 62]. Headache may 
occur after exposure to glare, flickering light, eye strain, noise, or a succession of 
harassing incidents [36]. Both subtypes of infrequent and frequent ETTH may be 
associated with anorexia. 
 
Although psychological stress and emotional tension may not be the causes for TTH, they 
may be triggers [51]. The most frequently reported triggers are stress and emotional 
conflict [66]. Depression and anxiety levels in TTH sufferers have also been observed to be 
higher than headache-free controls [67, 68] and daily stress was correlated with TTH 
frequency [69].  
  
Some triggers that are typically specific to migraine may also precipitate TTH [51], 
including a lack of sleep, fatigue, and missing meals [62], menstruation, weather changes, 
relaxation after stress, exposure to bright lights, strong odors and loud noises, and 
ingestion of alcoholic beverages [62][63][70]. One recent hospital-based study confirmed 
that emotional stress was the major trigger factor of TTH, as outlined in other studies [66, 
71]. Trigger factors could also worsen TTH [36]. Identification of triggers and coping with 
these factors may be of values [72]. However, these factors are not limited to times of 
emotional overload, but also include superimposed anxiety, stress, noise or glare [36].   
 
2.3.2.6  Pericranial muscular tenderness 
In ICHD-II, TTH is divided into with pericranial tenderness and without pericranial 
muscular tenderness for each subtype. This indicates that the presence of pericranial 
muscle tenderness may be experienced by certain patients with TTH [51]. Muscular 
tension and muscle soreness on of both the pericranial and cervical areas such as the 
frontal, temporal, masseter, pterygoid, sternocleidomastoid, splenius, and trapezius 
muscles may be detected by manual palpation [73]. During the headache attacks, TTH 
sufferers experienced more muscle tenderness than non-headache controls [61, 74]. 
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Hence, a thorough manual palpation of the pericranial muscles and tender insertions, 
which contribute to a proper diagnosis of TTH is recommended [5, 61, 73]. Muscle 
tenderness in the neck regsion has been found to become worse with increased headache 
frequency and severity [75, 76]. According to the ICHD-II, if such tenderness is presented, 
the diagnosis of TTH associated with pericranial tenderness should be assigned [51]. 
However muscle tenderness in TTH has been found in arms and legs, and does not limit to 
the neck region alone, reflecting that TTH is not simply due to the increased tenderness on 
pericranial and cervical areas. Such a finding has not been incorporated into the ICHD-II. 
 
2.3.2.7  Comorbid symptoms and associated phenomena 
TTH is rarely accompanied by any focal neurologic symptoms but the patients may 
experience a constant mild photophobia which usually not severe enough to make them 
retreat to a darkened room [36]. TTH patients may occasionally experience slight 
photophobia or phonophobia, scalp tenderness, muscle tension or soreness in their 
cervical region [77, 78]. Analysis of 600 headache patients‟ case histories identified 
episodic form of TTH sufferers were accompanied with usual migrainous symptoms of 
nausea and photophobia [79]. Sensitivity to light was found to be common among 40 TTH 
patients in one study [80], and the proportion of sensitive subjects was significantly higher 
among TTH patients than among headache-free controls. This study also found that slight 
nausea may be present in early morning or when their headache became worse. Despite 
of this, vomiting was rarely observed [36]. 
 
Some other symptoms such as abdominal distension, excessive belching, and passing of 
flatus were observed, which were regarded as the result of unnoticed air swallowing. In 
addition, indigestion, difficulty in concentrating and lacking of interest in work or hobbies 
were reported. More flagrant depressive symptoms may present due to the onset of their 
headache. Body pain such as pain under the left breast and pain in the back or coccygeal 
region may present [81]. However the study did not provide the percentage of TTH 
sufferers might present with one or more of the above symptoms.  
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2.3.3  A comparison of ETTH and CTTH  
ETTH is the most frequent, but least distinct type of primary headache [5, 25]. ETTH is 
previously considered as “stress headaches”, which indicated it is stress related and is 
usually triggered by stress, anxiety, fatigue or anger. It occurs in short episodes with 
duration varies from 30 minutes to 7 days [18]. In this subdivision of ETTH, the form of 
infrequent ETTH is fairly "frequent" and regarded as probably a normal, protective 
reaction to lack of sleep, and mental stress [47]. Such type of headache often occurs 
randomly and usually occasional and mild, with rare disabling and lack of associated 
features. Probably due to this, it is best defined as the “normal” headache [23, 31]. Most 
people suffered from it may usually simply put up with their discomfort and treat 
themselves with over-the-counter analgesics thus it is rarely a chief complain to clinician 
and seen in headache clinics [82, 83].  
 
One study, which observed natural history of TTH, found 16% patients with ETTH who had 
poor outcomes developed into CTTH [84]. The progression from ETTH to CTTH largely 
indicates refractoriness to treatment, frequent medication overuse, increasing disability 
and a large socioeconomic and personal cost [48]. 
 
CTTH is a daily or near daily headache, which typically described as a disorder evolves 
from ETTH [18, 31]. It occurs on 15 or more days of the month for at least 6 months. 
Duration of CTTH may last hours or be continuous [5]. It has the pain quality of TTH but 
the pain is almost always present. Its intensity varies throughout the day. Patients with 
CTTH are therefore more likely to seek medical consultation than those with ETTH. One 
study observed CTTH has a significantly (higher consultation rate than that of ETTH group 
(CTTH 74.%1 vs. ETTH 57.4%, P<0.01) [85]. Due to this, CTTH has become a major 
public health problem with considerable socioeconomic effects [85]. Comparing with ETTH, 
CTTH usually involve major diagnostic and therapeutic problems, more medication 
overuse, and more loss of quality of life [5]. Sufferers of this type of headache often seek 
for prophylactic treatment as acute treatment may not be effective [86]. In addition, CTTH 
often coexists with mental disorder [87]. Depression and anxiety are common in CTTH 
sufferers [32]. This population group are likely to be more associated with stress, anxiety, 
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and depression than those with the episodic type, and it is more easily mistaken for other 
primary headaches such as chronic migraine, new daily persistent headache or hemicrania 
continua [51]. CTTH is associated with more severe pain and more accompanying 
symptoms [41]. Comparing with ETTH, it is less influenced by daily hassles and/or stress 
[41] but always associated with disability and high personal and socio-economic costs [18, 
31]. Unlike ETTH, CTTH sufferers often complain of its associated somatic symptoms, such 
as nausea, generalized myalgias and arthralgias, changes in sleep patterns or insomnia, 
early morning or late day occurrence of headache, chronic fatigue, weight loss, dizziness, 
decreased libido, irritability, disturbed memory and poor concentration [87, 88]. CTTH 
require special management since it is often combined with medication overuse and 
associated with more severe pain and more accompanying symptoms [41]. Although TTH 
is never associated with typical migraine some headache features such as vomiting, 
severe photophobia, and phonophobia. In CTTH, it is allowed that only one of these 
accompanying symptoms may be presented [5].  
 
In summary, CTTH differs from ETTH in frequency of headache attack, lacking of effective 
treatment strategies, which have more medication overuse and more loss of quality of life 
than ETTH. Therefore CTTH is the most prevalent subtype and is more costly to the society 
[5].   
 
2.3.4  A comparison of TTH and migraine 
Migraine is an extraordinarily common disorder with the pain typically unilateral, 
throbbing or pulsating quality, moderate or severe intensity. The headache is often 
aggravated by routine activity, usually accompanied by some symptoms such as nausea, 
vomiting, phonophobia or photophobia [18]. Both migraine and TTH are highly prevalent 
primary headaches. The IHS diagnosis of migraine is typically depicted by the presence of 
“positive” features of photophobia and phonophobia, aggravation by activity, and nausea 
and/or vomiting whereas characterisation of TTH is based on the absence of such features 
[74]. TTH is clinically nonspecific which usually manifested as head pain without 
associated symptoms [89].  
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Although TTH and migraine are different disorders, they do share some features [89] and 
coexist in many patients [41]. The IHS-defined TTH are often accompanied symptoms that 
typically for migraine, for example, photophobia or phonophobia and aggravation by 
activity [89]. In one epidemiology study, 83% of the migraineurs suffered from TTH [25]. 
It has been widely acknowledged that differentiation between the two is the most 
challenging part of the primary headache diagnosis [90]. In clinical practice, it is common 
that TTH patients present their headache features more frequently associated with 
migraine [91]. Conversely, a report of 94% of migraineurs experience TTH, also, 56% 
experience frequent ETTH [28]. However, it is difficult in finding a distinct line between 
migraine and TTH [36, 79], especially form an early phase of some patients in clinical 
practice [92].  
 
Their similarity and differences may impose diagnostic challenges and management 
difficulties [93]. Hence, the two types of headaches are necessarily to be distinguished 
from its major and associated features, family history and other associated factors (Table 
5), because distinguishing the two types of headache has practical implications in 
management strategies [41, 90].  
 
2.3.5  TTH and Cervicogenic headache 
Apart from migraine, TTH is may also be confused with other secondary headache 
disorders. The presenting characteristics of ETTH might be occasionally coexist with the 
symptoms from cervicogenic headache, which is pain referred to the head from the bony 
nociceptive structures or soft tissues of the neck in the cervical spine [94], characterised 
by chronic hemicranial unilateral head pain affecting the neck and occipital region [95]. 
Detailed comparisons of clinical characteristics are presented in Table 5. 
 
In most cases, apart from the bilateral localisation of the headache and the absence of 
mechanical trigger factors, important diagnostic features of cervicogenic headache are the 
symptoms and signs of neck involvement, whereas these signs include mechanical 
precipitation of attacks, reduced range of motion in the neck, diffuse ipsilateral 
neck/shoulder/arm pain of nonradicular nature or, occasionally, arm pain of radicular 
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nature may allow differentiation between the two types of headaches [94]. The headache 
associated signs of impairment in the musculoskeletal system also include forward head 
posture, hyperalgesia, reduced mobility and disorders in the muscular system [96]. 
Particularly, there is evidence to support using the manual examination as a diagnostic 
tool in examining upper cervical joint dysfunction in the form of reduced segmental 
mobility at C1–C2 and C2–C3 can be helpful in differentiating cervicogenic headache from 
others [96-100]. 
 
In addition, muscle tenderness, an important differentiation has to be made between 
tender and trigger points, is common during and between TTH attacks [53]. TTH patients 
may often present bilateral pain with tender points but there are no trigger points. In 
contrast, when the trigger point is pressed, referred unilateral headache is however 
immediately elicited in cervicogenic headache [53]. Tender points are areas in which 
manual pressure induces whereas the trigger points are areas of localised deep 
tenderness in which sustained pressure also induces referred pain in another area in the 
region or in another region local pain [53, 73, 75]. While TTH patients reported tenderness 
in their scalp, temporal area, lateral ptelygoid, masseter, sternocleidomastoid, trapezius 
muscles, or even in the commonly referred neck [53], it is of possibility that when 
diagnosing TTH based on the tender points found in the pericranial musculature might be 
mistaken with the trigger points of cervicogenic headache presented in the upper cervical 
or occipital region [51].  
 
Table 5. Comparisons of clinical characteristics of Migraine, TTH, and 
Cervicogenic headache 
 
 
 
Migraine Tension-type headache Cervicogenic headache 
C
li
n
ic
a
l 
fe
a
tu
r
e
s
 Location  Unilateral  Bilateral  Unilateral 
Locus Supraorbital/ frontal region 
 
 
 
[60] 
Primarily occipital and 
suboccipital; frontal and 
occipital/frontal; location of pain 
might not fixed but changeable 
[60] 
Pain localized to the occipital, 
frontal, temporal or orbital 
regions 
 
 
Area of 
symptoms 
Temporal, frontal, or 
retro-orbital 
 
Muscle of head, periorbital, 
temporal and occipital; cervical 
symptoms may be present. 
Restricted active and passive 
neck range of motion; neck 
stiffness 
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Quality of 
symptoms 
Throbbing or pulsating, 
pounding; can be tight or 
bandlike. 
 
Dull, nonthrobbing; aching or 
pressure of tightness; heavy 
weight on head; pressing 
“vice”, ”band” or ”belt” like 
sensation; seldom or never 
experience pulsating pain. 
Pain is generally deep and 
nonthrobbing; radiating; 
throbbing may occur when 
migraine attacks are 
superimposed 
Intensity Moderate to severe   Mild or moderate  Moderate to severe 
Associated 
features 
Nausea and/or vomiting; 
visual disturbances and 
photophobia, sound 
sensitivity; neck pain; sinus 
pain; osmophobia; 
movement sensitivity;  
Nausea, vomiting , 
photophobia; 
Seldom associated features. 
 
Nausea; vomiting; 
photophobia, phonophobia, 
and dizziness; 
 
Others include ipsilateral 
blurred vision, lacrimation 
and conjunctival injection or 
ipsilateral neck, shoulder or 
arm pain 
Time and 
mode of 
onset  
Very rapid; patient awakens 
with headache, warning or 
aura of focal neurologic 
symptoms before headache  
 
[101] 
Patient awakens with headache 
less frequently 
 
 
 
[101] 
Intermittent attacks of pain 
lasting hours to days, 
constant pain or constant 
pain with 
superimposed attacks of pain 
 
 [18, 51, 60, 102] [1, 25, 29, 60, 103, 104] [95] 
Precipitating 
factors and 
aggravate 
factors 
 
Aggravated by routine 
activity and physical activity; 
Stress; bright lights; noise; 
exertion; dehydration; 
depression/ anxiety; 
frustration; anger; head or 
neck trauma; fatigue; sleep 
disturbances; strenuous, 
unaccustomed exercise; 
relaxation after stress; 
alcohol (especially red wine); 
food sensitivity (inc. 
chocolate, cheese, 
monosodium glutamate, 
nitrites and aspartame ); 
dietary excesses; barometric 
changes; hormonal changes 
and menstruation 
[60, 105] [31] 
Frequently attributed to stress 
or tension; not aggravated by 
jolting, usual exercise or 
positional change; Stress and 
mental tension; smoking (inc. 
passive smoking); weather 
changes; alcohol; certain foods; 
sexual activity; menstruation; 
poor self-rated health; inability 
to relax after work  
 
 
 
 
 
 
 
 
[26, 77, 84, 106, 107] 
Arthritic changes in the 
cervical spine; triggered by 
neck movement, sustained 
or awkward neck postures; 
digital 
pressure to the suboccipital, 
C2, C3, or C4 regions or over 
the greater occipital nerve; 
valsalva, cough or sneeze 
might also trigger pain 
 
 
 
 
 
 
 
 
[95] 
Family history  Yes 
[60] 
No 
[60] 
No 
[108] 
 
IHS Diagnosis 
criteria  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Migraine without aura 
(1) At least 5 attacks (each 4-72 
hrs)  
(2) Headache has at least 2 of 
following: 
 Unilateral location 
 Pulsating quality  
 Moderate or severe pain  
intensity 
 Aggravated by routine 
physical activity (e.g., 
such as walking or 
climbing stairs) 
At least 1 of the following 
symptoms: 
 Nausea and/or vomiting  
 Photophobia and 
phonophobia 
(3) Not attribute to another 
disorder 
 
(1) Headache lasting from 1/2 hr to 
7 days 
(2) Headache has at least 2 of the 
following characteristics: 
 Bilateral location 
 Pressing/tightening 
(non-pulsating) quality  
 Mild or moderate intensity 
 Not aggravated by routine 
physical activity ( e.g.,  
walking or climbing stairs) 
Both of the following: 
 No nausea or vomiting 
(anorexia may occur) 
 No more than 1 episode of 
photophobia or phonophobia 
(3) Not attribute to another disorder 
 
 
 
(1) Pain, referred from a source 
in the neck and perceived in one 
or more regions of the head 
and/or face, fulfilling criteria (3) 
and (4) 
(2) Clinical, laboratory and/or 
imaging evidence of a disorder 
or lesion within the cervical spine 
or soft tissues of the neck known 
to be, or generally accepted as, a 
valid cause of headache 
(3) Evidence that the pain can be 
attributed to the neck disorder or 
lesion based on at least one of 
the following: 
 demonstration of clinical 
signs that implicate a source 
of pain in the neck 
 abolition of headache 
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Migraine with aura 
(1) At least 2 attacks  
(2) Headache has at least 3 of 
following: 
 At least 1 fully reversible 
aura symptom 
 Gradual development of at 
least 1 aura symptom over 4 
or more min, or several 
symptoms occur in 
succession  
 No aura symptom lasts 
more than 1 hr 
 Headache follows or 
accompanies aura in 1 hr or 
less 
(3) Not attribute to another 
disorder 
 
 
 
 
 
 
 
following diagnostic 
blockade of a cervical 
structure or its nerve supply 
using placebo- or other 
adequate controls 
(4) Pain resolves within 3 
months after successful 
treatment of the causative 
disorder or lesion 
Sources: [1, 18, 25, 26, 29, 31, 51, 60, 77, 84, 95, 101-107] 
 
2.3.6  Comorbidity  
Comorbidity is the presence of additional separate disorders in relation to an index 
disorders in one individual and it is associated with worse health outcomes, more complex 
clinical management, and increased health care costs [109]. Comorbidity affects a large 
proportion of patients especially in patients with CTTH. Understanding and addressing its 
related comorbidities, such as sleep disturbance, fibromyalgia, and associated psychiatric 
conditions, are necessary for the therapeutic success [51]. 
 
2.3.6.1  TTH and sleep disturbance  
A significant proportion of TTH patients experienced a significant higher prevalence of 
sleeping problems than the general population [110-113]. These sleep disorders may 
include sleep-disordered breathing, insomnia, circadian rhythm disorders, and 
parasomnia [114]. Several population studies [84, 113, 115] observed an association 
between sleep disorders and TTH and such problems have been shown to be a poor 
prognostic indicator in ETTH [84]. Sleep-related problems have been reported to be 
common triggers whereas the good sleep itself relieves headache. Therefore, managing 
sleep disorder, and associated psychiatric comorbidities may improve associated 
headache [116, 117]. 
 
2.3.6.2  TTH and Fibromyalgia syndrome 
Fibromyalgia (FM) is a chronic pain syndrome of widespread musculoskeletal pain and 
muscular tenderness throughout the body [51], which affects approximately 2% of the 
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general population [118]. Like CTTH, it is a chronic pain condition of unknown origin [119]. 
Sleep disturbance (75%), stiffness (77%), fatigue (81%), and headache (52%) are 
common associated symptoms of FM [120].  
 
TTH and FM are epidemiologically comorbid and they have common clinical features and 
their pathogenic mechanisms are overlap partly [121]. A common pathophysiological 
basis of the central sensitisation was hypothesized for FM and TTH [119]. More than half 
of FM patients have complaints on headache and 23% FM patients had a prior diagnosis of 
CTTH [51, 122, 123]. Both CTTH and FM can be associated in patients as they have 
similarities in clinical, therapeutic and pathophysiologic features [119]. For example, a 
therapeutic neuro-modulation approach with antidepressants could be effective for both 
TTH and FM [121].  
 
2.3.6.3  TTH and psychiatric conditions 
In recent years, research has begun to recognise the phenomenon that comorbidity of 
headache and psychiatric disorders [124]. TTH patients may exhibit psychiatric illness, 
such as depression and anxiety, at a disproportionately higher rate than individuals with 
no history of recurrent headache, and [51, 124, 125]. In one large multicentre study, TTH 
was found to be comorbid with an overall 84.8% psychiatric disorders, and 52.5% with 
anxiety whereas 36.4% with depression [126].   
 
Depressed patients frequently complain of headache but the relationship between 
depression and headache is complex [127]. About one third of TTH patients have 
symptoms of depression [128], and anxiety is the most common disorder among 
psychiatric conditions associated with TTH [126]. Early studies contented that 
anxiety-provoking situations were contributory in all 400 patients with TTH [129] and 
many experiential studies concluded the similar results [130]. In a series of 100 TTH 
patients, 74 % were found to have obvious emotional tension whereas depression was 
apparent in 35%. Dependence, sexuality, and control of urges were also found to be the 
most common psychologic problems [131]. 
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Degree of psychiatric comorbidity correlates with frequency of TTH, i.e., higher psychiatric 
comorbidity were observed in greater TTH frequency [51]. Besides, patients with CTTH 
experience more psychiatric comorbidity than ETTH patients [59, 126]. In one study, the 
one-year prevalence observation of the young adults with ETTH, they did not appear to be 
at greater risk for mood disorders [132]. In another study on older CTTH patients, a 
twice-greater chance that suffering from depression was observed [133]. Findings from 
the above mentioned studies indicated age differences in TTH comorbid with psychiatric 
conditions. 
 
An association between types of headache and personality factors was found by using the 
California Personality Index [134]. Twenty-five (25) patients with TTH were found to have 
characteristics of hypochondriasis, depression, and hysteria; others have obtained similar 
data by using Minnesota Multiphasic Personality Inventory [135]. Although some 
personality profiles are more common in TTH, they remains far understudied and are of 
little value in clinical practice [136]. 
 
In summary, psychiatric comorbidities are common in CTTH patients as there is a 25% 
chance of them in developing secondary depression [88] and also higher rates of anxiety 
[137]. In patients with CTTH, depression and anxiety may cause a decreased threshold for 
pain and a higher frequency of headache [138]. 
 
 
2.4  Epidemiology and impact 
As headache usually varies significantly through one‟s life with a high prevalence rate, it is 
important to determine its time span. In this type of study, routinely used terminologies 
“lifetime prevalence” and “one-year prevalence” are the two concepts mostly relevant to 
assess its prevalence. The former concept measures the number of cases of the disease 
from a total number of individuals from the population. In headache epidemiological 
studies, the “lifetime prevalence” was estimated based on the proportion of people who 
had ever had a headache at the time of investigation. The “one-year prevalence” refers to 
the proportion of people who had suffered from headache in the 12 month preceding the 
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investigation. It defines the proportion of the disease from the population. 
 
There are numerous epidemiology studies for headache conducted in different countries, 
results among studies may have some discrepancy due to the different methodological 
and genetic or socio-cultural factors. Although a variety of methodologies had been used, 
the internationally accepted IHS classification has provided an operational diagnostic 
criterion for all headache disorders. Its convenience to the diagnosis of headache offers 
great opportunities to the validation of headache epidemiology studies. However, 
estimates TTH was difficult not only because the heterogeneity of this disorders, but also 
due to the complicating issue that the majority previous epidemiological studies were 
conducted before the release of the ICHD-II [51]. 
 
2.4.1  Prevalence and incidence 
Denmark has long been the major centre for headache studies, including TTH studies [48]. 
The first TTH population study was conducted in 1991 [29]. In this study, the one-year 
prevalence of ETTH ranges from 14.3% [139] to 93.0% [29], the CTTH had lower rate 
between 0.0 [139, 140] to 8.1 [140]. 
 
TTH affects 42% percentage of adult population among headache disorders worldwide 
[23]. It also has a high lifetime prevalence rate in general population, with a global lifetime 
prevalence of 69% [1] which ranks the top among primary and secondary headaches. Due 
to the variation from case definition, study design, study methods, demographic factors or 
particular ages [51], its prevalence estimates vary widely over a ranges among 30% to 78% 
in 2004 [18] and as high as 87% shortly after one year in 2005, which was observed from 
one of the latest epidemiologic studies [26]. However, the majority (51%-59%) had TTH 
1 day each month or less and were not in specific need of medical attention [25, 26]. 
 
The incidence of TTH has rarely been estimated and its results are uncertain [141]. One 
Danish epidemiologic study demonstrated the annual incidence for frequent TTH was 14.2 
per 1,000 person years (female-to-male 3: 1) [26, 84, 106]. 
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Frequency of headache attacks should be considered in studying prevalence of TTH [142]. 
In ICHD-II, subdivision of TTH was created on the basis of epidemiological studies where 
the prevalence of infrequent ETTH is at 40-50% of TTH cases in the general population 
[24-26]; and the frequent ETTH accounts for 37-39% of TTH cases in several population 
based studies [24-26]. However, epidemiological studies [18, 24, 26, 139, 140, 143-148] 
show that global prevalence of CTTH is quite uniform at 2% to 3% [25, 142, 144, 149]. 
Unlike ETTH, its prevalence is declines with increasing of education levels. 
 
2.4.2  Age and gender distribution 
The prevalence of TTH varies with age in both sexes [51]. Results from several 
cross-sectional epidemiologic studies indicate its most common onset ages were in the 
second and third decennium, specifically, averagely between 25 and 30 years [24-26, 143, 
144, 149]. 
 
TTH showed a proclivity to decrease with increasing age [61]. The prevalence peak of TTH 
is most likely between age of 30 and 39 years, and then decreases with increasing age for 
both men and women [24-26, 58, 144, 150]. Despite of its decrease by ages, in regard to 
the prevalence in elder population, the prevalence of approximate 25% was observed [4, 
24, 151]. 
 
The prevalence of TTH also varies with gender by showing female preponderance [61], 
with a lifetime prevalence of 69% in men and 88% in women [25]. Lower than the lifetime 
prevalence, its one-year prevalence has been estimated at 63% in men and 86% in 
women respectively [25]. 
 
TTH may start in childhood [36]. Studies identified TTH affects approximately 10% [77] to 
15% [152] boys and girls. An equal prevalence in both sexes was identified in 
schoolchildren [153]. Again, like the population-based studies in adults, the prevalence of 
TTH in adolescence varies according to studies from 9%-72 % [154, 155]. However, it is 
rather uniformed that a female predominance was observed in later in adolescence [156, 
157].  
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2.4.3  Geographical region and race 
TTH has been observed has a lower prevalence in Asia countries than in western countries 
[24, 29, 139, 147]. According to one recent study, the prevalence of TTH appears much 
higher in Europe as 80% than that in Asia (5%) or Americas (20-30%), however the data 
from Africa and Australia are lacking [23]. 
 
Studies examining the prevalence of TTH by race are somewhat relatively rare. A 
US-based study demonstrated a higher prevalence of TTH among Caucasians than 
African-Americans. Both ETTH (Caucasians: female 46.8% and male 40.1% versus 
African-Americans: female 30.9% and male 22.8%) and CTTH (Caucasians: female 3.0% 
and male 1.6% versus African-Americans: female 2.2% and male 1.0%) were consistent 
that males were marginally less affected from TTH than females. 
 
2.4.4  Socioeconomic and education level  
A population-based study investigated the epidemiology of TTH from 13345 community 
members in Maryland of the USA and observed the prevalence of ETTH increased with 
socioeconomic level [24]. It was more prevalent with higher levels of education [24]. In 
contrast, for CTTH, increased risk in less-educated groups or population with lower income 
were observed [24, 158, 159].  
 
2.4.5  Prognosis 
The prognosis of TTH has scarcely been considered in longitudinal epidemiologic designs, 
and there is limit analysis on it [5]. One 10-year clinical follow-up study observed that 75% 
of ETTH patients remain to be episodic but 25% had developed into the chronic variety. 
For those who with CTTH at their initial consultation, 31% continued to be chronic and 21% 
evolved into medication overuse. Interestingly, the remaining 48%, with or without 
prophylactic treatment, had reversed to the episodic type [160]. In addition, confirmed by 
an early cross-sectional clinical study, majority of the CTTH patients were progressed from 
the episodic TTH during a period of many years [161]. This finding turned to supported 
that patients with frequent episodes of headache are at risk for suffering from chronic and 
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treatment-resistant forms of TTH [5, 162-164]. In addition, psychiatric comorbidities of 
depression, anxiety, and medication overuse are often the particular predictors for a poor 
outcome [5]. 
 
2.4.6  Impact of TTH 
TTH has significant impact on the quality of life of the individual sufferers and also been 
associated with a large socioeconomic impact on the society [24, 25, 165]. Because of its 
high prevalence, there is no surprise that TTH is also the most socioeconomically costly 
than any other type of headache in the modern society [5, 24, 25, 48]. Due to its 
associated large proportion of decreased work effectiveness [166], it cause a 
socioeconomic burden [149]. 
 
Broadly, costs result from its socioeconomic impact may include direct costs, indirect costs 
and intangible costs [5]. The direct costs may include medical costs and its relevant costs 
of social services whereas the indirect costs may related to the lost production in the 
economy, and the intangible costs may relate to the reduced quality of life [5].  
 
A US study reported 8% of ETTH patients missed work and 44% diminished effectiveness 
at home work, or school due to TTH. In addition, CTTH patient lose more days from work 
and have more days or reduced effectiveness than ETTH patients [166, 167]. TTH is also 
accounted for sickness absence. In the general Danish population, 12% of TTH had missed 
one day or more work days in the previous year due to their headache. Among all 
employed adults, 9% of the employed population had been absent because of the TTH 
[166]. 
 
This worldwide population based study concluded the disability attributable to TTH is 
estimated larger than that of migraine [23]. One study from the US identified a high 
number of workdays lost were caused by both CTTH and ETTH [24], whereas one Danish 
study concluded TTH had three times higher workdays lost than migraine [166]. TTH is 
responsible for more loss of annual workdays than migraine, with 820 days of lost work 
days yearly per 1000 employees as a result of TTH versus 270 days per 1000 employees 
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on account of migraine [56]. Nevertheless, TTH has an even greater impact for those who 
remain at work with reduced productivity.  
 
The infrequent TTH may not regarded as a burden for either the individual or for society 
however CTTH is definitely a disease with a major impact on the individual [142]. In one 
study examined 245 TTH patients, anxiety and depression were detected in nearly a half 
of them, which were regarded to be contributed to their degree of impairment as well as 
to the severity of the pain itself. In addition, although a majority (74%) experienced days 
of disability with a mean of 7 days each in the past 6 months, most patients with CTTH 
persisted in carrying out their daily responsibilities at work [57]. One study has also 
demonstrated that CTTH had a negative effect on the emotional life of the affected 
patients as CTTH patients were seven times more likely than control who were classified as 
impaired on all of the subscale of quality-of-life instruments [57]. 
 
The individual impact of TTH may include physical suffering, loss of quality of life, and 
economic [5]. However, less than 15% TTH sufferers seek medical consultation whereas 
most TTH sufferers do not [168]. Although the direct costs caused by medical services and 
medications are rarely analysed, TTH lead to an overall cumulative and significant 
socioeconomic impact [5, 24, 56, 167, 169]. 
 
In summary, TTH is a common headache but a significant cause of distress and disruption 
to people‟s life [2]. It is clearly have a negative impact on the emotional life of its sufferers 
and resulting in marked reductions in quality of life and frequency of social and family 
activities [3]. 
 
 
2.5  Pathophysiology of TTH  
The exact aetiology and pathophysiological mechanisms of TTH remains unclear and have 
not been fully elucidated [4]. However, the formerly believed mechanism of muscle 
contraction has been argued as a consequence of tension headache rather than its cause 
[170, 171]. To date, the existing hypotheses of TTH mechanisms cover genetic 
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predisposition, psychological factors, peripheral factors, and central factors. 
Stress-related or cervical or cranial musculoskeletal abnormality may be associated with 
TTH. The increased pericranial tenderness on manual palpation is the most significant 
abnormal finding in TTH patients [31]. The issue that whether the pain of TTH originates 
from myofascial tissues or central mechanisms in the brain has been debated for decades 
[61, 172]. In TTH pathophysiology, it is likely that both peripheral and central factors play 
a major role [61, 162]. Peripheral pain mechanisms are thought playing a role in 
infrequent ETTH and frequent ETTH; whereas central dys-inhibition becomes predominant 
in CTTH [18, 28]. 
 
2.5.1  Genetic predisposition 
Due to the high prevalence of ETTH cause a positive family history simply by chance in 
most families, genetic epidemiological survey is not likely to elucidate the importance of 
genetic and environmental factors in the frequent subtypes of TTH [173]. In addition, the 
current understanding of ETTH is that that it is a heterogeneous headache disorder but its 
genetic factor is not clear. It may not have a genetic component, or it may also be caused 
by multiple genes in combination with environmental factors [174]. Nonetheless, the view 
that the great majority of the population may have the potential to develop TTH when 
exposed to sufficiently strong environmental factors has been generally adopted [175, 
176]. 
 
CTTH has not been thought to be genetically determined and been considered to be an 
inherited disorder previously, and the relative risk of CTTH in relatives has been examined 
in genetic epidemiologic studies [174, 177, 178]. By comparing the relative risk in 
relatives of CTTH group with that of a normal population, one family study demonstrated 
that the risk of the first degree relative increased by more than three folds [178]. In 
addition, an increased occurrence of CTTH in the first and second degrees relatives was 
identified. However, by contrast, spouses had no increased risk of CTTH. The finding that 
the significantly increased familial risk while no increased risk in spouses indicated that a 
strong component of genetic predisposition, rather than environmental factors, was 
involved in CTTH [177]. The observed transmission indicated complex inheritance of CTTH 
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[174] and therefore support the importance of genetic factors in CTTH [173].  
 
2.5.2  Psychological Factors 
Despite psychological stress and mental tension may not be the cause of TTH, they are the 
most frequently reported precipitating factors of TTH [62, 66, 77]. A positive correlation 
between TTH and stress has been shown and [179] behavioural and psychological 
therapies have demonstrated to be effective in treating TTH [165].  
 
In CTTH patients, anxiety and depression were implied to contribute to increased 
excitability in central nociceptive pathways [138, 179]. Stress has the similar effect on the 
central pain pathway [180]. These findings are in correspondence with the findings from a 
review, which concluded that patients with frequent TTH is associated with higher 
frequency of negative affective status of depression and anxiety, whereas those patients 
with infrequent/episodic TTH has been observed with a broad range of normal personality 
profiles with no increased anxiety or depression [136]. In addition to anxiety and 
depression [172], some other common psychologic factors such as, psychologic stress 
[181], suppressed anger [68] and feelings of inadequacy [182] are likely comorbid with 
CTTH [41, 172]. Therefore, apart from recognized as a sensory event, TTH is also 
regarded to be a cognitive, affective and behavioural event [36]. 
 
2.5.3  Peripheral Factors 
TTH is previously known as muscle contraction headache. Indicated by this name, for 
decades, it is widely accepted that development of the pain of TTH has long been 
attributed to increased contraction, and ischemia of pericranial and cervical muscle [61, 
73]. Although TTH sufferers are founded to develop more pain in the neck and shoulder 
and during or after static exercise than general healthy population do [183], 
electromyographic (EMG) studies using surface electrodes demonstrated that muscle 
activity is normal or only slightly increased in TTH [61]. However, the EMG activity was 
increased in trigger points significantly [184]. In addition, muscle lactate levels are 
demonstrated to be normal during static muscle exercise in patients with CTTH. As a result, 
all these findings reject that muscle ischemia is a main cause of TTH [185]. 
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Increased tenderness and hardness of pericranial myofascial tissues has been observed in 
both ETTH and CTTH patients [61, 179, 186], with the tenderness being founded to be 
uniformly increased through the pericranial region [61, 187, 188]. Pericranial tenderness 
positively correlates with muscle hardness [189], and with both intensity and frequency of 
TTH [75, 190]. However, it is likely not to be a consequence of headache only, as the 
increasing of tenderness and hardness is not only observed to be increased on days with 
headache, but also on days without headache [175].  
 
It is possible contracted muscles activate or even sensitise peripheral myofascial 
nociceptors, which in turn increase pain sensitivity in TTH. However the mechanism of 
peripheral nociceptor activation by a contracture are yet to be studied in detail [175, 176, 
191]. 
 
2.5.4  Central Factors  
More recently, central factors as one of the mechanisms has been found to play a crucial 
role in TTH, particularly in the more severe forms of TTH [192]. The increased myofascial 
pain sensitivity of TTH could be caused by central factors [175]. The measurement of pain 
sensitivity to different types of stimulus has provided significant information about the 
nociceptive system in TTH [175] and studies of pain thresholds in TTH patients uncovered 
differences between ETTH and CTTH [179]. 
 
Pressure-pain threshold (PPT) measured at the site of headache and in pericranial sites 
(forehead, temple, and occipital region) have been found to be different between ETTH 
patients and CTTH patients [179]. In patients with ETTH, PPT was not different from the 
health control [75, 193]. However in CTTH patients, hypersensitivity to various stimuli 
applied in cephalic and extracephalic regions has been observed [73, 162], including 
pressure [194-196], thermal [194] and electrical [196-199] stimuli and also 
intramuscular infusions of painful substances [200]. Sensitivity to these stimulus 
modalities is increased from the areas at both cephalic and extracephalic locations, to 
non-symptomatic locations, i.e., stimulation of various tissues such as muscle, skin, 
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tendons, and peripheral nerves [175, 194-198, 200]. Data from these studies suggest 
central sensitisation in patients with CTTH, i.e., increased excitability of neurons in the 
central nervous system (CNS) [179]. Central sensitisation, a commonly used term used to 
denotes amplification of neural signaling within the CNS that elicits pain hypersensitivity 
[201, 202].  
 
The expansion of hypersensitivity to other tissues is consistent with referred hyperalgesia 
[175], which could be caused by prolonged nociceptive input from tender pericranial 
myofascial tissues resulting in the central nervous system segmentally sensitised at the 
level of the upper cervical spinal dorsal horn/trigeminal nucleus [176].  
 
Pressure-pain tolerance threshold is found to be a better correlate to clinical pain rather 
than PPT [195]. Pain perception studies using such measurement demonstrated 
pronounced generalised hyperalgesia in CTTH patients [196, 198]. Furthermore, the 
increased myofascial tenderness in patients with CTTH is more pronounced than the 
increase in general pain sensitivity [162]. General hypersensitivity could thus explain only 
a minor part of the increased pericranial tenderness [179], indicating other factors may be 
involved. Amitriptyline, an anti-depressant has been shown to reduce central sensitisation 
can reduced the increased tenderness in patients with chronic TTH [163, 203], and this 
supports the hypothesis of central sensitisation in TTH.  
 
In recent years, the role of Nitric oxide (NO) in the pathogenesis of TTH has been assessed 
[51]. It plays an important role in the pathophysiology of CTTH [204] and sensitisation of 
pain pathways is associated with activation of nitric oxide synthase (NOS) [176]. It 
contributes to central sensitisation at various levels of medullary dorsal horn, trigeminal 
nucleus caudalis, and even periacqueductal gray matter [205, 206].  
 
One double-blind, placebo-controlled crossover study found that muscle hardness and 
pericranial myofascial tenderness, as well as the headache intensity reduced significantly 
after treatment with an NOS inhibitor, the NG-monomethyl-L-arginine hydrochloride 
(L-NMMA) [207]. In contrast, no significant reductions after treatment with placebo were 
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observed [164, 207]. Another experimental study found that glyceryl trinitrate, a donor of 
NO, induced a typical headache and caused more headache in patients with CTTH than in 
healthy controls [208]. In addition, an increased platelet NOS activity, which could 
possibly reflecting central upregulation of NOS, was observed in CTTH patients [209]. 
These findings from pharmacologic studies strongly support that NO-related central 
sensitisation may be an important factor in the underlying pathophysiology [208, 210]. 
  
Collectively, a number of studies demonstrated central pain modulation is abnormal in 
CTTH and it is most likely that central sensitisation may plays a pivotal role in the 
pathophysiology of CTTH [179], and as well for the chronification of TTH [175].  
 
 
2.6  Management  
TTH is one of the most prevalent headache disorders. However, The treatment strategies 
for TTH remain unspecific because the mechanisms underlying this prevalent disorder are 
unknown [5].  
 
The treatment goals for TTH are to use effective analgesic agents in relieving any current 
pain and identifying and ameliorating any circumstances that may trigger the headaches 
[211]. In a broad level, treatment of TTH may involve pharmacotherapeutic agents and 
alternative approaches. Pharmacotherapy is the principal mode of treatment in relieving 
headaches [60] which includes symptomatic relieve for acute treatment and prophylactic 
medications to prevent the chronic form of TTH [212]. However medications are 
associated with medication-over use headache and dangerous side-effects [6]. 
 
A majority (60%) of patients with severe headaches do not seek consultation but treat 
themselves with over-the-counter medications [213]. It is estimated that 80% 
over-the-counter analgesic were purchased by headache patients. However, this 
accounted for 2,000 to 7,000 deaths annually, which mainly due to gastrointestinal 
bleeding [214]. Although many patients get relief with such analgesic, others may 
experience a marked reduction in function and quality of life [3]. These drugs are often 
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combined caffeine with sedatives, excessive and frequent use of them may be associated 
with a high risk of MOH [204]. Moreover, those medications are associated with severe 
side-effects such as gastrointestinal toxicity, renal toxicity, and hepatotoxicity [3]. 
 
2.6.1  Acute pharmacotherapy 
In the acute treatment of TTH, simple analgesics and nonsteroidal inflammatory drugs 
(NSAIDs) are the mainstay, which has been widely accepted and are reported to produce 
a significant effect [47, 204]. However, daily use of acute treatments for TTH is highly 
discouraged due to the risk of developing medication-overuse headache. Analgesic 
overuse increases the frequency of TTH and render it refractory to treatment [215]. 
Therefore, no more than f two or three days per week of acute treatment is recommended 
[51, 74].  
 
2.6.1.1  Simple analgesics 
Aspirin and acetaminophen are the most widely used analgesics in the treatment of an 
acute episode of TTH [216] and have been proved by several randomized controlled trials 
[217-223]. One randomised, parallel, double-blind study compared the effect of 
acetaminophen with aspirin and placebo concluded that the acetaminophen had better 
effect than placebo but no significantly differed from aspirin [219].  
 
Although acetaminophen and aspirin are both effective in the treatment of mild or 
moderate episodes, acetaminophen is recommended as the first choice among analgesics 
and then by NSAIDs [224], due to the gastrointestinal safety profile of acetaminophen.  
 
2.6.1.2  NSAIDs 
NSAIDs, such as ibuprofen and naproxen sodium is another group of drugs used as a 
non-specific acute pharmacotherapy of TTH, and have the best evidence in treating acute 
episodes of TTH [32, 216].  
 
NSAIDs are recommended for moderate or severe episodes of TTH [216] as they are more 
effective than acetaminophen as more potent acute treatment of TTH [51]. One study has 
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demonstrated that 400 mg ibuprofen was more effective than 1000mg acetaminophen 
[225]; and another study observed 200 mg ibuprofen was more effective than 500 mg 
aspirin [221]. Naproxen is another commonly used NSAID; and its efficacy has been 
evaluated in a series comparative randomised controlled trials [226-228]. Although 375 
mg naproxen was found to be more effective than placebo, it is not better than 1000 mg 
acetaminophen [226]. Nevertheless, naproxen sodium 550 mg with rapidly absorbed 
formulation has been shown more effective than acetaminophen 650 mg [227]. 
 
2.6.1.3  Combination analgesics 
Apart from the simple analgesics and NSAIDs, the combinations of simple analgesics with 
caffeine or codeine are also widely used in treating acute episodes of TTH [216]. 
Combination of aspirin 1000 mg with caffeine 64 mg was observed more effective than 
acetaminophen 1000 mg alone in a double-blind placebo-controlled trial [225]. In addition, 
combination of ibuprofen 400 mg and caffeine 200 mg produced more efficacy than 
ibuprofen 400 mg or caffeine 200 mg alone did [229]. Another study compared the 
efficacy of two analgesic combinations, with one containing caffeine 130 mg, 
acetaminophen 500 mg and aspirin 500 mg, and tho other  caffeine 130 mg and 
acetaminophen 1000 mg [230]. Results of this study indicated that both combinations 
were more effective than acetaminophen 1000 mg alone or placebo. 
 
Codeine is another compound that used to combine into formulations containing aspirin or 
acetaminophen [231]. Combination analgesic involved such opioid analgesic has been 
reported to be better than placebo in relieving pain of TH with an average of six attacks per 
month [232].  
 
However, the potential of habituation, subsequent MOH and even development of 
dependency to caffeine, butalbital, or codeine [204, 231], have led to the 
recommendation of avoiding or cautiously using combined drugs consisting of analgesics, 
tranquillizers and sedatives [204].  
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2.6.1.4  Triptans and muscle relaxants 
Triptans, serotonin (5-hydroxytryptamine, 5-HT) agonists, are migraine-specific agents. 
They have also been observed to be useful for TTH that occurs in people with migraine. 
One study reported subcutaneous administration of 6 mg sumatriptan was effective in TTH 
patients coexisting migraine. Meanwhile, in this study, Triptans are also effective in the 
treatment of CTTH. It has also been observed that subcutaneous injections of 2-4 mg 
sumatriptan reduced headache significantly better than placebo did in patients with CTTH 
[233]. However, Triptans have no effect for pure TTH. The oral formulation of sumatriptan 
100 mg was identified not effective in relieving ETTH [234]. 
 
The use of muscle relaxants is largely on an empirical basis, and the results varied [231]. 
Tizanidine was reported to be effective in reducing headache intensity in one study [235] 
but the results could not be replicated in another study [236]. There is no evidence that 
muscle relaxant therapies are effective for TTH in general [74], or ETTH [237]. Therefore, 
due to the risk of habituation of most available muscle relaxants and insufficient studies 
[231, 238], it is recommended that muscle relaxants should be used neither in acute nor 
in CTTH [41]. 
 
2.6.2  Prophylactic pharmacotherapy 
Prophylactic pharmacotherapy of TTH is generally advised and considered for patients 
with CTTH, i.e., those who experience at least 2 to 3 days each week or headache on more 
than 15 days per month [47, 239]. The goals of treatment for CTTH patients are to initiate 
effective prophylactic treatment, and to manage their headaches while preventing 
frequent use of analgesics so as to reduce the risk for progression to chronic daily 
headache syndrome [211]. Part of preventive strategies is to limit the  use of sedatives, 
minor tranquilizers, antidepressants, and muscle-relaxant agents [240].  
 
2.6.2.1  Tricyclic Antidepressants 
Tricyclic antidepressants are the primary drug of choice of CTTH [86] as its analgesic 
actions may be beneficial for headache relief although the CTTH sufferers may not be 
depressed. Amitriptyline, one of the tricyclic antidepressants, is effective in CTTH [241] 
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and also the most widely used agents for CTTH prophylactic management [211]. The 
typical dose of amitriptyline is between 10 to 75 mg and its efficacy in CTTH patients has 
been confirmed by double-blind RCTs [242] However, it is not effect for episodic TTH 
management [241].  
 
For decades, some other tricyclic antidepressants, such as clomipramine, nortriptyline, 
mianserin, have also been evaluated for the TTH prophylaxis [104, 203, 241, 243-250]. 
However, not all of them have been found to have superior efficacy to placebo due to their 
drawbacks of small sample size, inadequate efficacy parameters, short duration of 
observation, or inadequate in abiding IHS trial guidelines [86]. Clomipramine may be 
slightly superior but has more side-effects whereas nortriptyline has fewer side-effects. 
Mianserin, like some other antidepressants, such as doxepin and maprotiline, can be used 
as a second choice for CTTH or frequent ETTH [86]. 
 
Despite the mechanism of action of tricyclics in TTH is unclear, a minimum duration of 6 
weeks therapeutic trial plus a follow-up 3 months maintenance was suggested in order to 
considering the efficiency of treatment [144]. Afterwards, a slow taper could be then 
considered [239]. However, the usefulness of tricyclic antidepressants is limited due to its 
anticholinergic related side-effects, such as dry mouth, blurred vision, orthostasis, and 
weight gain [211]. In addition, its toxicity, which can include seizures, syncope and even 
death by arrhythmia, lead to the cautious use of tricyclic antidepressants in the elderly, 
hypotensive, epileptic, and closed-angle glaucoma patients [51]. 
 
2.6.2.2  Selective serotonin reuptake inhibitors  
Although selective serotonin reuptake inhibitors (SSRIs) cause fewer side-effects, clinical 
trials in evaluating the efficacy of SSRIs for the prophylactic treatment of TTH have not 
provided convincingly evidence in proving its effectiveness for prevention of TTH [51]. Due 
to the significant effect is lacking in non-depressed patients, the SSRIs are not of decisive 
importance [41]. Despite SSRIs are questioned to be ineffective for TTH [51], several of 
SSRIs agents such as paroxetine, venlafaxine, and fluoxetine, have shown their efficacy in 
the prophylaxis of CTTH in small studies [211]. In summary, as TTH and depression often 
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coexist, the effect of SSRIs nevertheless appear to be favourable in TTH patients who 
coexisting depression [41]. 
 
2.6.3  Nonpharmacological therapies 
Pharmacotherapy is the most widely used method for TTH management, however it is 
associated with MOH and dangerous side-effects [6], such as risk of toxicity lead to  
kidney and liver problems. As generally advised, other nonpharmacological therapies, 
such as psychological managements, physical treatments, and manipulative treatments 
should be always considered for the management of TTH. 
 
2.6.3.1  Psychological managements 
Relief of the immediate headache attack and resolution of the underlying emotional 
conflicts are the two primary modes of treatment in the management of TTH [60]. 
Psychological view of headache onset is associated with psychological factors and believed 
that patients will continue to have TTH periodically or constantly if the psychological 
factors are not identified and addressed [60].  
 
Psychological treatment strategies have been used extensively in the treatment of TTH 
and showed promising results [251]. While pharmacotherapy relieves the immediate 
headache attack of TTH, psychological treatment helps TTH sufferers identify and address 
underlying psychological factors such as emotional conflicts, cope more effectively with 
the environmental and emotional situations that induce the stress and tension, and 
ultimately resolve underlying emotional conflicts [60]. Biofeedback training, relaxation 
training and cognitive behaviour therapy (CBT) are three main categories of psychological 
treatment for headaches [72]. 
 
Biofeedback training 
Biofeedback training is established to address the peripheral physiological mechanisms of 
TTH which is regarded to be muscular. EMG techniques are often involved in biofeedback 
training [252] by attaching electrodes or transducers to patients‟ scalp, face, or neck 
region to register the amount of muscle activity occurring, and the patients were 
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monitored the treatment process and provided feedbacks, in either form of auditory or 
visual [72, 212]. Patients are entailed to learn to recognise and control their underlying 
muscle tension through guided exercise and thus they are encouraged to use this skill to 
prevent and relieve the headache [212, 253]. 
 
Relaxation training 
Biofeedback training is often combined with relaxation training, which may include 
diaphragmatic breathing, visual imagery, meditation, prayer, yoga, self-hypnosis, and 
other methods of calming the mind and body [254, 255]. These techniques however 
require regular practice to become effective habitual responses, thus could help patients 
minimize their physiologic response to stress, decrease sympathetic arousal, and engage 
the parasympathetic nervous system [255]. In many forms of relaxations training, 
patients are usually provided an audiotape or audio-CD and instructed to practice 
themselves at home. Progressive relaxation, one of the most commonly used form of 
relaxation training, aims to help patients learn to recognize and control tension as it arises 
in the course of daily activities. Patients are instructed to sequentially tense and then 
release specific groups of muscles throughout the body, and notice how tension feels 
relative to relaxation [72]. 
 
Cognitive behaviour therapy (CBT) 
Physiologically, stress can effect pain throughout the CNS and releases epinephrine at the 
periphery [256, 257]. In the circumstances that the released epinephrine can aggravate 
sensitised nociceptors, nociceptive input from the periphery may activate the stress 
system conversely [256, 258]. Although the mechanisms that stress contributes to TTH 
are not clearly understood [257], daily stress correlates with its frequency of headache 
episodes [69]. CBT teaches patients to identify their thoughts that may generate stress or 
aggravate their headaches, and employ effective strategies for coping with these stressors 
[257, 259]. 
 
CBT focuses on examining the relationships between thoughts, feelings and behaviours of 
patients [260]. It may take different forms as some advocating a „standard package‟ of a 
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range of techniques [259] while some others supporting a broader more individualized 
approach based on the results of a functional analysis [261]. Although the advice that the 
best way to prevent headaches is to avoid the triggers [262], it is argued that avoidance 
can result in sensitisation to triggers and may eventually elicit anxiety in the future [263] 
Therefore, when exposure would clearly considered to be inappropriate, a „coping‟ 
approach to triggers, which involves controlled exposure for some triggers to promote 
desensitisation to the to promote desensitisation to the trigger, and avoidance of triggers, 
is recommended [72]. 
 
CBT could help patients cope more effectively with pain and distress alone with headache 
episodes[257] and may also provide additional benefit in patients with significant 
depression, anxiety, panic disorder, obsessive-compulsive disorder, eating disorders, 
sleep disorders, and other common comorbidities in patients with headache [74, 255]. The 
strategies help them understand the thoughts and beliefs that influence their behaviours 
that lead to self-destructive actions; limit negative psychologic consequences (e.g., 
depression and disability) of recurrent headaches; and pertain to the antecedents and 
consequences of headaches [72, 257]. Thus CBT can be used to explore and direct 
patients‟ patterns of thinking that give rise to stress and negative emotions so as to 
improve coping.  
 
CBT may not only help reduce headache but also prevent its recurrence [72]. One review 
concluded that CBT showed its long term effects for TTH sufferers, by maintaining its 
benefits at 2-year follow-up [264]. Another individual study evaluated CBT using an 
individualized approach which based on the results of functional analysis on TTH and 
migraine sufferers, and reported an average decrease in headaches of 68% 
post-treatment, which had extended to 77% at 12-month follow-up [265]. 
 
Based on the treatment efficacy, CBT could be most useful when administered in 
conjunction with relaxation interventions others such as biofeedback or relaxation 
therapies in patients with higher levels of daily hassles [253], as the techniques focus on 
the underlying stress issues as well as the muscle relaxation training [266]. In addition, 
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for patients with CTTH, it is also recommended that the combination of stress 
management therapies with drug therapies might produce better results than either 
treatment alone [86, 251, 267, 268].  
 
2.6.3.2  Physical treatments 
Physical treatments include acupuncture, ergonomic instruction, massage, 
transcutaneous electrical nerve stimulation, the application of heat or cold [86, 269]. 
Acupuncture will be discussed in details in latter section of this chapter.  
 
Although physical treatment can be used in relieving acute TTH episodes, they produce 
little in the way of positive long-term benefits [212]. Moreover, none of them has been 
proved as effective in the long term. One study demonstrated that physical therapy 
reduced average intensity of TTH by only 23% [270]. One physical treatment programme 
combined various techniques of massage, relaxation, and home-based exercises, showed 
a modest effect among, but only in chronic but not episodic TTH [271]. Another review 
concluded that physical therapy is more effective than massage therapy for the treatment 
of TTH and appears to be most beneficial for patients with a high frequency of headache 
episodes [269]. However, in that review, due to the published case series and controlled 
studies are of low quality, the author concluded the these treatments could not able to 
establish their efficacy in reducing headache frequency, intensity, duration, and disability 
in many commonly encountered clinical situations. 
 
2.6.3.3  Manipulative treatments 
Manipulative treatments consist of spinal manipulation and mobilisation that performed by 
a physiotherapist, chiropractor or osteopathic physician. Although passive physical 
manipulation and active cervical muscle stretching or exercise programs are often advised 
for TTH [74, 271], the results of manual therapies are however mixed, with some studies 
reporting significant benefit while others claiming little effectiveness [212]. Although 
chiropractic manipulation demonstrated a trend toward benefit in the management of TTH, 
its evidence is weak [269]. To date, a systematic review of randomised clinical trials 
concludes that there is insufficient evidence to support or refute the effectiveness of 
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manual therapies in patients with TTH [272]. 
 
 
2.7  Measurement 
Measurement of headache is essential to gauge treatment efficacy [273]. In monitor the 
response to treatment of headache trials or in practice, frequency, intensity and duration 
are commonly used as outcome measures [273-278]. Although it could not be realistic or 
possible, abolition of the headache could be expected to be the ultimate aim of treatment 
[273].  
 
However, patient expectations may differ from practitioners. In one study, despite the 
majority (66%) physicians indicated that they believed pain relief was the patient‟s 
primary objective, patients may not have the same desire. Only one thirds (31%) of 
patients indicated that pain relief was their main expectation, and nearly a half (46%) of 
them expected an explanation of what was causing their headache [279]. Hence, 
awareness of these expectations plus accurate headache measurement may contribute to 
a better and satisfactory treatment outcome. 
 
Measurement of headache is largely reliant on patient descriptions, as headaches are 
subjective experience. Since pain is a complex and multidimensional, accurate and 
complete measurements of headache need to reflect sensory, affective and motivational 
domains. In clinical settings, measurement of headache is usually by patient retrospective 
report to interview, questionnaires, or headache diaries [275].  
 
2.7.1  Measurement of headache  
Measurement of headache pain can be grouped into three broad types: intensity, 
frequency and duration and pain quality. The intensity of headache can be assessed by 
using verbal rating scales (VRS), numerical rating scales (NRS) or a Visual analogue scales 
(VAS), whereas the quality of headache can be measured by using the McGill Pain 
Questionnaire (MPQ) [280]. Thus, information of headache frequency and duration can be 
obtained by asking patients how many days in headache they experience in a week and 
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how long does it lasts for each attack.  
 
In ICHD-II, headache diaries are recommended and appear to be the „gold standard‟ for 
data collection in clinical situation [273]. For patients with CTTH, the approach to 
prophylaxis largely relies on keeping a diary of headaches, which has a great capacity for 
keeping records of very detailed information including triggers that may aggravate 
headaches, record of headache intensity, and the use of medication [32]. Due to the 
different purpose of studies and the population being studied, the content of headache 
diary may vary, from the headache intensity to medication consumption, or to their 
regular diet and activities [273]. Diaries have traditionally kept in forms of either cards or 
booklets. Headache patients are instructed to record the number of hours of headache 
based on the change of their headaches during the day that they had a headache. All such 
information recoded in the headache diaries may be used to evaluate treatment efficacy 
and track treatment progresses.  
 
Questionnaires and scales are particularly useful for assessing setting factors [72]. A 
number of instruments have been developed for measuring pain and hence headache 
intensity, disability and quality of life in headache sufferers. Assessing the reliability and 
specificity of questionnaires and outcome measure helps the evaluating of therapeutics.  
 
2.7.1.1  Verbal rating scales (VRS) 
VRS usually consists of a series of pain description such as „none‟, „mild‟, „moderate‟, 
„severe‟, which made the assessment easy to understand and to record. or each descriptor 
may be assigned with a numerical value. Although VRS is usually easy to understand, they 
may be relatively insensitive [273]. However in data analysis, the numerical values cannot 
be assumed that there are equal spacing between ratings and hence they do not 
necessarily provide interval or ratio data. For example, when the value meaning a rating 
of 10, it does not indicate the pain doubles intense as a rating of five.  
 
2.7.1.2  Numerical rating scales (NRS) 
NRS normally is a defined scale with numerical values, for example, four-grade scale, from 
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0 to 4 corresponds to no headache, mild pain, moderate pain and severe pain and patients 
are required to rate their pain on it. There are many variations of NRS, such as 11 point 
(0–10), 21 point (0–20) and 101 point (0–100) [281]. Both 11 point and 21 point scales 
were sensitive enough to measure chronic pain [282], and the 11 point scale was observed 
to be 55% more sensitive than a 4 point scale in detecting clinically importance difference 
when measuring intensity of migraine [283]. In administration of the 11 point (0–10), 
patients are instructed to choose a number from 0 to 10 that best describes their current 
pain, in which 0 would mean „No pain‟ and 10 would mean „Worst possible pain‟. The 
cut-off points of its responses clustered into three ranges: 0 for no pain, 1–4 for mild pain, 
5–6 for moderate pain, and 7–10 for severe pain [284-286]. One of the advantages of NRS 
is that the scale can be administered verbally. However, like the VRS, these types of scale 
do not provide interval or ratio data. Therefore, analysis of group data of such scales 
should be performed using non-parametric techniques [273]. 
 
2.7.1.3  Visual analogue scales (VAS) 
VAS is another most frequently used measurement to pain intensity which requires the 
patient to rate their pain severity on a defined scale. In administration of the VAS, patients 
are instructed to point to the position on the line between the faces to indicate how much 
pain they are currently feeling. Usually, a 10 cm line anchored by “no pain” at the far left 
and “pain as bad as it could be” at the far left end. Sometime it was assigned with a 
numerical value to each descriptor, where 0 is no pain and 10 is the worst pain imaginable. 
Both VRS and VAS are the most frequently used measurements. Comparing to the VRS, 
VAS is recognised to be more sensitive and reflecting a more precisely changes in pain 
intensity [287, 288]. VAS also has the advantage in understanding and quick 
administration. Among the VRS, NRS and VAS, VAS has been observed highly correlating 
with VRS and NRS. However, it appears to be more reliable in measuring current pain than 
remembered pains [273]. In addition, it is thought to produce ratio data when applied for 
group measurement [281, 289]. 
 
2.7.1.4  McGill Pain Questionnaire (MPQ) 
The MPQ [280], which was developed by Melzack and colleagues, is designed to access 
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components that reflecting the sensory, affective, and evaluative dimensions of pain. It 
contains 78 pain descriptors using adjective in 20 categories. Scoring of MPQ is using a 
Pain Rating Index (PRI) for each subclass and a total PRI. The MPQ is a valuable tool which 
has been widely used for research investigation. Reliability and validity of MPQ have been 
tested extensively in both acute and chronic pain [290-294]. Completing MPQ may take 
about 5-10 minutes for those who has some experiences with it and 15-20 minutes if a 
patient is unfamiliar with it [280]. Due to its time consuming and complex scoring system, 
the MPQ has been used widely for research but less applied in clinical practice [273]. 
 
2.7.2  Measurement of health-related quality of life (HRQoL) and 
headache-related disability 
Headache disorders are often accompanied with a series of symptoms [295] and 
reductions in functioning and in quality of life [296]. Although such disorder is among the 
most common pain complaints seen by physicians, however, the measurement of 
health-related quality of life (HRQoL) in headache patients is in its earliest stages [297, 
298]. In addition, studies that relevant to such part of measures are however sparse on 
TTH, but to include all types of headaches and have been mostly focused on migraine and 
chronic daily headache [296]. These studies indicated that migraine extensively impairs 
people‟s functions in different activity domains during attacks and diminishes HRQoL 
[255]. In terms of the measuring of HRQoL in headache sufferers, there are two types of 
questionnaire have been used: general and disease-specific instruments. 
 
The General quality-of-life (QoL) instruments measure QoL with respect to a number of 
activities within physical, social, psychological, and behavioral life domains by useding 
scales [297]. For example, the 36-Short-Form Health Surveys (SF-36), which is the 
standard measure of QoL in headache, remains to be one of the most widely used generic 
measures of HRQoL [255, 297, 299]. SF-36 assesses a range of symptoms and function 
associated with common diseases and consists of eight scales which provides measures on 
physical functioning, role disability due to physical problem, bodily pain, general health, 
vitality, social functioning, role disability due to emotional problems, and mental health 
[295]. Such quality of life scales have administered by a number of studies to headache 
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sufferers in different countries [299-301]. One study using SF-36 generic QoL instruments 
demonstrated that chronic headache disorders were associated with significant limitations 
in all eight health domains of patient wellbeing and functioning [297]. 
 
Studies has shown that headache suffers have decreased quality of life [302-304]. 
Therefore it is important to measure the impact of headache on patient‟s quality of life, in 
both during and between the headache attacks [273]. Over the past two decades, several 
instruments have been developed in quantifying the disability related to headache. Rather 
than the generic QoL assessment tool listed above. The more recently developed 
disease-specific instruments, for example, the migraine disability assessment (MIDAS) 
and the headache impact test (HIT) [305], are designed to assess disability rather than 
quality of life per se. 
 
2.7.2.1  Headache Impact Questionnaire (HImQ)   
In 1998, an international, expert working group proposed a questionnaire to assesses the 
effects of migraine on quality of life as well as absence from work and reduced productivity 
[306]. The HImQ is a 16-item questionnaire, which assessing headache frequency, pain 
intensity and disability, the latter measured as total lost time in employment, household 
work and non-work activities and has been widely used in clinical research. Despite the 
HImQ has been proven to be an excellent tool for research and being of scientific reliability 
and validity [306, 307], it is relatively complex to score, requiring mathematical equations, 
and not intuitive to use due to it was based on a composite of pain, frequency and 
disability measures [308]. Therefore, the HImQ is not suitable in applying in primary care 
[308]. 
 
2.7.2.2  Migraine Disability Assessment (MIDAS) 
The MIDAS questionnaire [309] is the most trusted and commonly used questioner 
developed to assess headache related disabilities in clinical practice. It was designed by 
Stewart and Lipton based on their HImQ [306]. Due to its scoring difficulties, HImQ was 
subsequently reduced to five questions and became MIDAS. MIDAS was initially designed 
for the migraine population, and it is now also used for other types of headaches [310]. It 
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has been found to be more suitable for self-administrated research than the HImQ.  
 
The five questions of MIDAS cover three activity domains. The measurement relies on the 
patient‟s recall over based on a three-month time frame for estimating days lost or 
productivity reduced by more than 50% in their employment, household work and family 
and social activities domains [309]. The total score of number of lost days owing to these 
domains is obtained by summing the answers to the five questions and categorised into 
four severity grades:  
 
 Grade I is defined as minimal or infrequent disability, with the scores between 0-5;  
 Grade II indicates mild or infrequent disability, with the scores between 6-10; 
 Grade III refers to moderate disability, with the scores between 11-20; and  
 Grade IV implies severe disability, with the score is 21 and over.  
 
The MIDAS also includes two additional questions. Question A is designed for headache 
frequency whereas question B is for intensity. Although these two other questions are 
neither scored nor included in the total MIDAS score, they were designed to provide 
practitioner with clinically relevant information on patients headache frequency and pain 
intensity [273]. 
 
MIDAS questionnaire was tested extensively for its reliability and validity [311, 312]. It is 
regarded to be reliable, accurate, easy to use and score, and intuitively meaningful to 
physicians [311-313], not only that the MIDAS has such of these features support its 
suitability for use in clinical practice, but also has been proposed as an aid to 
communication between patients and healthcare professionals [308]. 
 
2.7.2.3  Headache Impact Test (HIT) 
The HIT [305] is another instrument measuring the impact of headache. The scores on 
MIDAS and HIT-6 are highly correlated. However, MIDAS seems to be more influenced by 
frequency of headache where the HIT-6 is more influenced by intensity of headache. In 
addition, comparing with the MIDAS, which assesses disability, HIT is used as a global 
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assessment of headache impact [308]. This instrument contains 54 items and is a useful 
disability and life-of-quality questionnaire measuring the impact that headaches have on 
a person's ability to function on the job, at home, at school and in social situations. The 
HIT has a standardised short version used for computerised adaptive testing of headache 
impact [314], the Short-Form Headache Impact Test (HIT-6) [315], which contains only 6 
questions that address aspects of quality of life as pain, social functioning, cognitive 
functioning, and psychological distress, which functions as well as the standard HIT. The 
choices of responses for each item are: never (scored as 6), rarely (8), sometimes (10), 
very often (11), and always (13). The scores of HIT-6 may possibly range from 36 to 78 
and be categorised into four grades which represent minimal, mild, moderate and severe 
impact due to headache [308].  
 
Compared with the MIDAS, it measures the headache impact over a relatively short period 
of time which based upon the past 4 weeks‟ time period. The HIT-6 is short and easy to be 
complete. The HIT-6 is also reliable and valid. Items were achieved with the evaluations of 
content validity, internal consistency, score distributions, linguistic analyses, and item 
response theory [315]. HIT-6 has 11 language versions (U.S. English, Canadian English, 
French, Greek, Hungarian, U.K. English, Hebrew, Portuguese, German, Spanish, and 
Dutch) [316]. However, the HIT-6 does not have a Chinese version yet, and its application 
and validation in Chinese population is lacking.  
 
2.7.3 Summary 
In sum, given the multidimensional nature of headache, it is recommended to use a range 
of methods in judgement of treatment outcome. Hence, as a rule, the accurate outcome 
should include frequency and a valid and reliable instrument to measure headache pain 
and headache related disability [273]. 
 
 
2.8  Chinese Medicine (CM) Understanding of TTH  
2.8.1  The fundamental theory and key concepts of CM 
Unlike WM, CM utilises an ancient Chinese philosophically based framework to explain 
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health and illness. This framework covers several concepts that derived from the 
observation of nature, such as Yin and Yang, and the Five-Elements theory. They were 
fundamental to all natural sciences in ancient China [317]. Other key concepts include the 
Zang-Fu (Internal Organs: visceral/solid organs and hollow organs or bowels); vital 
substances of body including Qi, Blood, Body Fluid, Humour; and the Meridian system 
[318].  
 
Zang-Fu, Body and spirit into one 
Central to the CM theory, the Zang-Fu concept of the internal organs is regarded to best 
represent the view of body as an integrated whole [319]. In CM, the names of the internal 
organs of human body are basically the same as those used in WM, however, the concepts 
and functions are not the same. Different from the physical organs in WM, the Zang-Fu 
theory of internal organs in CM is a complex system encompassing not only their anatomic 
unity, but also a concept of physiology and pathology. Zang (the Five-Zang) consists of 
heart (including the pericardium), lung, spleen, liver, and kidney, and Fu consists of gall 
bladder, stomach, large intestine, small intestine, urinary bladder, and the Sanjiao (three 
areas of the body cavity). Functionally, Zang mainly manufacture and store essence of Qi, 
Blood, and Body Fluids, whereas Fu receive and digest food, absorb nutrient substances, 
and transmit and excrete wastes. Both of them correspond to emotions, tissues, sense 
organs, mental activities, and environmental influences (such as climates). They also 
ensure the production, maintenance, replenishment, transformation and movement of the 
Vital Substances, Qi, Blood, Essence and Body Fluids [319]. For example, the chief 
function of Liver in CM is responsible for the storing Blood and ensuring the smooth 
movement of Qi (flow of vital energy) throughout the human body. When Liver is 
dysfunction, the person tends to get angry easily and suffers from headache as Liver is 
associated with anger (emotion) and Liver Qi tends to go up to the head when it is not in 
balance with other Zang-Fu organ Qi.  
 
In CM perspectives, emotions are believed to be an integral and inseparable part of the 
sphere of action of the Internal Organs [319], and human‟s mental activities are 
respectively generated and governed by the Five-Zang (Table 6) and reflect emotions. 
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There is a saying in the Plain Questions: “the five-zang organs dominate five kinds of 
visceral qi to produce various emotions” [320]. According to CM, the mental 
activitiesgeneralised and governed by the Five-Zang and reflect emotions of joy, anger, 
anxiety, contemplation, grief, terror, and fear [321]. Since the body and mind are 
integrated inseparable, the emotion can play an important role in the causes of disease 
when they persisted a long period of time, especially when not expressed or acknowledged 
[319]. For example, as one of the seven types of emotion, anger corresponds with Liver 
and makes Qi rise. Nevertheless, most of the emotions can give rise to Fire because they 
can cause stagnation of Qi. When Qi is compressed in such way over a period of time, it 
then creates Fire [319]. For example, when someone harbours anger for years, such 
emotion becomes a cause of disease [319]. In CM, the term “anger” may include more 
other emotional states rather than itself, such as the allied resentment, repressed anger, 
or irritability [319]. Clinically, the disease caused by anger may manifest in the head and 
neck, such as headache, dizziness, thirst, or bitter taste. Nevertheless, one of the most 
common symptoms/diseases caused by anger could be the headache. 
 
Table 6. Basic functions of the Five-Zang 
 
Organs 
 
Main functions Related functions 
Heart governs blood and blood vessels 
and to house the Mind 
 
 governs Blood 
 controls the blood vessels 
 manifests the complexion 
 houses the Mind 
 opens into the tongue  
 controls sweat 
Liver 
 
storing Blood and ensuring the 
smooth movement of Qi 
throughout the body;  
 
responsible for overall planning of 
the body's functions by ensuring 
the smooth flow and proper 
direction of Qi 
 stores Blood 
 ensures the smooth flow of Qi 
 controls the sinews 
 manifests in the nails 
 opens into the eyes 
 houses the Ethereal Soul 
Lungs govern Qi and respiration and in 
particular are in charge of 
inhaling air;  
 
control the blood vessels in that 
the Qi of the Lungs assists the 
Heart in controlling blood 
circulation 
 govern Qi and respiration 
 control channels and blood 
vessels 
 control dispersing and descending 
 regulate Water passages 
 control skin and hair 
 open into the nose  
 house the Corporeal Soul 
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Spleen 
 
assist the Stomach digestion by 
transporting and transforming 
food essence, absorbing the 
nourishment from food and 
separating the usable from the 
unusable part of food 
 governs transformation and 
transportation 
 controls the Blood 
 controls the muscles and the four 
limbs 
 opens into the mouth and 
manifests in the lips 
 controls the “raising Qi”  
 houses Thought 
Kidneys 
 
 
 
store the Essence which is partly 
derived from the parents and 
established at conception 
 govern Water 
 control the reception of Qi 
 open into the ears 
 open into the ears 
 control the two lower orifices 
 house Will Power 
Sourced from ref.[319]  
 
Holism and Pattern identification  
The philosophical view of holism and pattern identification (Bian Zheng), which is also 
widely referred as syndrome differentiation, are two essential characteristics of CM. The 
former concept of holism, i.e., the human body is an organic integrity, mainly refers to the 
integrity of the human body itself as well as the unity of the human body and the nature. 
As in CM, the human body is composed of a number of viscera, organs and tissues [322]. 
Parts of the human body, which have their own respective functions, are believed 
inseparable in structure, coordinative in physiology, and mutually interacting in pathology. 
Meanwhile, the human lives in nature, and the nature provides conditions indispensable to 
human's survival. Such a unity implies the fact that the human body function is influenced 
by the nature conditions, and affected by the changes in the nature to which it is subjected. 
As a result, human beings have to adapt to nature in order to maintain their normal vital 
activities [321]. Therefore, when CM diagnosing and treating diseases, it emphases not 
only on the unity of the human body, but also on the interrelationship between the body 
and nature [322]. 
 
The latter concept of pattern identification describes the process of synthesising and 
analysing clinical data of symptoms and signs of patient‟s condition to determine the 
location, cause and nature of a patient‟s health condition [319]. It is an integral system of 
CM clinical practice that guides the direction of treatment on the basis of CM theories [322]. 
A pattern is a generalisation of a variety of symptoms and signs that exist in a health 
condition. Distinguishing and analysing a variety of symptoms and signs is an essential 
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step to pattern identification [323]. 
 
2.8.2  TTH in CM: definition and aetiology 
In CM, TTH is not a recognised disorder (Bing Ming). It belongs to the category of “Tou 
Feng” and “Tou Tong” [324]. Although CM does not give an explicit name for TTH, it is 
treated as “headache” with certain patterns. When TTH patients seek medical consultation 
from CM, their headache has to be categorized into one of patterns. 
 
In CM, the basic pathogenesis of pain is either blockage/obstruction or malnourishment of 
Qi and Blood, meridian, Zang-Fu organs. In general, headaches are caused by disorders of 
Qi and Blood, or lacking of nourishment of the channels and collaterals [325]. According to 
CM theory, the head is regarded as the place where Yang-Qi converges and the sea of 
marrow resides. Many factors may cause headache, for example, Qi and Blood disorders in 
the organs, Qi and Blood disorders in the head caused by external damage, extreme 
emotions, or over work [325]. Broadly, headache has two types of aetiology, i.e., invasion 
by an exterior pathogen or internal disorder (Figure 2).  
 
A number of external pathogens such as wind, cold, summer heat, dampness and fires 
enter the skin and move through channels upward to invade the head, causing headache 
seen in flu or cold (externally contracted headache) or during a sun stroke [326]. The 
headache is characterised by an acute onset with severe pain, usually throbbing, moving 
from one side to another, distending and / or heavy. The other type of headache is the 
internal injury headache (or miscellaneous disease headache) [12], which is largely 
caused by dysfunction of CM Liver, Spleen and Kidney [327]. Headaches related to the 
Liver are mainly caused by emotional upsets, which may lead to a failure of the Liver to 
maintain its function of soothing flow of qi. It may also lead to binding restraint of Liver-Qi 
whereas the chronic constraint can transform into fire. Headaches related to Spleen 
dysfunction may result in the production of phlegm and blockage of the clear Yang. 
Headaches related to Kidney are mostly due to a lack of kidney essence and the difficulty 
in generation of Qi and Blood to nourish the head. Such functional imbalances may lead to 
the heat not receiving proper nourishment and cause pain [325]. In contrast to the 
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external category, a headache caused by internal disorders is described by a slow onset, 
intermittent pain and often chronic. The pain is usually described as empty, vague and 
accompanied with dizziness.  
  
 64 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 2. Schematic Diagram for aetiology and Pathology of headache  
(Adapted from ref. [326] with modification) 
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2.8.3  Classification of headache and understanding of TTH 
In 1992, the Group of Encephalopathy Emergency of State Administration of Traditional 
Chinese Medicine (TCM) of the People's Republic of China classified Headache into nine 
patterns, and they are 1).Wind (风证), 2). Fire and Heat (火热证), 3). Phlegm-Dampness 
(痰湿证), 4).Blood stasis (血瘀证), 5). Stagnation of Liver-Qi / Liver-Qi depression (郁证), 6). 
Qi deficiency (气虚证), 7). Blood deficiency (血虚证), 8). Yin deficiency (阴虚证), and, 9). 
Yang deficiency (阳虚证) [328]. 
 
Although the standard provided a practical basis for headache subgroup identification, the 
classifications was based on CM knowledge without cross-referencing to WM diagnosis. For 
instance, WM diagnosis was not mentioned, and TTH was not differentiated from migraine. 
Furthermore, the patterns provided were regarded to be incomplete, as some patterns 
observed by others (listed below) were not listed [324]. Hence, consensus of TTH pattern 
identification is still lacking. Due to the cause of TTH is rarely owing to a cold or flu [329], 
TTH has consequently been classified into the miscellaneous (internal) disease headache 
in CM [330, 331]. In one of the most renowned work for CM diagnosis written by Deng on 
headache classification [12], a total of 11 patterns of disharmony were summarised to 
guide the clinical practice for all miscellaneous (internal) disease headache. However, in 
another contemporary textbook, a total 6 patterns were listed for internal or injury-related 
headache [327].  
 
In recent years, several published CM studies specific to TTH in China proposed different 
TTH patterns with some overlaps among them. A summary of eleven (11) patterns is 
presented in Table 7. Li and Ye [332] identified three patterns based on clinical 
observation, i.e., Ascendant hyperactivity of Liver-Yang (肝阳上亢) (Pattern 1), Kidney 
deficiency (肾虚) (Pattern 2) and Spleen deficiency (脾虚) (Pattern 3). Based on clinical 
experience, Yan [333] classified TTH into five patterns, including  patterns of Liver-Qi 
stagnation (肝气郁结) (Pattern 4), Stagnated Gallbladder-Qi with disturbing Phlegm (胆郁
痰扰) (Pattern 5), Liver-Fire ascending (肝火上炎) (Pattern 6), Cold congealing in the 
Jue-Yin meridian (寒凝厥阴) (Pattern 7), and Static Blood blocking collaterals (瘀血阻络) 
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(Pattern 8). Zheng [334] identified three patterns, including Liver-Qi stagnation (肝气郁结) 
(4), Deficiency of Heart and Spleen (心脾两虚) (Pattern 9), and Kidney-Yin deficiency (肾
阴亏虚) (Pattern 10). Similarly, Mao [335] classified TTH into Stagnation of Liver-Qi (肝气
郁结) (4), Deficiency of Heart and Spleen (心脾两虚) (9) and Deficiency of both Liver-Yin 
and Kidney-Yin (肝肾阴虚) (11). 
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Table 7. Potential patterns proposed for TTH diagnosis from literatures 
 
Patterns Symptoms and signs  
 
1. 肝阳上亢 
Ascendant 
hyperactivity of 
Liver-Yang 
(Liver-Yang Rising)  
 
These include distending pain with dizziness on the temporal region, eyes or 
lateral side of the head, with. Aggravated after the patient is angry or irritable, 
flushed face and ears, bitter taste in the mouth, dry throat, distending pain in the 
hypochondria, vexation, liability to anger, nightmare. There may also be tinnitus, 
deafness, dry mouth and throat, insomnia, irritability, feeling worked-up, 
shouting in anger. These may also include tenseness, agitation and a tendency to 
be easily angered, a red face and eyes, headache, distention of the eyes, possibly 
dizziness, yellow urine, bound stools. [332] 
2. 肾虚 
Kidney deficiency 
 
 
 
 
These include empty pain and dizziness in the head, aggravated at excessive 
work, overstrain and alleviated after sleep, fatigue, poor memory, dizziness, 
tinnitus, lassitude in loin, lower back, knees and legs, seminal emission or vaginal 
discharge, leukorrhea, palpitation and insomnia, shortness of breath on exertion, 
rapid and weak breathing, difficulty in inhaling, cough, asthma, sweating, cold 
limbs, cold limbs after sweating, swelling of the face, thin body, mental 
listlessness, clear urination during asthma attack, soreness of the back. [332] 
3. 脾虚 
Spleen deficiency 
These include shortage of qi, laziness in speaking, fatigue and lack of strength, 
tearing of the eyes, torpid intake and diminished appetite, abdominal distention 
after eating, sloppy stools, no appetite, abdominal distension after eating, 
tiredness, lassitude, sallow complexion, weakness of the limbs, loose stools. 
[332] 
4. 肝气郁结 
Liver-Qi stagnation 
These include depression, a tendency to sigh, distention and pain of the chest and 
rib-side area, distention of the breasts, abdomina1 pain prior to menstruation, 
lack of regulation of the time of menstruation, possibly accumulations and 
gatherings. [333-335] 
5. 胆郁痰扰 
Stagnated 
Gallbladder-Qi with 
disturbing phlegm  
These include heaviness of the head with clouding dizziness, or headache with 
muddled mind, lassitude of the limbs, fullness oppression and oppressed feeling 
in the chest, anorexia, nausea, vomiting and phlegm. [333] 
6. 肝火上炎 
Liver-Fire 
ascending 
 
 
These include a hot, red face, red eyes that are swollen and painful, headache, a 
tendency to be easily angered, vexing agitation, difficulty in sleeping, a bitter 
taste in the mouth, a dry throat, short, red urination, bound stools, Irritability, 
propensity to outbursts of anger, tinnitus, deafness, temporal headache, 
dizziness, thirst, bitter taste, dreamdisturbed sleep, constipation with dry stools, 
dark-yellow urine, epistaxis, haematemesis, haemoptysis. [333] 
7. 寒凝厥阴 
Cold congealing in 
the Jue-Yin 
meridian 
 
The primary manifestations are pain, distending pain, hyper-tonicity, sores, 
wilting weakness with a lack of strength, paralysis or impaired movement along 
the course of the channel (i.e., the vertex of head, the darks of the eyes, the 
throat, the chest and rib-side, the area of the stomach duct, the lesser abdomen, 
the anterior yin [genitals] and testicles, the inguinal region, the posterior medial 
aspect of the leg, the inner aspect of the dorsum of the foot and the great toe). 
[333] 
8. 瘀血阻络 
Static blood 
blocking collaterals 
These include swelling and distention of a given area or the creation of concretion 
and accumulation glomus lumps, piercing pain that refuses pressure and is in a 
fixed location, a green-blue purplish skin color, a dark and dusky facial 
complexion, carapace-like skin (i.e., skin that has lost its rich moisture and is 
rough and dry like scales or a shell). [333] 
9. 心脾两虚 
Deficiency of Heart 
and Spleen 
 
These include a white face without luster or a withered yellow face, pale white lips 
and nails, dizziness, heart palpitations, heart vexation, difficulty in sleeping, 
shortage of qi, laziness in speaking, fatigue, lack of strength, torpid intake, 
diminished appetite, abdominal distention. [334, 335] 
10.  肾阴亏虚 
Kidney-Yin 
deficiency 
 
These include soreness and weakness of the lumbus and knees, head dizziness, 
ringing in the ears, tinnitus, seminal emission, a thin and emaciated body, vexing 
heat of the five hearts, tidal fever or low fever, night sweating, red cheeks, a dry 
mouth and throat, thirst, yellow urine, bound stools, vertigo, poor memory, 
deafness, night sweating, 5-palm heat, sore back, ache in bones, nocturnal 
emissions, constipation. [334] 
11. 肝肾阴虚 
Deficiency of both 
Liver-Yin and 
Kidney-Yin 
Swallow complexion, dull occipital or vertical headache, insomnia, 
dream-disturbed sleep, numbness of limbs, malar flush, dizziness, dry eyes, dry 
throat blurred vision, propensity to outburst of anger, soreness of the lower back, 
dry throat, tinnitus, night sweating, feeling of heat of palms and soles, 
difficult-dry stools, nocturnal emissions, scanty menstruation or amenorrhoea, 
delayed cycle, in women infertility. [335] 
Source: [12, 326, 327] 
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Despite of some variations existed among the patterns listed above, all of these studies 
identified some patterns related to the Liver, with three out of four studies listed the 
pattern of Liver-Qi stagnation, indicating the important link between TTH and functional 
energy of the Liver-Qi. TTH with a Liver pattern is often accompanied with a set of 
symptoms and signs related to the function of the Liver from the CM perspective, such as 
indigestion, nausea, pain in the hypochondriac area, nervousness, and possible 
premenstrual tension in females [336].  
 
Indeed, among the Five-Zang, the Liver could be one of the major cause of TTH [337]. In 
addition, in the earlier 2000 (recruitment completed around 2004, paper published in 
2009), by utilising a Delphi method, a group of German acupuncture trialists proposed 8 
CM patterns for TTH and migraine. They were (1)Liver-Qi stagnation, (2)Liver-Yang rising 
(Ascendant hyperactivity of Liver-Yang), (3)Liver-Fire rising (“Like” Liver-Yang rising), 
(4)Phlegm stagnation, (5)Spleen-Qi deficiency, (6)Liver-Blood deficiency, (7)Kidney-Yin 
deficiency and (8)Kidney-Yang deficiency [338]. The study is among the first in identifying 
patterns specific for the IHS defined headaches patterns of Liver-Qi stagnation, Spleen-Qi 
deficiency, Liver-Yang rising, and Phlegm are considered to be more specific for TTH 
diagnosis in their clinical observation [338]. 
 
In that study, a questionnaire was used for assisting practitioners in making diagnosis. 
Majority of patients were diagnosed with 2 to 4 different CM patterns. The top 3 patterns 
of TTH were Liver-Qi stagnation (62%), Spleen-Qi deficiency (52%) and Liver-Yang rising 
(36%). However the applied diagnostic questionnaire may have some drawbacks: it was 
not validated; it may lack of distinct criteria or guidance was lacking for making proper 
pattern diagnosis; the proposed patterns, similar to other studies, were expert opinion 
based but not evidence-based; and the listed symptoms and signs were not adequate 
enough in covering each pattern precisely, as only 4-9 items were proposed for each 
pattern.  
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2.8.4  Experts’ consensus-based pattern identification of TTH 
Although TTH has been detected to be associated with different patterns of CM diagnosis, 
there is still no standard CM diagnostic procedure or category existed for TTH in CM. More 
recently in 2009, on the basis of the literature information and the potential classifications 
listed above, a panel of 7 international experts in the fields of CM and acupuncture were 
invited to provide their experts opinions on classifications of TTH patterns to a predefined 
diagnostic protocol of TTH in relation to a clinical trial of TTH funded by the National Health 
and Medical Research Council (NHMRC) in Australia.  
 
A predefined diagnostic protocol, which was generated in accordance with literature and 
textbooks and used to guide the acupuncture treatment for the trial participants, was sent 
to them for comments. Experts‟ opinions were exchanged via email correspondences. 
Feedbacks and comments on the predefined treatment protocol were collated and 
integrated.  
 
Initially, a total 10 patterns, that all related to TTH, were proposed. They were: (1) 
Ascendant hyperactivity of Liver-Yang (Liver-Yang rising), (2) Liver-Fire (Liver-Fire rising), 
(3) Liver-Qi stagnation, (4) Phlegm rises to cloud the Mind (Phlegm stagnation), (5) Dual 
deficiency of Qi and Blood, (6) Dual deficiency of Spleen and Kidney, (7) Spleen-Qi 
deficiency, (8) Kidney-Yang deficiency and (9) Liver-Blood deficiency, and (10) Stagnation 
of Blood. This is similar to the 8 patterns proposed by the German group [338], except for 
the patterns of (5), (6), (8), and (10). 
 
Experts recommended simplifying the patterns because the selection of acupuncture 
points is similar among different patterns. Accordingly, pattern (2) was combined with (1), 
whereas (6,7,8,9) were combined with (5). Finally, five of them were considered to be 
more specific for TTH in guiding the acupuncture treatment. They were 1). Ascendant 
hyperactivity of Liver-Yang (Liver-Yang uprising), 2). Liver-Qi stagnation, 3). 
Accumulation of Phlegm disturbs head, 4). Dual deficiency of Qi and Blood, and 5). 
Stagnation of Blood. Their key criteria and symptoms and signs of each pattern are listed 
in Table 8.  
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Table 8. Experts’ consensus based pattern identification of TTH: a list of 
symptoms and signs of TTH patterns (proposed for the “Combined therapy of 
electroacupuncture and cognitive behavioural therapy for Tension-type headache: a randomised 
controlled trial”) 
 
1) Ascendant hyperactivity of Liver-Yang (inc. Liver-Fire) 
Pain characteristics: 
Pulsing, pounding, throbbing, or piercing headache, vertigo, pain on the one side of the 
head, with pain concentrating at the vertex and temporal region, Pain aggravated by 
anxiety. 
Accompanying symptoms and signs:  
Irritability, insomnia, flushed face, blurred vision, bitter taste in the mouth, hypochondriac 
pain, tension in the neck and shoulder, nausea, vomiting. 
Tongue and pulse: 
Superficial forceful pulse. Red tongue with yellow tongue coating.  
 
If the patient has Liver-Fire pattern, the patient might present headache with heat sensation, 
red eyes, stinging or burning in the eyes, sensitive to light, blurred vision, flushed face, bitter 
taste in the mouth, short-tempered, or having outbursts of anger. 
2) Liver-Qi stagnation 
Pain characteristics:  
Distending headache in the temporal region, or moving from one place to another, pain 
aggravated by stress, anger or anxiety. 
Accompanying symptoms and signs:  
Stuffy chest, irritability, anxiety, tension in the neck and shoulder, or reflux, nausea or loss 
of appetite brought on by stress.   
Tongue and pulse: 
Normal tongue colour; String taut pulse. 
3) Phlegm rises to cloud the Mind 
Pain characteristics:  
Dull distending headache, with pressure or heavy sensation in the head, or headband 
sensation, mental cloudiness, headache worsened by damp weather or over consumption of 
oily food.  
Accompanying symptoms and signs: 
Heaviness in the body, nausea, feeling of fullness, vomit sputum, diarrhea, tend to have 
swelling hands and feet. 
Tongue and pulse: 
Moist white tongue coating, or large tongue with tooth mark; slippery pulse. 
4) Dual deficiency of Qi and Blood  
Pain characteristics:  
Empty pain, constant dull or diffuse headache, dizziness, emptiness in the head. Headache 
worse at the end of the day or when tired.  
Accompanying symptoms and signs: 
Excessive fatigue or being tired easily, lack of motivation, tinnitus or deafness, stiffness or 
pain in the low back, swollen legs, cold hands and feet, feeling of numbness or tingling in 
the hands and feet at night and at rest, weak knees, pale face and complexion, frequent 
clear urination; poor appetite, diarrhea or loose stools, feeling bloated easily, suffering from 
irritable bowel syndrome, getting worried easily, shortness of breath, decline to talk, 
spontaneous sweating, palpitations, insomnia; brittle finger nails.  
Tongue and pulse: 
Pale and delicate tongue body, white coating; thready weak or deep pulse. 
5) Stagnation of Blood 
Pain characteristics:  
Headache could be anywhere but fixed in location; the pain is fixed, stabbing, will be sharp 
rather than dull and radiating 
Accompanying symptoms and signs: 
Dark complexion, fixed masses, pale face with possibly purple lips or nails, dizziness, 
stress-induced deafness, emaciation, weakness of the muscles.  
Tongue and pulse: 
Purple tongue body, may company with purple spots; wiry, choppy pulse. 
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2.8.5  CM treatment of headaches 
2.8.5.1  Treatment principle  
CM is viewed as “personalised medicine” as CM diagnostic approach guides the tailored 
treatment for each individual [14]. In headache treatment, the guiding principle is to 
enhance and strengthen the deficient syndromes or eliminating and dispelling the 
excessive pathogens. According to the above mentioned five pathogenesis of CM patterns, 
the principle of treating TTH may include calming the Liver and suppress Yang, and/or 
removing fire (for Ascendant hyperactivity of Liver-Yang); soothing Liver-Qi stagnation 
(for Liver-Qi depression); resolving Turbid Phlegm (for Phlegm rises to cloud the Mind); 
warming Kidney and tonify Yang (for Dual deficiency of Qi and Blood); and invigorating 
Blood in order to expel Blood stasis (for Stagnation of Blood). 
 
2.8.5.2  Chinese Herbal Medicine 
Chinese herbal medicine is a major aspect of CM treatment regimes, which aims to restore 
a balance of Qi and blood of the body, energy and spirit to maintain health. Usually, the 
herbals may be composed into different types of formula in treating different type of 
unbalances. For example, administration of Tian Ma Gou Teng Yin (Gastrodia and Uncaria 
Beverage, 天麻钩藤饮) (Table 9) decocted in water and taken orally, which composed by 
11 types of herbals, could be suitable for headache due to Ascendant hyperactivity of 
Liver-Yang.  
 
Table 9. Prescription and explanation of Tian Ma Gou Teng Yin 
 
天麻 Tian Ma 10g Rhizoma Gastrodiae pacify the Liver and subdue 
Yang 钩藤 Gou Teng 10g Ramulus Uncariae Cum Uncis 
石决明 Shi Jue Ming 30g Concha Haliotidis subdues Yang and suppresses 
counterflow 
山栀 Shan Zhi 10g Fructus Gardeniae clear fire from constraint in the 
Liver and Gallbladder 黄芩 Huang Qin 10g Radix Scutellariae 
益母草 Yi mu Cao 10g Herba Leonuri moves the Blood and dispels 
stasis 
川牛膝 Chuan Niu Xi 10g Radix Cyathulae 
supplement the Liver and 
Kidney 
桑寄生 Sang Ji Sheng 10g Herba Taxilli 
杜仲 Du Zhong 10g Cortex Eucomnuae 
夜交藤 Ye Jiao Teng 15g Caulis Polygoni Multiflori nourish the heart and calm the 
Mind 茯神 Fu Shen 10g Sclerotium Poriae Pararadicis 
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2.8.5.3  Tuina (Chinese medical massage) 
Tuina, a form of Chinese manipulative therapy, is used to stimulate the channels and 
acupuncture points in order to free flow the qi and blood and achieve a balance between 
yin and yang,  thereby treating the headache [322]. The primary manipulations of Tuina 
for the treatment of headache include the techniques of pressing, grasping, pushing, 
brushing, kneading, rolling and rubbing on the areas between the areas between the 
joints. 
 
2.8.5.4  Acupuncture  
Acupuncture, a key treatment modality of CM, is an invasive stimulation technique using 
thin needles on specific acupoints along the skin of the body, which may correct 
imbalances in the flow of qi through meridians. It has a long history in alleviating pain and 
related problems and has gained credibility in the treatment of chronic painful conditions 
including headaches [339]. In addition, it has also been recommended as a prophylactic 
treatment of chronic tension-type headache [340]. The effectiveness of acupuncture for 
TTH has been further supported by recently published guidelines. In 2012, the National 
Institute for Health and Clinical Excellence (NICE) of United Kingdom (UK) have published 
new guidelines on the management of various types of headaches based on scientific 
evidence [9]. The NICE guidelines are among the first headache guidelines that take into 
account the cost effectiveness of treatment as well as clinical effectiveness [341]. In this 
guideline, acupuncture, has been recommended for the prophylactic treatment of CTTH. 
 
2.8.5.5  Combined treatments of CBT and acupuncture: A combined therapy for 
TTH  
Treatment for TTH are recommended to be individualised and holistic [51]. A 
comprehensive therapeutic approach by incorporating both nonpharmacologic and 
pharmacologic means is believed to be successful for more than 90% TTH patients [3]. 
Combination of two effective therapies may provide better and longer outcomes for 
tension headaches sufferers. However, given the hundreds of trials of psychological 
treatments and the thousands of trials of pharmacological treatments, only a few studies 
have compared the two approaches or integrated them [72]. Furthermore, varies 
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nonpharmacologic treatments were seldom combined. However, one recent study granted 
by the Australia National Health and Medical Research Council (NHMRC) can be referenced 
as an example for such extension of combination. 
 
The titled study of “Combined therapy of electroacupuncture and cognitive behavioural 
therapy for tension-type headache: a randomised controlled trial” utilises 
electro-acupuncture (EA) and CBT to provide another possibility in the management of 
TTH. The study is to determine whether the combination would overcome the 
shortcomings of these two commonly used therapies for headache patients. The design of 
this multicentre RCT avoided the proved limitations of drug therapies, for example, 
adverse effects of dry mouth, drowsiness, weight gain, dizziness and increased appetite. 
Instead it combines the advantages of two well recognised non-pharmacotherapies: EA 
seems to act more quickly with a shorter duration of effect but does not address mental 
stress. Therefore it could be the reason that regular acupuncture treatments are required 
to maintain the therapeutic effect. Nevertheless, CBT tends to take a longer duration to 
benefit the patients however the effect is long-lasting. The combined two therapies are 
likely to address different aetiological and aggravating factors of TTH and take effect at 
different times. As a result, such combination may induce a synergistic effect, producing a 
fast-acting effect with long-term benefits. CBT and acupuncture have much to offer 
patients with TTH. There is strong evidence supporting the use of either therapy alone, 
and these interventions may also help to reduce headache and prevent its recurrence 
when combined. 
 
2.8.5.6  Problems in current acupuncture research  
Although the latest Cochrane systematic review supports that acupuncture could be a 
valuable non-pharmacological tool in patients with either frequent episodic or chronic 
tension-type headaches [10], there was considerable variations among the studies, which 
lead to different conclusions for the treatment efficacy [342]. Many design issues may 
cloud the results therefore proper assessment and comprehensive evaluation may be 
required. The use and evaluation of acupuncture for TTH is covered elsewhere (Chapter 3) 
in this thesis. 
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2.9  Chapter summary  
This chapter reviewed the literature regarding the TTH classification, diagnosis, 
epidemiology, mechanisms, and management and assessment from the WM perspective. 
The chapter also presented headache from the CM perspective and discussed its 
understanding to TTH including TTH definition, aetiology and pattern identification. 
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CHAPTER 3  Acupuncture for Tension-type headache: a 
systematic review of randomised, sham acupuncture 
controlled trials 
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Foreword 
A major part of this chapter has been published in  “Factors Associated with Conflicting 
Findings on Acupuncture for Tension-Type Headache: Qualitative and Quantitative 
Analyses” [342].  
 
This chapter differs from the publication in a few areas. Firstly, the present chapter 
updates the search to the end of June 2015. The publication includes the search to August 
2010. Secondly, in the Results part, this chapter fully explores and discusses all potential 
factors that may affect the effectiveness of acupuncture treatment. In the publication, 
only factors of type of acupuncture, needle retention, treatment frequency and number of 
study centres were explored. In this chapter, potential factors related to point selection, 
CM diagnosis, and sham acupuncture were also explored. As a result, more factors were 
compared in the Results and Discussion parts.  
 
In summary, an extra 31 full-text papers were identified from the new search. Fourteen 
(14) of them were excluded for being not RCTs or being Quasi-randomised RCTs. None of 
the remaining 17 studies met the selection criteria. Nine (9) of them had more than one 
items not met criteria, whereas 8 of them were of invalid control intervention. As a result, 
the updated search of databases did not produce new data for analysis. No change has 
been made to the conclusion. 
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3.1  Introduction 
Acupuncture, as one of the ancient treatment methods, has been used to treat different 
types of diseases, ranging from respiratory, cardiological, infectious, gastrointestinal, 
psychiatric, gallbladder, urinary, eye, ear, nose and throat, to musculoskeletal and 
especially painful diseases [343-346]. 
 
In recent decades, it has been widely used to relieve headache as one of the 
nonpharcological interventions. Despite of gaining considerable attentions, trials on 
acupuncture for TTH produced conflicting results. A recent Cochrane Library Systematic 
Review concludes that acupuncture is valuable for the management of TTH [10]. Results of 
sham-acupuncture controlled trials showed, however, inconsistent results. Some trials 
concluded real acupuncture being significantly better than sham intervention [347, 348] 
whereas others have not found statistically significant difference between the two 
[349-352]. A consensus on whether real acupuncture is superior to sham acupuncture has 
not been reached [353-357]. 
 
Acupuncture is a complex intervention and there is „„difficulty in defining precisely what, 
exactly, are the „active ingredients‟ and how they relate to each other‟‟ [358, 359]. Its 
„active ingredients‟ are not well defined [358, 359]. A recent Delphi study of expert 
opinions on the essential components of quality acupuncture treatment has identified 14 
domains with 26 items, including needle stimulation mode, treatment duration, frequency 
of treatment, practitioner training and trial monitoring [360]. 
 
To improve the quality of efficacy research on acupuncture for TTH, there is a need to 
identify factors contributing to the inconsistent outcomes, for instance whether 
acupuncture treatment was adequate or appropriately administered. Based on the key 
areas identified to determine quality of acupuncture intervention, the present systematic 
review aimed to identify the factors contributing to conflicting findings through conducting 
a meta-analysis and subgroup analyses comparing the effects of real and sham 
acupuncture on TTH. Specifically, this review explored the effect of the factors that have 
been considered to have direct impact on the quality of acupuncture trial as described 
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elsewhere [360]. These factors are mode of acupuncture, manipulation of needle, 
frequency of treatment and the number of trial centres, and other factors identified 
through qualitative assessment of the included studies.  
 
 
3.2  Methods 
3.2.1  Search strategy  
Thirteen (13) major databases were searched consisting of 4 leading Chinese databases 
(CNKI, CQVIP, Wanfang database and CBM) and 9 English databases (Pubmed, EMBASE, 
CINAHL, Proquest, Cochrane library, Acubriefs, Science Direct, SCOPUS, Informit) up to 
June of 2014. There were no restrictions on year or language of publication. The search 
terms were: tension-type headache, acupuncture, randomised controlled trial and their 
variations. A sample search strategy is provided in Table 10.  
 
Table 10. Search strategy and search terms 
 
A. Search strategy to locate “tension-type headache” 
# 1. tension-type headache [MeSH] 
# 2. tension headache [tw] 
# 3. headache [MeSH] 
# 4. TTH [tw] 
# 5. TH [tw] 
# 6. or/# 1-# 5 
B. Search strategy to locate acupuncture interventions 
# 7. acupuncture [MeSH] 
# 8. acupuncture therapy [MeSH]  
# 9. electroacupuncture [MeSH]  
# 10. electro-acupuncture [tw]   
# 11. brief needling [tw] 
# 12. dry needling [tw] 
# 13. electrical acupuncture [tw] 
# 14. acupuncture points [MeSH] 
# 15. body acupuncture [tw]  
# 16. scalp acupuncture [tw] 
# 17. routine acupuncture [tw] 
# 18. manual acupuncture [tw] 
# 19. abdomen acupuncture [tw] 
# 20. or/#7-#19 
C. Search strategy to locate RCTs or Semi RCT  
# 21. Randomized Controlled Trial [MeSH] 
# 22. RCT [tw] 
# 23. Controlled Trial [tw] 
# 24. CT [tw] 
# 25. or/#21-#24 
D. Search strategy to locate studies for this review 
#6 AND #20 AND #25 
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3.2.2  Selection criteria 
RCTs or Quasi-RCTs were considered in this review. Studies that did not have sham 
acupuncture control group were excluded. Adult patients must have been diagnosed with 
tension-type headache according to the IHS diagnostic criteria or Ad hoc committee‟s 
criteria if studies conducted before 1988. Studies did not separate TTH patients from those 
with other types of headache, such as migraine, were excluded. Acupuncture in this review 
was limited to needle insertion type, i.e., invasive methods. Points needled include 
acupoints, Ashi point, and / or trigger/tender points. Interventions such as point injection 
were excluded because it is difficult to differentiate if the efficacy was from medication or 
acupuncture itself. Dry-needling was not considered because its theory and practice is not 
in accordance with traditional acupuncture. Included studies must have reported 
headache days as an outcome measurement.  
 
3.2.3  Outcome measure  
The outcome measure was headache days [361] at the end of the treatment and follow 
ups. 
 
3.2.4  Data extraction 
Two reviewer authors (Mr. Xinyu Hao, Dr. Lin Dong) extracted data from eligible trials 
independently by using a standard pre-defined data extraction form. Major characteristics 
including methods, participants, interventions and outcome measures were recorded for 
analysis. Other information including protocols of treatment and selection criteria was also 
extracted for study comparisons. Disagreements were solved by discussion and consult 
with a third reviewer (Dr. Zhen Zheng). Authors were contacted for insufficient 
information and missing data. 
 
3.2.5  Assessment of methodological quality 
The methodological quality of each study was assessed by two reviewers (Mr. Xinyu Hao, 
Dr. Lin Dong) using three main scoring methods, i.e., Jadad Scale [362], Internal Validity 
Scale (IVS) [363] and the Oxford Pain Validity Scale (OPVS) [364]. The Jadad scale 
applied in this review was the revised Jadad Scale used by one published Cochrane Library 
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Systematic review [349]. The latter two scales were added because Jadad scale had its 
limitations such as it did not consider sample size [365]. Additionally, allocation 
concealment was ranked according to Cochrane Handbook for Systematic Reviews of 
Interventions as A: adequate, B: unclear, C: inadequate and D: not used [366]. A study 
with a score of 3 or more points on a Jadad scale was considered high quality. Similarly, 
with IVS and OPVS rating, studies reach 60% of the total scores can be regarded as high 
quality [367].  
 
3.2.6  Data analysis and synthesis 
Review Manager 5.1 was used for meta-analysis. Assessment of heterogeneity was 
evaluated using the I2 test, a low, moderate and high I2 value was indicated by 25%, 50% 
and 75% respectively [368]. A random-effect model was used if significant heterogeneity 
(I²≥50%) among the trials was detected. For continuous data, weight or standard mean 
difference (WMD or SMD) was used. When different scales were used for assessing one 
outcome measure, SMD was calculated. 
 
3.2.7  Subgroup analysis  
When heterogeneity was high, qualitative data were examined to identify the potential 
sources. Subgroup analyses were then conducted to verify the sources [366].   
 
 
3.3  Results 
3.3.1  Search result and eligibility  
One hundred and fifty-one (151) potential studies were identified with full-texts obtained, 
and 59 of them were subjected for detailed evaluation. Two reviewers (Mr. Xinyu Hao, Dr. 
Zhen Zheng) checked the eligibility of those studies independently; and finally five trials 
involving 838 TTH participants [348-350, 369, 370] met the inclusion criteria. Reasons for 
exclusion are listed in Figure 3 and Appendix 1. 
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Figure 3. Flow chat of study selection 
 
 Potentially relevant published 
studies screened by electronic 
search in 4 Chinese databases 
(n=154) 
 
Studies excluded 
through title and abstract 
review 
(n=635) 
 92 excluded for not  
being RCTs or CTs 
 (n=59) 
 
RCTs eligible for review 
(n=5) 
RCTs included for 
meta-analysis 
(n=5) 
 
Full-text Chinese papers 
retrieved for further assessment 
(n=69) 
 
Publication excluded for further 
evaluation  
(n=54) 
 
 Invalid outcome measure: 6 
 Had more than one items not 
met criteria : 20 
 Duplicated outcome: 1 
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 Invalid intervention:2 
 Invalid control:23 
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3.3.2  Study characteristics  
The characteristics of the five trials were listed in Table 11. Three (3) [350, 370, 371] were 
conducted in Germany, and the remaining two [348, 369] were from the UK and Australia, 
respectively. All five studies adopted IHS criteria for the diagnosis of TTH with four studies 
[348, 350, 369, 371] using the first edition (ICHD-I) [40]. The sample size of each study 
ranged from 40 to 409 with three multi-centre trials [350, 370, 371] having a larger 
sample size. Two multi-centre trials [350, 370] had 409 and 270 participants, respectively. 
There were more females than males in the studies. The average age of the participants 
ranged from 30-50 years [348, 350, 369, 371]. 
 
Table 11. Characteristics of the included studies 
 
Study  
(author & year) 
White 2000 Karst 2001 Xue 2004 Melchart 2005 Endres 2007 
Country England Germany Australia Germany Germany 
Sample size 50 69 40 270 409 
Age range 41-50 41-50 41-50 41-50 30-40 
Gender 
ratio 
(f/m) 
Real 
group 
18/7 17/17 13/7 95/37 163/46 
Sham 
group 
20/5 21/14 13/7 46/17 158/42 
TTH Type ETTH ETTH+CTTH ETTH+CTTH ETTH+CTTH ETTH+CTTH 
Diagnosis 
standard  
IHS 1997 
ICD-10 
IHS 1988 ICHD-I IHS 1988 ICHD-I IHS 1988 ICHD-I IHS 2004 ICHD-II 
Setting Multiple health 
centres 
Not mentioned  Research clinic in 
university 
28 outpatients 
centres 
122 outpatient 
family practice 
Design Multi-centre 
trial 
2-arm parallel 
RCT 
Single site trial 
2-arm parallel RCT 
Single site trial 
crossover RCT 
Multi-centre trial 
3-arm parallel 
RCT 
Multi-centre trial 
3-arm parallel 
RCT 
Interventions Active:   
Acupuncture   
 
Control:  Sham 
acupuncture                      
Active:   
Acupuncture   
 
Control:  Sham 
acupuncture                    
Active:   
Electro-acupunctur
e  
 
Control:  Sham 
acupuncture                      
Active:   
Acupuncture   
 
Control:  Sham 
acupuncture;                      
Waiting list 
Active:   
Acupuncture   
 
Control:  Sham 
acupuncture;                                   
Amitriptyline 
group 
Outcome 
variables 
Headache days; 
VAS; Frequency 
of headache;  
GHQ;SF-36 
Headache days; 
VAS; CGI; 
Frequency of 
headache; ELQ; 
LS; D-S;NHP; 
Headache days; 
VAS; PTH; HDI; SIP 
Number of 
headache days; 
Pain disability 
index; SES; ADS 
depression scale; 
SF-36;  
Headache days; 
medication 
use;SF-12;Von 
Korff chronic pain 
grade scale; 
Global patient 
assessment 
Dropout Acu: n=1 
Sham: n=1 
Not reported Group A: n=1 
Group B: n=1 
Acu: n=6 
Sham: n=1 
Waiting list: n=6 
Acu: n=1 
Sham: n=5 
Summary of 
results 
No significant 
differences  
between the 
groups. 
No significant 
differences 
between the 
groups. 
Real acupuncture 
produces a 
significantly better 
outcome than sham 
acupuncture. 
Acupuncture was 
more effective 
than no 
treatment, but 
not significantly 
more effective 
than minimal 
acupuncture. 
Verum 
acupuncture was 
superior to sham 
for most 
secondary 
endpoints. 
Quality 
assessment 
Jadad:5 (2-2-1) 
IVS:6 
(1-1-1-1-1-1) 
OPVS:14 
(6-1-2-1-1-1-1-1) 
Jadad: 3 (1-2-0) 
IVS: 3.5 
(0.5-0-1-0.5-0.5-1) 
OPVS:12 
(3-2-2-1-1-1-1-1) 
Jadad: 5 (2-2-1) 
IVS: 5.5 
(1-1-1-1-0.5-1) 
OPVS:14 
(6-1-2-1-1-1-1-1) 
Jadad: 5 (2-2-1) 
IVS: 5.5 
(1-1-1-1-0.5-1) 
OPVS:16 
(6-3-2-1-1-1-1-1) 
Jadad:5 (2-2-1) 
IVS:6 
(1-1-1-1-1-1) 
OPVS:13 
(3-3-2-1-1-1-1-1) 
Allocation 
concealment 
A - Adequate B – Unclear A - Adequate A - Adequate A – Adequate 
 83 
 
 
3.3.3  Quality of the trials  
The methodological quality of included studies was assessed with three scales to identify 
if any study were of high risk of bias. Scores of Jadad, IVS and OPVS are also presented in 
Table 11. Based on the Jadad sores, all five studies were of high methodological quality 
(scoring 3 or more).  
 
Four (4) [348, 350, 369, 370] of them had a full Jadad score and adequate allocation 
concealment. Only one study (Karst 2001) could not be regarded as a high methodological 
quality although it has 3 scores in Jadad rating but it had 3.5 score in IVS which did not 
met 60% of the total scores. 
 
There was a high correlation between Jadad and IVS scores (r=0,97 P=0.006 ), but not 
between either Jadad and OPRS or IVS and OPRS. Chi-Square (Chi2) tests were used to 
examine the correlation between methodology quality and treatment effect, and no 
correlation was identified.  
 
There was however no strong link between methodology quality and treatment effect, as 
studies with similar quality scores reported different treatment outcomes, only two of the 
five studies had positive treatment outcome.  
 
3.3.4  Characteristics of acupuncture treatments  
The characteristics of acupuncture treatments were presented in Table 12. Of the five 
studies, one study [348] used electro-acupuncture (EA) and selected distal points only 
whereas others [350, 369-371] chose manual acupuncture (MA) and both local and distal 
points were used.  
 
IHS: International 
Headache Society 
ICD: International 
Classification of Diseases 
ICHD: International 
Headache Classification 
CTTH: Chronic 
Tension-type Headache 
 
ETTH: Episodic Tension-type 
Headache 
RCT: Randomized Controlled 
Trial CGI: Clinical Global 
Impressions 
D-S: von Zerssen 
Depression Scale  
ELQ:Everyday-Life-Question
naire  
GHQ: General Health 
Questionnaire 
HDI: Headache Disability Index 
LS: Life-Quality scale  
NHP: Nottingham Health Profile  
PTH: Mechanical Pain Threshold 
PPT: Pressure Pain Thresholds 
SESL:Schmerzempfindungs-Sk
ala 
SF-36: The Short-form 36 
Quality of Life 
SF-12:12-Item Short-Form 
Health Survey 
SIP: Sickness Impact Profile 
VAS: Visual Analogue Scale  
IVS: Internal Validity Scale 
OPVS: Oxford Pain Validity 
Scale 
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Four (4) studies [348, 350, 370, 371] had 30 minutes needle retention with De-Qi 
sensation elicited whilst one study applied 15 seconds of needling stimulation with no 
intention to obtain De-Qi and with no needle retention [371]. 
 
Total treatment sessions of the five studies ranges from eight to 15 between four to eight 
weeks, and the frequency of treatment were twice a week or once a week. Three studies 
applied CM diagnosis [348, 350, 370], by means of pulse and tongue diagnosis or 
diagnostic questionnaires. All trials reported number of practitioners and their 
backgrounds except for one study [371]. 
 
Of the 5 studies, three ways of point selection were used. Basic points plus supplementary 
points were used by three multicentre trials [350, 369, 370]; one single site trial chose 
fixed points for all patients [371] and another single site trial [348] developed four groups 
of points. Except for one study with fixed points [371], all others studies intended to 
achieve individualised treatment through semi-structured protocols. 
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Table 12. A comparison of real acupuncture treatment protocol 
 
 
A comparison of sham acupuncture procedure is provided in Table 13. All studies used 
non-acupuncture points. Three (3) [348, 350, 370] avoided using any points on the head. 
Three studies [348, 349, 370] used an invasive method, by means of superficially 
inserting the needles on non-points without De-Qi. The other two studies [369, 371] used 
a non-invasive method. All studies applied the same needle retention time as that in the 
real acupuncture treatment. 
  
Study White 2000 Karst 2001 Xue 2004 Melchart 2005 Endres 2007 
Stimulation style MA MA EA MA MA 
De-Qi elicited? De-Qi or 
manipulate for 15s 
Not reported De-Qi De-Qi De-Qi 
Number of 
applied needles 
Only a single 
needle  
in succession 
6-10; 
max 15 needles 
8 Maximum 25 10-25 
Uni/bilateral Bilateral Not reported Bilateral  Bilateral Bilateral 
Depths of 
insertion 
Not reported Not reported Not reported Not reported 2-30 mm 
Needle retention 
time 
No retention 
(15s or until De-Qi 
if sooner) 
30 min 30 min 30 min 30 min 
Total treatment 
sessions 
(treatment 
duration) 
8 sessions 
(6 weeks) 
10  sessions 
(5 weeks) 
8 sessions 
(4 weeks) 
12 sessions  
(8 weeks) 
10-15  sessions 
(6 weeks) 
Point selection  Local + distal 
points  
Local + distal 
points 
Distal points only Local + distal 
points  
Local + distal 
points 
Treatment 
Frequency 
Once a week for 6 
weeks then once a 
month for two 
months 
Twice a week Twice a week Twice a week in 
the first four weeks 
then once a week 
in the remaining 
four weeks 
Twice a week 
Points used 
in real 
acupuncture 
 
Obligatory 
points+  
supplementary 
points 
 
Obligatory points: 
GB20; LI4 
Fixed points 
GB 20; LI 4; LR 3; 
GB 8; GB 14; GB 
21; GB 41; UB 2; 
UB 10; UB 60; LU 
7; TW 5; ST 8; ST 
36; ST 44; DU 20; 
Extra1 
Four types of 
formula: 
1) LI 4;SJ 
5;ST40;GB60 
2) LR 3;LR 2;LI 4;LU 7 
3) SP 6;ST 36;LI 4;SJ 5 
4) LR 3;LI 4;KI 3;SJ 5 
Obligatory points 
+ supplementary 
points 
 
Obligatory points: 
GB 20; GB 21; LIV 
3 
Obligatory points 
+ supplementary 
points 
 
Obligatory points: 
GV 20; LI 4; LR 3 
( or LR 2);GB 20 
(or BL 10) 
CM diagnosis 
applied? 
No No Yes Yes  Yes 
Practitioner’s 
background 
Accredited  
acupuncturists 
Not reported Registered 
acupuncturist 
Physicians 
received 
>140h training 
Physicians 
received 
>140h training 
No. of 
practitioners 
5 Not reported 1 43 122 
No. of patients 
received real 
acupuncture  
25 34 20 132 209 
Rationale for 
treatment* 
B C A A A 
*Rating on Rationale for Treatment: 
A: rationale for treatment has been clearly stated in text. 
B: rationale for treatment can be assumed through the text. 
C: rationale for treatment can be assumed through the text but not clear. 
D: didn‟t mention the rationale for design of the treatment protocol at all. 
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Table 13. Comparisons of sham acupuncture procedure 
 
 
3.3.5  Efficacy of acupuncture in headache days  
All 5 studies [348, 350, 369-371] were included in the meta-analysis. SMD was calculated 
because one study reported headache days per week [369]; two studies [348, 371] per 
month and other two [350, 370] per four weeks. 
 
Overall, the results of meta-analysis indicated real and sham acupuncture group was not 
statistically different at any time point with regard to headache days at the end of the 
treatment (SMD -0.31; 95% CI -0.72 to 0.09, P=0.13) with a high heterogeneity 
(P=0.0004;I2=81%). The forest plot showed that two [348, 370] of the five studies found 
that acupuncture was effective for TTH, three found no treatment difference [350, 369, 
371] with one showing a trend favouring sham acupuncture [369]. 
 
Study White 2000 Karst 2001 Xue 2004 Melchart 2005 Endres 2007 
Invasive 
needling method 
used?  
No  No  Yes  Yes   Yes   
Stimulation 
style 
Blunted 
cocktail-stick 
tapped in by 
avoiding tender 
area and 
acupoints 
Blunt needle 
inserted on the 
real points in real 
group  through a 
cube-shaped 
elastic foam to 
cause a pricking 
sensation without 
actually 
puncturing the 
skin 
Superficial 
insertion by same 
needle with real 
intervention with 
very low 
frequency 
Superficial 
needling by same 
type of needle 
with real group 
Superficial 
insertion by same 
type of needle 
with real group 
Points on head? Yes   
Sham points are 4 
standard areas (2 
selected from the 
occipital 
protuberances, 
spines of scapula, 
vertex of skull 
and spinous 
process of 6th 
cervical vertebra, 
and 2 areas at the 
middle of 2nd 
metacarpal bone 
of each hand) 
Yes  
Same points as 
the real 
acupoints. 
Include:  
GB20 LI4 LR3 
GB8 
GB14 GB21 GB41  
BL2 BL10 BL60 
LU7 TE5 ST8  
ST36 ST44 GV20  
Extra1 (Yintang) 
No No No 
Location of 
points 
5-10 mm away 
from real points 
Same points used 
in real group 
5-10 mm away 
from real points 
Non-acupoints Non-acupoints 
Manipulation on 
needle  
Gentle pressure 
while rotating for 
15s on each 
Not mentioned No further 
manipulation 
Avoid manual 
stimulation 
No stimulation 
Needle retention 
time 
Manipulate for 15 
seconds (without 
retention) 
30 min 30 min 30 min 30 min 
De-Qi elicited? Not mentioned Not mentioned Avoid De-Qi Avoid De-Qi Avoid De-Qi 
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Meta-analyses results are presented in Figure 4. Real and sham acupuncture group was 
not statistically different at any time point with regard to headache days. A significant and 
high heterogeneity (P=0.0004; I2=81%) was identified at the end of the treatment. Low 
heterogeneities were presented for analyses of short term and long term follow-up periods 
(I2=33% and I2=30% respectively). 
 
 
Figure 4. Acupuncture vs. Sham acupuncture (outcome: Headache days) 
 
3.3.6  Subgroup analyses and investigation of heterogeneity 
Subgroup analyses were conducted to exam the source of heterogeneity according to 
qualitative data of the features of acupuncture treatments (Table 12), results were shown 
in below Figures 5 to 18 and summarised in Table 14. 
 
Figures 5-18: Exploration of heterogeneity [begining] 
3.3.6.1  Type of acupuncture (EA vs. MA) 
When 4 [350, 369-371] MA studies were compared with one EA study, there was a 
statistically significant subgroup difference favouring EA. The overall heterogeneity was 
moderate (I2=57%) (Figure 5).  
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Figure 5. EA vs. MA (1) 
 
After the removal of White‟s study, which had no needle retention, the heterogeneity was 
reduced to minimal. The subgroup difference remained to be statistically significant 
(Chi2=12.69, P=0.0004) (Figure 6). 
 
 
Figure 6. EA vs. MA (2) 
 
3.3.6.2  Needle retention (30 minutes vs. no retention) 
Four (4) studies [348, 350, 370, 371] with 30 minutes needle retention with De-Qi 
sensation were compared with one study with 15 seconds of needling stimulation with 
neither an intention to obtain De-Qi nor needle retention [371]. There was a high 
heterogeneity (I2=78%) in the 30 minutes retention group due to the significant better 
results of one EA study (Figure 7).    
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Figure 7. 30 minutes vs. no retention (1) 
 
After the removal of the EA study, heterogeneity was reduced to minimal (I2=0%). Among 
the remaining four MA studies, there was statistically significant subgroup different 
between studies having 30 minutes retention and those with no needle retention (Chi2 = 
5.70, P=0.02) favouring longer needle retention (Figure 8). 
  
 
Figure 8. 30 minutes vs. no retention (2) 
 
3.3.6.3  Frequency of treatment (twice a week vs. once a week) 
Four (4) studies [348, 350, 370, 371] with twice a week treatment sessions were 
compared with one study having weekly treatment [371]. This subgroup analysis involved 
exactly the same studies as that of the comparison of needle retention, the same result 
was obtained (Figures 7 and 8).  
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3.3.6.4  Point selection (semi-standardised vs. formula treatment) 
Of the 5 studies, three methods of point selection were involved. Basic points plus optional 
points was adopted by three multicentre trials [350, 369, 370]; one single site trial chose 
fixed points for all patients [371] and another single site trial [348] developed four groups 
of points. Except for one study with fixed points [371], others studies intended to achieve 
individualised treatment through semi-structured treatment.    
 
Subgroup analysis was then made on four semi-standardised studies and one [371] with 
formula treatment. Result from subgroup analysis indicated no significant treatment result 
(P=0.20 and P=0.21 respectively) on both group, in addition, a very high heterogeneity 
(I2=85%) was found in the semi-standardised group (Figure 9). 
 
 
Figure 9. Semi-standardised vs. Formula treatment (1) 
 
We firstly removed the EA study, the heterogeneity was still high (I2=70%), and the result 
was still insignificant (P=0.69) (Figure 10). 
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Figure 10. Semi-standardised vs. Formula treatment (2) 
 
We then keep removing White‟s study from the comparison, a significant treatment result 
(P=0.01) was found from another two studies in this group, and a less than 25% I2 value 
was presented (I2=17%) (Figure 11). 
 
 
Figure 11. Semi-standardised vs. Formula treatment (3) 
 
To determine which study contributed/lead to a higher weight/proportion to the 
heterogeneity, we tried to remove White‟s study alone. As a result, a significant difference 
presented (P=0.05), but with an even higher heterogeneity (I2=86%) (Figure 12). 
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Figure 12. Semi-standardised vs. Formula treatment (4) 
 
Indicated from the results by removing both studies, White and Xue‟s studies were the 
main contribution to the overall heterogeneity, since two studies are different to others, 
one is not a conventional treatment and another is EA. 
 
3.3.6.5  Number for study centre (multicentre vs. single site) 
Three (3) multi-centred trials were compared with two single-site studies. There was no 
statistically significant difference (Chi2=1.60, P=0.21).  
 
When data pooled, multicentre trial group presented a significant heterogeneity (I2=70%), 
whilst an even higher heterogeneity (I2=88%), was reported by single site trials (Figure 
13). 
 
 
Figure 13. Multicentre vs. Single site (1) 
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When White‟s study been removed from the multicentre group, a significant difference 
result was presented (P=0.01) and the heterogeneity reduced (I2=17%) (Figure 14). 
 
 
Figure 14. Multicentre vs. Single site (2) 
 
3.3.6.6  CM diagnosis (trails applied CM diagnosis vs. not applied CM diagnosis) 
Three studies applied CM diagnosis [348, 350, 370], by means of pulse and tongue 
diagnosis or diagnostic questionnaires (Figure 15). 
 
 
Figure 15. CM diagnosis vs. no CM diagnosis (1) 
 
A subgroup comparison on CM diagnosis was made, a significant difference was obtained 
from studies applied CM diagnosis (P=0.05). Its high heterogeneity was however 
contributed from Xue‟s study. After this study was removed, its heterogeneity reduced 
dramatically (I2=17%) (Figure 16). 
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Figure 16. CM diagnosis vs. no CM diagnosis (1) 
 
3.3.6.7  Sham acupuncture (having sham points on the head vs. not on the 
head) 
Subgroup analysis result indicated a significant difference from the studies with sham 
points not on head, but accompanying a considerable high heterogeneity (I2=86%) 
(Figure 17), again, Xue‟s study was regarded contributed this high heterogeneity, after 
their study removed, a positive result obtained (P=0.01; I2=17%) (Figure 18). 
 
 
Figure 17. sham points on the head vs. not on the head (1) 
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Figure 18. sham points on the head vs. not on the head (2) 
 
Figures 5-18: Exploration of heterogeneity [ending] 
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Table 14. Results of subgroup analyses (after treatment) 
 
Outcome titles Number of 
studies 
Number of 
patients 
Effect size  
SMD(95% CI) 
Test for overall effect 
P-value 
Heterogeneity 
 1. Type of acupuncture   
   (EA vs. MA) 
Before 
removal 
EA 1 [348] 40 -1.60 [-2.33, -0.88] P < 0.0001 N/A 
MA 4 [350, 369, 370, 
371] 
689 -0.13 [-0.41, 0.14] P = 0.33 I2 = 57%; Tau2= 0.04 
After removal 
of White 2000 
MA 3 [350, 370, 371] 639 -0.26 [-0.42, -0.10] P = 0.001 I2 = 0%; Tau2= 0.00 
 2. Needle retention  
    (No retention vs.30 minutes retention) 
Before 
removal 
 
Needle retention not 
applied 
1[369] 50  0.45 [-0.11, 1.01] P = 0.12 N/A 
Needle retention 
applied for 30 min 
4 [348, 350, 370, 
371] 
679 -0.46 [-0.87, -0.06] P = 0.02 I2 = 78%; Tau2= 0.12 
After removal 
of Xue 2004 
Needle retention 
applied for 30 min 
3 [350, 370, 371] 639 -0.26 [-0.42, -0.10] P = 0.001 I2 = 0%; Tau2= 0.00 
 3. Point selection  
    (Semi-standardised vs. Formula treatment) 
Before 
removal 
Formula treatment 1 [371] 69 -0.30 [-0.78, 0.17] P = 0.21 N/A 
Semi-standardised  4 [348, 350, 369, 
370] 
660 -0.33 [-0.84, 0.18] P = 0.20 I2 = 85%; Tau2= 0.21 
After removal 
of Xue & White 
Semi-standardised 2 [350, 370] 570 -0.25 [-0.44, -0.06] P = 0.01 I2 = 17%; Tau2= 0.00 
After removal 
of Xue 2004 
Semi-standardised 3 [350, 369, 370] 620 -0.07 [-0.43, -0.28] P = 0.69 I2 = 70%; Tau2= 0.07 
After removal 
of White 2000 
Semi-standardised 3 [348, 350, 370] 610 -0.55 [-0.18, -0.01] P = 0.05 I2 = 86%; Tau2= 0.18 
 4. Treatment frequency  
    (Twice a week vs. Once a week) 
Before 
removal 
Once a week 
 
1[369] 50  0.45 [-0.11, 1.01] P = 0.12 N/A 
Twice a week 4 [348, 350, 370, 
372] 
679 -0.46 [-0.87, -0.06] P = 0.02 I2 = 78%; Tau2= 0.12 
After removal 
of Xue 2004 
Twice a week 3 [350, 370, 371] 639 -0.26 [-0.42, -0.10] P = 0.001 I2 = 0%; Tau2= 0.00 
 5. CM diagnosis  
   (CM diagnosis not applied vs.CM diagnosis applied) 
Before 
removal 
CM diagnosis not 
applied  
2 [369, 371] 119  0.06 [-0.68, 0.80] P = 0.88 I2 = 75%; Tau2= 0.21 
CM diagnosis 3 [348, 350, 370] 610 -0.55 [-1.08, -0.01] P = 0.05 I2 = 86%; Tau2= 0.18 
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applied 
After removal 
of Xue 2004 
CM diagnosis 
applied 
2 [350, 370] 570 -0.25 [-0.44, -0.06] P = 0.01 I2 = 17%; Tau2= 0.00 
 6. Location of sham points  
(Sham points on head vs. Points not on head) 
Before 
removal 
Sham points on 
head 
2 [369, 371] 119  0.06 [-0.68, 0.80] P = 0.88 I2 = 75%; Tau2= 0.21 
Points not on head 
 
3 [348, 350, 370] 610 -0.55 [-1.08, -0.01] P = 0.05 I2 = 86%; Tau2= 0.18 
After removal 
of Xue 2004 
Points not on head  2 [350, 370] 570 -0.25 [-0.44, -0.06] P = 0.01 I2 = 17%; Tau2= 0.00 
 7. Centre of study 
    (Multicentre vs. Single site) 
Before 
removal 
Single-site trial 
 
2 [348, 371] 109 -0.92 [-2.20, 0.35] P = 0.15 I2 = 88%; Tau2= 0.75 
Multicentre trial 
 
3 [350, 369, 370] 620 -0.07 [-0.43, 0.28] P = 0.69 I2 = 70%; Tau2= 0.07 
After removal 
of White 2000 
Multicentre trial 2 [350, 370] 570 -0.25 [-0.44, 0.06] P = 0.01 I2 = 17%; Tau2= 0.00 
SMD: standard mean difference  
CI: confidence interval 
EA: electroacupuncture 
MA: manual acupuncture 
N/A: not applicable 
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3.3.7  A comparison of two multi-centre trials  
Methodology of the two multicentre trials was published separately [372, 373], allowing a 
detailed comparison of the two studies [350, 370] (Table 15). They were similar in their 
design, but had differed in outcomes, with one study showing significantly less headache 
days reported in real acupuncture group than sham group [370] (SMD -0.31; 95% CI 
-0.51 to -0.12) and the other reporting no group difference [350] (SMD -0.10; 95% CI 
-0.42 to 0.21). 
 
Table 15. Similarities and differences of the two multicentre trials 
 
 
In spite of many similarities existed in designing, needling techniques, and methodological 
quality, two studies differed in treatment protocol development and administration. In 
Study Melchart 2005 Endres 2007 
De-Qi Required to achieve if possible  De-qi was required on all points 
 Repeated De-qi was required (2-3 
times) 
Literature support No description 40 acupuncture textbooks were 
analysed 
Requirement on 
point selection 
No description Had to be formulated as precisely as 
possible based on the appropriate CM 
principles 
Classification of 
optional points 
selection 
 Classical acupoints 
 Microsystem points 
 Ah-Shi points 
 Trigger points 
 Channels 
 Internal level CM patterns 
 Ah-Shi points 
 Symptomatic points 
CM diagnosis 
 
A traditional Chinese pattern 
diagnosis was requested, but not 
mandatory 
 Identifying affected meridians 
 Identification of CM patterns 
 Tongue diagnosis was used 
additionally 
 A predefined questionnaire was 
designed 
 Mimicking an individualised CM 
acupuncture procedure 
Administration 
 Physicians were free to 
choose needle length and 
diameter 
 Recommendations for 
additional points were made, 
but practitioners were free to 
choose others 
 One centre did not use basic 
points on patients 
 Type of needles and intensity of 
needle stimulation, minimum and 
maximum number of needles to be 
inserted were consistent during 
treatment 
 Independent clinical monitors were 
set  
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Melchart‟s study, point selection was based on four types of CM patterns of TTH and 
locations of headache. In Endres‟ study, additional points on affected meridians were also 
chosen. Both studies required De-Qi upon needling. It was not mandatory in Melchart‟s 
study; and; whereas in Endres‟ study, De-Qi was required to be elicited at all points during 
the treatment and repeated De-Qi was achieved by manipulating needles two or three 
times during a treatment session.  
 
Furthermore, in Endres‟ study protocol-adherence was enforced with trial monitors visiting 
the centres regularly; in Melchart‟s study, administration of the trial was not described. In 
that study, one centre did not use two (GB20, GB21) out of three mandatory points as the 
points were considered unnecessary for the majority of patients by the trial practitioners 
at the centre. Data from the centre were excluded from the final outcome. Nevertheless 
the incident highlighted the importance of protocol adherence and trial monitoring.  
 
 
3.4  Discussion  
When all eligible trials were included, result from meta-analysis showed no statistically 
significant difference between real and sham acupuncture on headache days. By exploring 
the source of heterogeneity through subgroup analyses, we found that mode of 
acupuncture stimulation, duration of needle retention and frequency of treatment could be 
the contributing factors to a lack of difference. The impact of the number of trial centre on 
the outcome of acupuncture treatment for TTH is not clear. Through qualitative analysis of 
two multi-centre trials, we further identified that adherence to treatment protocol could be 
another key contributing factor for multicentre trials.  
 
3.4.1  A comparison with other reviews  
Among four existing meta-analyses comparing the effectiveness of real with sham 
acupuncture intervention [10, 349, 355, 374, 375], only two used the headache days as 
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one of the outcome measures [10, 355], including the latest Cochrane review by Linde and 
colleagues finding that real acupuncture was significantly better than sham acupuncture 
on reducing headache days (WMD -1.56; 95% CI -3.02 to -0.10), and the other by Davis 
which concluded no difference between the two interventions,  same as ours, and 
considerable heterogeneity existed.  
 
The Linde review included four out of five studies selected for the current review. They 
excluded one cross-over EA study because that study had less than eight weeks 
observation period from its randomisation. However the same five studies in the current 
review were included in the Davis review. We included the EA study because we 
considered a six-week observation period be sufficient to detect the short-term effect of 
acupuncture. Data after cross-over phase were not used in our review.  
 
We utilised subgroup analyses to explore the source of heterogeneity, which was not 
conducted in either of the two reviews. Subgroup analyses are frequently used to extract 
valuable information from RCTs [376-378]. It has also been applied in acupuncture 
systematic reviews to investigate and interpret heterogeneity [379]. To ensure that only 
high quality studies were included, we employed three commonly used scales, i.e., Jadad, 
IVS and OPRS, considering selection bias, performance bias and attrition bias, as well as 
the sample size and outcome measures used in pain studies. We found all five studies 
being of high reporting and methodological quality.  Results of the analyses are discussed 
in the following sections.   
 
3.4.2  Methodological quality of the study design  
A variety of methodological assessment tools have been generated to evaluate the quality 
of studies. We employed three commonly used scales: Jadad assessing reporting quality, 
IVS assessing internally validity and OPRS focusing on validity of pain studies. We found 
that all five studies were of high quality based on all three scales. Results of the Jadad and 
IVS were highly correlated, indicating they assessed the similar attributes of the studies. 
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OPRS includes an assessment of the sample size and outcome measures in additional to 
selection bias, performance bias and attrition bias included in Jadad and IVS. 
Consequently OPRS scores were not correlated with either Jadad or IVS. For future 
reviews on pain studies, OPRS is more appropriate given its comprehensiveness.  
 
3.4.3  Adequacy of acupuncture treatment and reporting of treatment 
details  
One of the problems in the existing systematic reviews of acupuncture is that adequacy 
and quality of treatment was seldom assessed in the reviews [380]. Including studies with 
inadequate treatment in any reviews will distort the conclusion of the systematic reviews 
[380-382]. The Standards for Reporting Interventions in Controlled Trials of Acupuncture 
(STRICTA) has been developed and revised to guide the reporting of acupuncture 
treatment, but not quality of the treatment design and delivery. In the published reviews, 
the adequacy of acupuncture treatment is often judged by acupuncturists on the review 
team based on their clinical experience without stating the criteria [365] or with the 
criteria without supporting evidence that such criteria are essential [383]. 
 
Researchers have recognized that trial design and reporting quality of acupuncture 
intervention only reflect part of the quality of acupuncture trials. Adequacy of acupuncture 
treatment is equally important. A recent study using the Dephi method [360] attempted to 
identify contributing factors as recommended by experts. Mode of acupuncture, frequency 
of treatment and needle manipulation, identified in the current review, were also 
recommended by experts as key contributing factors.  
 
3.4.3.1  De-Qi 
De-Qi is regarded as the essential part of acupuncture and the predictor of a positive 
outcome during a acupuncture treatment [384]. Evidence has shown that subjects 
experienced De-Qi sensation had a better responder than those who did not experienced 
that [384]. 
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A strong correlation between De-Qi and analgesic effect was found in healthy 
humans[385]. Of the included studies in this review, one study (Melchart 2005) 
mentioned De-Qi was required without specifying for how long and on which points; 
whereas the other study (Endres 2007) required De-Qi to be achieved in all points and to 
be elicited repeated for two to three times during the treatment. However, due to the 
insufficient and ambiguous statement of De-Qi, subgroup analysis was not performed.  
 
Future research needs to identify to what degree that the duration and intensity of De-Qi 
contribute to the outcome of acupuncture treatment.  
 
3.4.3.2  Stimulation mode: EA versus MA  
Literature suggested that while evaluating the result from one style of acupuncture, no 
matter positive or negative, consideration should be given on that 1) do these protocols 
accurately represent Ease Asian practice and the tradition of experience in which it is 
based and 2) do these protocols reflect as adaption of Chinese medicine, and if so is this 
version of Chinese medicine substantiated in either the East Asian medical tradition or in 
scientific terms? [386]. Furthermore, assessment of acupuncture clinical efficacy need to 
consider the style it was used, especially between traditionally based and innovative styles 
of acupuncture [387].  
 
In this review, the study with EA produced the best result in headache reduction than MA 
did. EA has found to be effective in reducing pain by other researchers [388, 389]. Up to 
now, there has not been any study directly comparing EA with MA on TTH. However, 
comparisons were made in some other areas, EA was better than MA in treating patients 
with tennis elbow [390], knee osteoarthritis [391] and fibromyalgia syndrome [379].  
 
During the past a few years, functional magnetic resonance imaging (fMRI) has been used 
to examine correlations between acupoint stimulation and brain activity [392]. A human 
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study showed that EA produced a more widespread signal increase in the brain than MA 
did when measured with fMRI [393]. Results from an animal study which compared 
analgesic effects of MA, EA and Transcutaneous Electric Nerve Stimulation (TENS) 
confirmed EA produced a greater analgesic effect than the other two interventions [394]. 
Results from a healthy human study also confirmed that EA produced a greater analgesic 
effect than MA or sham acupuncture did [395]. Future SRs needs to separate EA from MA 
for analysis when possible. 
 
3.4.3.3  Needle retention  
Currently, standards or guidelines of needle retention time are not available. In the Delphi 
study mentioned above, experts had diverse view about needling retention. The items of 
a minimum of 20-minute needle retention and twice a week treatment were excluded from 
the final list because the agreement was 78.5% and 66.6%, respectively, not reaching 80% 
the cut-off points.  
 
Needled retention is necessary as the effect of acupuncture appeared after a latent period 
[396]. In most acupuncture clinical trials for headache, 20-30 minutes treatments with 
more than 10 minutes needle retention per session were applied [397-401]. A study for 
cerebral palsy reported that the group with needle retention of 30 minutes had better 
results than the group with 5 minutes needle retention [402]. Even for the EA stimulation, 
one recent study also identified 15-20 minutes was better than that of 5 minutes or 10 
minutes [403].  
 
In White‟s study [369], there was no needle retention but needles were applied only 15 
seconds or taken out immediately right after De-Qi. This type of short-duration of needling 
is not a conventional acupuncture treatment, and the study is not comparable to others.  
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3.4.3.4  Treatment frequency 
Another factor is the frequency of treatment. One study in this review applied weekly 
treatment, which was regarded insufficient to produce analgesia effect [384]. Short 
needle retention time together with inadequate acupuncture treatment frequency, for 
example, weekly 5-minute treatment, could underestimate the treatment effect [404].  
 
3.4.3.5  Other factors identified  
Other potential factors identified through qualitative analyses of the data in this reviews 
are De-Qi, point selection, CM diagnosis, background of trial acupuncturist and adherence 
to trial protocol. Due to insufficient data, we did not conduct subgroup analyses.  
 
Studies included in this review had two categories of point selection, i.e., fixed or 
semi-standardised point selection. This is common in all acupuncture trials. For example, 
in acupuncture for chronic low back pain (cLBP), points selection has been based on fixed 
points [405-407] or according to affected meridians, CM patterns [408-410]. However for 
headache, researchers concluded that fixed, predetermined acupuncture treatment 
protocol was not suggested in headache clinical trials [411], given the varieties of 
headache presentations. Individualised or semi-standardised point selection requires 
standard CM diagnosis of TTH. In the present review, three studies mentioned CM 
diagnosis [348, 370, 372] , two of those [348, 370] made further description on how CM 
diagnosis was performed by the practitioners. For instance, tongue and pulse diagnosis, 
meridian diagnosis and / or diagnostic questionnaire could be used to standardise the 
process. Variations in these studies also indicate a need to establish the CM differentiation 
diagnosis of TTH before further acupuncture trials being conducted. 
 
Related to diagnosis is the education and clinical background of trial acupuncturists. In 
non-pharmacological trials, the quality of treatment largely rely on the skills and 
experience of those who deliver the treatment [412].  
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Most pharmacological studies assume that patients are given similar treatment as the 
treatment is given independently from any human intervention. This however is not the 
case in non-pharmacological interventions, such as acupuncture. Are trial acupuncturists 
trained to make CM diagnosis? For instance, is it adequate to have western medical 
acupuncturists to make CM diagnosis and select points accordingly as in the two trials 
included in this review [350, 370] ? 
 
Multicentre studies inevitably encounter more problems than single centre trials, 
especially in non-pharmacological studies. As described previously, the delivery of 
intervention could vary from one to another even the same protocol is used. As a result, 
reporting and assessment on how adherence of care providers with the protocol is 
imperative [412]. Of the three multicentre studies [350, 369, 370] included in the present 
review, descriptions on how protocol adherence can be identified from two of them [350, 
370], with one having regular monitoring and the other not. A careful monitoring is 
necessary for ensuring the credible results [413]. In addition, the quality of 
non-pharmacological treatment largely relies on the skills and experience of the trial 
practitioners. As a result, skilled practitioners and reporting and assessment on 
protocol-adherence  are imperative [412].  
 
3.4.3.6  Point selection: fixed points versus individualised     
There is not such an universal acupuncture treatment standard for specific conditions, as 
acupuncture is of heterogeneous [388]. The studies in this review involved two categories 
of point selection, i.e., fixed or manualised point selection. This is common in all 
acupuncture trials. For example, in acupuncture for cLBP, some trials used fixed points 
[405-407] while others [408, 409] applied individualised point selection according to 
affected meridians, CM patterns or phases [410].   
 
Although fixed point selection protocol was proved to be effective for some conditions 
[414], for instance, knee pain and emesis [415-417]. After an investigation on the 
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variability of CM diagnosis and point selection for frequent headache subjects, 
investigators concluded that fixed, predetermined acupuncture treatment protocol was 
not suggested in headache clinical trials [411], since the diagnosis might be varied.   
 
Also, subgroup analysis from a review study on fibromyalgia support individual acupoint 
selection had significant effects on pain [379]. In addition, there is a tendency in recent 
years to use manualised semi-structured acupuncture treatment, with obligatory points 
plus optional points or individual points in point selection [373, 401, 409, 418-421]. 
Individualisation treatment was regarded to be the standard clinical approach for some 
complex clinical conditions [414].  
 
Manualisation not only promote standardisation and flexibility of treatment, but also 
balances the need of individualised treatment and replicability requirement in designing 
acupuncture treatment protocols [387] [414].  
 
3.4.3.7  Chinese medicine (CM) diagnosis  
Headache as a symptom has a variety of CM diagnosis. As TTH is not an established CM 
disease category, descriptions in TCM textbooks include headache due to either external 
factors as a common cold or flu, or from internal disorders without limiting the discussion 
to TTH or migraine. These two types of headache has been shown to share some common 
TCM patterns [422].  
 
Literature in CM diagnosis of TTH is limited, yet there is no golden CM standard to classify 
TTH, since none established TTH eligibility criteria in CM diagnosis [411]. Due to this, 
differentiation diagnostic criteria of pattern identification in treatment varied which 
subsequently lead to variation in selection of acupuncture points and needling techniques 
[411]. However, CM diagnosis is of value and essential in both acupoint selection and 
needling procedures [404]. Description on how practitioners applied CM diagnosis is more 
meaningful than simply stating whether CM diagnosis was carried out given CM pattern 
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diagnosis are based on subjective information collected by trial practitioners and there is 
a high inter-rater variability [423, 424]. In the present review, three studies mentioned 
CM diagnosis [348, 370, 372], two of those [348, 370] made further description on how 
CM diagnosis was performed by the practitioners. For instance, tongue and pulse 
diagnosis, meridian diagnosis and / or diagnostic questionnaire could be used to 
standardise the process. 
 
Variations in these studies also indicate a need to establish the CM differentiation 
diagnosis of TTH before further acupuncture trials being conducted. This will help identify 
the significance of clinical outcome led by the variation from acupuncturists‟ diagnosis and 
point selection [411].  
 
3.4.3.8  Practitioners’ background 
Reporting of practitioners‟ background is necessary, especially in non-pharmacological 
trials where the quality of treatment largely rely on the skills and experience of those who 
deliver the treatment. Most pharmacological studies assumed that patients were given 
equally similar treatment by the same physician or in same centre and the observed 
outcome was independent from any human intervention. However in nonpharmacologic 
trials, subjects treatment received by the subjects might be different due to the skill and 
training of the practitioners [412].  
 
Patient outcome was associated with care providers in nonpharmacologic treatments, as 
differential expertise applied by different care providers would lead to different treatment 
outcomes [412]. As one of the nonpharmacologic intervention, acupuncture treatment 
also encounters the same situation since it is an experience and technique based skill. 
Consequently it is almost impossible to conduct a double-blind trial. Although it has been 
suggested to use acupuncture naïve persons to administer the treatment [425], this 
approach is neither scientific nor ethical [426].  
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This item is particularly important to multi-centre trials where more than one trial 
acupuncturists are employed. Although STRICTA had three items pertained to details of 
acupuncturists‟ background, it has still been questioned as it is impossible to measuring 
practitioners‟ expertise based on the information [427]. And in multicentre trials, 
clustering effect which refers to the participants treated by the same practitioner or in one 
centre [428] might be resulted. The treatment result may vary from one practitioner to 
another, or from one centre to another. In such circumstance, reporting number of 
practitioners could help for the appraisal of the validity of a nonpharmacologic trial [428], 
as how many participants were treated by per practitioners could be calculated. By 
identifying this together with the intracluster correlation coefficient which was defined as 
the correlations between any 2 participants treated by the same practitioner or centre 
would help enhancing its/trials‟ statistical power [428]. Otherwise by using standard 
methods of analysis with ignorance of clustering effect could lead to incorrect estimation of 
treatment [429-434]. These methods are used after trials.  
 
To prevent the variations in treatment delivery, trial acupuncturists need to be carefully 
trained and assessed on their performance prior to the commencement of the trial [435]. 
Furthermore, ongoing assessment and monitoring during the trial are essential. Video 
recording of treatment sessions at random could be a solution.  
 
Such information should be reported together with practitioners‟ background including 
professional qualifications, how many years in practice, how many interventions have 
performed, and how advanced the practitioner is in the treatment delivered. For instance 
it is not feasible to employ a practitioner specialised in Japanese acupuncture to perform 
Chinese style needling; equally inadequate is to ask medically train acupuncturists to 
perform CM diagnosis and select points accordingly.  
 
Lacking adequate reporting of these information will lead to limited opportunities for 
readers to appraise risks of bias and applicability of the trial outcomes [436] . 
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3.4.3.9  Protocol-adherence and treatment administration in multicentre trials 
Multicentre studies inevitably encounter more problems than single centre trials, 
especially in non-pharmacological studies. As described previously, the delivery of 
intervention could vary from one to another even the same protocol is used. As a result, 
reporting and assessment on how adherence of care providers with the protocol is 
imperative [412]. Of the three multicentre studies [350, 369, 370] included in the present 
review, descriptions on how protocol adherence can be identified from two of them [350, 
370], with one having regular monitoring and the other not. A careful monitoring is 
necessary for ensuring the credible results [413].  
 
Administration of trial intervention reflects the quality standard of a trial, and it includes 
the process of diagnosis, performance of treatment and adherence to the protocol. Of the 
three multicentre studies [350, 369, 370] included in the present review, descriptions on 
how protocol adherence can be identified from two of them [350, 370]. However, two 
studies varied from theirs administration adherence in aspect of treatment regime, which 
could have contributed to the different outcome.  
 
Poor protocol-adherence could bias the trial [437]. Although trial acupuncturists might be 
received some training prior to commencement of the trial, it‟s still remain a challenge 
whether treatment is consistently conducted during the trial because nonpharmarcological 
investigators, might act differently to the normal roles as clinicians [438].  
 
With the two German multicentre trials, one [370] complied the protocol however another 
did not. A careful monitoring will guarantee the credible results [413] and ensures the trial 
acupuncturists to adhere to the set protocol to maintain a high quality control [438] as well 
as ensure acupuncture trials to be considered equally as valid and scientifically rigorous as 
pharmaceutical clinical trials [439].  
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3.4.4  Strengths and limitations  
This review is among the first studies that explore the contributing factors to inconsistent 
findings from systematic reviews of acupuncture on TTH. It does not aim to assess the 
effect and safety of acupuncture for TTH as other systematic reviews aimed to achieve, nor 
make conclusion on which would make more efficacy between active and placebo 
intervention. But more importantly, there was a huge heterogeneity from the different 
acupuncture treatments deserve to be considered. It is however the first study that 
exploring the various factors which might influence the treatment outcome into 
consideration. This review contributed to discussion on the components would affect the 
effectiveness in treating TTH by exploring the heterogeneity.  
 
As a result, we included all sham-acupuncture controlled trials without including studies 
comparing real acupuncture with no acupuncture or other active treatments. We 
contacted authors of two studies [369, 371] with insufficient data, but did not obtain a 
reply from them. Also, we have systematically searched Chinese literatures from the 
leading Chinese databases, but none met the selection criteria.   
 
Acupuncture styles and treatment protocol used in the clinical trials and in usual practice 
have a wide variety but lacking of consensus on the optimal treatment. To some extent, 
that can be regarded as some patients were not able to receive best treatment which 
finally contributed to the negative outcome and make it difficult to explain the difference 
in effectiveness with sham acupuncture [382].  
 
The limitation of this review is the small sample size with only five studies meeting the 
selection criteria.  As a result, some potential factors, such as obtaining De-Qi during the 
treatment, CM diagnosis and point selection were not able to be explored. Furthermore, 
the conclusion of the current review is limited by the weakness of subgroup analyses, 
which help identify the source of heterogeneity, but do not provide definite answers as 
studies that directly compare the factors do. For instance, EA was found to be better than 
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MA in the current review. A definite conclusion can only be drawn when EA and MA are 
compared in a study. 
 
A consensus on quality acupuncture needs to be reached. The Delphi study by Smith and 
colleagues has provided the first step. Our review illustrates the importance of some 
factors. The factors identified from the Delphi and this review should be assessed via 
subgroup analyses planned in systematic reviews of acupuncture and purposely designed 
trials in patients and healthy humans.  
 
 
3.5  Conclusion  
Evidence of acupuncture for TTH depends on the studies selected. This is due to the 
considerable heterogeneity among acupuncture trials. This chapter identifies that the 
stimulation mode, needle retention and treatment frequency are important factors 
contributing to the outcome of acupuncture treatment for TTH.  
 
Other factors such as number of trial sites, point selection, practitioner training and 
protocol-adherence could also be important. Ideal acupuncture treatment protocol for TTH 
is EA with 30 minute needle retention and twice weekly treatment. To ensure systematic 
reviews and trials of acupuncture are of high quality, consensus on quality acupuncture 
treatment and administration need to be established with evidence-based approaches. To 
improve quality of acupuncture treatment, standards of adequate acupuncture treatment 
and administration need to be established. Special attentions need to be paid to the 
needling techniques, point selection, training of the trial acupuncturist and monitoring of 
the treatment performance.   
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4.1  Introduction 
This chapter provides background information about questionnaire design and its 
development processes. This chapter starts with general concepts related to questionnaire 
(Section 4.2), such as the types of questionnaires, type of questions and responses. 
Section 4.3 illustrates the development steps of the questionnaire. Sections 4.4 and 4.5 
elaborate on varies types of reliability and validity to assess the quality of questionnaires. 
Section 4.6 summaries the whole chapter. 
 
 
4.2  General concepts of questionnaire 
Questionnaires are the most frequently used research instrument. In many areas, it 
serves as a major source of information in data collection. In healthcare research, 
questionnaires are the most frequently used data collection method [440].  
 
A questionnaire is defined as a document containing a series of questions designed to 
obtain statically valuable information about a given topic [441]. Questionnaires are 
structured surveys [442]. 
 
Being a type of survey, questionnaire is systematically gathering a wide range of 
information from a large number of individuals, often referred to as respondents. Answers 
obtained from questionnaires are often standarised which make it simple for data 
compiling and further measurements [443]. 
 
Self-administered questionnaires, or completed by respondents on their own, are the most 
frequently used form because it is cheap and easy to administer and does not require  the 
presence of the researcher [444]. Completing self-administrated questionnaires can either 
on paper, or online [442]. Basically, depends on the methods of administering, its data 
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collection operations can be in forms of face-to-face, postal, telephone approaches and 
web-based or electronic questionnaire (Table 16). 
 
Table 16. Types of questionnaires 
 
Type of 
questionnaires 
Administering 
methods 
Advantages Disadvantages/Demerits 
Face-to-face 
/Group 
administered 
questionnaire 
Questionnaires 
delivered in group 
settings 
 Easy to distribute 
 Highest response rate 
 Allow respondents assisted 
and comprehended with 
questions being asked  
 Allow for large number of 
questions 
 Verbal (facial) expressions can 
be noted 
 Good for complex questions 
 Reduced missing answers 
 Expensive data collection 
method 
 Less anonymous 
 May take long time to complete 
 Answering personal questions 
are likely to be embarrassed 
Postal 
questionnaire 
Questionnaires 
mailed to 
respondents 
 Inexpensive data collection 
method 
 Cover respondents dispersed 
over a wide geographical area  
 Respondents have more time 
to complete questionnaires at 
home 
 No distributor to explain 
questions if questions are not 
understood by respondents 
 Respondents may not return 
questionnaires 
 Reading and writing skills 
required to respondents 
 No opportunity to correct 
misunderstanding 
 Not suitable when quick reply is 
required 
  
Telephone 
questionnaire 
Asking questions 
via telephone 
 Quick response and fast data 
collection method 
 No requirements on 
respondents‟ reading and 
writing skills 
 Respondents may feel more 
comfortable answering 
personal questions 
 More costly than other 
questionnaire methods 
 Time consuming  
 Difficulty in obtain 
respondent‟s phone numbers 
 Calling at random can annoy 
respondents  
 Subject to the respondents 
availability and their 
willingness of participating  
 Questions cannot be too 
complex  
 Limited number of questions 
Web-based and 
electronic 
questionnaire 
Sending 
questionnaires 
via e-mail; or 
inviting 
respondent to 
complete 
questionnaire 
online 
 Inexpensive data collection 
method 
 Easy to distribute 
 Wider sample coverage 
 Saving times to contact 
respondents 
 Easy to send reminder 
 Reduced labor for data input 
 Reports can be generated by 
program software 
 More anonymous 
 Respondents may limit as 
computer skills and internet 
access required 
 Response rate may be low 
 No opportunity to correct 
misunderstanding 
 No contacts with respondents  
Source: [442, 444-450] 
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4.2.1  Type of questions  
Questions of a questionnaire fall into two main types: open-ended and closed-ended. The 
open-ended questions are also known as free text response, or free answer questions. 
There are neither any options nor predefined categories suggested in this type of 
questions. In open-ended questions, respondents answer the questions in their own words. 
Since this form of questions do not place restrictions on its answers, open-ended questions 
are valuable in exploratory investigation and can be useful to the early stage of developing 
a questionnaire and thus is often included in pilot studies [440, 451].  
 
Close-ended questions are the most common type of questions. Unlike open-ended 
questions, the close-ended questions provide a range of the most likely answers to 
respondents for determination [452]. This type of questions normally equipped with 
multiple-choice options and predefines the set of responses and as well as its format. Due 
to the answers of close-ended questions are pre-determined to a finite, which may restrict 
the depth of respondents‟ responses. As a result, the answers are likely more consistent 
among respondents and easier to analyse than open-ended questions [452]. Sometimes 
this distinct characteristic is also regarded as the main limitation of the close-ended 
questionnaire, as it may “force” respondent to provide answers between given alternatives 
that may not truly reflect their opinions [453]. Nevertheless, close-ended questions have 
several advantages as this type of questions tends to be relatively easy to score, analyse 
and interpret [454]. When comparing with the open-ended questions, they are quicker to 
be answered thus enables obtaining more information within a limited time frame. 
Responses obtained from such questionnaires are easier to be coded and thus makes data 
entry and analysis easier.  
 
A list of question types is shown in Table 17. 
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Table 17. Examples of Types of Questions 
 
Type Sample Question Sample Response Options 
Date What is your birth date? _ _._ _._ _ _ _ 
mm-dd-y y y y 
Numeric What is your height? _ _. _ inches 
Yes/No During your lifetime, have you smoked 
more than 100 cigarettes? 
□ YES 
□ NO 
Categorical/Multiple
-choice: nominal 
What is your sex? 
 
□ Female 
□ Male 
What is your favorite type of film? 
 
□ Action/drama 
□ Comedy/musical 
□ Documentary 
□ Other:_______ 
Categorical/Multiple
-choice: ordinal 
(ranked) 
What is the highest level of education you 
have completed? 
□ Less than high school 
□ High school 
□ Some college but no degree 
□ College degree or more advanced 
How much do you agree with this 
statement:  
“No matter how much I exercise, I will not 
be able to lose weight.” 
□ Strongly  disagree 
□ Disagree 
□ Neutral 
□ Agree 
□ Strongly agree 
On a scale of 1 to 5, with 1 meaning poor 
and 5 meaning excellent, how would you 
rate your hearing? 
 
Poor   --------  Excellent 
□1  □2  □3  □4  □5 
Paired-comparisons  Do you prefer to drink coffee or tea? □ I prefer coffee 
□ I prefer tea 
□ I like coffee and tea equally 
□ I do not drink coffee or tea 
Rank-ordering List the following four political issues in 
order from most important to you (1) to 
lease important to you (4): crime/safety, 
environment/energy, foreign 
policy/defense, taxes/revenue 
Number from 1 (most important) to 4 
(least important): 
__ Crime/safety 
__ Environment/energy 
__ Foreign policy/defense 
__ Taxes/revenue 
Open-ended/free-re
sponse 
What is your biggest personal health 
concern at present? 
 
(______________________) 
Adapted from ref.[453] with modification 
 
4.2.2  Type of responses   
Depends on the types of format, questionnaires can be structured or unstructured. 
Unstructured questionnaires usually refer to questionnaires formulated around 
open-ended questions and opinion-type questions. Information obtained from such 
questionnaires is often in qualitative. Qualitative data is not in numerical form but 
typically descriptive data without limitation to words or text, as it could be also videos, 
sound recordings, photos, and so on [455]. Structured questionnaires usually consist 
of closed questions with predefined choices of answers and often associated with 
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quantitative data collection operations. Quantitative data is often collected in form of 
numbers. As the numerical data can be assigned into categories, or measured in unites 
and comparatively straightforward to analysis, quantitative data is regarded to be easier 
to analyse than qualitative data [456].  
 
Of the responses in a questionnaire, any variable that is not quantitative is qualitative, or 
categorical. Categorical variables are observation sorted into categories, for example, 
gender, ethenicity, or place of birth. Such values have no numerical meaning when 
measured. Categorical variables can be as simple as between two choices, known as 
dichotomous variables (responses), or they can be multi-chotomous, ranked or 
rated. Dichotomous responses refer to a two-item response, such as Yes/No, or 
True/False response; whereas multi-chotomous responses refer to more than two 
responses, such response also known as multiple-choice response, for example, 
Yes,No,Maybe; or High,Medium,Low.  
 
Ranked responses (Table 1818) are those items for which the individual responses put 
in order from smallest to largest (e.g.,1st, 2nd, 3rd, etc.) used to compare different items 
directly to one another, whereas the rated responses are items provided to compare 
items and degree the indication of individuals opinions (e.g., “completely agree, mostly 
agree, mostly disagree, completely disagree”). 
 
Table 18. Examples of Responses for Ranked Questions 
 
Categories Response formats 
Level of 
Satisfaction 
(7-point) 
1 2 3 4 5 6 7 
Completely 
dissatisfied 
Mostly 
dissatisfied 
Somewhat 
dissatisfied 
Neither 
satisfied or 
dissatisfied 
Somewhat 
satisfied 
Mostly 
satisfied 
Completely 
satisfied 
Level of 
Acceptability 
(7-point) 
1 2 3 4 5 6 7 
Totally 
unacceptable 
Unacceptable Slightly 
unacceptable 
Neutral Slightly 
acceptable 
Acceptable Perfectly 
Acceptable 
Level of 
Importance 
(7-point) 
1 2 3 4 5 6 7 
Not at all 
important 
Low 
importance 
Slightly 
important 
Neutral Moderately 
important 
Very 
important 
Extremely 
important 
Level of 1 2 3 4 5   
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Familiarity 
(5-point) 
Not at all 
familiar   
Slightly 
familiar 
Somewhat 
familiar 
Moderately 
familiar 
Extremely 
familiar 
  
Frequency  
(5-point) 
1 2 3 4 5   
Never Rarely Sometimes Often Always   
Level of 
Concern 
(5-point) 
1 2 3 4 5   
Not at all 
concerned 
Slightly 
concerned 
Somewhat 
concerned 
Moderately 
concerned 
Extremely 
concerned 
  
Level of 
Desirability 
(5-point) 
1 2 3 4 5   
Very 
undesirable  
Undesirable Neutral Desirable Very 
desirable 
  
Likelihood 
(5-point) 
1 2 3 4 5   
Extremely 
unlikely 
unlikely Neutral Likely   Extremely 
likely 
  
Level of 
Quality 
(5-point) 
1 2 3 4 5   
Poor   Fair   Good Very good   Excellent     
Level of 
Participation 
(3-point) 
1 2 3     
No, and not 
considered 
No, but 
considered 
Yes     
Level of 
Consideration 
(3-point) 
 
1 2 3     
Would not 
consider 
Might or 
might not 
consider 
Definitely 
consider 
    
Source:[457] 
 
According to the level of measurement, dichotomous and multi-chotomous responses 
belong to nominal variables whereas the ranked or rated responses belong to ordinal 
variables (Table 19).  
 
Table 19. Type of variables 
 
Type of variables Definitions Characteristics Examples in medicine 
 
 
Qualitative  
 
Nominal  Variables are 
classified into 
categories that 
describe the 
characteristic.  
 no intrinsic order of 
categories (order is 
arbitrary) 
 no measure of distance 
between values 
 Gender  
 Blood type  
Ordinal Variables have an 
inherent order to the 
relationship 
 categories are in 
implied ordering of 
categories   
 variables are ordered or 
ranked  
 distance between levels 
is unknown or may not 
be the same 
 Stage of cancer 
 Satisfaction level  
 
 
 
Quantitative 
 
Interval  Variables have 
constant, equal 
distances between 
values 
 variables can be 
measured along a 
continuum and have a 
numerical value 
 zero point is arbitrary 
 the difference between 
two values is 
meaningful  
 Pain level (0-10) 
 Intelligence (IQ test 
score) 
 119 
 
Ratio Variables have equal 
intervals between 
values 
 zero of the 
measurement indicates 
that there is none of 
that variable 
 numerical relationship 
between numbers is 
meaningful 
 Weight 
 Height 
 Pulse rate 
Sources: [458, 459]  
 
To sum up, responses of questionnaires can be qualitative or quantitative depends on the 
purpose of the observer. According to the levels of measurement, they are hierarchically 
categorised into four levels of nominal, ordinal, interval and ratio (Table 17).  
 
 
4.3  Questionnaire development steps 
A well-designed questionnaire takes considerable time to develop. The development of a 
questionnaire is made up of five sequential steps (Figure 19). 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 19. Questionnaire development process 
 
Preliminary identifying 
research questions 
Questionnaire 
conceptualisation 
 
Questionnaire 
construction 
Pre-test (piloting) and 
revision of questionnaire 
Establishing reliability 
and validity 
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4.3.1  Preliminary identifying research questions  
It is important to be clear about the aims of developing a specific questionnaire in this 
initial step. Having a thorough understanding of the research background is essential or a 
requisite. Searching and reading literature are helpful to the determination of the purpose, 
objectives, research questions, and hypothesis of the proposed research. Determining the 
subject population, identifying general question categories, such as type of questions to 
be used, selecting specific question topics, proposing the methods for administrating the 
questionnaire, and considering the approach to sampling are also parts of this step. 
 
4.3.2  Questionnaire conceptualisation (Item generation) 
The second step is about questionnaire conceptualisation by generating items and 
constructing questions. Item generation requires substantial work and efforts. In this step, 
information extracted from different sources is transformed into items or questions that 
are directly involving the next step of the questionnaire construction. Literatures, 
theoretical framework, or expert opinions are sources for item generation.  
 
In addition, an initial rough listing of variables is suggested to be composed prior to the 
questionnaire constructing. Such listing, called item pool, contributes to the establishment 
of important domains under a theoretical framework. Potential items and questions that 
could be included in the proposed questionnaire are required to be listed as 
comprehensive as possible to match the variables appear in the conceptual framework.  
 
4.3.3  Questionnaire construction 
Constructing questionnaire is the third step, which serves the core process of 
questionnaire development. In this step, a series of components of questionnaire are 
involved as they may influence the quality of a questionnaire and have important 
consequences to its development process. 
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These components including determining question structure and format of response; 
selecting appropriate measuring scales; wording and phrasing quesitons; ordering 
question sequence; and, finalising layout of questionnaire. 
 
4.3.3.1  Determining question structure and format of response  
Every question requires a response. Questions and their responses are highly correlated 
properties. Consideration to both properties provide basis for effective measuring. 
Responses to questions are subject to the question types, design and the objectives of the 
questionnaire investigation. Although a wide variety of question options are available. The 
extensively used type of questioning in large formal surveys is close-ended questions.  
 
The close-ended questions may include a variety of responses formats, such as date and 
time variables, numeric variables and categorical variables [453]. The date and 
time variables are used to calculate the length of time. Numerical variables are 
responses in numerical values, which measures subject into actual precise numbers, such 
as height or length [454]. For example, numerical values of “how many” or “how much”. 
For numeric variables, values are numbers displayed in standard numeric format. For 
instance, “8” as the number of days on headache in one month, or “2” of kilogram of 
weight change within one week. In contrast to numeric variables, categorical variables 
do not measured or counted; this type of responses does not have numbers on their values 
but in format of a set of categories. 
 
Information obtained using the closed-ended questions normally in one of the three 
ways/forms, choosing one best answer from a number of independent options, choosing 
one answer from two options, and choosing one most appropriate answer from a rating 
scale.  
 
In close–ended questions, the often referred multiple-choice questions are suggested to 
be applied into questionnaire whenever possible. This type of questions only asks 
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respondents to select the best possible answer out of the choices from a list of pre-defined 
options. In this form, a list of response categories are provided, and the respondents need 
to select one or more of the alternatives as a response to each question. Responses to 
close-ended questions can be formed into single-answer options or multiple-answer 
options. The single-answer questions allow only one answer to be chosen, whereas the 
multiple-answer questions allow more than one answers. Multiple-choice questions are 
effective assessment technique. They are easy to administer, to code and analyse. In 
addition, such questions often require less time to complete than those materials requiring 
written responses.  
 
Applying the close–ended questions into a questionnaire does have its drawbacks. To 
overcome some of the disadvantages, a „Don‟t know‟ category can be considered if not all 
of the respondents familiar with the pre-defined answers. In addition, response categories 
may not always adequately cover options what the respondent wants to convey. Hence, it 
is beneficial to provide an “other” option that link to an open field which allows 
respondents to provide their own opinion under such circumstance, although such 
responses can be time consuming. 
 
4.3.3.2  Selecting appropriate measuring scales       
Scales are widely used quantitative technique. The purpose of applying scales in 
questionnaires is to distinguish different intensities of characteristic on a particular 
variable among respondents, such as level of importance or familiarities [442] [460]. 
Selecting appropriate measuring scales is an important component in constructing a 
questionnaire, as the survey results can be impacted by the scales chosen. Basically, the 
scaling variables (responses) fall into classifications of categorical, numerical and ordinal 
[453]. 
 
Categorical scales are used to classify items according to whether they have more or 
less of a characteristic. This type of scales refers to the qualitative classification technique. 
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Categorical scales are also known as nominal scales. In such scales, variables 
(responses, categories) cannot be quantified or even listed in ranking orders, however can 
only be measured when the individual items belong to certain distinct categories [461]. In 
nominal scales, categories have no natural orders for each other. Using this type of scales, 
the response categories are listed for respondents to choose [454]. For example, people 
are required to choose the groups they belong to, such as gender. A nominal scale uses 
numbers for categories labeling, e.g., male=1, female=2; however the assignment could 
be arbitrary [461]. Thus, this type of scaling refer to a classification rather than a 
measurement [462]. Some other examples that can be measured on nominal scales 
include religious belief, religion or political affixation. In nominal scales, questions are 
suggested to include all possible responses. In the case that response categories listed are 
not applicable to some of the respondents, an “other” category is sometimes suggested to 
be included accordingly to relevant questions [463].  
 
Numerical scales (and date/time scales) are derived classes of the categorical 
scales [464]. Opposite to the categorical scales which classify qualitative data, numerical 
scales are a quantitative measurement method. However, this type of scales (including the 
date/time scales) inherit from categorical scale with additional functionality provided 
[465]. Scales that constructed from categorical variables translate the object values into 
numerical values. In the numerical method, responses are measured numerically.  
 
Another type of scales is ordinal scales. Ordinal scales are effective devices for 
quantitative measuring since they are easy to use and interpret. Responses involve rating 
or ranking something like attitudes, individuals, or items are often referred to this type of 
scales. As the main characteristic of the ordinal scales, response of the topic are usually 
logically listed in an inherent order of importance or degree in an ordinal scale, so as to 
permit the measurement of degrees of difference.  
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In the cases that respondents may not know or familiar to some topics, sometimes an 
alternative “neutral” options of middle category/response are accordingly included [463]. 
Some of the ordinal scales are equipped with odd numbers of 5 or 7 categories so that the 
“neutral” category such as “don‟t know”, “not applicable” "undecided/uncertain", or "no 
opinion" can be listed in the middle. Examples of such neutral category of ordinal scales in 
agreement level are strongly disagree, disagree, neutral, agree, strongly agree, whereas 
in satisfaction level are very dissatisfied, dissatisfied, neutral, satisfied, very satisfied. 
 
Rating scales and ranking scales are common ordinal scales.  
 
Ranking scales, which composed of multi choice, are the most common ordinal scales. 
Choices in ranking scales are ranked according to the level of specification. Each item in 
such scale has a unique value. Responses of the ranking scales are their answers. For 
example, in satisfaction ranking question of level of importance, respondents need to 
indicate what items are the “most important” to “least important,” from items of “not at all 
important”, “slightly important”, “important”, “fairly important”, and “very important”.  
 
Rating scales, such as frequency scales or agreement scales, are extensively used in 
research, especially in surveys. This type of scales is very structured method and easily 
understood by respondents. A rating scale provides more than two answering alternatives 
that arranged in hierarchical order and asks respondents selecting one from them [466]. 
They can be itemised into three-point, five-point, and seven-point scales that allows 
respondents provide answers in neutrality over questions. The five-point scale is the most 
common scale but the seven-point scales are becoming more prominent. As the five-point, 
and seven-point scales help respondents discriminate among choices, they are the most 
used options in questionnaires.  
 
Likert scale is an often used attitudinal measurement to uncover degrees of opinion. It is 
widely used to measure agreement, satisfaction, likelihood, frequency, quality. The Likert 
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scale, which named after its developer, is an attitude scaling technique created to quantify 
respondents‟ response on particular questions [442].  
 
In data analysis, like other ordinal scales, responses of Likert scales are easy to be coded. 
For instance in a five-point Likert scale, responses can be coded accordingly as: strongly 
disagree = 1, disagree = 2, neither agree nor disagree = 3, agree = 4, strongly agree = 5. 
In addition, since the choice of each item is quantified, scores that obtained can be added 
for the whole questionnaire. Such data collected thus can be analysed as numerical data. 
It is acceptable that the responses obtained from the ordinal scales are allowed to be 
treated as interval data as to the use of common parametric tests [440]. For example, the 
five-point Likert scale contains five ordinal values are treated as yielding interval data.  
 
4.3.3.3  Wording and phrasing questions 
Respondents are expected to provide reliable answers to each question in a questionnaire. 
However the interpretation of the question by respondents is certainly associated with the 
wording of questions. Even slight difference in the way questions are worded may confuse 
the respondents [467] and lead to incorrect interpretations, which may eventually 
influence their responses.  
 
Wording of question should be carefully dealt with. Simple and clear questions make a 
questionnaire easy to complete. Since the clear understanding of respondents on a 
questionnaire is established on their vocabulary. Poorly worded questions may confuse 
them, however may also affect content validity therefore impact on the accuracy of survey 
results.  
 
The wording and content of questions require considerable work during questionnaire 
development. Getting the wording right is one of the major difficulty in producing good 
survey questions [467]. The general principle of question wording is the question close to 
the point without ambiguity [468]. There are varies of suggestions provided in literatures 
 126 
 
guiding researchers developing questionnaires with well worded questions. In summary, 
directness, simplicity, specificity, and discreteness are four important characteristics of 
effective questions [469]. In developing a questionnaire, sentences are required to be 
succinct, free of grammatical errors [442]. Questions are advised to be written in a 
straightforward way, kept be simple and the specific questions brief, and not to ask overly 
personal or direct sentence especially when dealing with sensitive issues [469].  
 
In order to generate accurate and reliable response, several types of questions with 
wording problems should be avoided in constructing a questionnaire [453]. Summarised 
by De Vaus [470], a checklist of questioning that maybe helpful in mitigating poorly 
constructed questions is provided as follow:   
 
- Is the language simple?  
- Can the question be shortened?  
- Is the question double-barrelled?  
- Is the question leading? 
- Is the question negative?  
- Is the respondent likely to have the necessary knowledge? 
- Will the words have the same meaning to everyone? 
- Is there a prestige bias? 
- Is the question ambiguous? 
- Is the question too precise?  
- Is the frame of reference for the question sufficiently clear? 
- Does the question artificially create opinions? 
- Is personal or impersonal wording preferable? 
- Is the question wording unnecessarily detailed or objectionable? 
- Does the question have dangling alternatives? 
- Does the question contain gratuitous qualifiers? 
- Is the question a „dead giveaway‟? 
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4.3.3.4  Ordering question sequence  
Questions should be put into an appropriate sequence. The ordering of the questions is 
important and will help to create a certain flow to a survey investigation. As a general 
guideline, there are three areas need to be aware of regarding question sequence: 
opening questions, question flow, and location of sensitive questions [471]. 
 
Opening questions: At the start of a survey, simple, easy, interesting and non-threatening 
questions should be placed in the beginning of the questionnaire to put respondents at 
ease. By doing so, it may build motivation and confidence of respondents [471]. In return, 
respondents may be stimulated and encouraged in participating in the investigation. Due 
to different reasons, many respondents complete questionnaires partially. Putting the 
most significant part of information in the first half of questionnaire ensures some 
important information being obtained from those who do not complete the questionnaires.   
 
Question flow: A poorly organised questionnaire may confuse respondents and bias the 
responses. Questions should be numbered and ordered in a way that is logical to the 
respondent. Questions should be ordered as such to bring a good flow of ideas and logic to 
a survey investigation. Once a general topic has been established, all related questions 
with similar themes should come up before a second topic is raised, and presented in an 
ordered way that makes the questionnaire logical and easier to answer. Any illogical jumps 
or abrupt changes of topic may create confusion and affect the accuracy of the responses 
[471]. For some cases, adding filtering questions and conditional questions are helpful to 
filter the unsuitable respondents or avoid irrelevant questions to some group of 
respondents [471]. For instance, it could be unprofessional to ask female participants 
questions related menstrual to those menstrual cycles already ended. In such case, 
putting a filter question like “do you still have menstrual cycle?” can reduce such irrelevant 
bothering on unqualified respondents. 
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Location of sensitive questions: It is most appropriate to place the sensitive questions at 
the end of the questionnaire although there are no set rules on this. Placing such questions 
at the beginning may bias the results, or in the worst case, reject the investigation, as 
respondent may not have built up their trust and confidence to the investigation at the 
beginning of the survey. Similarly, difficult questions and demographics information are 
usually left towards the end of the survey, and then the respondent may be more willing to 
answer. 
 
4.3.3.5  Finalising layout of questionnaire 
In designing a questionnaire, the overall format and layout is important. The appearance 
of a questionnaire influences the accuracy of responses. Questionnaires need to be 
attractive, neat and orderly. Questions listed in the questionnaire are required to be 
sequenced in a logical order, and allowing a smooth transition from one topic to the next 
[472]. 
 
A number of general questionnaire design principle are suggested to ensure a 
questionnaire is of quality in its layout, which make it attractive and convenient to be 
completed. 
 
It is advisable to provide a clear instruction that explains the overall purpose of the 
investigation, including estimating how long it may take to complete the questionnaire. 
The title of survey should appear on the first page, and if possible, include the name of 
investigator and conducting organisation [450]. Such information is particularly helpful for 
self-administered questionnaires, since respondents are expected to complete 
questionnaires without any assistance [450].  
 
Questions should not be crowded in convenience of facilitating questionnaire 
administration. There must be sufficient space between questions for comfort. Section 
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breaks are also important to facilitate data entering, and segregating broader topics. 
Respondents may be confused in completing a questionnaire without section breaks. 
 
It is always better to use prominent visual elements such as brightness, color, and shape 
in questionnaires to define the desired navigational path and guide respondents to 
complete the investigation. Questions should be numbered sequentially throughout the 
questionnaire even it is divided in several sections or by several pages [471]. Appearance 
of font layout should be in proper size and clear enough for the consideration of 
respondents with some problems in visual capacity [473]. Response options should be 
pre-coded as well. In addition, there should be another option in open-ended format such 
as “others” provided. Sufficient space should be left to write for the average expected 
answer length [450].  
 
4.3.4  Pre-test and amendment 
Pre-testing questionnaire is necessary for any newly developed measures during its 
development process. Once a rough questionnaire is drafted, an important step is to carry 
out a preliminary pilot study. The prepared questionnaire should be pre-tested with a small 
sample of respondents before it is used in a full-scale survey. Pretesting questionnaire in 
pilot study is practical for detecting major defects of design. It may be costly in both time 
and money, but will avoid an even greater deal of wasted effort on the unquantifiable 
responses and uninterpretable results produced by unintelligible questions [474]. 
The pre-testing procedure also provides basis for amendment of questionnaire. 
Performing pilot testing helps identifying the likely problems by checking the vocabulary 
clarity, consistency and ambiguity, as well as highlighting items discriminate between 
respondents, or whether the responses obtained match the intended types of responses 
[440]. It is also helpful in estimating the average time for completing questionnaires. In 
this step, all aspects of a questionnaire should be tested in this pre-test procedure [460]. 
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In addition, aspects such as wording, content, question sequence, questionnaire layout 
and even instructions should also be evaluated through the procedure. 
 
Obtaining representative results from the pilot study is not the main purpose of the 
pre-test procedure. It is unnecessary to pilot questionnaire on a large number of 
respondents. The selected respondents should be representative of the target population 
in the main study and usually its sample size is between 15 and 25 [471] or 30 [460]. In 
theory, an interviewing method should be applied in piloting the questionnaire, and the 
pre-tests are best performed by personal interviews. Or if the questionnaire is in form of 
a self-completion questionnaire, it should be completed by the respondents themselves. 
 
Pre-testing questionnaire provides a chance that the questionnaire can be revised or 
restructured based on the observations. Once the feedback obtained from the pilot study, 
questions that are not providing useful information can be discarded amendments and 
revisions should be carried out to correct problems. Aspects of a questionnaire, such as 
the question content, sequence and instruction, are suggest to be examined through a 
pre-test procedure [460]. 
 
The pre-test procedure also serves as a method for item generating and questionnaire 
formulation. Open-ended questions could be applied in the pilot testing to collect 
information at a broad level. Issues most frequently reported could be included as 
close-ended questions during questionnaire revision [452]. To develop a well-established 
questionnaire, several rounds of pilot testing may be required until no further changes are 
required [453].  
 
4.3.5  Establishing reliability and validity 
In the last step of questionnaire development, questionnaires should be ready for 
establishing reliability and validity. Both concepts are the most important fundamental 
issues of questionnaire development, and measurements are supposed to be free of bias 
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and distortion [475]. Applying reliable and valid questionnaires in investigations helps 
minimizes the errors and maximizes the quality of survey investigation [447]. 
 
 
4.4  Reliability 
Reliability refers to the extent to which assessments or measuring instruments are of 
consistency or stability over time [430, 442, 476]. The concept was initially introduced 
into psychological measurement by Spearman in 1940. Reliability can be conceptualized 
into reproducibility or dependability. It is the first prerequisite of a questionnaire, 
measurement, test, observation or any measuring instrument. It is essential that 
reliability can be demonstrated, as an instrument of measurement would never be valid if 
not reliable [442]. 
 
Reliability can be estimated based on variance, a statistical concept which measures any 
dispersion and homogenous of scores within a sample. There are several types of 
reliability tests,  including test-retest reliability, interrater reliability, alternate form and 
internal consistency [442]. Among them, internal consistency, which reflects the 
consistency of the results delivered in a test, is the most often used way of measuring. 
 
4.4.1  Internal consistency 
Internal consistency evaluates individual items of a measurement in comparison with one 
another for their inter-correlation ability, ensuring that the various items measuring the 
different constructs delivery consistently appropriate results [442, 477, 478]. Several 
methods, including Cronbach‟s alpha technique and Kuder-Richardson method of rational 
equivalence, can be used.  
 
The Cronbach‟s alpha is the most commonly used method to demonstrate the internal 
consistency [479]. Alpha coefficient is an indicator to determine whether items are 
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measuring the same domain [440, 476]. It is also known as Cronbach alpha coefficient, 
coefficient alpha or coefficient alpha index. The value of this reliability coefficient ranges 
from 0 to 1.0 [442]. A higher coefficient indicates a higher reliability of the instrument, 
with 0 stands for no reliability, i.e., with full of error whereas 1.0 represents the perfect 
reliability, i.e., total absence of error. However 1.0 can never be reached as all tests have 
some error [480]. The closer a score to 1, the better the reliability is [446]. Different 
recommendations have been made regarding the acceptable reliability standards [446]. 
Generally, a test is assumed to have good internal consistency if its coefficients are above 
0.7 (and 0.8 very good), whereas the value could be decreased to 0.6 in exploratory 
research [481]. However, it would not be a reliable instrument if the value below 0.5 
[482].  
 
The Kuder-Richardson (K-R) method [483] is another method to assess internal 
consistency. The most widely used formula is the KR-20 which is developed to estimate 
reliability of a test from a single test administration [484]. Both coefficient alpha index and 
KR-20 can be used to determine the correlations among items. Nevertheless, the KR-20 
formula is typically to assess measurements with dichotomous items, e.g., responses of 
Yes or No; Right or Wrong questions; whereas the coefficient alpha estimates reliability of 
items featured with various point values, e.g., attitude responses by degrees of “a little 
agree”, “strongly agree”. In fact, KR-20 is a special case of coefficient alpha [484]. In 
addition, the coefficient alpha can be usually calculated for each section within a 
measurement separately rather for the entire domain [440]. 
 
4.4.2  Stability / Test-retest reliability 
Stability, the second aspect of reliability, is sometimes called test-retest reliability or 
intra-rater reliability. It is a coefficient of reliability determined by the test-retest method 
on different days [484]. Test-rest reliability is estimated with correlations between the 
scores from one time to another. The procedure involves repeated administrating the 
same measure to the same group of respondents at different time points, normally within 
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one or two week‟s interval. The interval cannot be too long as actual changes may occur 
between the two test administrations [484]. 
 
Pearson product-moment coefficient of correlation, and Spearman rho are two traditional 
statistical analytic methods for assessing test-retest reliability [442]. In general, 
coefficients exceed or equal to 0.7 is considered as good test-retest reliability [485].  
 
 
4.5  Validity  
Reliability and validity are related properties. Measurements are expected to be both 
reliable and valid. However reliability can exist without validity yet validity cannot exist 
without reliability [486]. A reliable measurement may still be invalid [442, 487]. Validity is 
the property concerning the extent to which the measure what it purports to measure, or 
the data truly reflect what they are intent to reflect [442]. It refers to the accuracy, 
usefulness of a measurement and emphasise on the legitimacy of the measurement 
scores [430]. 
 
Face validity, content validity, criterion-related validity (predictive validity), construct 
validity, factorial validity, concurrent validity, convergent validity and divergent or 
discriminant validity are several different forms of validity (Table 20). Not all measures of 
validity are necessary to be performed [486]. Determination of which types of validity for 
the instrument tested depends on the objectives of the study, the kind of data generated, 
and precision of the response variables [442]. Of the above listed forms of validity, content 
validity and construct validity are most commonly entities to be assessed for a new 
measurement although not have to be acquired at one time. 
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Table 20. Summary of major types of validity 
 
Type of validity Definition Summary 
Face validity The extent that the test 
appears to be valid 
Largely relies upon the judgment of 
the observer 
Content validity  The extent to which the 
content of the test covers the 
area that it is intended to cover 
Valid if the test provides adequate 
coverage of the subject being studied 
Criterion 
validity 
The extent to which the scores 
on the test are in agreement 
with an existing criterion. 
Examines the ability of the measure to 
predict a variable that is designated as 
a criterion.  
Construct 
validity 
 
The extent to which a 
measurement reflect 
theoretical constructs 
Defines how well the measure up to its 
claims. 
 
Sources:[488-490] 
 
4.5.1  Face validity 
Face validity is a property of an instrument intended to measure what people want to 
measure [442]. The establishment of face validity depends on a clearly defined concept to 
be measured without reliance on an established theory for support. In other words, the 
measurement could have face validity if it “looks like” which it is going to be measured. For 
example, preparing an examination of math, to test whether the students being able to 
perform arithmetic division. After the test, if students agreed that the test looks like to test 
such ability, or if they thought the examination was good, the face validity of the test is 
demonstrated. Since the face validity is such a general measure at „face value‟ based on 
cursory review on items without trained judges, it is considered to be a weak form of 
measurement validity [442].  
 
Despite the face validity is not at all considered as a measure or test of validity by many 
researchers [485], it can affect people's attitudes toward a test.  
 
Although it might not be considered as a sufficient documentation test, face validity is a 
useful property serving an important scientific purpose supporting construct validity. It 
also enables refinements for the next step of research project, since an instrument lacking 
face validity may not be acceptable by either the administrator or the respondents [442].  
 
 135 
 
4.5.2  Content validity 
Content validity refers to the representativeness of the questions, i.e., how accurately a 
measurement tool assesses the specific construct in question [491]. It is related to face 
validity and often contrasted with face validity. It concerns the degree to which the 
essential components and items of the construct are covered in the questionnaire or within 
a concept. Content validity is also known as logical or rational validity, which estimating 
how much a measurement represents all facets of a construct [492].  
 
Determination of the content validity is a typically subjective process [442]. It can be 
ascertained via a rational analysis of the questionnaire by obtaining the opinions from a 
group of experts of the specific area that is intended to be tested. Despite the assessment 
can be subjective, it is of reason and logic [481]. In this process, all items will be reviewed 
and provided with opinions by experts so as to some level of agreement can be reached. 
Generally, the content validity of a measurement can be achieved by reviewing and 
determining whether the items satisfy the content domains [442]. Specifically, 
examinations may include the domain clarity, content relevance, and content 
representativeness [486], as well as readability and comprehensiveness of items. 
 
4.5.3  Face validity vs. Content validity  
Content validity and face validity are similar properties as both are concerning whether the 
contents represent the proposed concepts that a questionnaire indented to measure. 
Hence the two have been suggested to be regarded as one component [442]. However 
content validity is regarded as a strong type of validity which requires carefully evaluation. 
Content validity differs from face validity in its evaluation. Face validity is a more general 
validity requiring personal judgment and participants often have input, and may not rely 
on established theories for support. It is a component of content validity which is seldom 
tested formally; whereas content validity is theory-based and utilizes carefully evaluated 
approaches based on statistics [493, 494]. For surveys and tests, content validity is 
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always inferred from a panel of experts who rate and give opinions about whether the 
questions are relevant or of rational to the construct [495].  
 
4.5.4  Criterion validity  
Criterion validity refers to the extent to which a measure relates to a gold standard or 
some external criterion [496]. In short, it compares whether the responses obtained on a 
particular questionnaire with other validated instruments or well-established standards. It 
reflects “the ability of an instrument to measure an abstract construct” [442]. Concurrent 
and predictive validity are two forms subdivided from criterion validity based on the time 
period involved. The former type refers to the criterion measures obtained at the same 
time as the test scores (concurrently), whereas the predictive validity investigates the 
criterion obtained after the test [442].  
 
If an existing instrument has already been determined to be valid, then this well 
established instrument can be regarded as a “gold standard”. Criterion validity involves 
comparing the measuring result between the “gold standard” with the newly developed 
instrument in the same population [442]. Criterion validity can be quantified by correlation 
coefficient, which is regarded to be the most practical and objective method in testing 
validity [442]. A new instrument could be regarded as having meaningful criteria if it 
demonstrates a strong correlation (usually the correlation coefficient is close to 1.00) with 
the “gold standard”. In interpreting validity coefficients, four levels of validity can be 
determined by using the cut-off values. A coefficient of 0.80 and above is regarded as 
excellent; and a coefficient between 0.70 and 0.79 is good, whereas between 0.60 and 
0.69 is fair. However, a value of 0.5 or below indicates an unacceptable correlation [486]. 
 
Unfortunately, in many areas, a gold standard is not always available as a choice for more 
abstract constructs. However, standard criteria, which are considered acceptable criterion, 
are readily available for validating. In such case, existing standard criteria can be used as 
the reference standard for criterion validation [442].  
 137 
 
 
Validation of the criterion validity is a straightforward process if there is a “standard” exists 
for comparison. However, for many objective measurements, such as pain measurements 
which require the patient‟s inputs, there could be no reference standard to be compared. 
In such circumstances, the criterion validity cannot be achieved, some other indirect 
methods might be sought after [497]. 
 
4.5.5  Construct validity 
Construct validity is another valuable yet basic issue in instrument development. It is a 
theory-based concept [475] which reflects the degree to which a theoretical measure 
matches a theoretical definition [442]. In other words, it examines how many 
relationships of the variables predicted by the theories can be found after the analysis of 
data. 
 
However, the concept of construct measured refers to a theoretical factor that may not be 
observed directly [486]. Evaluation of construct validity is based on the assumption that 
the target variable has the well-developed theories or hypothesized relationship to other 
variables being measured in one study [447]. Three steps should be followed when 
evaluating construct validity. The first is the specification of the theoretical relationships, 
inclusive of their interrelations. The second step is the development of a method to test the 
experimentally-determined constructs. The third step is to exam the empirical 
relationships among the measures of concept constructs and their manifestations [475].  
 
Construct validity can be further examined with more advanced statistical techniques 
when internal consistency is relevant. Since the construct validity relates to the 
examination of how many relationships can be predicted by the underlying conceptual 
structure [486], factor analysis, which in attempt to explain the nature of the 
interrelationships among a large number of variables, is among the most common 
approaches to test construction validation [442].  
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In general, to enable factor analysis, a minimum number of 100 cases are required to 
ensure stability of the variance-covariance matrix [498-500]. Some researchers do not 
regard 100 cases being sufficient and recommended a preferable sample size for 
conducting factor analysis would be five respondents per item [501].  
 
 
4.6  Chapter summary  
This chapter reviewed the background information of questionnaire design and instrument 
development. The concepts of questionnaire, process of questionnaire development steps, 
reliability and validity were outlined. The development and evaluation of the CMHQ for TTH 
pattern identification were guided by the principles discussed in the above sections. The 
detailed methods and roadmaps are illustrated in the next chapter.  
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5.1  Introduction  
This chapter explains the methodology for the designing and development of the CMHQ. 
To develop and validate the CMHQ, a range of strategies including literature search, 
face-to-face interview with participants, internal group discussion and expert consultation 
were performed. In addition, a variety of statistical analytic methods such as frequency 
analysis, correlation tests, factor analysis and cluster analysis were used for CMHQ 
validation. 
 
There are 10 sections in this chapter. Section 5.1 briefly introduces the strategies used for 
CMHQ development and validation. Section 5.2 outlines the CMHQ development process; 
Section 5.3 covers the ethical consideration of the project; Section 5.4 describes the 
participants recruitment and selection criteria; Section 5.5 describes the methods of 
delivering the initial CMHQ; Section 5.6 describes the strategies adopted for CHMQ 
amendments; Section 5.7 illustrates the analysis methods of CMHQ validation; Sections 
5.8 and 5.9 present data analysis methods of the TTH pattern identification and the 
correlation with other instruments; and Section 5.10 is a summary of the chapter. 
 
 
5.2  CMHQ development: the roadmap  
A total three phases were arranged for its development (Figure 20). These phases account 
for the three versions of CMHQ. Validation of CMHQ was performed at different stages of 
its development. 
 
Phase One was the initial construction of the CMHQ, which focused on item generation and 
initial construction of the questionnaire. A two-stage process of literature search and a 
face-to-face interview were involved in this phase. As the first stage of the CMHQ 
constructing, information related to the CM diagnosis and treatment of TTH were screened 
and extracted from the literatures into an item pool. Pooled items were then evaluated and 
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converted into items which were later formed into an initial version of CMHQ (CMHQ-1). 
Using literature search, items related to TTH patterns were separated into sections of 1). 
Pain description, 2). Aggravating and relieving factors, and 3). Accompanying symptoms 
for CMHQ-1 initial construction. The second stage involved a face-to-face interview which 
was subsequently conducted in order to test the items extracted from literature. Twenty 
TTH participants were involved in the face-to-face interview. The interview also aimed to 
identify additional potential diagnostic information of TTH that was not covered in the 
literature search. This phase ended with an internal group discussion. During the 
discussion, face validity of the CMHQ was assessed. Based on the results of the interview, 
the CMHQ-1 was amended becoming CMHQ-2 
 
Phase Two was a preliminary investigation (pilot study), which aimed to examine and 
refine the CMHQ-2 in a larger sample of TTH participants. In this clinical investigation, 
practitioners made CM diagnosis based on the completed CMHQ. A group of advisory 
external expert panel members were invited to comment on the CMHQ-2. Its content 
validity was assessed and enhanced during the process. Results of this pilot study provided 
evidence for the final amendment/modifications of CMHQ-2 and resulted in the 
construction of CMHQ-3. 
 
Phase Three was the final stage of CHMQ validation as well as the full scale survey of the 
research project. A bilingual multicentre online survey and paper-based investigation was 
designed for this phase, and aimed to validate CMHQ-3. A relevant larger sample size was 
recruited in this phase. A total 497 volunteers with headache participated in the survey. 
Internal consistency reliability, test-retest reliability and construct validity were assessed 
in this phase. In this phase, TTH patterns were explored using factor and cluster analyses. 
Some other validated questionnaires such as PSS, MIDAS and a comorbidity checklist 
were also applied in the exploration of individual levels of self-perceived stress, severity of 
disability due to headache and co-morbidity associated with TTH.  
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Figure 20. Process of the CMHQ development and validation
Phase 1. CHMQ initial construction 
Aim: item generation and CMHQ-1 construction  
Methods: 
Stage 1. Literature review 
 Identifying literature source 
 Defining search strategy 
 Extracting literature information to item pool 
 Item generation 
 CMHQ-1 construction 
Stage 2: Face-to-face interview of TTH participants 
 Population identification and participant recruitment 
 Administration of CMHQ-1 
 Frequency analysis  
 Internal discussion 
 CMHQ-1 amendment into CMHQ-2 
Phase 2. CHMQ: a pilot study 
Aim: examining CMHQ-2 and constructing CMHQ-3 
Methods:  
 Population identification, participant recruitment and selection  
 Implementation of the study and administrating CMHQ-2 
 Frequency analysis  
 Expert‟s consultation  
 CMHQ-2 amendment 
Phase 3. CHMQ validation: the full-scale survey 
Aim: evaluating CMHQ-3 and exploring TTH patterns 
Methods:  
 Population identification, participant recruitment and selection  
 On-line survey preparation: designing screening questionnaire 
 Implementation and administrating CMHQ-3 
 Data collecting and data synthesis 
 Data analysis 
 Expert‟s consultation  
 
Outcomes  
 Content validity 
evaluated 
 Feasibility tests of CMHQ  
 Initial TTH pattern 
explored 
 CMHQ-3 constructed 
Outcomes 
 Research questions 
identified 
 Item extracted 
 Initial item (pool) 
generated 
 Additional items 
identified 
 Item reduction 
 Face validity determined 
 CMHQ-2 constructed 
Details presented 
in Chapter 7 
Outcomes 
CHMQ-3 evaluation 
(assessments of Internal 
consistency reliability, 
Test-rest reliability, and 
Construct validity) 
Details presented 
in Chapter 8 
Details presented 
in Chapter 6 
Outcomes 
Exploration of TTH pattern  
 TTH pattern identification 
 Exploration of 
correlations of other 
instruments 
Details presented 
in Chapter 9 
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5.3  Ethical consideration  
In this project, ethical considerations were taken into account when investigations were 
proposed, and the study protocols were approved by relevant ethics committees. Firstly, 
ethical approvals were obtained from the relevant committees in written permission in 
advance of the investigations. In Phase One and Two, as the investigations were embedded 
in a clinical trial. Researchers obtained written permission from the Human Research Ethics 
Committee (HREC) of RMIT University to conduct this survey. In Phase Three, the survey 
was conducted in both online and paper-based approaches. The online approach and the 
paper-based investigation conducted in Australia with approval from the College Human 
Ethics Advisory Network (CHEAN) of Science Engineering and Health, RMIT University. Two 
Chinese collaborating sites, performed paper-based investigations in their hospitals, 
obtained Human ethic approval from the hospital and the university respectively. Copies of 
the approvals are attached in Appendices 2 to 6 respectively. Secondly, before participants 
gave their consent to for participation, copies of plain language statements were provided 
to all potential participants. Those who completed the questionnaire received an 
explanation of the aims, purposes and intent of the investigation. Thirdly, in protecting the 
privacy of participants and preventing leakage of personal information,  participants were 
assured their confidentiality and anonymity. Online data were kept anonymous and in a 
linkable fashion; whereas paper documents were stored in a locked filing cabinet at 
Discipline of Chinese Medicine, RMIT Bundoora campus. Soft copies of the data were stored 
in a password protected computer in a pass-word protected network. These data were 
unidentifiable, and only the investigators listed in the ethic application had access to the 
data. Finally, research outcomes were provided via email to those participants who 
expressed their interest to be notified after the project completion.  
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5.4  Population identification 
5.4.1  Participant recruitment of Phase One and Phase Two studies 
(2009-2011) 
People who suffered from TTH were the target group to be approached to participate in this 
survey. 
 
In Phase One (2008-2009) and Phase Two studies (2010-2011), participant recruitment 
was embedded in a clinical trial entitled “Combined therapy of electroacupuncture and 
cognitive behavioural therapy for tension-type headache: a randomised controlled trial”. 
TTH patients were recruited from residence in the metropolitan area of Melbourne, Australia. 
The Recruitment strategies are listed below: 
 
1) Advertisements in the mainstream newspaper (The Age, and Herald Sun,); 
2) Advertisements in the local community newspapers (Leaders, and MX); 
3) Advertisements posted in the RMIT teaching clinics of Chinese medicine, 
Chiropractic, Osteopath and Psychology;  
4) Flyers placed around university campuses (RMIT University, University of 
Melbourne, NMIT, La Trobe University) and;  
5) Flyers placed in notice boards of local communities, libraries and sports centres.  
6) Email distribution of the recruitment news to all RMIT University students and staff 
via RMIT email system. 
 
5.4.2  Participant recruitment of Phase Three study (2011-2012) 
The full-scale study conducted between 2011 and 2012 was carried out as online and 
paper-based surveys (Figure 21).  
 
Recruitment of participants for the paper-based survey included two groups of population, 
i.e., participants in Australia and participants in China. In Australia, a group of TTH 
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participants were recruited from the above mentioned clinical trial by using the same 
strategies in Phase One and Two studies (listed in Section 5.4.1). In the two Chinese 
collaborating sites in Beijing and Chengdu, participants were recruited by local researchers 
at each site from their outpatient departments of the hospitals. 
 
The online participants were recruited through several approaches. 
 
Online advertisements were the primary source, which was supported by a list of headache 
associations and organisations. Survey information was advertised via the following 
websites and entities: 
 
 RMIT University website (Australia)  
(http://www.rmit.edu.au) 
 Headache Australia (Australia)  
(http://headacheaustralia.org.au) 
 The Australian Cluster Headaches website (Australia) 
(http://www.clusterheadaches.com.au) 
 Headache & migraine news and information website (Australia) 
(http://www.headache.com.au) 
 British Association for the Study of Headache (UK)  
(http://www.bash.org.uk) 
 
Secondary recruitment approaches included disseminating survey information via social 
networks such as Facebook® and LinkedIn®. In addition, e-mail invitations for potential 
participants were applied with the assistance of the members of the following associations: 
 
 Federation of Chinese Medicine and Acupuncture Societies of Australia (FCMA) 
 Chinese Medicine and Acupuncture Society of Australia (CMASA) 
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Figure 21. Recruitment strategies of the full-scale survey 
 
5.4.3  Selection criteria for Phase One and Phase Two studies 
The study followed the clinical trial screening procedure. To participate in the trial, headache 
patients were screened against the inclusion and exclusion criteria, which developed based 
on IHS TTH diagnostic criteria.  
 
5.4.3.1  Inclusion criteria  
Headache patients who met the following conditions were included:  
1). aged between 18 and 65 years (inclusive);  
2). adequate comprehension in conversational and reading English;  
3). met the ICHD-II criteria (codes 2.2, 2.3 or 2.4) for TTH; and   
4). suffers more than one day with TTH per month for at least one year. 
 
5.4.3.2  Exclusion criteria  
Headache patients with one or more of the following conditions were excluded: 
1) had been taking analgesic for more than 15 days per month for more than two 
years; 
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2) had migraine attacks (with aura, ICHD-II 1.2) more than once per month; or had 
migraine attacks (without aura, ICHD-II code 1.1) more than four times per month; 
3) TTH onset after 50 years old;  
4) participants refused to maintain existing treatments of TTH, including prophylactic 
medication for TTH during the trial period; 
5) had been whiplashed or a history of significant head injury that required hospital 
stay; 
6) severe unstable arrthymia or heart failure, pregnancy or intent to get pregnant, 
active epilepsy, brain tumour, cancer, haemophiliac or wearing cardiac 
pacemakers; 
7) had eight or more sessions of acupuncture or CBT for TTH in the last six months,  
8) with intellectual disability, or had been psychotic judged by the trial psychologists.   
 
In Phase One and Two, included participants were given Plain Language Statement 
(Appendix 7) of the clinical trial and verbal explanation about the trial and the investigation. 
Signed consent forms (Appendix 8, and Appendix 9) were obtained from them prior to their 
participations. 
 
5.4.4  Selection criteria for Phase Three study 
Potential headache sufferers were screened against the inclusion and exclusion criteria 
listed below.  
 
5.4.4.1  Inclusion criteria 
Headache patients who met the following Inclusion criteria were included: 
1). Aged between 18 and 65 years at entry;  
2). Able to read English or Chinese;  
3). Met the ICHD-II criteria of TTH or probable TTH; and,  
4). Had 1 day or more TTH attacks per month for at least one year. 
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5.4.4.2  Exclusion criteria 
Headache participates had one or more of the following exclusion criteria were excluded: 
1). Participants with more than 4 migraine attacks without aura (ICHD-II 1.1 
migraine) per month; 
2). Participants with any migraine attack with aura (ICHD-II 1.2) per month; 
3). TTH onset after 50 years old; 
4). Had been hospitalised because of the head or neck injury; or 
5). Had migraine attacks but not able to distinguish it from TTH. 
 
In Phase Three the full-scale survey, a Plain Language Statement (Appendix 10) was 
displayed or given beforehand of the survey commencement. Participants were notified 
that they were free to quit the survey at any time. Completion of the survey was 
deemed that the participants had given their consents to their participation.  
 
 
5.5  CMHQ item generation and construction  
In order to identify the outcome measures used to assess TTH clinical features, the two 
steps of item generation and CMHQ initial construction were considered to be an important 
foundation phase for CMHQ development. 
 
5.5.1  Literature search  
Literature search was conducted for initial item generalisation. To obtain a broad list of items, 
a range of literature on Chinese medicine were searched and retrieved. 
 
Several steps were implemented in this phase: 
 
1) Identifying literature source 
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2) Defining search strategy  
3) Extracting literature information to item pool 
4) Item generating  
5) CMHQ-1 constructing 
 
5.5.1.1  Source of literature  
Literature source included contemporary tertiary text books, clinical monographs and 
electronic sources of journal articles. The search aimed to be broad so as to identify CM 
patterns for headache.  
 
Contemporary tertiary text books, which are representative of the guidelines used in the 
current CM education and practice, were used as the major source of the search. The 
secondary sources were clinical monographs and journal articles. These materials were 
considered as they might contain individual practitioners‟ experiences on treating different 
types of headaches or experts opinions, which were not covered in text books. In addition, 
to obtain the latest information of TTH in both research and practice aspects, two major 
electronic sources of Chinese databases, CNKI (http://www.cnki.net) and CQVIP 
(http://www.cqvip.com) were searched.   
 
Selection of the reference books of the contemporary textbooks was due to these literatures 
compiled by groups of experts who were of national or international fame in CM. In addition, 
those textbooks was not only used in the CM education in universities but also referred by 
lots of practitioners across the nation. Therefore, they could be capable of representing the 
CM understanding on headaches.  
 
5.5.1.2  Restriction of language and year  
The literature search on books and databases were limited in Chinese language up to the 
year of 2008 (December 2008). 
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5.5.1.3  Defining search strategy  
The search terms relevant to TTH and CM diagnosis were considered and were divided into 
two categories. 
 
Search terms listed below were to identify “Tension-type headache” and its variations:  
1).  headache（头痛）  
2).  tension headache（紧张型头痛） 
3).  tension-type headache（紧张性头痛） 
4).  muscle contraction headache（肌收缩性头痛） 
5).  tou-feng（头风） 
 
Search terms listed below were to identify CM patterns and classifications on headaches: 
6).  pattern identification（辨证） 
7).  syndrome differentiation（辨证） 
8).  patterns（证型） 
9).  syndromes（证型） 
10). diagnosis（诊断） 
11). classification（分类） 
 
5.5.1.4  Extracting literature information  
Descriptions on all types of headache were considered. Information related to the following 
headache pattern diagnosis were extracted: 
1).  pain descriptions 
2).  clinical features (or presentations) 
3).  aggravating or alleviating factors 
 
Information were not considered for extraction if (1) headache was due to external causes, 
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such as headache due to wind or cold, i.e., headache when one has a cold or flu; (2) naming 
of headache patterns that defined by practitioners themselves but not supported with 
literatures or experts; (3) headache related to menstruation, such as menstrual related 
headaches; or (4) other diagnostic information related to headache, such as characteristics 
of tongue or pulse.  
 
5.5.2  Face-to-face interview  
Face-to-face interview is an effective method for data collection. It is conceivable that the 
answers of the participants reflect the actual conditions of their lives [502]. By asking direct 
questions to the participants helps the researcher to seek answers for their research 
questions. In addition, information collected directly from the participants could be used for 
further development of the questionnaire.  
 
The purpose of this face-to-face interview was to identify additional information that not 
covered in the literature search so as to ensure that a wide spectrum of TTH characteristics 
can be obtained. Results of identified related diagnostic information would assist in 
generating additional items as well as ideas for construction of CMHQ, such as the format, 
structure, choice of wording and item content. The interview also aimed to develop, trial, 
refine, improve the conception and face validity of the CMHQ. 
 
The interview was performed by a registered CM practitioner who was also a trained trial 
acupuncturist. The training procedure of the CM diagnostic technique followed the previous 
mentioned clinical trial training protocol, and the skill of the trial acupuncturist was 
examined by two experts before the commencement of the clinical trial. Participants were 
given draft CMHQ, and answered the questions by ticking appropriate choice boxes. The 
practitioner explained the aim of the questionnaire to the participants, and answered 
questions related to the wording and items of the questionnaire.   
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Once the participants completed the CMHQ, their tongue and pulse were checked by the 
trial acupuncturist, who then made a CM diagnosis for each participant based on the 
information obtained. Participants were asked further information related to their conditions 
if the information obtained from their completed questionnaire were insufficient to make a 
proper diagnosis. Each participant was diagnosed with a single CM pattern or a pattern 
combination. 
 
The face-to-face interview reflects the standard procedure of practice and contributed to the 
development of a refined CMHQ for pre-testing in the pilot study. Frequency analysis and 
internal group discussion were conducted. All items responded in the CMHQ were assessed 
with frequency analysis. Additional information collected from the interview was evaluated 
at internal group discussion and used for further item generation. Responses and other 
additional information collected from the interview were used for further development of the 
CMHQ. They were coded and converted/generated into items for further evaluation. 
 
 
5.6  CMHQ revision and pre-test  
Group discussion could be an effective method for problem-solving by collecting valuable 
opinions from others [503-505]. In this project, internal group discussion was conducted for 
CMHQ revision and the external experts‟ consultation was introduced for its amendment, 
before the implementations of the pilot study and the full-scale survey.  
 
During the discussions, the face validity and content validity of the CMHQ were evaluated. 
Results of the discussions directly contributed to the CMHQ construction and amendment. 
This section outlines the brief procedures of internal group discussion and external experts‟ 
consultation. Detailed discussion results are presented in Chapter 7 and Chapter 8.  
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5.6.1  Internal group discussion 
Internal group discussion was adopted as a prerequisite approach for CHMQ development 
amendment before its piloting. To ensure the quality and the effectiveness of the discussion, 
the group members should have an undergraduate degree of CM, and have teaching or 
clinical practice experience.  
 
The group consisted of 9 persons whose task was to evaluate item collection as well as 
provide their professional opinions based on their experience of practice and research in the 
field of CM. The group members invited for discussion were from the RMIT Chinese medicine 
discipline, included 2 teaching staffs (Dr. Zhen Zheng, Dr. Lin Dong), 3 research fellows (Dr. 
Yanyi Wang, Dr. Claire Zhang, Ms. Tracey Bourne) and 4 research students (Mr. David Lu, Dr. 
Wan Najbah Nik Nabil, Dr. Amy Hsiewe Ying Tan, Dr. Johannah Shergis). All group members 
were registered CM practitioners and/or acupuncturists with the Chinese Medicine 
Registration Board of Victoria (CMRBV).  
 
The group discussion aimed to evaluate the face validity and readability of the CMHQ. Prior 
to the discussion, results of frequency analysis including additional items were provided for 
discussion. 
 
Internal group discussion was carried out after the face-to-face interview, aimed to refine 
the CMHQ as well as evaluate its face validity. Therefore, two parts of works were considered. 
Firstly, the discussion focused on the CHMQ amendments of its items and structures. Based 
on the frequency results of responses, items were amended, reduced and combined. Based 
on the group discussion, items were structured for a more systematic information collection. 
On the other hand, in evaluating its face validity, the group members judged whether the 
CHMQ measured what it intended to measure and whether it was feasible for TTH 
evaluation.  
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The detailed criteria and content of item amendment are described in Chapter 7. 
 
5.6.2  External experts consultation 
Experts‟ opinion plays one of the most important roles in CM clinical practice and research 
[506, 507]. Given there are no guidelines or CM diagnostic criteria for TTH, experts‟ 
opinions are considered as the gold standard in disease diagnosis and classification of 
illnesses. 
 
Therefore, experts‟ opinions are a valuable source of information for assessing the content 
validity of the questionnaire. In this study, experts‟ opinions were obtained after the pilot 
study and before the implementation of the full survey, aiming to establish the content 
validity of CMHQ. External experts included those in the field of CM, western medicine, 
neurology and psychology.  
 
Potential experts were approached for their academic reputation and clinical practice on 
headache. To ensure the quality of their opinions, invited experts should have 
demonstrated experience in either treating headache or headache research. The invited 
experts met at least two of the following selection criteria:  
 
1). being an author or co-author of two or more peer-reviewed publications; 
2). has a post-graduate degree (Master or PhD) or title of Professor( or equivalent) 
related to the relevant field;  
3). has received research funds/grants that support acupuncture or headache related 
studies; or 
4). currently work for an education institution or hospital. 
 
Eligible experts received an email invitation including the following attachments: 
1). a brief summary of the project with its background and aims; 
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2). CMHQ questionnaire; 
3). screening questionnaire; and 
4). criteria and contents to be commented. 
 
Experts‟ opinions were sought for the 1) completeness of the CMHQ items; 2) relevance of 
each sign and symptom; and 3) wording and the format of the CMHQ. Experts were also 
invited to provide their opinions via emails for further discussion, such as interpretation and 
explanation of cluster analysis results. 
 
5.6.3  Pre-testing CMHQ in the pilot study (CMHQ-2) 
Piloting the CMHQ provided opportunities to identify and eliminate major flaws, irrelevant 
questions or any mistakes that needed correcting. Between 2010 and 2011, after the face 
validity of the CMHQ-2 assessed by internal group members, it was tested in a pilot study.  
 
In Phase Two, a pilot study was conducted to examine the CMHQ-2 in a clinical investigation 
with a lager sample size. The purpose of this pilot study was to evaluate the CMHQ feasibility 
in CM pattern identification. The piloting also aimed to establish its content validity. 
 
5.6.4  CMHQ final amendment (CMHQ-2 into CHMQ-3) 
Final amendment of CMHQ-2 was based on the pilot study results. In Phase Two, results 
obtained from the pilot study were used to make minor modifications in the questionnaire. 
The process of final amend included analysis of the pilot study data, comparisons of the CM 
diagnosis, internal group discussion of the feasibility of CMHQ diagnosis and exchange of 
opinions of internal group members and external experts.  
 
By the end of this phase, TTH patterns were explored, and the CMHQ was amended into the 
final version (CMHQ-3).  
 
 157 
 
5.6.5  CMHQ Translation 
In Phase Two, the CMHQ was translated into Chinese when CMHQ-2 amended into CMHQ-3. 
The CMHQ was developed in Chinese and English and was developed based on results from 
review of Chinese literature and the face-to-face interview in English. CMHQ was in English. 
After its readability, face validity and content validity being tested in English, it was 
translated into Chinese for the implementation of the online and hospital-based survey in 
Phase Three.  
 
A well-translated survey questionnaire should being of semantic equivalence across 
languages, conceptual equivalence across cultures, and normative equivalence to the 
source survey [508]. As most items identified were originally extracted from Chinese 
literature, the major challenge was to convert the expressions into plain language. The 
English version of the CMHQ-3 was back-translated to Chinese by two independent bilingual 
researchers in order to establish semantic equivalence. The aim was to achieve conceptual 
rather than literal meaning of the items in the questionnaire and a reiterative process was 
used until semantic equivalence was established. A six stage model of forward and 
backward translation to adapting self-report measures for cross-cultural use which 
proposed by Beaton et al. (1998) [509], was used to guide the process of translation of the 
CMHQ. A detailed process was described in Chapter 7. 
 
 
5.7  CMHQ evaluation: analysis of reliability and validity 
Reliability analysis in this project included evaluation of internal consistency reliability and 
test-retest reliability. Validities of CMHQ assessed included face validity, content validity and 
construct validity. Detailed statistical analyses are included in Section 5.9. 
 
Of these analyses and tests, assessment of face validity was performed in Phase One; 
content validity, was evaluated in Phase Two; internal consistency reliability, test-retest 
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reliability and construct validity were evaluated in Phase Three. 
 
5.7.1  Face validity (Phase One) 
Prior to the initial construction of the CMHQ, to identify the research aims, a literature 
search was conducted under the theory framework of CM. The search also aimed at CMHQ 
item generation. Contents obtained from the literature were used for TTH pattern 
identification and represented what it is trying to measure. In addition, during the 
face-to-face interview, the subject, i.e., TTH participants, had their input to the CMHQ 
development. Their responses were extracted and combined for further item generation. In 
the process of the internal group discussion, each items obtained from the literatures and 
the participants were carefully discussed. These steps and strategies finally improved and 
achieved the face validity of the CMHQ. 
 
5.7.2  Content validity (Phase Two) 
As content validity cannot be assessed empirically, in this study, evaluation of the content 
validity was assessed during the initial CMHQ development process, by identifying research 
aims, searching literature, interviewing TTH participants and discussing with internal group 
members, consulting experts‟ opinion, and finally enhanced in Phase Two, the pilot study. 
 
The process of CMHQ construction, pre-testing and its amendment all were based on 
communication. Construction process of CMHQ inherited inputs from internal group 
members based on the face-to-face interview results. In pre-testing the CMHQ, 
administration and application of the CMHQ were implemented by the two trial practitioners, 
who made pattern identification based on the questionnaire information. During experts‟ 
consultation, their opinions were not only obtained for the final amendment of CMHQ, but 
also used to build its content validity. In this phase, all these steps and strategies performed 
ensured the CMHQ being of considerable content validity. 
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5.7.3  Internal consistency reliability (Phase Three) 
The internal consistency reliability was assessed by calculating the value of Cronbach‟s 
alpha coefficient, a corrected item-total coefficient. As an indicator of internal consistency 
reliability, its achievable values ranges from 0 to 1, indicating the internal consistency 
reliability from no internal consistency to identical results.  
 
In this thesis, a value of more than 0.7 is considered as a marker of a good degree of 
reliability [481]. Data collected were the responded values from the participants to each 
question of the CMHQ. The internal consistency was calculated for the whole questionnaire 
and subsections of the CMHQ.  
 
5.7.4  Test-retest reliability (Phase Three) 
Test-retest reliability refers to the consistency to which a measure obtained for the same 
person can be replicated on different occasions. Forty-eight (48) participants in Phase Three 
study were administrated the questionnaire twice with one week interval. The test 
compared two sets of data collected from the first and second administrations of CMHQ.  
 
Spearman's rank correlation coefficient was calculated correlation coefficients (rho) were 
calculated to indicate the test-retest reliability. A score of high positive association between 
the data was assumed the test is reliable. Spearman‟s rank correlation with a coefficient 
level of < 0.5 considered as low, 0.5–0.69 as moderate,0.7–0.89 as high and 0.9–1.0 very 
high [510]. 
 
5.7.5  Construct validity (Phase Three)  
Factor analytic techniques are among the most common approaches to assess construct 
validation [442]. Such approaches are applied to determine the domains within the 
questionnaire [440]. More specifically, the techniques refer to whether items form only one 
domain or more than one throughout a questionnaire [496, 511, 512]. For example, 
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symptoms in a questionnaire could be divided into two scales comprised of somatic and 
psychological factors [513]. 
 
In this project, factor analysis was used to determine the underlying/latent factor structures 
of CMHQ. Such factor structures were then discussed by the internal experts to assess their 
relevance to the CM theoretic framework. The detailed steps are covered in later section of 
this chapter (Section 5.9.8). Its results and findings are presented in Chapter 9. 
 
 
5.8  Inclusion of other measurements in Phase Three study 
In Phase Three, the conduction of the full-scale survey, other established instruments were 
included in order to explore the correlations among those measurements and assessing TTH 
in a multidimensional manner. The following section outlines the measurement tools for 
self-perceived stress, headache-related disability level and comorbidity. 
 
5.8.1  Migraine Disability Assessment (MIDAS) Questionnaire  
The MIDAS questionnaire has a validated Chinese version for the Chinese population[514]. 
In clinical research, the HImQ has been widely used to evaluate the impact of headache on 
headache sufferers. However, due to its scoring difficulties, HImQ was revised and became 
MIDAS. The latter was regarded to be more suitable for self-administrated research than 
the HImQ. MIDAS was initially designed for the migraine population to evaluate the severity 
of migraine. Recommended by its author, the MIDAS is also suitable in evaluating disability 
of TTH and other types of headache (W.F Stewart, personal communication, February 2008) 
[312] (Appendix 11, and Appendix 12). 
 
5.8.2  Perceived Stress Scale (PSS)  
The PSS is among the most widely used instrument in measuring nonspecific psychological 
stress [515]. It was developed by Sheldon Cohen and his colleagues in 1983. Currently 
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there are three versions (PSS-4, PSS-10 and PSS-14) available for stress assessment. In a 
range of clinical and research settings, the 10-item version of PSS is the most widely used 
tool to measure global perceived stress in in relation to the health-related outcomes [516]. 
In addition, the author recommended use of the PSS-10 not only due to this 10-item version 
provides as adequate measure as the longer 14-item version, but also because of the 
PSS-10 had a slightly better internal reliability than PSS-14 [517]. 
 
Therefore, in this study, PSS-10 [518] was chosen due to its shortness and simplicity. The 
PSS-10 measures the degree of the individual's response to stressful situations by asking 
their feelings during the last month so as to estimate the extent to which respondents find 
their lives unpredictable, uncontrollable, and overloaded [519]. Some direct queries about 
current levels of experienced stress. The responses of PSS for each item vary from 0 to 4 
which stand for never, almost never, sometimes, fairly often, and very often, respectively 
(Appendix 13, and Appendix 14).  
 
In PSS-10, items 4, 5, 7 and 8 are defined as positively stated questions. PSS scores are 
obtained by reversing the scores on four positive stated items and then summing across all 
items of the scale. Factor analysis of the PSS established a 2-factor structure according to 
its original listed positive and negative items. Both of them were being of adequate level of 
internal consistency [520]. The first structure, which reflects general distress, was labelled 
as Perceived Distress [520], or Perceived Avoidance [521], comprising of items in relation 
to adaptional symptoms (1,2,3,6,9,10). The second factor was labelled as Perceived Coping 
[520], or Perceived Controllable [521], comprising of items reflecting coping ability 
(4,5,7,8). 
 
PSS has no cut-offs or threshold values, since this scale is not for diagnosis. A higher score 
demonstrates a higher level of perceived stress whereas low score lower levels of stress. In 
PSS-10, the maximum score of 40 indicates the highest degree to which an individual 
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appraises his or her life as unpredictable, uncontrollable, and overloaded over the past 
month [516]. There are some normative data of a representative U.S. sample could be 
helpful for comparisons [517]. A score around 13 is considered as an average level. The 
mean score in the male group is 12.1 whereas 13.7 for female group [517]. 
 
5.8.3  Designing of the comorbidity checklist 
In this full scale survey, a checklist was developed to assess the comorbidity of TTH. 
Development of the checklist was based on the Cumulative Illness Rating Scale (CIRS) [522] 
and the World Mental Health Composite International Diagnostic Interview (WMH-CIDI) 
[523].  
 
The CIRS is an instrument for comorbidity measurement by organ system. It measures the 
chronic medical illness within 14 organ systems: cardiac, vascular, haematological, 
respiratory, ophthalmological–oto-rhino-laryngological, upper gastrointestinal, lower 
gastrointestinal, hepatic-pancreatic, renal, genitourinary, musculoskeletal-tegumental, 
neurological, and endocrine-metabolic-breast and psychiatric. The scale was initially 
developed to measure chronic medical illness [524]. Because its short, easy to complete 
and reliable, it is suitable to assess multi-morbidity in primary care [525] (Appendix 15).  
 
The WMH-CIDI is an assessment of mental disorder which developed by WHO. It was 
designed based on the definitions and criteria of two classification systems. One is the 
Diagnostic and Statistical Manual of Mental Disorders, Fourth Edition (DSM–IV), which was 
published by the American Psychiatric Association (APA) that includes currently 
recognised mental health disorders; and the WHO International Classification of Diseases, 
Tenth Revision (ICD–10) is another system of the WMH-CIDI.  
 
Completing both of the CIRS and the WMH-CIDI would be time-consuming for TTH 
participants. Despite the CIRS is short, rating on each item could impact on the total 
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administration time of the survey. In addition, because WMH-CIDI has a comprehensive 
structure for interviewing, completing the WHM-CIDI requires average of 75 minutes in a 
general population sample made its administration in this survey impractical. 
 
Therefore, to better adapt to the survey, modifications on both instruments were made. For 
the CIRS, as we only need a checklist of the comorbidity, the original rating scale after each 
category was abandoned. Only its 14-item of categories was retained. For female 
participants, an added category of “female hormonal and reproductive” was designed. After 
this modification on CIRS, examples of diseases related to each category were listed. By 
doing this, participants are provided with a clear structure on diseases of different systems. 
 
WMH-CIDI involves huge information for completion. During the development of the mental 
comorbidity checklist, one of our external experts and a professor in psychology, was 
consulted. To collect the diagnosed mental disorder of TTH participants, the WMH-CIDI 
information was extracted and shortened into a three-item checklist, which contained a 
broad level of mental disease with anxiety disorders, mood disorders and substance use 
disorders. Similar to the somatic comorbidity checklist, to detail each category of the 
mental comorbidity, examples were provided after checkboxes. This modification made it 
simple and clear for participants to complete. 
 
Finally, the items were reformatted in a coherent manner and the comorbidity checklist 
comprised two parts involving 18 checkboxes to tick, i.e., somatic comorbidity assessment 
evaluated by 15 CIRS items and the mental comorbidity assessment by 3 categories 
summarised from the WMH-CIDI. As a result, the 18-item comorbidity checklist was 
embedded into the CMHQ-3 (Part 4 of CMHQ-3) for the evaluation in the full-scale survey.  
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5.9  Statistical analysis methods for data analysis  
The Statistical Package for the Social Sciences (SPSS) software version 19 for Windows was 
used for data analysis. A P-value ≤ 0.05 was considered to be statistically significant. A set 
of statistical analytic methods were applied for interpretation of the survey results and 
CMHQ evaluation, including descriptive analysis, frequency analysis, correlation analysis 
and analysis of variance (ANOVA). Moreover, the explorative statistical analysis of factor 
analysis and cluster analysis were the two major statistical techniques applied in this 
project, and were used alone and/or conjunctionally.   
 
In the full-scale survey, the dataset was examined for missing values. The reliability and 
validity of CMHQ were evaluated. Prior to this, the dataset was also evaluated for the 
appropriateness for factor analysis. TTH pattern explorations were performed using factor 
analysis and cluster analysis. ANOVA and Chi-Square tests were employed to explore the 
correlations between instruments and to examine the group differences.  
 
Below is a detailed explanation of the application of each form of analysis and a table of 
summary is given in Table 21.  
 
Table 21. Summary of statistical methods applied in this study 
 
Study Type of method Purpose 
Phase One:  
Literature search and 
face-to-face interview  
Descriptive statistics item generation 
Frequency analysis verify the literature descriptions  
Phase Two:  
Pilot study 
Frequency analysis item evaluation 
Chi-Square tests subgroup comparisons on items 
Phase Three:  
Full-scale survey  
Spearman's Rank-Order 
Correlation 
evaluation of test-retest reliability 
ANOVA determine group differences among 
patterns 
Factor analysis item reduction; and evaluation of 
construct validity 
Cluster analysis classify participants into groups 
 
5.9.1  Descriptive statistics  
Descriptive statistics was used to report the basic features of the data such as demographic 
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characteristics and summary of CMHQ item frequencies such data were described with 
simple graphics analysis such as histograms or bar charts. In the full-scale survey, 
descriptive statistic was also used to illustrate general information of the survey, reporting 
of the demographic information and summary of item responses of other instruments. 
 
5.9.2  Frequency analysis  
Frequency analysis was used to determine the number of times and indicate the quantities 
of the responded variables. Analysis of item frequency was used for item amendment. In 
Phase One literature search and face-to-face interview, frequency analyses were conducted 
to verify the literature descriptions as well as to provide evidence for new identified 
variables. In Phase Two pilot study, it was used for identifying the contribution of items in 
each pattern. In Phase Three survey investigation, frequency analysis was applied to screen 
items for cluster analysis. 
 
5.9.3  Chi-Square test 
The Chi-Square test was used to determine whether a significant difference between the 
expected frequencies and the observed frequencies existed in one or more groups. In Phase 
Two pilot study, it was used for group comparisons of item distribution between the two 
largest subgroups. 
 
5.9.4  Correlation analysis  
Spearman's Rank-Order Correlation, the nonparametric version of the Pearson 
Product-Moment Correlation, is a common measure of how well the paired variables are 
related.  
 
The Spearman's correlation coefficient, often denoted by the Greek letter ρ (rho) ( ) or as 
rs ( ), a statistical measure of the strength of association between a paired variable. The 
achievable values of Spearman‟s correlation coefficient are between -1 and 1. The 
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closer   to +1 indicates a stronger positive association of ranks, whereas the closer   
to 0 indicates the weaker association between ranks [526]. Interpretation of the correlation 
coefficient can be verbally described based on its absolute value, whereas 0.4 is a cut point 
indicating strength of the relationship.   below 0.40 indicates that the value of correlation 
is weak;   ranges from 0.40 to 0.59 indicates a moderate correlation;   ranges from 
0.60 to 0.79 indicates a strong correlation;   ranges from 0.80 to 1.0 indicates a very 
strong correlation. 
 
In this project, the repeated test results of CMHQ for its test-retest reliability evaluation 
were chosen. Spearman's Rank-Order Correlation was used to determine the relationship 
between the repeated test results of CMHQ for its test-retest reliability evaluation. 
 
5.9.5  Analysis of Variance (ANOVA) 
The statistical technique of ANOVA is used to compare the means of three or more groups. 
It examines whether samples are grouped from populations with equal means [527]. 
ANOVA calculates the F value, and an alpha level of .05 determines the level of significance. 
The null hypothesis is rejected if the value is large, indicated that there were significant 
difference in means across groups [481]. 
 
In this project, TTH participants were partitioned into subgroups based on the cluster 
analysis results. ANOVA was used to calculate the differences in the means of each group 
and to examine their group difference among the CM pattern types, in MIDAS levels and in 
perceived stress levels of the participants. Multiple comparisons of group means were 
performed via the post-hoc test of Bonferroni correction when P-value was smaller than 
0.05.   
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5.9.6  Cluster analysis 
5.9.6.1  Basic concepts of clusters and clustering 
The classification of objects is a fundamental human activity and also fundamental to the 
development of science [528].  
 
Cluster refers to “a number of similar things that occur together ” [529] and clustering thus 
is the process of gathering and collecting a set of objects into groups (clusters). The 
clustering is a method for discovery against prediction. It is an unsupervised learning 
method for classification as the clustering of objects/classes doesn‟t involve prediction 
[530]. 
 
Cluster analysis is a multivariate statistical method used to separate and classify cases 
(individuals or objects) that show similar characteristics into subgroups so that those 
objects within a group are different from the cases of other subgroups. In other words, the 
purpose of cluster analysis is to search for homogeneous and distinct subgroups based on 
multivariate observations [528].  
 
Cluster analysis is most frequently employed as a data exploration tool in the development 
of the typology, which a classification system does not yet exist [528]. By arranging those 
objects into subgroups, the analysis helps revealing the characteristics of patterns present. 
Furthermore, the clustering method can also be used as a confirmation tool [528] to 
investigate previously established theoretical subgroup solutions.  
 
5.9.6.2  Hierarchical cluster analysis and the K-means cluster analysis  
The widely used classical approaches of hierarchical and K-means algorithms suffered 
different problems. Hierarchical clustering is restricted to small datasets whereas the 
K-means limited to continuous variables [531]. In dealing with such disadvantages, 
previously, a possible recommendation is to conjunct k-means clustering with hierarchical 
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method. The strategy initially adopts the hierarchical clustering to summarise the dataset 
and determine the number of cluster solutions, then refine the solution in k-means 
clustering method and makes it effective for depicting relationships. 
 
5.9.6.3  The TwoStep cluster analysis 
In recent years, a newly introduced clustering algorithm of the TwoStep cluster analysis, is 
largely a combination of the methods of hierarchical and K-means clustering, was 
developed by the SPSS Inc. [532]. This method promised to avoid some of the 
disadvantages of both the hierarchical methods and the K-means methods. Like the 
K-means clustering, it is an interactive partitioning method. In addition, this cluster analysis 
integrates the best of both approaches of hierarchical and partitioning clustering algorithm 
with adding attributes to cluster objects [533]. The TwoStep clustering handles large data 
sets quickly as it uses a quick cluster algorithm upfront. 
 
In particular, it is more of a valuable tool than just an analysis. It deals with mixed type 
attributes of scale and ordinal data in the same model. Particularly, it gives the researchers 
choices either in predefining the number of clusters or letting the program make decision 
automatically [532]. Such tasks are normally assigned to the researchers in hierarchical 
and the K-means analyses. 
 
One of the remarkable features of the TwoStep clustering is the capability in handling a 
mixture of variables. It is effective for large datasets involved both continuous and 
categorical variables, such as demographics (e.g., gender, ethnicity) and ratings on a scale. 
Cluster models can be created using this type of approach based on both continuous and 
categorical variables [531]. Quantitative variables and nominal scaled variables can be 
handled concurrently [534]. In such occasion, the researchers need only define the nature 
of the variables and assign them into either continuous or categorical dataset for 
computing. 
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The TwoStep cluster analysis involves two steps, the pre-clustering and the clustering step. 
The clustering step is the hierarchical algorithm. In identifying groupings, prior to running 
hierarchical algorithm, it computes pre-clustering first. In this first step, cases are 
pre-clustered into small sub-clusters. In the second step of hierarchical algorithm, these 
small sub-clusters are assigned into the desired number of clusters. Alternatively, as 
mentioned previously, a pre-defined number of clusters can be specified in the TwoStep 
method like a K-means method.  
 
Being of an improved technique as well as the latest clustering method, the TwoStep 
clustering is the method of choice for many applications. It provides automatic selection of 
optimal number of cluster; ultilises unique cluster model simultaneously based on 
categorical and continuous variables; and features of scalable and distinct visualised 
presentation on cluster partitioning results. Therefore, in this project, the TwoStep cluster 
method was adopted for TTH pattern exploration. 
 
Although the TwoStep algorithm may provide the optimal number of clusters automatically, 
it is also argued that the automatic clustering routine yields too few clusters and is not 
usually useful. In addition, such algorithm does not handle missing data and therefore 
respondents with any missing values may be excluded from the analysis, which may lead to 
the decrease of sample size [535]. In such case, the pre-handling of missing values of the 
dataset may help the analyst treating the potential disadvantage. 
 
5.9.7  Factor analysis 
Factor analysis is one of the multivariate statistical procedures that is commonly used in 
questionnaire development for interpreting self-administrated questionnaires [536]. 
Conducting factor analysis helps investigators explain the nature of the interrelationships 
among a large number of variables [537]. It is a technique used to determine the underlying 
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structure of latent variables of the observed data [481]. By examining whether its 
constituent items load in the same factor, i.e., under same dimension [538], factor analysis 
can be used to demonstrate the dimensionality of an instrument [539]. 
 
In factor analysis, factor refers to the combination of variables that highly interrelated [537]. 
The grouped variables define part of construct and in attempt to represent different 
dimensions within the dataset [481]. The word „factor‟ may have different meanings despite 
of sharing the same name. In analysis of variance techniques, it refers to the independent 
variable [540].  
 
This study utilises factor analysis to uncover latent factors underlying the collected variables 
so as to evaluate the CMHQ construct validity. Additionally, as a dimensionality reduction 
technique, it was also applied to simplify the dataset and used in conjunction with cluster 
analysis for TTH pattern exploration.  
 
5.9.7.1  Types of factor analysis 
Depending on the research purpose, exploratory factor analysis (EFA) and confirmatory 
factor analysis (CFA) are two methods can be used.  
 
EFA is the most common method of factor analysis used to reduce a set of variables into a 
smaller group of factors with a minimum loss of information [541]. It is often used to 
explore the possible underlying factor structure of a set of observed variables when little 
prior knowledge about its structure [542]. Since the preconceived theory is not imposed by 
performing this technique, the researchers interpret the structure on the outcome based on 
its factor loading. In other words, the technique helps researchers define concept 
(construction) [537]. 
 
CFA seeks to examine the degree to which the number of factors meets the expected 
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structure on the basis of pre-established theory. It allows the investigators to specify the 
exact nature of the factor model [498]. As named with “confirmatory”, it is often used to 
verify the factor structure [543] and confirm the preconceived theory [481].  
 
In this study, although the theory of CM is tentatively applied to guide the CMHQ 
development, there is little knowledge about its pattern of inter-correlations among 
variables. In defining the underlying factor structure and the number of constructs of CMHQ, 
EFA was used.  
 
5.9.7.2  Type of factoring 
Common factor analysis (also known as principal axis factoring) and component factor 
analysis (also known as principal component factor analysis) are two broad classes of 
methods for factoring [481, 544, 545]. In making decisions on choosing an appropriate 
factoring model from the two methods, there has been debates among analysts [536].  
                   
Common factor analysis is related to principal component analysis (PCA) but not identical. 
Although both could be used to reduce a large set of (observed) variables to a smaller 
number of variables and components (dimensions) [545], they serve different purposes. 
 
Common factor analysis aims to find the least underlying latent variables (factors) that 
account for the common variance (correlation) of the measured variables [512]. Therefore, 
it concerned with covariance (correlations), as the covariances in the observed variables are 
estimated to be explained by the factors, which are regarded as the causes of those 
variables [512]. In contrast, PCA concerns with variance. PCA deals with all the variances of 
a variable. It accounts for the total variance of the variables. That is, common variance plus 
specific (unique) variance, as well as error variance are analysed in this method [546]. 
Since variables in PCA reflected a combination of total variance, PCA is thus assumed to be 
reliable and without error [546]. In factor analysis, the terms of „factor‟ and „component‟ are 
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often interchanged used. However, factors in PCA are often referred as components. PCA 
seeks to identify observed variability by smaller number of components whereas the 
components are estimated to represent the variances of the variables [512]. As opposite to 
common factor analysis, this approach is typically used to achieve the goal of data reduction 
[512]. In PCA, components are summaries on the basis of variance [498]. That is, the first 
component extracted explains/represents the most variance, and the second accounts for 
the next highest possible amount of variance from the remaining variance, and so on, until 
all the variance within the test items has been explained [442].  
 
Although both techniques lead to the similar results, performing common factor analysis 
however has more restrictive assumptions [481]. In addition, such factoring is more 
problematic and complicated [481]. As one of the approaches to factor analysis, PCA is the 
most commonly used method in exploring interrelationship of items and identifying the 
associated underlying concepts and domains of a questionnaire [440, 498], as well as in 
establishing preliminary solutions in EFA [547]. In addition, PCA is also a typical default 
method of factor analysis. Particularly, it is recommended when no prior theory or model 
exists [548]. 
 
In conclusion, choosing PCA is more practical when performing factor analysis. Hence, in 
this study PCA was used for factor extraction.  
 
5.9.8  Steps for conducting factor analysis 
In general, there are four steps in conducting factor analysis, i.e., assessment of the data 
suitability, factor extraction, factor rotation and factor interpretation.  
 
5.9.8.1  Tests for data suitability 
Sample size and the strength of data set are two prerequisite issues for consideration of the 
appropriateness of performing factor analysis [540]. There are however different rules on 
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determination of the sample size. Some recommended a preferable sample size for 
conducting factor analysis would be five respondents per item [501, 549], while others 
suggested at least a sample size of 300 cases is adequate, or 150 is sufficient [550]. In 
general, to undertake this technique, a minimum number of 100 cases is required to ensure 
stability of the variance-covariance matrix [498-500, 548, 551]. 
 
Regarding the strength of the intercorrelations among the variables, several procedures are 
recommended to ensure the appropriateness of dataset for analysis [481].  
 
Visual inspection of the correlation matrix is used to predict the heterogeneity of the data 
set. A correlation matrix displays the relationships between individual variables [536]. 
Variables sharing too much variance or correlated with each other are impractical to 
perform this technique [536]. Conducting factor analysis should base on the evidence of 
correlation coefficients (no upper limit, maximum value 1.0) that over 0.3, which supports 
a lacking of high correlations between variables [481, 540]. In other words, the correlation 
matrix of 0.3 represented the factors explain about 30% relationship within the data [536]. 
If the correlations less than 0.3 was examined, factor analysis may not be a proper method 
for statistical analysis [536].  
 
In SPSS, two statistical measures are available in assessment of the factorability of the 
correlation matrix [540]. Bartlett‟s test of sphericity [552], which is used to help examining 
whether the entire correlations matrix are uncorrelated or not, should be significant 
(P<0.05) in considering of an appropriate factor analysis. In addition, the 
Kaiser-Meyer-Olkin (KMO) is the index which ranges from 0 to 1 to measure the sampling 
adequacy [553, 554]. The KMO value should be greater than 0.5 as a value less than 0.50 
is unacceptable. Therefore 0.5 is a cut-off value for a satisfactory factor analysis whereas 
0.6 indicated as the minimum value for a good factor analysis [550].   
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5.9.8.2  Factor extraction  
The purpose of data extraction is to generate factors from a large number of variables [536]. 
There is however no single criterion assumed to be adequate in determining factor 
extraction [24], majority of factor analysts use multiple criteria [481].  
 
The Kaiser‟s criteria (eigenvalue > 1 rule) [553] is the most commonly used method in 
determining the number of factors to extract [481]. The eigenvalue indicates the degree of 
the total variation explained by a factor [555]. Proposed by Kaiser, factors with eigenvalue 
less than 1 implies the scores would have negative reliability [556], whereas factors with 
eigenvalue of 1 indicate substantial amount of variation were explained [555]. Hence, in 
Kaiser criterion, all factors having an eigenvalue greater than 1 should be retained. 
 
Another popular approach to determine the number of factors to extract is based on the 
Catell‟s scree test [557]. In this method, the eigenvalues are plotted against its associated 
factor/s, and the eigenvalues linked with a line (Figure 22). There will be some factors 
having higher eigenvalues than others (for example, factor 1 to 4 in the figure). As a result, 
a sharp descent of the plotted curve will be presented. Afterwards, determination of the 
number of factors can be made with the visual inspection of the point where the line levels 
off or break in the plot [558]. Points above the break (exclusive of the break itself) are 
indicated to be retained, as the major factors contribute the most to the explanation of the 
variance in the data set has been divided by this point [536, 540].  
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(figure adapted from: ttp://www.hss.bond.edu.au/stats/public_html/FA/faex.htm) 
Figure 22. Eigenvalues in a scree plot 
 
Therefore in this study, examinations of Kaiser‟s criteria and scree test criterion were used 
to measure the sampling adequacy. 
 
5.9.8.3  Factor rotation 
Rotation is used to produce an easier and more simplified way for data interpretation. 
Selection of rotational method is another consideration once the number of factors has been 
defined. Factor rotation maximises high item loadings whilst minimizes low item loadings 
[536]. In this procedure, high item loadings refer to the loadings of variables with a strong 
relationship with a factor. In contrast, low item loadings refer to those variables that have 
a weaker association with a factor [440].  
 
Orthogonal rotation and oblique rotation are two common rotation techniques. Orthogonal 
rotation, the simplest type of rotation, offers uncorrelated factor structures. In contrast, the 
oblique rotation allows factor structures to be correlated [559]. However in practice, 
performing either of them produce similar results [550]. 
 
There is no specific rules in choosing a particular method of rotation [481]. Although the 
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oblique rotations are more realistic [481], orthogonal rotation results are easier to interpret 
than oblique approaches [550]. Amongst different methods of orthogonal rotation 
technique, varimax method is the most commonly used technique in factor analysis, which 
attempts to minimize the number of variables that have high loadings within each factor 
[540]. Therefore, the present study adopted orthogonal varimax rotated solution for factor 
rotation. 
 
5.9.8.4  Factor interpretation  
The EFA demonstrates internal structures of a measurement by examining whether the 
items being tested measure the intended factor appropriately. It detects the coefficient on 
each item of the questionnaire, thus the number of latent constructs underlying a set of 
items can be determined. This coefficient of item is known as the “factor loading” which 
refers to how strong each variable is associated with the proposed factor. More specifically, 
factor loading indicates the strength that the factors influence the measured variables. 
When items are grouped into factors using factor analysis, those factor loadings are used to 
explain the correlation between the individual item and the overall factor [442].  
 
In general, the factor loading magnitude accounts for the variance of three levels. Only the 
absolute value is considered in interpretation of the magnitude [442]. A coefficient below 
0.4 indicates the loading condition is weak, 0.6 a moderate level, between 0.6 and 0.8 being 
large, and 0.8 or above being very good high loading condition [560]. In addition, another 
criterion classified the factor loading into three level of „„strong‟‟, „„moderate‟‟ and „„week‟‟, 
which corresponding to absolute loading values of >0.75, 0.75–0.50 and 0.50–0.40 
respectively [561]. 
 
However, factor loadings greater than 0.3 could be considered indicative of some degree of 
relationship [5], as the loadings between 0.3 and 0.4 are regarded to meet the minimal 
level in interpreting the factor structure [481]. As a rule of thumb, although the loadings of 
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0.3 or 0.4 are minimally acceptable, to retain a factor for practical significance, a cut-off 
value of greater than 0.5 is considered necessary in general [481]. Ideally, loading of the 
items are expected to be high under each proposed factor. For those items with low loading 
under the proposed factor, or high loading on the incorrect factor, revisions and 
re-evaluations are expected based on the characteristics showed by the EFA results [486]. 
In the present study, the cut-off value of 0.5 was adapted for factor extraction. 
 
Labelling of factors is another aspect involved in the interpretation of factors. Basically, a 
meaningful interpretation can be given to a factor that is loaded with 2 or more variables 
[536]. However, the factor labelling is a theoretical and inductive related process [547]. 
Both objective and subjective judgments are recommended to be used when interpreting 
factors [481]. Ultimately, labelling factors is dependent on the researchers‟ definition [562], 
but the contents labelled should be operational and descriptive [536]. More importantly, the 
constructs should represent its theoretical and conceptual intent [536].   
 
 
5.10  Chapter summary 
This chapter outlines and explains the research design, plan and its methodology. The 
CMHQ development process, ethical consideration, population identification, CMHQ item 
generation and construction, CMHQ revision and pre-test, CMHQ evaluation, data analysis 
methods are discussed.  
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6.1  Introduction 
Since TTH is not a disease entity in CM, therefore, recognition of such a disorder in clinical 
practice has to be based on the CM classification of general headache. However, these CM 
patterns are largely based on expert opinions or experiences, which may lead to variations 
in diagnosis [563]. Previous studies have shown that it is possible to standardise and 
validate patterns using objective methods and evidence-based approaches [442, 564].  
 
In Chapters of 4 and 5, essential methods of developing a valid questionnaire and the 
strategies for the CMHQ development are described respectively. In developing a 
questionnaire for accessing CM patterns, reviewing diagnostic information across various 
literatures such as classical literature, contemporary textbooks, journals, and other types of 
publications is the most common choice for its initial construction [14, 329, 338, 563, 
565-567]. For instance, as mentioned previously, the Body Constitution Questionnaire 
identified Stasis-related items from CM textbooks and a literature review [14]. Similarly, 
another study conducted by German CM experts identified headache related items from 
various literature sources [338]. This chapter aims to illustrate how the items of CMHQ were 
generated via literature search and face-to-face interview.  
 
 
6.2  Specific objectives 
The initial version of CMHQ was developed using a step-by-step approach with following 
specific objectives:  
 
1).  to extract TTH diagnostic-related information from literatures;  
2).  to generate items for CMHQ-1 construction based on literature search; 
3).  to identify additional items via the face-to-face interview; 
4).  to examine and evaluate the eligibility of CMHQ items via internal group 
discussion; 
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5).  to refine CMHQ-1 and construct CMHQ-2; and 
6).  to evaluate face validity of CMHQ-2.   
 
 
6.3  Literature search  
6.3.1  Methods  
6.3.1.1  Search strategy 
The literature search on this topic was limited in Chinese literatures. The primary sources of 
literatures included contemporary tertiary textbooks and clinical monographs obtained 
from RMIT library and Discipline of Chinese Medicine collection. The reasons for reviewing 
the literatures of textbooks and monographs were due to they were written by renowned 
experts in CM, which were regarded to have established the authors‟ interpretation to the 
classical literature and representative of the CM theory for the study of headaches. The 
secondary sources of literatures were journal articles searched via two largest Chinese 
online databases of CNKI and CQVIP. The reasons for searching online databases were due 
to the journal articles may contain updated information of CM recognition that in relation to 
TTH.  
 
Predefined search terms keywords of “紧张性头痛” (Tension-type headache), “紧张型头痛 
(Tension headache) and, “肌收缩性头痛” (Muscle contraction headache) were used to locate 
TTH, whereas  “辨证”, “证型”, “诊断”, and ”分类” were applied for identifying classification of 
CM patterns. A sample search strategy is provided in Table 22. 
 
Table 22. Search strategy and search terms 
 
A. Search strategy to locate Tension-type Headache 
# 1. 紧张性头痛 (Tension-type headache) 
# 2. 紧张型头痛 (Tension headache) 
# 3. 肌收缩性头痛 (Muscle contraction headache)  
# 4. or/# 1-# 3 
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B. Search strategy to locate Pattern identification 
# 5. 辨证 (pattern identification; syndrome differentiation) 
# 6. 证型 (pattern, syndrome pattern) 
# 7. 诊断 (diagnosis)  
# 8. 分类 (classification) 
# 9. or/#5-#8 
C. Search strategy to locate studies for this search 
#4 AND #9  
 
6.3.1.2  Selection criteria 
Diagnostic information, which could in the forms of items, phases or sentences, which 
associated with TTH pattern identification, were considered in this literature search. 
However, information such as the signs on facial complexion, tongue and pulse that require 
CM practitioners‟ observation, were excluded from the literature search. This exclusion was 
made because the form of CMHQ is designed to be a patient-report self-completed 
questionnaire.  
 
6.3.2  Search result 
Seven (7) textbooks and 6 monographs (Appendix 16) were reviewed as the primary 
sources. In terms of the secondary source of journal articles via electronic databases, 1134 
articles were found. Articles were screened by reading titles and abstracts to identify 
diagnosis related information that related to CM, such as practitioners‟ treatment 
experiences, CM classification, or clinical observations of patients symptoms and signs. 
Finally, 99 articles in full-text were selected (Appendix 17). 
 
6.3.3  Extraction of literature information  
In order to reflect the conventional process of CM pattern identification, diagnostic 
information related to CM diagnosis on headaches, such as headache characteristics, 
location of pain, aggravating factors, relieving factors and accompanying symptoms, were 
extracted from the above mentioned sources into an item pool so as to further construct 
into the initial version of CMHQ. 
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Due to extracted information were originally in language of Chinese, the items were firstly 
translated by the chief investigator into English and confirmed by two bilingual registered 
CM practitioners who worked at RMIT Discipline of CM. 
 
6.3.4  Item pool 
The item pool consisted of 131 items, with 9 items related to frequency of headache (Table 
23), 20 items related to headache characteristics, 20 items related to headache location, 42 
items related to aggravating factors, 5 items related to relieving factors, and 35 items 
related to accompanying symptoms. 
 
Table 23. Summary of the pooled items (n=131)  
 
Items related to rhythm of headache (n=9) 
Continuous  Intermittent Frequent Steady  Prolonged 
Persistent Fluctuate Recurrent Lingering  
Items related to quality of headache (n=20) 
Pressing Tightness Pulsating Radiating Distending   
Heavy   Pulling Empty Knocking Prickling 
Explosive Cutting or Sharp Burning Throbbing Drilling 
Vague Stabbing Dull Piercing Pounding 
Items describing to headache location (n=20) 
Unilateral Bilateral Exchangeable Whole head Forehead 
Vertex Occipital Neck Inner canthus Outer canthus 
Temple  Eyebrow Forehead Cheeks Supra-orbital ridge 
Ear Tip of ear  Tai Yang point Face No particular 
location 
Items related to aggravating factors (n=42) 
Overwork Exercise Cough When tired Swallowing 
Opening mouth Laughing Brushing teeth Thinking Sitting straight 
Turning head Neck flexion Washing face Yawning Sticking out tongue 
Eating Using eyes  Alcohol Chocolate Milk 
Coffee Ice cream Monosodium 
Glutamate(MSG) 
Exertion Spicy food 
 
Over consumption of 
oily food 
Change of weather Warm or hot weather Cold weather Windy days 
Humid weather or 
rainy days 
Change in 
temperature, from 
hot to cold 
Change in 
temperature, from 
cold to hot 
Before menstruation During menstruation 
After menstruation Stress Anxious Nervous Irritable 
Pregnancy Menopause    
Items related to relieving factors (n=5) 
Pressing Lying prone Rest Sleepiness with medications   
Items related to accompanying symptoms (n=35) 
Nausea Photophobia Dizziness Blurred vision Neck stiffness 
heavy sensation in 
the head 
Irritable Double vision Fainting Sensitive to sounds 
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Vomiting Tinnitus Pale face Sweating Swollen painful eyes 
Red face Palpitation Twitching Fatigue Diarrhoea 
Weight loss Loss of appetite Dripping eyelid Runny nose Poor memory 
Black out Poor concentration Chronic Illness Neck pain Shoulder pain 
Lower back pain Cold hands and feet 
 
Bitter taste in the 
mouth 
Short-tempered, or 
having outbursts of 
anger 
Weak knees 
 
 
6.3.5  Item generation 
Two CM practitioners (Mr. Xinyu Hao and Dr. Zhen Zheng) screened the extracted 
information. Discussed by the practitioners, these original information were phased into 
items for CMHQ construction. 
 
During this process, items with similar description were deleted. For example, knocking was 
deleted as it was similar to pounding. Items were combined if the meanings were similar or 
may confuse respondents. For example, items were rephrased for better descriptions if it 
was in jargon or unclear/inadequate description. For example, “photophobia” was replaced 
by sensitive to light; “using eyes” was rephrased into “computer or reading for a long time”.  
 
Finally, a total 100 items were retained for initial CMHQ construction. 
 
 
6.4  CMHQ-1 Construction  
The CMHQ-1 (Appendix 18) comprised of three parts reflecting the key component of a CM 
interview: Part 1. Pain description (combining headache quality and location); Part 2. 
Aggravating and relieving factors (combining aggravating and relieving factors); and Part 3. 
Accompanying symptoms.  
 
Tick-boxes were used for data collection. For each section, an option of “others” was given 
allowing further identification of uncovered information. 
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6.4.1  Part 1. Pain description (20 items) 
This part has three sections containing 20 items and a series of head images for shading. 
The first section was about headache rhythm. Participants were required to define their 
headache rhythm from the options of continuous and intermittent. The second section was 
to identify the location of headache. The third section was about the quality of headaches.  
 
In the second section, the original information on headache location of headache was in 
form of items, such as forehead, vertex, Tai Yang point. To avoid misunderstandings of 
terminologies by participants, these items were replaced by four images displaying different 
sides of the head with shaded pain areas. Participants were instructed to indicate the 
location of their headache by shading the head images. 
 
6.4.2  Part 2. Aggravating and relieving factors (47 items) 
This part included two sections, i.e., aggravating factors and relieving factors. Of the total 
47 items, 42 were aggravating factors and 5 items related to the relieving factors. The 
former was then categorised into exercise related, neck exercise related, diet related, 
weather related, menstruation related, and emotion and other factors. 
 
6.4.3  Part 3. Accompanying symptoms (33 item) 
Originally, a total 35 (Table 23) items were comprised in this part. Due to the CMHQ-1 was 
designed for self-administrated, items not suitable for self-observation and may require 
practitioner‟s input, such as facial complexion, were removed. As a result, 33 items were 
retained in this part.  
 
 
6.5  Face-to-face interview 
Our literature search showed that there were neither agreed TTH pattern identifications nor 
consensus-based TTH pattern model in the literature; and the diagnostic information for CM 
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pattern identification from the real TTH patients was rare. To fill the gaps in the literature, 
we conducted a face-to-face interview on TTH patients to uncover information related to 
TTH 
 
During the interviews, each participant was informed about the purpose of the interview, 
which was to identify further TTH related symptoms and signs and make CM pattern 
identification based on the information provided.  
 
The interview was performed by a qualified CM practitioner, who was a registered 
practitioner with 3 years of experiences. In order to obtain a diversity of information related 
to TTH, the pulse, tongue and facial complexion of each participant were also checked. In 
addition, participants were encouraged to provide more detailed descriptions in terms of 
their quality of headache, aggravating and relieving factors related to the headache, and 
other accompanying symptoms. 
 
6.5.1  Procedure 
The Phase One study of face-to-face interview was conducted between 2008 and 2009 at 
the RMIT University, with ethic approval obtained from the RMIT HREC. Participants spent 
15 minutes to complete the CMHQ-1, and another 15 minutes for the CM interview. 
 
Each participant filled out the CMHQ-1 independently and then handed it to the practitioner 
once completed. In each section throughout the questionnaire, a blank item was listed 
allowing each participant make comments. The practitioner then conducted a normal 
interview similar to those in a clinical setting, the practitioner made diagnosis after 
confirming the answers and checking participants‟ tongue and pulse. Additional questions 
related to participants‟ signs and/or symptoms of headache were clarified during the 
interview when the information obtained from the CMHQ-1 was insufficient to make a 
proper diagnosis. 
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6.5.2  CM diagnostic criteria for pattern identification 
Identification of CM patterns on TTH participants were based on information from analysing 
organ functions, internal/external factors, clinical symptoms, and tongue diagnosis 
according to the treatment protocol of the clinical trial, which gained experts‟ consensus 
based classification of TTH (listed in Chapter 2, Section 2.8). These patterns predefined in 
the protocol consisted of common CM patterns of Ascendant hyperactivity of Liver-Yang, 
Liver-Qi stagnation, Phlegm rises to cloud the Mind, Dual deficiency of Qi and Blood, and 
Stagnation of Blood (listed in Chapter 2, Table 8). 
 
6.5.3  Data collection and data analysis  
Collected data was extracted into an excel spread sheet for evaluation. Using the SPSS 
(version 19), frequency analysis was calculated for each variable and further evaluated by 
the internal group.  
 
6.5.4  Results of face-to-face interview  
During May 2008 and February 2009, convenience sampling attending for the clinical trial 
fulfilling the selection criteria were included for the face-to-face interview. The inclusion and 
exclusion criteria were listed previously (Chapter 5, section 5.4.3). Of the included 20 local 
TTH participants, 14 were female and 6 were male participants, with an average age was 
37.8 years (SD=9.8). The youngest participant was 27 years old and the oldest participant 
was 61 years old.  
 
The results of Part 1 were presented in Table 24. Calculation number of items was based on 
the actual responses by participants. As a result, the total number of items was counted as 
106 due to 6 items were added in Part 1. Specifically, some participants ticked both items 
of “continuous” and “intermittent”. In addition, the head images in part 1 were deemed as 
five items. More than half participants reported their headache were continuous (65%) 
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rather than intermittent (20%). In addition, 3 participants (15%) reported the headache 
were of both continuous and intermittent. The commonly reported location of headache 
were the whole head (35%) and temporal (30%). The commonest sensations of headache 
that more 50% participants responded were described as pressing (65%), heavy (65%) 
and tightness (50%). 
 
Table 24. Frequency analysis of Part 1 items 
 
Part I. Pain description (item=26) 
1.1 Pain rhythm Counts Percentage 
1.1.1 Continuous 13 65 
1.1.2 Intermittent 4 20 
 Both of 1.1.1 and 1.1.2 3 15 
1.2 Pain location Counts  Percentage  
1.2.1 Frontal 5 25 
1.2.2 Vertex 0 0 
1.2.3 Temporal 6 30 
1.2.4 Occipital 2 10 
1.2.5 Whole head 7 35 
1.3 Pain quality Counts Percentage 
1.3.1 Pressing 13 65 
1.3.2 Explosive 3 15 
1.3.3 Burning 2 10 
1.3.4 Drilling 2 10 
1.3.5 Cutting or sharp  5 25 
1.3.6 Stabbing 1 5 
1.3.7 Distending  1 5 
1.3.8 Heavy 13 65 
1.3.9 Pulling 4 20 
1.3.10 Empty 0 0 
1.3.11 Vague 3 15 
1.3.12 Dull 9 45 
1.3.13 Piercing 3 15 
1.3.14 Tightness 10 50 
1.3.15 Pulsating 5 25 
1.3.16 Radiating 3 15 
1.3.17 Pounding 6 30 
1.3.18 Throbbing 8 40 
 
As indicated in Table 25, the most common aggravating factors that more 50% participants 
responded were overwork (65%), when tired (50%), stress (80%) and anxiety (60%), 
whereas the commonest relieving factors were sleep (60%), rest (55%) and medication 
(50%). 
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Table 25. Frequency analysis of Part 2 items 
 
Part 2. Aggravating and relieving factors (item=47) 
2.1 Aggravating factors Counts Percentage 
2.1.1 Overwork 13 65 
2.1.2 Exercise  4 20 
2.1.3 Cough  0 0 
2.1.4 When tired 10 50 
2.1.5 Swallowing  0 0 
2.1.6 Opening mouth  1 5 
2.1.7 Laughing  0 0 
2.1.8 Brushing teeth  0 0 
2.1.9 Thinking  6 30 
2.1.10 Sitting straight  2 10 
2.1.11 Turning head  1 5 
2.1.12 Neck flexion  4 20 
2.1.13 Washing face  0 0 
2.1.14 Yawning  0 0 
2.1.15 Sticking out tongue  0 0 
2.1.16 Eating  0 0 
2.1.17 Computer or reading long time 11 55 
2.1.18 Alcohol 8 40 
2.1.19 Chocolate  1 5 
2.1.20 Milk 0 0 
2.1.21 Coffee 2 10 
2.1.22 Ice cream  1 5 
2.1.23 Monosodium Glutamate  3 15 
2.1.24 Exertion  0 0 
2.1.25 Spicy food  1 5 
2.1.26 Over consumption of oily food 1 5 
2.1.27 Change of weather 4 20 
2.1.28 Warm or hot weather  5 25 
2.1.29 Cold weather 4 20 
2.1.30 Windy days 5 25 
2.1.31 Humid weather or rainy days 2 10 
2.1.32 Change in temperature, from hot to 
cold 
2 10 
2.1.33 Change in temperature, from cold to 
hot  
0 0 
2.1.34 Before onset of menstruation 
bleeding  
3 (of 14) 21.4 (in female) 
2.1.35 During menstruation bleeding  6 (of 14) 42.9 (in female) 
2.1.36 After the end of the menstruation 
bleeding  
2 (of 14) 14.3 (in female) 
2.1.37 Stress 16 80 
2.1.38 Anxiety 12 60 
2.1.39 Nervous 7 35 
2.1.40 Irritability  6 30 
2.1.41 Pregnancy  0 (of 14) 0 (in female) 
2.1.42 Menopause 1 (of 14) 7.1 (in female) 
2.2 Relieving factors Counts Percentage 
2.2.1 Pressing 9 45 
2.2.2 Lying  9 45 
2.2.3 Rest 11 55 
2.2.4 Sleep  12 60 
2.2.5 With medications  10 50 
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As shown in Table 26, items of accompanying symptoms that more 50% participants 
responded (highlighted in bold) were fatigue (85%), neck pain (75%), poor concentration 
(70%), heavy sensation in the head (65%), neck stiffness (60%), shoulder pain (55%), 
sensitive to sounds (50%), nausea (50%) , irritability (50%), and short-tempered (50%). 
 
Table 26. Frequency analysis of Part 3 items 
 
Part 3. Accompanying symptoms (item=33) 
Accompanying symptoms Counts Percentage 
3.1.1 Sensitive to sounds 10 50 
3.1.2 Sensitive to light 8 40 
3.1.3 Nausea 10 50 
3.1.4 Vomiting 2 10 
3.1.5 Dizziness 6 30 
3.1.6 Blurred vision 5 25 
3.1.7 Double vision  1 5 
3.1.8 Neck stiffness/tension  12 60 
3.1.9 Fainting 1 5 
3.1.10 Black out 1 5 
3.1.11 Fatigue (or tired)  17 85 
3.1.12 Cold hands and feet  5 25 
3.1.13 Heavy sensation in the head 13 65 
3.1.14 Twitching 2 10 
3.1.15 Weight loss  1 5 
3.1.16 Sweating 5 25 
3.1.17 Palpitations 3 15 
3.1.18 Swollen painful eyes 2 10 
3.1.19 Dripping eyelid 0 0 
3.1.20 Tinnitus of deafness  0 0 
3.1.21 Runny nose 2 10 
3.1.22 Poor memory 8 40 
3.1.23 Poor concentration 14 70 
3.1.24 Diarrhea 1 5 
3.1.25 Poor appetite 8 40 
3.1.26 Bitter taste in the mouth 1 5 
3.1.27 Irritability 10 50 
3.1.28 Short-tempered 10 50 
3.1.29 Chronic illness 0 0 
3.1.30 Neck pain 15 75 
3.1.31 Shoulder pain 11 55 
3.1.32 Lower back pain 8 40 
3.1.33 Weak knees  4 20 
 
Assessed by the practitioner, results of tongue and pulse diagnosis were summarized in 
Table 27. Tongue colour in red (60%) was most common among the participants, and 
nearly a half participants presented tongue with toothmark (40%). In regard to the pulse 
diagnosis, rapid (50%) pulse and slippery (45%) pulse were most commonly observed in 
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this interview.  
 
Table 27. Frequency analysis of tongue and pulse diagnosis 
 
Tongue and pulse  
Tongue  Counts Percentage 
 Thin 7 35 
Thick 0 0 
Greasy 2 10 
Slippery 1 5 
White 6 30 
Yellow 4 20 
Swollen 0 0 
Cracked 4 20 
Quivering 1 5 
Toothmarked 8 40 
Pale 5 25 
Pink 1 5 
Red 12 60 
Deep-red 0 0 
Purple 2 10 
Pulse Counts Percentage 
 
Weak 5 25 
Superfical 2 10 
Deep 6 30 
Rapid 10 50 
Thready 6 30 
Stringy 7 35 
Slippery 9 45 
 
6.5.5  Summary of CM diagnosis results 
Table 28 lists the CM diagnosis of the 20 participants. The patterns of Dual deficiency of Qi 
and Blood (35%) and Liver-Qi depression (35%) were the two largest pattern groups in this 
investigation no participants were diagnosed as Stagnation of bloods in this face-to-face 
interview. 
 
Table 28. Results of CM diagnosis 
 
CM diagnosis Counts Percentage 
Stagnation of Blood 0 0 
Dual deficiency of Qi and Blood 7 35 
Phlegm rises to cloud the Mind 2 10 
Liver-Qi depression 7 35 
Ascendant hyperactivity of Liver-Yang 4 20 
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6.5.6  Identification of items from the interview  
The face-to-face interview identified 125 additional items included symptoms and signs 
counted in sentences or phases that experienced by TTH sufferers. Those items were 
evaluated in the subsequent internal group discussion. 
 
 
6.6  Internal group discussion 
As mentioned in Chapter 5, the internal group discussion had intentions of CHMQ 
amendments as well as evaluation of its face validity. 
 
6.6.1  Membership of the internal groups members 
Of the 8 group members, two teaching staff had more than 10 years of clinical, teaching and 
research experiences each. Two research fellows were of more than 5 years clinical and 
research experience. All of the three research students were qualified practitioners. All of 8 
group members were fluent in English, with 1 had English as her first language. The other 
7 were bilinguals in both Chinese and English.  
 
6.6.2  Procedure 
Tasks of the group members were to provide and exchange their own opinions with other 
members. Based on the frequency results of the interview, items were firstly screened by 
the investigator and then submitted to group discussion for evaluation of items and face 
validity. As a result, eligibility of items and face validity of CMHQ were assessed during the 
process: all members were firstly instructed to read the CMHQ and informed about the 
existing CMHQ structure. A summary of frequency results for items were then displayed. 
They were required to comment on the items based on their clinical experiences. 
 
6.6.3  Criteria of item evaluation  
Generally, all collected items were evaluated for clarity and simplicity of expression. In 
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addition, a specific criterion on item discussion was set according to its response rate. Two 
practitioners (Mr. Xinyu Hao and Dr. Zhen Zheng) screened the items that had less than 20% 
response rate. Among those items, some were removed if both considered them being 
irrelevant; and the others were retained for evaluation by the internal group if the two 
practitioners did not agree with each other. Furthermore, items that were not directly 
related to TTH, or unclear for pattern identifications in clinical significance, were candidates 
for evaluation. Consensus was required from practitioners in determining the exclusion of 
such items. If consensus were reached for deletion, the item was removed; if not, items 
were retained for (further) group discussion.  
 
Determination of item retention required an agreement of more than 80% of the group 
members. As a result, ineligible items were deleted from the CMHQ list whereas eligible 
items were retained for CMHQ-2 construction. 
 
6.6.4  Evaluation of items  
CMHQ-1 had 106 items identified from the literature. Together with another 125 items 
identified from the interview, totally 231 items were evaluated. 
 
In evaluating the original CMHQ-1 items, a total 24 items were deleted due to the low 
response rate (Table 29). 
 
Table 29. CMHQ-1 items deleted (n=24) 
 
Original item Percentage 
 
1.3.6 Stabbing  5 
1.3.7 Distending 5 
2.1.3 Cough  0 
2.1.5 Swallowing  0 
2.1.6 Opening mouth  5 
2.1.7 Laughing  0 
2.1.8 Brushing teeth  0 
2.1.10 Sitting straight  10 
2.1.11 Turning head  5 
2.1.12 Neck flexion  20 
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2.1.13 Washing face  0 
2.1.14 Yawning  0 
2.1.15 Sticking out tongue  0 
2.1.16 Eating  0 
2.1.20 Milk 0 
2.1.22 Ice cream  5 
2.1.25 Spicy food  5 
2.1.26 Over consumption of oily food  5 
2.1.41 Pregnancy  0 
3.1.7 Double vision 0 
3.1.15 Weight loss 5 
3.1.19 Dripping eyelid 0 
3.1.21 Runny nose 10 
3.1.29 Chronic illness 0 
 
The other 35 items that have a low respond rate were reserved for further evaluation by the 
internal group members. As a result, they were retained or revised with modification (Table 
30). 
 
Table 30. CMHQ-1 item amendments (n=35) 
 
Original item Outcome of amendment 
Status of evaluation Modification 
1.2.1 Frontal  Item revised “Front of the head” 
1.2.2 Vertex  Item revised “Top of the head” 
1.2.3 Temporal  Item revised “Sides of the head 
1.2.4 Occipital  Item revised “Back of the head 
1.3.5 Cutting or sharp Item revised separate to “cutting” and “sharp” 
1.3.8 Heavy Item revised “Heaviness” 
1.3.10 Empty Item revised “Emptiness” 
2.1.2 Exercise  Item revised “Physical activities” 
2.1.9 Thinking Item revised “Mental strain” 
2.1.17 Computer or reading long 
time  
Item revised “Eyestrain  
(Reading, computer or TV)” 
2.1.19 
Chocolate  
Item retained without 
change 
-------------- 
2.1.21 
Coffee 
Item retained without 
change 
-------------- 
2.1.24 Exertion  Item revised “Physical exertion” 
2.1.27 
Change of weather 
Item retained without 
change 
-------------- 
2.1.29 
Cold weather 
Item retained without 
change 
-------------- 
2.1.28 Warm or hot weather  Item revised “Hot weather” 
2.1.31 Humid weather or rainy 
days 
Item retained without 
change 
-------------- 
2.1.32 Change in temperature, 
from hot to cold 
Item revised “Change in temperature” 
2.1.33 Change in temperature, 
from cold to hot  
Item revised Combined with  
“Change in temperature” 
2.1.34 Before onset of 
menstruation bleeding  
Item revised “Before period” 
2.1.35 During menstruation Item revised “During period” 
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bleeding  
2.1.36 After the end of the 
menstruation bleeding 
Item revised “After period" 
2.1.39 Nervous Item revised “Nervousness” 
2.1.40 Irritability  Item revised “Anger or irritability” 
2.1.42 
Menopause 
Item retained without 
change 
-------------- 
2.2.2 Lying  Item revised “Lying-down” 
2.2.4 Sleep Item revised “Sleeping” 
2.2.5 With medications  Item revised “Medication” 
3.1.8 Neck stiffness/tension Item revised “Neck stiffness” 
3.1.18 Swollen painful eyes  Item revised “Swollen eyelids” 
3.1.20 Tinnitus of deafness  Item revised “Tinnitus (Ringing in the ears)” 
3.1.22 Poor memory Item revised “Forgetfulness or poor memory” 
3.1.33 Weak knees  Item revised “Knee weakness” 
3.1.16 Sweating Item revised “Sweating upon mild activity” 
 
Apart from the original CMHQ-1 items, as mentioned, the second part of discussion was 
focused on the items collected from the face-to-face interview. In determining the inclusion 
of these items, eligibility of the 125 items was evaluated in its feasibility of their presence of 
actual clinical significance to pattern identification. During the process of the internal 
discussion, items were excluded, retained, modified, and rephrased (Table 31) for the 
CMHQ-2 construction. If the new items identified from the interview had similar meanings 
or overlapped with the item in CMHQ-1, then the two items were merged or combined. 
 
Table 31. Evaluation of items identified from face-to-face interview (n=125) 
 
Part I PAIN DESCRIPTION 
(n=22) 
Outcome of assessment 
 
Specification 
Mixed headache rhythm of both 
continuous and intermittent  
Excluded due to not helpful with 
diagnosis 
No particular location of headache Included -------------- 
A band of pain around the head like a 
“head band”  
Included Modified into A “band-like” 
sensation around the head 
Headache in distending sensation Excluded due to overlap 
A series of areas affected by the 
headache, such as 1).neck; 2). 
shoulder; 3).ears; 4).eyebrow; 
5).eyes; 6).face; 7).cheeks; 8).jaw;  
and 9).nose/bridge of nose. 
Included n=9 
Tightness around sinus area Excluded due to overlap 
Lingering Excluded due to not helpful with 
diagnosis 
Numbness Excluded due to overlap 
Cloudiness Excluded due to overlap 
Pricking Excluded due to overlap 
Steady headache Excluded due to not helpful with 
diagnosis 
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Prolonged headache Excluded due to not helpful with 
diagnosis 
Persistent headaches Excluded due to not helpful with 
diagnosis 
Headache Worse at night Included -------------- 
(10 deleted; 1 modified; 11 included) 
12 retained 
Part 2 AGGRAVATING FACTORS 
(n=20) 
 
Outcome of evaluation 
 
Specification 
Hunger Included -------------- 
Muscle tightness Included -------------- 
Bruxism Excluded due to not relevant 
Lack of sleep  Included -------------- 
Screen watching  Included Combined with “Eyestrain” 
Bright light  Included Combined with “Sensitive 
to light” 
Cheese  Included -------------- 
Tea  Included -------------- 
Change in temperature Included -------------- 
Sneezing Included -------------- 
Teeth grinding Included -------------- 
Depression Included -------------- 
Humid weather Included Combined with “Humid 
weather or rainy day” 
Windy days Included -------------- 
Wet weather Included Combined with“Humid 
weather or rainy day” 
Nervous Included Modified into 
“Nervousness” 
Being emotional Excluded due to overlap 
Stress Included -------------- 
Distress  Excluded due to overlap 
Anxiety Included  
(3 deleted; 1 modified; 4 combined; 12 included) 
13 retained 
Part 2 RELIEVING FACTORS 
(n=15)  
Outcome of evaluation 
 
Specification 
Cold drink Included -------------- 
Eating food Included Modified into “Eating”  
Light exercise  Included Modified into “Gentle 
exercise” 
Heat Included Modified into “Warmth” 
(n=3) Hot shower (or bath) 
Warm water preference 
Hydration Excluded due to not helpful with 
diagnosis 
Pressing on the pain area  Included Combined into: “Pressing/ 
pressure on the pain area” 
(n=2) 
Massage 
Resting Included  
Relaxing Included Combined with “rest” 
Sleeping Included -------------- 
Cold drink Included -------------- 
Exercise  Included Modified into “Gentle 
exercise” 
Eating food Included Modified into “Eating” 
(1 deleted; 7 modified; 3 combined; 4 included) 
9 retained 
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Part 3 ACCOMPANYING 
SYMPTOMS (n=68) 
Outcome of evaluation 
 
Specification 
Loose bowel motion Included replaced “Diarrhoea” 
Insomnia Included -------------- 
Sore throat Included -------------- 
Sigh Included Modified into “Sigh often” 
Flank pain  
(pain in the lower rib area) 
Included Modified into “Flank 
(hypochondriac) pain” 
Sore eyes Included -------------- 
Upper back pain Included Modified into “Pain in the 
upper back” 
Middle back pain  Included Modified into “Pain in the 
middle back” 
Shoulder tension/soreness Included Combined with neck 
stiffness 
Dry mouth   Included -------------- 
Dry eyes Included -------------- 
Shaking hands Included Excluded due to not helpful 
with diagnosis 
Constipation Included -------------- 
Feeling hot easily Included -------------- 
Feeling cold easily Included -------------- 
Bloating Included Modified into “Belching” 
Heart burn Excluded due to not helpful with 
diagnosis 
Period pain Included Combined into “Abdominal 
pain during or before 
periods”(n=2) 
Abdominal distension 
Hot palms Included Modified into “Hot 
sensation in the palms” 
Watery bowel motion Included -------------- 
Dry stools Included -------------- 
Constipation  Included -------------- 
Dry eyes Included -------------- 
Thirst Included -------------- 
Sore throat Included -------------- 
Reflux Included -------------- 
Belching Included -------------- 
Indigestion Included -------------- 
Yellowish urine Included -------------- 
Frequent urination  Included -------------- 
Cold lower back Included -------------- 
Poor concentration Included -------------- 
Heavy sensation in the body Included -------------- 
Feverish sensation Included -------------- 
Feeling depressed Included -------------- 
Short of breath Included -------------- 
Sigh often Included -------------- 
Sweating upon mild activity Included -------------- 
Night sweating Included -------------- 
Excessive phlegm Included -------------- 
Irritability (short-tempered) Included -------------- 
Feeling hot easily Included -------------- 
Feeling cold easily  Included -------------- 
Early periods Included -------------- 
Irregular periods Included -------------- 
Delayed periods Included -------------- 
Light bleeding Included -------------- 
Excessive bleeding Included -------------- 
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Bleeding with clots Included -------------- 
Bright red menstrual bleeding Included -------------- 
Dark menstrual bleeding Included -------------- 
Light red menstrual bleeding Included -------------- 
Abdominal pain during or before 
periods 
Included -------------- 
Lower back pain during or before 
periods 
Included -------------- 
Excessive watery discharge Included -------------- 
Yellow discharge Included -------------- 
Jaw pain Included -------------- 
Ear ache Included -------------- 
Neck pain Included -------------- 
Shoulder pain (Pain in the shoulders) Included -------------- 
Pain in the abdominal Included -------------- 
Lower back pain (Pain in the lower 
back) 
Included -------------- 
Pain in the arm/hands Included -------------- 
Pain in the leg/feet Included -------------- 
Pain in everywhere of the body Included -------------- 
Pain in the hips Included -------------- 
Pain in the buttocks Included -------------- 
(2 deleted; 6 modified; 3 combined; 57 included) 
62 items retained 
 
6.6.5  Summary of item generation and item evaluation  
The CMHQ-1 had 106 items (including one added item of “continuous” and “intermittent”, 
and the 5 items indicating different sides of headache area ). Through the face-to-face 
interview, a further 125 items were identified. Twenty-four (24) CMHQ-1 items, were 
removed due to low response rate. Fourteen (14) interview identified items were excluded 
because they were less related/important to the pattern identification and had weak 
consensus among group members. In addition, a consensus towards to detect headache 
subtypes in adapting the IHS criteria was reached, by adding one section of headache days 
per month. 
 
As a result, 177 items were retained for evaluation, after modification and combination a 
total 161 items were kept for CMHQ-2 construction (Figure 23). 
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Figure 23. Item evaluation and CMHQ-2 construction 
  
Literature search 
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CMHQ 
Item generation 
Face-to-face interview 
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Total retained: 96 
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6.7  CMHQ-2 construction 
The CMHQ-2 (Appendix 19) was designed for self-completion. Objective findings such as 
pulse or tongue diagnosis were omitted for CMHQ construction, since such information was 
not suitable for self-observation by participant but could only be performed by the CM 
practitioners. 
 
The CMHQ-2 consisted of 3 parts of Pain description, Aggravating and relieving factors, and 
Accompanying symptoms, and included 161items. Comparing with its previous version, the 
main structure of CMHQ-2 was kept almost the same. Changes were made mainly in the 
aspects of pain description and accompanying symptoms. Under each part, more sections 
were added to make the information collection more comprehensive.  
 
A total 10 sections were compiled for the allocation of newly identified items. Items were 
categorised into relevant sections. In addition, items that involved special terminologies or 
might confuse the participants were given brief explanations. For example, in part 1 section 
4, the item of “Continuous” was defined as “constant, persistent, non-stop, unceasing or 
uninterrupted”. 
 
In Part 1, PAIN DESCRIPTION, section 1 was designed to identify the location of headache. 
In its previous version CMHQ-1, identification of the headache area was using a set of 
headache image for shading. In CMHQ-2, such layout was abandoned for the convenience 
of data coding. Section 2 listed the areas that regarded to be affected by headache. Section 
3 inherited the previous version in obtaining information on sensation of headache. Section 
4, as mentioned above, each item was expanded with descriptions. In section 5, based on 
the ICHD-II, three items were applied to distinguish TTH subtypes based on the ICHD-II 
descriptions by asking days on headache per month. In section 6, five options were listed to 
determine the time that the headache became worse during a day respectively. 
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In Part 2, AGGRAVATING AND RELIEVING FACTORS kept almost the same as in CMHQ-1 but 
were grouped into categories accordingly. In section 1, 10 items were removed, and two 
items were given short descriptions. Section 2 had 4 more factors involved than that was in 
CMHQ-1. 
 
In Part 3, ACCOMPANYING SYMPTOMS, two sections were included. One section listed 
accompanying symptoms that headache sufferers may have; whereas the other section 
listed pain in other parts of the body that are not part of the headache.  
 
Those amendments contributed to an expanded collection on TTH presentations and 
broadened investigations on pain and non-pain symptoms. 
 
 
6.8  Evaluation of face validity  
The face validity of CMHQ was established during the process of item evaluation. Abide by 
the principle and criteria of discussion, items were revised, reworded, combined, added, 
deleted, or reduced in the process. For example, the 20% cut point was set for initial 
screening of low responded items. Items had low consensus were retained and submitted 
for group discussion; exclusion of items may be determined if the decisions was supported 
by evidences or clinical experiences, or for items that unclear were retained for further 
examination in the subsequent pilot study evaluation.  
 
In addition, in evaluating the readability of CMHQ-2, the following criteria were considered: 
1). whether the expression of CMHQ items was clearly presented and easily understood 
by the publics; 
2). whether the completion of CMHQ reflected a process of CM diagnosis for headaches; 
and, 
3). whether the using of CMHQ was valid for TTH diagnosis 
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Evaluated by all members, the CMHQ items, which look like to measure headache, were not 
only regarded to be similar to literature descriptions but also simple and clear to headache 
sufferers. As a result, the amended CMHQ-2 was designed in a systematic manner and had 
good face validity in collect information from headache sufferers for TTH pattern 
identification. 
 
 
6.9  Discussion  
This chapter outlines the methods and results of item generation. In summary, three 
components of Pain Description, Aggravating and Relieving Factors, and Accompanying 
Symptoms were ultilised for the initial construction of CMHQ. Literature search was used for 
initial item identification. The face-to-face interview was performed for further item 
identification. The reason by utilising such methods was due to the major limitation that 
TTH is not an entity in CM. Due to different diagnostic systems between Western medicine 
and CM, the recognition and description toward to the same disorder were consequently not 
consistence. In CM literatures, traditional diagnostic information was about a variety of 
headaches, but not limited to TTH. Hence, some items described in patterns of headache 
may not be essential for TTH.  
 
Another limitation of TTH in CM may be due to a lack of consensus of the CM patterns of TTH.  
Nevertheless, the limitation of literature search was compensated by the face-to-face 
interview. In the interview, collected literature descriptions were checked among a small 
group of TTH patients, and more information reported by the patients were extracted into 
items.  
 
During the pilot study, participants completed the CMHQ-1 with little difficulty. Using the 
combined information from CMHQ-1 and face-to-face interview, the trial acupuncturist was 
 202 
 
able to give TTH pattern diagnosis to each participants. Although none of them was 
classified into the pattern of Stagnation of bloods, which may be biased by such a small 
group of samples, the overall results indicate the CMHQ-1 was being of good face validity, 
and it can be used in collecting valuable information for CM diagnosis. 
 
In order to ensure the questionnaire is reliable, CHMQ-1 was evaluated by internal group 
members. Based on the outcome, items were deleted, modified, reworded and combined 
for CMHQ-2 construction. In the process of internal group discussion, the face validity of 
CMHQ was determined for the amended CMHQ (CMHQ-2) and the amended version of 
CMHQ at this stage of development also paved the way for its piloting in next stage.  
 
 
6.10 Chapter summary 
By using three methods, the initial development and clarification of the CMHQ items was 
conducted in a planned, systematic and profession way. CMHQ-2 has established face 
validity for future application.    
 203 
 
CHAPTER 7  A pilot study: CMHQ amendment 
 
Contents 
 
7.1  Introduction   
 
7.2  Specific objectives   
 
7.3  Methods   
7.3.1  Design   
7.3.2  Personnel: roles and training   
7.3.3  Population identification (Step 1)   
7.3.4  Instrument   
7.3.5  Procedure (Step 2)   
7.3.6  Determination of TTH patterns   
7.3.7  Data collection and data analysis (Step 3)   
7.3.8  Experts consultation (Step 4)   
7.3.8.1  Identification of external experts  
7.3.8.2  Method and procedure of consultation  
7.3.8.3  Criteria and content of discussion  
7.3.9  Internal group discussion  
 
7.4  Results of the pilot study   
7.4.1  Participants   
7.4.2  Frequency analysis results   
7.4.2.1  Part 1: Pain description   
7.4.2.2  Part 2: Aggravating and relieving factors   
7.4.2.3  Part 3: Accompanying symptoms   
7.4.3  Summary of CM diagnosis results   
7.4.4  Subgroup comparisons 215 
 
7.5  Experts’ consultation  
7.5.1  Background of the external experts   
7.5.2  Summary of experts‟ comments   
7.5.3  CMHQ amendment  
7.5.4  Evaluation of content validity   
 
7.6  CMHQ-3 construction (Step 5)   
7.6.1  CMHQ-3 layout   
7.6.1.1  Part 1. Pain description (46 items)   
7.6.1.2  Part 2. Aggravating and relieving factors (48 items)  
7.6.1.3  Part 3. Accompanying symptoms (102 items)   
7.6.2  Translation of CMHQ   
 
7.7  Discussion  
 
7.8  Chapter summary   
 204 
 
7.1  Introduction 
In the previous chapter, initial version of CMHQ was constructed via literature search and 
face-to-face interview. After being evaluated by the internal group members, items were 
reduced, deleted and modified and the CMHQ-1 was amended into CMHQ-2. In the group 
discussion, the face validity of the CMHQ-2 was established and the CMHQ-2 was ready to 
be tested in the pilot study. 
 
The pilot study aimed to examine the content validity and feasibility of CMHQ-2 and to 
develop CMHQ-3. This chapter presents the implementation of the pilot study. The 
amended version of CMHQ-2 was also tested in this stage.  
 
The feasibility of CMHQ-2 was examined by applying to a group of TTH participants, and the 
content validity was established during the process of the pre-testing, experts‟ consultation 
and final amendment (in this chapter). The end result is that the CMHQ-2 was refined into 
CMHQ-3 according to the experts‟ comments and translated into Chinese version for further 
evaluation in the full-scale survey.  
 
 
7.2  Specific objectives 
The objectives of this pilot study were  
1). to assess whether the items in CMHQ-2 adequately captured features of TTH;   
2). to amend CMHQ-2 and develop CMHQ-3;  
3). to evaluate content validity of CMHQ-3; and, 
4). to translate CMHQ-3 into Chinese. 
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7.3  Methods 
7.3.1  Design  
This pilot study was performed from March of 2009 to November of 2010 and embedded in 
a clinical trial conducted from 2008-2012 titled “Combined therapy of electroacupuncture 
and cognitive behavioural therapy for tension-type headache: a randomised controlled 
trial”. 
 
The following steps were planned in order to examine CMHQ-2 and construct CMHQ-3 
(Figure 24), and the participation procedure is outlined in Figure 25. 
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Figure 24. Steps of CMHQ piloting 
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Figure 25. Procedure of participation 
 
 
7.3.2  Personnel: roles and training 
Two registered CM practitioners ( Mr. Xinyu Hao and Dr. Lin Dong), made diagnosis for each 
participant of the pilot study and provided acupuncture treatment to participants recruited 
for the previously mentioned clinical trial. Both were experienced in acupuncture for pain 
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management with at least 3 years of clinical experiences, and were strictly trained by one 
of the chief investigators using the trial protocol. The training was to ensure the consistency 
in diagnosis. Records of 3 coded TTH patients were used for training purpose and discussed 
in details to minimise the discrepancy in pattern differentiation. At the end of the training, 
both acupuncturists needed to demonstrate their ability in making consistent CM diagnosis.  
 
7.3.3  Population identification (Step 1) 
Screening of the participants‟ eligibility consisted of two steps, i.e., initial evaluation by 
completing headache diaries, and face-to-face interview. 
 
Upon receiving their express of interest to participate, an information package of the clinical 
trial, which contained a brochure (Appendix 20), a screening questionnaire (Appendix 21) 
and a 4-week headache diary (Appendix 22), was mailed to potential participants who 
responded to the advertisements. A preliminary selection process was conducted based on 
the returned, completed questionnaire and headache diaries. Senders of incomplete 
screening questionnaires were contacted for further information by the clinical assistant 
over the telephone. Potential participants were invited to attend face-to-face interview at 
RMIT for further screening assessment.  
 
7.3.4  Instrument 
A checklist was designed for demographic information collection (Appendix 23). It consisted 
of 6 sections, which were gender, date of birth, age range, ethnicity, marital status and 
level of education. Section 4, ethnicity classifications and Section 6, level of education were 
sourced from the broad level of the Australian Bureau of Statistics web site [568]. The 
CMHQ-2 was used for data collection about headache.  
 
7.3.5  Procedure (Step 2) 
Eligible TTH patients who gave their consent were then invited to take part in the study and 
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assured their confidentiality.  
 
Prior to administration of the CMHQ, participants were informed about the following 
information about their participation: 
 
1 ). The purpose of the study 
2 ). Their roles in the participation  
3 ). Duration of 15 to 20 minutes for completing the CMHQ 
4 ). They need to complete the CMHQ with every question responded 
5 ). CMHQ items are multiple-choice and they are allowed to select more than one 
descriptor 
5 ). They are allowed to ask trial assistant for help if they were not clear about the 
terminology of the CMHQ contents 
 
7.3.6  Determination of TTH patterns  
The following information about five common TTH patterns (outlined in Chapter 2) were 
given to the two trial acupuncturists to guide the diagnostic process.  
 
1). Ascendant hyperactivity of Liver-Yang  
2). Liver-Qi depression 
3). Phlegm rises to cloud the Mind 
4). Dual deficiency of Qi and Blood 
5). Stagnation of Blood 
 
The above mentioned five types of patterns gained experts‟ consensuses (Chapter 2). 
Based on their suggestion, the practitioners were allowed to determine up to two diagnoses 
for each participant.  
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7.3.7  Data collection and data analysis (Step 3) 
Collected data was extracted into an excel spread sheet and doubled checked by the trial 
coordinator. Data was then exported to SPSS (version 19), which was used for data analysis. 
Frequency analysis was calculated for each variable as well as TTH patterns. Chi-Square 
tests were used to examine item correlation (especially accompanying symptoms) between 
or among patterns. 
 
7.3.8  Experts consultation (Step 4) 
In step 4 of the present study, in order to finalise the CMHQ as well as evaluate its content 
validity, experts were consulted to gain their assessment of the adequacy of the items as 
well as its appropriateness of category allocation.  
 
7.3.8.1  Identification of external experts 
In the present study, experts‟ consultation was used to establish the content validity of 
CMHQ. Therefore, a global-wide range of experts that being of fames in headache research 
or headache management were ideal candidates to be invited and make comments to the 
CMHQ. Basically, the following two sources were considered in identifying the external 
experts: 
 
1). Experts referred by the chief investigators in the clinical trials; and 
2). Searching of journal articles associated with headache, clinical trials, Chinese 
medicine, and acupuncture to identify authors via the renowned/ popular electronic 
databases, such as Pubmed, EMBASE and CNKI. 
 
Identification of the potential external experts was based on the selection criteria listed in 
Chapter 5, Section 5.6.2. Additionally, evaluation of experts was limited to the areas of their 
professions and discipline as well as language. In the present study, potential experts had 
to be fluent in either English or Chinese. Determination of the potential expert was based on 
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their willingness of participation and intention of making inputs.  
 
7.3.8.2  Method and procedure of consultation  
Expert opinions were obtained via email correspondences for the evaluation and 
amendment of CMHQ. In general, at least two rounds of emails were sent. In the first email 
(Appendix 24), an invitation letter was stent and experts were informed of the study 
objectives and procedures. Once the experts expressed their willingness to comment on the 
CMHQ, the second email (Appendix 25) was sent, with the detailed instructions towards to 
the areas to be commented on.  
 
7.3.8.3  Criteria and content of discussion 
The tasks of the external experts were, firstly, to review the CMHQ-2 with their 
understanding and experiences on TTH research and management.  
 
Secondly, to provide overall comments of the wording of the questions and items to support 
CMHQ content validity which listed as following areas:  
1)  Comprehensiveness of the items; 
2)  Relevance of each sign and symptom; and 
3)  Wording is easy to understand by the participants 
 
Thirdly, to examine the adequacy of the items used for TTH diagnosis specifically, such as 
its layout, ordering, clarity of the instructions. Questions were asked about for each part of 
the CMHQ-2 as follow:  
 
In Part 1, PAIN DESCRIPTION, questions were mainly about the items, by asking whether 
the items reflect the nature of TTH.  
 
In Part 2, AGGRAVATING AND RELIEVING FACTORS, experts need to confirm whether these 
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factors commonly reported by the TTH sufferers.  
 
In Part 3, ACCOMPANYING SYMPTOMS, questions were divided into two sections, i.e., one 
for CM experts and another for non-CM experts. Question designed for CM experts was 
about the comprehensiveness and appropriateness of items in making CM diagnosis, 
whereas the question designed for non-CM experts were to confirmed the accompanying 
symptoms were commonly experienced by TTH suffers.  
 
In addition, further comments and thoughts of experts were sought for further 
communication via emails. 
 
7.3.9  Internal group discussion 
In following up to the experts‟ consultation, an internal group discussion was performed 
toward to the refinement of CMHQ-2, which was made in an effort to construct the CMHQ-3 
for the implementation of the full scale survey.  
 
The tasks of the group members were to evaluate and synthesises the pooled experts 
opinions once collected, as well as providing their thoughts in the final amendment of the 
CMHQ. 
 
All experts‟ opinions were to be evaluated and discussed by the internal group members. In 
dealing with the experts comments, the following guiding principles were considered: 
 
1).  If expert‟s opinions were of consensus to one question, CMHQ were to be amended 
accordingly; 
2).  If experts had different opinions toward to one question, their concerns were to be 
discussed by the internal members.  
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Accepting or rejecting the experts opinions were subject to the consensus of the internal 
group member discussion to reach a more than 50% agreement. 
 
 
7.4  Results of the pilot study  
7.4.1  Participants 
A total 87 eligible participants enrolled into this pilot study. On average, completing the 
CMHQ-2 took each patient 15 minutes. During their participation, none of them had 
difficulty in understanding the CMHQ-2, and no literacy assistance was required during their 
participation.  
 
Of the 87 participants, 26 (29.9%) were males, and 61 (70.1%) were females. The mean 
age was 40.20 years, with a standard deviation of 12.43 years and ranging from 20 to 63 
years of age. In terms of the ethnicity distribution, the majority of participants were 
Australians (61.6%) (Table 32).40% of the total sample were married (40.2%) (Table 33). 
Over two thirds of the sample had a bachelor degree or above (Table 34).  
 
Table 32. Ethnicity distribution 
 
Ethnicity distribution Frequency Percent 
Valid 
Percent 
Valid 
Australian People  53 60.9 61.6 
British 10 11.5 11.6 
Irish 1 1.1 1.2 
Western European 3 3.4 3.5 
Northern European 2 2.3 2.3 
South Eastern European 3 3.4 3.5 
Eastern European 2 2.3 2.3  
Chinese Asian 1 1.1 1.2 
Other north-east Asian 2 2.3 2.3 
Southern Asian 5 5.7 5.8 
North American  1 1.1 1.2 
South American  1 1.1 1.2 
South and east African  1 1.1 1.2 
Others  1 1.1 1.2 
Total 86 98.9 100.0 
Missing 1 1.1  
Total 87 100.0  
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Table 33. Marital status 
 
Marital status Frequency Percent 
Valid 
Percent 
Valid Single 25 28.7 29.1 
Married 35 40.2 40.7 
Partnered 18 20.7 20.9 
Divorced 6 6.9 7.0 
Widowed 2 2.3 2.3 
Total 86 98.9 100.0 
Missing 1 1.1   
Total 87 100.0   
 
Table 34. Level of education 
 
Level of education Frequency Percent 
Valid 
Percent 
Valid Postgraduate degree level 19 21.8 22.1 
Graduate diploma and graduate 
certificate level 
10 11.5 11.6 
Bachelor degree level 29 33.3 33.7 
Advanced diploma and diploma level 10 11.5 11.6 
Certificate (TAFE) level 5 5.7 5.8 
Secondary education 10 11.5 11.6 
Primary education 1 1.1 1.2 
Other education  2 2.3 2.3 
Total 86 98.9 100.0 
Missing 1 1.1   
Total 87 100.0   
 
7.4.2  Frequency analysis results 
7.4.2.1  Part 1: Pain description 
Table 35 presented the frequencies and percentage of each section of pain description. 
Headache on the front and sides were mostly reported by participants. During a headache 
attack, both neck and shoulders were commonly affected. Pressing, tightness, emptiness 
and heaviness were most common sensations when describing the headache whereas the 
sensations of cutting, burning, explosive and distending were less rated by the participants. 
When describing the nature of headache, intermittent was more common than continuous. 
More than half of the participants had headache between 1 and 14 days per month, that is 
episodic headache. However, nearly 40% had chronic headache, which is having headache 
more than 15 days per month. During the course of the day, headaches that were worse in 
the afternoon were rated more frequently than often headache in other times of the day.  
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Table 35. Frequency analysis of Part 1 items 
 
Headache location Counts Percentage 
1.1.1 Front of the head 51 58.6 
1.1.2 Sides of the head 60 69 
1.1.3 Back of the head 41 47.1 
1.1.4 Top of the head 15 17.2 
1.1.5 Whole head 15 17.2 
1.1.6 No particular 
location 4 4.6 
Headache affected area Counts Percentage 
1.2.1 Neck 67 77 
1.2.2 Shoulder 49 56.3 
1.2.3 Ears  10 11.5 
1.2.4 Eyebrow 27 31 
1.2.5 Eyes 43 49.4 
1.2.6 Face 12 13.8 
1.2.7 Cheeks 5 5.7 
1.2.8 Jaw 21 24.1 
1.2.9 Nose/Bridge of 
nose 20 23 
Sensation of headache Counts Percentage 
1.3.1 Pressing 50 57.5 
1.3.2 Explosive 4 4.6 
1.3.3 Burning 3 3.4 
1.3.4 Drilling 11 12.6 
1.3.5 Cutting 2 2.3 
1.3.6 Sharp  26 29.9 
1.3.7 Vague 16 18.4 
1.3.8 Distending 2 2.3 
1.3.9 Dull  31 35.6 
1.3.10 Heaviness 35 40.2 
1.3.11 Pulling 7 8 
1.3.12 Emptiness 4 4.6 
1.3.13 Throbbing 37 42.5 
1.3.14 Piercing 7 8 
1.3.15 Tightness 51 58.6 
1.3.16 Pulsating 23 26.4 
1.3.17 Radiating 17 19.5 
1.3.18 Pounding 27 31 
1.3.19 A “band-like” 
sensation around 
the head  25 28.7 
Nature of headache Counts Percentage 
1.4.1 Continuous  28 28.7 
1.4.2 Intermittent 61 70.1 
1.4.3 Mixed(of 
continuous and 
intermittent) 1 1.1 
1.5 
 
Days on headache 
per month 
Level of item presentation (n/%) 
headac
he < 1d 
14d > headache > 1d headache > 15d 
 0(0%)  52 (59.8%)  35 (40.2%) 
Time during the day that 
headache gets worse 
Counts Percentage 
1.6.1 Worse in the 
morning 25 28.7 
1.6.2 Worse in the 37 42.5 
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afternoon 
1.6.3 Worse at the end of 
the day 25 28.7 
1.6.4 Worse at night 8 9.2 
1.6.5 All day 30 34.5 
 
7.4.2.2  Part 2: Aggravating and relieving factors 
Stress, anxiety, tension or conflict at work / or at home, muscle tightness, anger or 
irritability, and mental strain were identified as the most common aggravating factors, 
whereas medication, sleeping and rest were the commonest relieving factors of the 
headaches (Table 36). 
 
Table 36. Frequency analysis of Part 2 items 
 
Aggravating factors Counts Percentage 
2.1.1 Overwork 36 41.4 
2.1.2 Exercise  15 17.2 
2.1.3 When tired  42 48.3 
2.1.4 Physical exertion 15 17.2 
2.1.5 Muscle tightness 52 59.8 
2.1.6 Lack of sleep 41 47.1 
2.1.7 Eye strain  35 40.2 
2.1.8 Mental strain  47 54 
2.1.9 Alcohol  26 29.9 
2.1.10 Coffee  11 12.6 
2.1.11 Hunger / Being 
hungry 37 42.5 
2.1.12 Chocolate 14 16.1 
2.1.13 MSG 12 13.8 
2.1.14 Cheese 2 2.3 
2.1.15 Tea 5 5.7 
2.1.16 Change of weather 18 20.7 
2.1.17 Hot weather 26 29.9 
2.1.18 Cold weather 10 11.5 
2.1.19 Windy days 12 13.8 
2.1.20 Humid weather or 
rainy days 9 10.3 
2.1.21 Change in 
temperature 20 23 
2.1.22 Nervousness 32 36.8 
2.1.23 Anger or 
irritability 45 51.7 
2.1.24 Anxiety 56 64.4 
2.1.25 Depression 22 25.3 
2.1.26 Stress 77 88.5 
2.1.27 Tension or 
conflict at work / 
or at home 52 59.8 
2.1.28 Before period (29 of 87)   (47.5 in female) 
2.1.29 During period (21 of 87)   (34.4 in female) 
2.1.30 After period (8 of 87)   (13.1 in female) 
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2.1.31 Menopause (7 of 87)   (11.5 in female) 
2.1.32 Sneezing 3 3.4 
2.1.33 Teeth grinding 21 24.1 
Relieving factors Counts Percentage 
2.2.1 Rest 48 55.2 
2.2.2 Lying-down 36 41.4 
2.2.3 Sleeping 56 64.4 
2.2.4 Cold drink 8 9.2 
2.2.5 Gentle exercise 17 19.5 
2.2.6 Eating  16 18.4 
2.2.7 Medication 57 65.5 
2.2.8 Pressing/pressure 
on the pain area 37 42.5 
2.2.9 Warmth ( warm 
environment, hot 
shower or hot 
pack ) 30 34.5 
 
7.4.2.3  Part 3: Accompanying symptoms 
The most frequently rated items of accompanying symptoms with headaches were neck 
stiffness, fatigue or feeling tired easily, poor concentration, sensitive to light, nausea, 
irritability, and, forgetfulness or poor memory (Table 37). Apart from headaches, neck, 
shoulder and lower back were mostly complained areas with pain (Table 38).  
 
Table 37. Frequency analysis of Part 3 items of accompanying symptoms 
 
Eye related Counts Percentage 
3.1.1 Dry eyes 18 20.7 
3.1.2 Sore eyes 30 34.5 
3.1.3 Muscle or eye 
twitching 20 23 
3.1.4 Blurred vision 15 17.2 
3.1.5 Swollen eyelids 5 5.7 
3.1.6 Sensitive to light 43 49.4 
Mouth, ear and nose 
related 
Counts Percentage 
3.1.7 Dry mouth 15 17.2 
3.1.8 Thirst 21 24.1 
3.1.9 Bitter taste in the 
mouth 8 9.2 
3.1.10 Sore throat 6 6.9 
3.1.11 Runny nose  8 9.2 
3.1.12 Sensitive to sound 33 37.9 
3.1.13 Tinnitus (Ringing in 
the ears) 13 14.9 
Digestion related Counts Percentage 
3.1.14 Nausea 41 47.1 
3.1.15 Vomiting 12 13.8 
3.1.16 Reflux 7 8 
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3.1.17 Belching 3 3.4 
3.1.18 Indigestion 10 11.5 
3.1.19 Poor appetite 17 19.5 
Urine and bowel related Counts Percentage 
3.1.20 Yellowish urine 9 10.3 
3.1.21 Frequent urination  16 18.4 
3.1.22 Watery bowel 
motion 6 6.9 
3.1.23 Loose bowel motion 10 11.5 
3.1.24 Dry stools 5 5.7 
3.1.25 Constipation 15 17.2 
Neck, shoulder back and 
limb related 
Counts Percentage 
3.1.26 Neck stiffness  71 81.6 
3.1.27 Cold lower back  7 8 
3.1.28 Knee weakness 12 13.8 
3.1.29 Cold hands and 
feet/ Cold limbs 31 35.6 
3.1.30 Hot sensation in the 
palms 5 5.7 
Other related symptoms Counts Percentage 
3.1.31 Forgetfulness or 
poor memory 36 41.4 
3.1.32 Dizziness  28 32.2 
3.1.33 Fainting 2 2.3 
3.1.34 Fatigue or feeling 
tired easily 59 67.8 
3.1.35 Palpitation 5 5.7 
3.1.36 Insomnia (difficult 
to fall asleep or 
maintain sleep) 30 34.5 
3.1.37 Poor 
concentration 56 64.4 
3.1.38 Heavy sensation in 
the body 10 11.5 
3.1.39 Feverish sensation 10 11.5 
3.1.40 Feeling depressed 29 33.3 
3.1.41 Short of breath 7 8 
3.1.42 Sigh often 19 21.8 
3.1.43 Sweating upon mild 
activity 9 10.3 
3.1.44 Night sweating 7 8 
3.1.45 Excessive phlegm 7 8 
3.1.46 Irritability  39 44.8 
3.1.47 Feeling hot easily  15 17.2 
3.1.48 Feeling cold easily 
(Sensitive to low 
temperature / Catch 
cold easily) 21 24.1 
Female related  N=61 
Counts Percentage 
3.1.49 Early periods  3 4.9 
3.1.50 Irregular periods  1 1.6 
3.1.51 Delayed periods  2 3.3 
3.1.52 Light bleeding 8 13.1 
3.1.53 Excessive bleeding 9 14.8 
3.1.54 Bleeding with clots 19 13.1 
3.1.55 Bright red 6 9.8 
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menstrual bleeding 
3.1.56 Dark menstrual 
bleeding 16 26.2 
3.1.57 Light red menstrual 
bleeding  3 4.9 
3.1.58 Abdominal pain 
during or before 
periods 26 42.6 
3.1.59 Lower back pain 
during or before 
periods 23 37.7 
3.1.60 Excessive watery 
discharge 4 6.6 
3.1.61 Yellow discharge 5 8.2 
 
Table 38. Frequency analysis for Part 3 items of pain in other parts 
 
Items Counts Percentage 
3.2.1 Jaw pain 24 27.6 
3.2.2 Ear ache 13 14.9 
3.2.3 Neck pain 60 69 
3.2.4 Pain in the 
shoulders 48 55.2 
2.2.5 Flank pain (pain in 
the lower rib area) 4 4.6 
3.2.6 Pain in the 
abdominal 6 6.9 
3.2.7 Pain in the upper 
back 20 23 
3.2.8 Pain in the middle 
back 10 11.5 
3.2.9 Pain in the lower 
back 26 29.9 
3.2.10 Pain in the 
arm/hands  8 9.2 
3.2.11 Pain in the leg/feet 12 13.8 
3.2.12 Pain in everywhere 
of the body 0 0 
3.2.13 Pain in the hips 14 16.1 
3.2.14 Pain in the buttocks 3 3.4 
 
7.4.3  Summary of CM diagnosis results  
Of the included 87 participants, 43 and 34 participants were categorised into the groups of 
Ascendant hyperactivity of Liver-Yang group and Liver-Qi depression group respectively. 
The remaining 10 participants were diagnosed with Dual deficiency of Qi and Blood group 
(n=6), Phlegm rises to cloud the Mind (n=2) and Stagnation of Blood group (n=2) (Table 
39). 
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Table 39. Results of CM diagnosis 
 
CM diagnosis Counts Percentage 
Ascendant hyperactivity of Liver-Yang  43 49.4 
Liver-Qi depression  34 39.1 
Dual deficiency of Qi and Blood  6 6.9 
Phlegm rises to cloud the Mind 2 2.3 
Stagnation of Blood 2 2.3 
 
7.4.4  Subgroup comparisons  
Forty-three (43) and thirty-four (34) participants were diagnosed to the pattern of 
Ascendant hyperactivity of Liver-Yang and Liver-Qi depression, of which the two largest 
groups which accounted for a total 88.5% population.  
 
Of these two largest groups in this sample, several items especially in accompanying 
symptoms were shared with a high response rate. For example, sore eyes (39.5% vs. 
32.4%), nausea (51.2% vs. 44.1%), neck stiffness (79.1% vs. 91.2%), forgetfulness (46.5% 
vs. 35.3%), dizziness (32.6% vs. 32.4%), fatigue (74.4% vs. 58.8%), poor concentration 
(65.1 vs. 61.8%),  
 
In order to identify the key differences between the two patterns, frequency of each of the 
two groups were subjected to comparisons via Chi-Square tests. To ensure the significance 
was not due to errors created by multiple comparisons, the significant level was reduced to 
P≤0.01 (bolded in table). The key differences were that the patterns of Ascendant 
Hyperactivity of Liver-Yang was more likely to have headache with sensitive to light and 
sound, and feel irritable (Table 40) (data picked from Appendices 26 to 28).   
 
Table 40. Group comparisons of group items 
 
Items Groups (frequency & percent) Chi-Square 
Ascendant 
hyperactivity of 
Liver-Yang 
Liver-Qi 
depression 
P-value (2-sided) 
1.1.5 Whole head 4(9.3) 9(26.5) .046 
2.1.31 
Menopause 
6(20%) in 30 
Female 0 in 24 Female 
.023 
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2.1.33 Teeth grinding 16(32.6) 4(11.8) .032 
3.1.6 Sensitive to light 29(67.4) 10(29.4) 0.001 
3.1.8 Thirst 14(32.6) 3(8.8) .013 
3.1.11 Runny nose  1(2.3) 5(14.7) .044 
3.1.12 Sensitive to sound 23(53.5) 8(23.5) 0.008 
3.1.30 Hot sensation in the 
palms 5(11.6) 0 
.040 
3.1.46 Irritability  28(65.1) 10(29.4) 0.002 
 
 
7.5  Experts’ consultation  
7.5.1  Background of the external experts 
A list of 10 potential experts was identified across Australia and worldwide. Initial contact by 
sending the first email invitation resulted in 9 replies, with 8 experts (Table 41) agreed to 
participant and 2 rejected. However, one of them lost contact in the subsequent follow-up 
email of the detailed questions. In total, seven provided their experts‟ opinions on the 
CMHQ via emails.  
 
Table 41. Summary of external advisory panel members 
 
Experts Country Profession Source of identification 
Prof. Lin-Peng Wang China CM practitioner Clinical trial external expert 
Prof. Fan-Rong Liang China CM practitioner Clinical trial external expert 
Prof. Albrecht Molsberger   Germany CM practitioner Identified by published journal 
articals  
Prof. Robert Helme Australia Neurologist  Clinical trial external expert 
Prof. Paul Martin Australia Psychologist Clinical trial external expert 
Prof. Ken Greenwood Australia Psychologist Clinical trial internal expert 
Dr. Jerusa Alecrim Brazil  Medical doctor Expert‟s refferred  
Dr. Remy R. Coeytaux U.S Medical doctor Identified by published journal 
articals 
 
Each of the invited experts had a high profile in terms of their authorship, academic 
qualification, and expertise. They all had extensive knowledge and experiences in both 
management and research in headache area. The panel constitution represents a various 
backgrounds described. It comprised of three CM practitioners, one neurologist and two 
psychologists and two western medical doctors. 
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7.5.2  Summary of experts’ comments 
Experts acknowledged that the CMHQ-2 was a valuable measurement tool for TTH 
information collection. Its format, structure, wording and contents were operational in 
helping practitioners make CM diagnosis and the CMHQ was able to classify the majority of 
participants into at least two or more subgroups. The items of CMHQ-2 were relevant and 
comprehensive for pattern identification. 
 
Specifically, some comments and suggestions were summarised as the following points: 
 
1). CM patterns are important in TTH diagnosis and management and it is always 
important to translate TCM textbook phrases in clinical reality; 
2). some of the terminologies to be re-worded to be colloquially acceptable; and  
3). scaling items could be operational in making more appropriate diagnosis.  
 
7.5.3  CMHQ amendment  
CMHQ-2 was made minor changes based on the comments collated from the experts. In 
order to capture the symptoms and signs more precisely from participants, items were 
further modified, re-worded, or short descriptions applied according to the experts‟ 
suggestions.  
 
The major amendment was on its response format. To indicate the severity of symptoms, a 
five-point Likert scale was applied to most items, with higher scores indicating a more 
important status of frequency to the symptoms and signs. 
 
The Likert scale were applied to seven sections such as the location of headache (1.1), 
headache affected areas (1.2) and the nature of headache (1.4) in part one. In part two, all 
items of aggravating (2.1) and relieving factors (2.2) and the accompanying symptoms (3.1) 
and female related items (3.3.2) in part three. 
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7.5.4  Evaluation of content validity 
The amended CMHQ-3 was then sent back to the experts for their confirmation. By 
conducting this expert consultation process, the contents of CMHQ were evaluated. Thus, 
the content validity of the CMHQ has been established via 4 approaches of CMHQ 
pre-testing, objective experts‟ judgments of contents, subjective experts‟ agreements, and 
internal group member discussion. 
 
Firstly, the CMHQ was constructed in a systematic manner, which served for the evaluation 
of symptoms and signs from TTH participants effectively. Its face validity, which severs as 
part of content validity, has been assessed previously. In this piloting, the items were 
demonstrated to be logical and theoretical thus connected to the construct. Participants had 
no difficulty in completing the CMHQ-2, which indicated some degree of its readability and 
ensured of its previously established face validity. Secondly, the experts‟ opinions was 
commonly regarded suitable for new research and exploratory studies [14]. The content 
validity was tested by a panel of 6 experts to evaluate CMHQ expressions. The experts were 
professionals with clinical experiences in clinical experience on headaches management. 
During the process of experts‟ consultation, the questions were detailed into each section of 
the CMHQ with distinct criteria applied, which ensured its contents being of objectively valid. 
Thirdly, as mentioned previously (chapter 5, section 5.5.2), evaluation of the content 
validly was a subjective process, but can be reasonable and being of logic. In the present 
study, majority of experts accepted the CMHQ format and regarded the CMHQ-2 contents 
were appropriate in collection TTH related information. Despite of the evaluation can be 
being of subjective, experts made their contribution based on the predefined criteria. Lastly, 
during the subsequent group discussion, addressing the comments and concerns raised by 
experts, such as wording and contents, amendment of terminology, format of responses, 
and, concerning of the respondents‟ ability to answer questions, ensured the amended 
CMHQ being of content valid. As a result, the evaluation of the content validity of CMHQ 
achieved its aim, that is the questionnaire measures “what it intent to measure”, and it 
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could be considered as a valuable tool for collecting diagnostic information to assist 
practitioners in make CM diagnosis of TTH. 
 
 
7.6  CMHQ-3 construction (Step 5) 
Based on the findings of the content validation, the CMHQ-2 was revised becoming CMHQ-3, 
which was used to generate data for exploratory factor analysis. A pool of items was 
retained which reflect the conceptual framework of CM diagnosis. The third draft of the 
CMHQ consisted of a total 196 items which were grouped into three broad categories of pain 
description, aggravating and relieving factors, and accompanying symptoms. 
 
The CMHQ-3 (Appendix 29) provided a wide range of dimensions for participants to 
illustrate theirs headache systematically. Structure of the CHMQ-3 was kept the same as its 
predecessors, with 3 parts involving 11 sections. The major change was on items response 
format. The majority items of CMHQ-3 were equipped with a 5-point Likert-type scale 
(never, seldom, sometimes, often and almost always). Items of headache related 
symptoms and signs were quantified, with higher scores indicating more pronounced 
presentation. 
  
7.6.1  CMHQ-3 layout  
7.6.1.1  Part 1. Pain description (46 items) 
The Part 1, Pain description, consisted of 6 sections which contained 46 items. Section 1 
was composed of 7 items describing headache locations. Section 2 illustrate the areas that 
affected by the headache by outlining 9 related areas. Section 3 applied 19 sensations of 
quality of headache. Section 4 used two pairs of adjectives describing the nature of 
headache. Section 5 was an item containing three options on the days on headache during 
the past three months. Section 6 listed 6 items collecting the period when the headache 
became worse of a day. 
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7.6.1.2  Part 2. Aggravating and relieving factors (48 items) 
Part 2 of the CMHQ-3 was related to aggravating and relieving factors, which consisted of 
aggravating factors in section 1 and relieving factors in section 2. A total 48 items were 
involved. In section 1, there were five categories outlining the trigger factors related to 
tension (8 items), diet (15 items), weather (8 items), emotion (6 items) and other factors 
(2 items). There were 9 items of relieving factors were allocated in section 2. 
 
7.6.1.3  Part 3. Accompanying symptoms (102 items) 
In part 3, three sections had 102 items. The first section was accompanying symptom 
classified by categories of eye related (11 items), face related (9 items), digestion related 
(7 items), urine and bowel related (6 items), muscles and joints related (9 items), and other 
symptoms (20 items). The second section collected pain in other parts of the body rather 
than the headache itself. A total 20 areas in items were allocated. The third section was 
designed to collect information related to women‟s health, which focused on 20 items of 
menstrual related information.   
 
7.6.2  Translation of CMHQ 
In order to be administrated to Chinese participants for investigation in a followed full-scale 
survey, CMHQ was adapted to a Chinese version (Appendix 30) with the goal to achieve 
equivalence between the original version and the translated version. In addition, to ensure 
the consistency between the two languages versions being of similar content validity. The 
translated Chinese version of the CMHQ-3 was reviewed and examined by an 
interdisciplinary research team composed of 7 internal group members (Dr. Yanyi Wang, Dr. 
Claire Zhang, Mr. David Lu, Dr. Wan Najbah Nik Nabil, Dr. Amy Hsiewe Ying Tan, Dr. 
Johannah Shergis, Ms. Tracey Bourne), and two external Chinese experts (Prof. Lin-Peng 
Wang and Prof. Fan-Rong Liang) with two of their research assistants (Ms. Chang-yu Pan 
and Mr. Ming-xiao Yang). 
 226 
 
 
The English version of the CMHQ was developed based on the Chinese literature. As 
mentioned in Chapter 5, a model of forward and backward translation, which provides a six 
stage process of Initial translation, Synthesis, Back-translation, Experts review, Pretesting, 
and Appraisal [509], was used to guide the process of translation of the CMHQ items back 
into Chinese. 
 
In the present study, the source of six stage process was adopted accordingly. Firstly, the 
author of the CMHQ and another bilingual researcher each translated the questionnaires. 
The two versions were then compared and sought opinions from selected internal group 
members. All members were fluent in both languages. Of them, four members were English 
native speakers and three members are Chinese native speakers and have high proficiency 
in English. Translation with disputes were recorded and discussed internally until a 
consensus was reached. Secondly, in order to achieve conceptual rather than literal 
meaning of the items in the questionnaire, both the Chinese and English versions were 
emailed to the Chinese experts who had clinical experiences in headache and pain 
management. The two experts were also fluent in English. The translated version was then 
thoroughly examined by comparing it with the English version using the same criteria on the 
content validity of its English version. This process was reiterative between two experts until 
both semantic and conceptual equivalence was established. Thirdly, the approved Chinese 
version of Chinese version of CMHQ had been tested on a small group of Chinese patients 
with different types of primary headaches. Finally, the Chinese version of the CMHQ was 
ensured its content validity and met the requirement of simple and clear to be understood. 
 
 
7.7  Discussion  
The CMHQ was developed under the CM theory framework. However in CM clinical research, 
objective measuring of clinical parameters, such as the changes of symptoms and signs 
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from participants, are generally lacking [569]. In overcoming subjectivity of clinical inquiry, 
the CMHQ was equipped with a close-ended response structure with the multiple choices 
provided, such method is recommended in the development of CM research questionnaires 
[569]. This method targeted the specific domains and also makes it simple to complete.  
 
In previous chapter, face validity of CMHQ has been accessed. Evaluated by the experts, the 
present study established content validity of CMHQ. With the assistance from internal group 
members and external colleagues and external experts, the CMHQ-3 was translated into 
Chinese. The content validity of the translated version was also established during the 
process of translation. Both of the two external experts had their mother language in 
Chinese. They were not only fluent in both Chinese and English but also had extensive and 
adequate knowledge in CM area, with having more than 20 years of experience in treating 
headaches and a variety of pain syndromes. They had provided valuable opinions when 
evaluating the English version of CMHQ and contributed its content validity. Moreover, their 
familiarity with two languages, experiences and expertise ensured accurate translation of 
CMHQ in reflecting the intended meaning of the questions. Therefore, in examining the 
translated version of CMHQ, the same criterion of content validity on English version was 
applied. Such a process ensured the translated Chinese version of CMHQ reflected a way of 
simple enquiry as its English version in clinical application and being of cultural adaptations. 
 
Criterion validity measures how well the scores of existing instrument stacks up against 
another instrument [485]. However in this project, it could not be assessed because the 
CMHQ was not designed to be a "diagnostic tool" but for assisting practitioners in making 
(proper) diagnosis. As described earlier, for many subjective measurements, there may not 
be “golden standards” available to be achieved for validation process [497]. The CMHQ is 
such type of questionnaire that not developed with an intention to generate a CM diagnosis 
automatically. In addition, there is no such diagnostic tool for TTH at present. Hence, there 
are no “criterion validity” comparisons for such testing at this stage. 
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The second version of CMHQ has demonstrated some degree of content validity. However, 
to some degree, it may have disadvantage in capturing major symptoms and signs of 
headache from participants. For example, when participants responded to several items to 
describe their headache simultaneously, it is difficult to determine the primary and 
secondary symptoms and signs without conducting a face-to-face interview. Therefore, 
CMHQ-3 equipped with numeric scale on variable frequency was developed in its 
amendment for a more precise and graded response. 
 
 
7.8  Chapter summary 
This chapter defines the aims and objectives of the pilot study, describes its methodology 
and presented the results. The CMHQ-2 was revised based on the findings of internal group 
discussion of content validation. Based on the experts‟ opinion of the CMHQ-2, CMHQ-3 had 
numeric scale on mosto f the items, enabling quantitative data collection and exploratory 
factor analyses and cluster analysis. 
 
In summary, the feasibility of CMHQ-2 was evaluated in the pilot study, and the content 
validity of its amended version of CMHQ-3 was established for further evaluation.  
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8.1  Introduction 
In the previous chapter, a pilot study was conducted to evaluate the content validity and 
feasibility of CMHQ-2 in differentiating CM patterns. In CM perspective, two largest 
subgroups of participants were detected with CM patterns of Ascendant hyperactivity of 
Liver-Yang (49.4%) and Liver-Qi depression (39.1%) respectively. The two groups were 
identified based on researchers‟ examinations of a series aggravating factors and 
accompanying symptoms. They were however could not be differentiated from the main 
characteristics of TTH, such as the number of days in or intensity of headache. The finding 
highlights the possibility of subtypes of TTH of the similar severity.  
 
Based on the pilot study results, CMHQ-2 was refined into CMHQ-3. The main amendment 
was to indicate the severity of most items by applying a five-point Likert scale. A good 
questionnaire should being of both reliability and validity to reduce measurement errors, 
improve the quality of data collected, and ensure the investigation to be free of bias [430, 
570]. Therefore, in this full-scale survey, the primary aims were 1). to assess both reliability 
and validity of CMHQ-3, 2). to explore TTH patterns, and 3). to explore the differences in 
and correlations of various outcome measures. 
 
The results of the full-scale survey, which conducted between 2011 and 2012, are 
presented in Chapters 8 and 9. In this chapter (Chapter 8), methodology issues of the 
survey implementation that was not outlined in the method chapter (Chapter 5) are detailed 
in this chapter, which include specific methods of the procedure and implementation of the 
survey, CHMQ administration and personnel training, issues of data analyse and 
interpretation. The current chapter also reports part of results (Results- Part A, B, and C). 
Specifically, it reports results of the recruitment, missing data handling (Part A), 
demographic data of participants and frequencies analysis of symptomatic features of TTH 
Part B). Most importantly, it reports results of the questionnaire evaluation, including the 
assessment of internal consistency reliability, test-rest reliability, and construct validity of 
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CMHQ-3 (Part C). 
 
Chapter 9 presents the remaining parts of results (Results- Part D, E, F and G): TTH pattern 
identification (Part D), comparisons of TTH subtypes and demographic data among clusters 
(Part E), MIDAS, and PSS data among TTH subtypes (Part F), and other comparisons related 
to TTH subtypes (Part G). Discussion of survey results are also presented in Chapter 9.  
 
 
8.2  Specific objectives  
The specific objectives of this study were:  
1). to evaluate the internal consistency, reliability, test-retest reliability and construct 
validity of CMHQ-3;  
2). to access symptomatic features of TTH participants obtained from CMHQ-3.  
 
Others aims are presented in Chapter 9.   
 
 
8.3  Methods 
8.3.1  Design  
The survey was implemented from February 2011 to June 2012. In an effort to obtain a 
broad sample of headache population, a paper-based survey and an online survey were 
implemented in parallel.  
 
The online survey was performed via the SurveyMonkey® platform 
(www.surveymonkey.com), which is the leader in web-based survey solutions.  
 
The paper-based survey was a collaborative multi-site investigation. The questionnaires 
were administrated at three sites, one in Melbourne, Australia, and another two in Beijing 
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and Chengdu, China. The survey implemented in Melbourne was nested in the mentioned 
ongoing clinical trial, and carried out in the RMIT University Bundoora campus. The two 
Chinese sites were the Acupuncture and Moxibustion Department, Beijing Hospital of TCM 
Affiliated to Capital Medical University, and the Teaching Hospital of Chengdu University of 
TCM. 
 
The English version of CMHQ-3 was used at the Melbourne site and the Mandarin version 
used in China. To explore the relationship between TTH patterns and headache induced 
disability, psychological stress level, and comorbidity of TTH, validated instruments, such as 
MIDAS, PSS-10 and a comorbidity checklist designed for collection of both somatic and 
mental comorbidity, were also applied together with CMHQ-3. For those included 
questionnaires, valid Mandarin version was used for Chinese population.  
 
8.3.2  Human research ethical approvals 
This collaborative survey investigation in both forms of online and paper-based surveys was 
reviewed and assessed by the relevant ethics departments. Ethics approvals at each site 
were obtained by the collaborating sites prior to the commencement of the investigations. 
 
The survey was approved for the Melbourne site by CHEAN of Science Engineering and 
Health, RMIT University (Appendices 2 to 4), for the Beijing by the Department of Science 
Research, of the Beijing TCM Hospital (Appendix 5), and for the Chengdu site, by the 
Department of Science and Technology, Chengdu University of TCM (Appendix 6). 
 
8.3.3  Screening questionnaire development 
To ensure the consistency of selection process in the online-survey and face-to-face 
interview, a screening questionnaire was developed in both languages (Appendices 31 to 
34). All potential participants were screened against this questionnaire prior to their 
participation either online or in paper-based surveys. Its content was firstly extracted from 
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the selection criteria and then formatted into questions provided with choices. The 
development process of the screening questionnaire were discussed by the internal group 
members for clarity of wording and then reviewed and commented by a medical doctor (Dr. 
Jerusa Alecrim-Andrade) for its content validity and feasibility. 
 
8.3.4  Training of investigators and clinicians  
To ensure the quality and the consistency in research conduct among different collaborating 
sites, personnel of each site were explained the survey purposes and the standard 
implementation procedure and were trained to adhere to the survey protocol prior to its 
implementation. Furthermore pilot training was also carried out at all three sites.  
 
8.3.5  Procedure of survey implementations  
8.3.5.1  Implementations of the online survey 
The online survey was anonymous. Based on the SurveyMonkey® online survey platform, 
advertisements (Appendix 35) listed via the associated headache associations and 
organisations (listed in Chapter 6, Section 6.4.2) (Appendix 36) were directed to the online 
survey address for completion (Appendix 37, and Appendix 38). As mentioned, two 
language versions of the CMHQ were mapped. Additionally, in adhering to the structure and 
format of the CMHQ-3 paper version, designing of the interface and style of the electronic 
survey were also considered. 
 
For those participants took part in the online survey, general information of the survey 
procedure was informed on the webpage. The survey began with an electronic version of 
Plain Language Statement (Appendix 10) and participants then responded to a list of 
questions on the screening questionnaire (Appendix 33, and Appendix34). All participants 
were allowed to complete the survey without informing their eligibility. Consents were given 
by participants by completing the online survey. An average of twenty minutes was 
estimated in completion of the online survey. 
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8.3.5.2  Implementations of the paper-based survey  
In regard to the paper-based survey, the Plain Language Statement (Appendix 10) of the 
survey was provided to all potential participants prior to their participation. Registered 
practitioners made diagnosis for participants who enrolled for the paper-based survey 
against the inclusion and exclusion criteria (Appendix 31, and Appendix 32). Eligible TTH 
participants were administered the questionnaires by trained research assistants. Verbal 
consents were obtained from the participants before filling in the questionnaires.  
 
At the Melbourne site, questionnaires were administrated by a trial assistant, and the trial 
acupuncturists were in charge of questionnaire collection and CM diagnosis. In the two 
Chinese sites, the diagnostic procedure was performed by the CM practitioners who were 
specialised in neurology with more than 10 years of clinical experience. Having diagnosed 
with TTH, participants were screened against the inclusion and exclusion criteria by 
research assistants. The research assistants involved in the study were master students 
with a bachelor degree in medicine. It took 20 to 30 minutes to complete the survey 
questionnaire. 
 
8.3.6  Data analysis 
8.3.6.1  Source of data collection 
Data of this investigation were obtained from the SurveyMonkey® online survey platform 
and three collaborating sites located in Melbourne, Beijing and Chengdu. 
 
8.3.6.2  Data contents 
Data of this survey investigation was composed of five parts: 1) CMHQ data, 2) comorbidity 
data (comorbidity checklist), 3) PSS data, 4) MIDAS data, and 5) demographic data. 
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8.3.6.3  Data Coding 
Items on Likert scale, i.e., “Never”, “Seldom”, “Sometimes”, “Often” and “Almost always” 
were coded with numeric value of 0, 1, 2, 3, 4, respectively to indicate the different degrees 
of frequency values. In case of dichotomous data, such as gender, were coded 0 and 1 for 
analysis.  
 
8.3.6.4  Data collation and synthesis 
All data collated were processed at RMIT University by the chief investigator. The survey 
data of both demographic characteristics and questionnaires answers were described as 
frequency (%) or mean (standard deviation).  
 
The online survey data were downloaded from the SurveyMonkey® website in the format of 
excel spread sheets, whereas the paper questionnaires were collected by each collaborating 
site separately. For the paper-based questionnaire data collation, a standard predefined 
excel spread sheet template was used for data entry. Data entry was performed by the 
investigator at each site. Double-check of the manually entered data sets were performed 
by research assistants at each collaborating site before collation. 
 
The primary investigator synthesised and combined different source of datasets into one 
excel spread sheet for further statistical analysis. Responses obtained from MIDAS were 
scored by the researcher. A total PSS score was obtained by summing all ten items with the 
scores of four positive worded items reversed.  
 
8.3.6.5  Missing data pre-processing 
Missing data is a common problem to any branches of analysis. it is also known as item 
nonresponse, indicating that valid values on some variables are not available for analysis 
[481]. Missing data will inevitably arise [571]. However, processing of missing data process 
is not ignorable [481]. In the cluster analysis, although the simplest way is to use only the 
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completed data set, it is not the best solution as it can greatly reduce the number of cases 
available for analysis [572].  
 
Case deletion  
Missing data from the data sets were pre-processed for data analysis by means of deletion 
or imputation [481, 571, 573]. Cases with high level of missing data are candidates for 
deletion, whereas those on acceptable level of missing data can be generally treated [481]. 
In regard to case deletion, in general, cases with a high proportion of missing data were 
candidates for deletion. However, there is no such guideline that exist firmly implies the 
necessary levels for deletion. Suggestion for case deletion is thus to made base on both 
empirical and theoretical considerations [481].   
 
Imputation for extracted factors 
As a rule of thumb, missing data of less than 30% can often be remedied [481]. Imputation, 
the process of estimating the missing value depends on other usable values of the dataset, 
has been widely applied in dealing with missing data [481]. Estimating miss values is often 
suggested by applying imputation method, for example, mean imputation for a continuous 
variables and the mode imputation for categorical variables [572]. The expectation–
maximisation algorithm, abbreviated as the EM algorithm, is an iterative two-stage 
procedure which alternates between performing an E (expectation) and an M (maximisation) 
stage. The E stage creates the best possible estimation of the missing data, whereas the M 
stage computes and estimates parameters such as means, standard deviations or 
correlations, maximising the values by assuming the missing data were replaced [481]. As 
recommended by Hair et al. (2009), this model-based approach has been demonstrated 
quite effectively in non-random missing data imputation [481].  
 
Therefore, in this study, both case deletion and imputation methods were applied in 
handling of missing data. Cases having more than 30% missing values within the total 193 
 237 
 
items were deleted from the dataset, whereas cases having less than 30% missing values 
were firstly calculated and reported in frequencies of descriptive statistics. Its prediction 
and substitution were then performed for extracted factors using EM imputation. 
 
8.3.7  CMHQ evaluation 
A range of statistical analytic methods were employed to assess CMHQ-3 reliability and 
validity. Those methods included descriptive statistic, frequency analysis, Cronbach‟s alpha 
coefficient, correlation, factor analysis, and cluster analysis.  
 
The Cronbach‟s alpha coefficient value was calculated for internal consistency reliability 
evaluation; Spearman's correlation coefficient was used to assess test-retest reliability; 
factor Analysis was used to establish the construct validity of CMHQ. In diagnosing the 
factorability of the correlation matrix, visual examination of the correlation matrix, 
Bartlett‟s test of sphericity, and the Kaiser-Meyer-Olkin (KMO) measure of sampling 
adequacy were performed. 
 
 
8.4  Results – Part A: Recruitment results and missing data 
handling 
8.4.1  Sample and response rates  
From February 2011 to June 2012, a total of 656 (548 online and 108 paper-based) 
responded to the survey, and 497 completed it. This resulted in 75.8% response rate.  
 
8.4.2  Participant recruitment 
Of the 497 participants who completed the survey, 389 of them were from the 
SurveyMonkey® platform, the other 108 participants were recruited from the 3 
collaborating sites. Table 42 lists the source of participants.   
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Table 42. Source of participants 
 
Source Number of 
participant 
Number of 
completion 
Response rate 
SurveyMonkey 548 389 71% 
Melbourne site 35 35 100% 
Beijing site 33 33 100% 
Chengdu site 40 40 100% 
Total number of completion:  362 --- 
Total response rate: --- 75.8% 
 
8.4.3  Screening of participations 
A total of 171 TTH participants fulfilled the selection criteria. All eligible participants were 
evaluated with missing value (Section 9.5.4). One participant was removed from the 
analysis due to a high proportion of missing values beyond 30%. Finally, 170 participants 
were included for data analysis. Figure 26 illustrates the process of participant recruitment 
and screening. 
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Figure 26. Flow chart of participant recruitment and screening process 
 
Participants approached 
online  
(n = 548) 
Participants completed 
online survey  
(n=389)  
Assessment of eligibility 
against selection criteria 
Participants recruited from 
the 3 collaborating centres 
(n = 108)  
Participants completed 
paper-based questionnaire 
(n=108) 
Total number of survey 
completion 
(n=497) 
Total number of 
participants fulfilling 
selection criteria 
(n=171) 
Deletion of case with 
missing data>30% 
(n=1) 
Number of participants 
included for data analysis 
(n=170) 
Number of participants 
fulfilling selection criteria 
(n=83) 
Number of participants 
fulfilling selection criteria 
(n=88) 
Data synthesis and 
evaluation of missing data 
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8.4.3.1  Screening of the diagnosed TTH online respondents  
Of the 389 online respondents, 174 were categorised into the “Previous diagnosed TTH” 
group as they have responded their headaches had been diagnosed by medical practitioners. 
The other 215 were classified into the “Previous un-diagnosed TTH” group according to their 
responses to their previous diagnoses on their headaches.  
 
Table 43 summaries the reasons of exclusion for diagnosed and un-diagnosed TTH 
respondents in details. The majority was excluded due to meeting more than one exclusion 
criterion. Of the 174 diagnosed respondents, 112 were excluded due to various reasons. Of 
the 215 un-diagnosed respondents, 35 of them met the TTH diagnostic criteria whereas 
other 180 respondents were non-TTH sufferers. After a further evaluation against the 
selection criteria on these 35 TTH sufferers, 14 of them were excluded due to various 
reasons. Finally, 62 participants previously diagnosed with TTH and 21 un-diagnosed 
participants from the online survey were included.  
 
Table 43. Reasons of exclusion: On-line respondents 
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Reasons for exclusion in detail 
 
Number of exclusion 
had TTH less than one year  4 
hospitalized because of the head or neck injury 2 
had MG but unable to distinguish TTH from migraine  8 
had >4 times migraine attacks in the past 4 weeks  3 
had >1 migraine attacks with aura per month  6 
suspected MOH  13 
had met more than one exclusion criteria 76 
 
Number of evaluation: n=174 
 
Number excluded: n=112 
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Reasons for exclusion in detail 
 
Number of exclusion 
 
Non-TTH 
respondents 
(n=180) 
unable to meet TTH diagnostic criteria 11  
 
 
180 
had < 1 day headache onset per month 41 
headache attributed to other diseases 12 
suspected Cluster headache 7 
suspected cervical genic headache 5 
had met more than one exclusion 
criteria 
104 
TTH 
respondents 
(n=35) 
had TTH less than 1 year  12  
14 had MG but unable to distinguish TTH 
from migraine 
2 
 
Number of evaluation: n=215 
 
Number excluded: n=194 
 241 
 
 
Total number of online respondents:  
n=389 
 
Total number of 
exclusion:  
n=306  
 
8.4.3.2  Screening results of the volunteers with paper-based questionnaires  
Of the 108 TTH participants who completed paper-based questionnaires, 20 were 
excluded for reasons listed in Table 44. Finally, 88 TTH participants who participated in the 
paper-based survey were included.  
 
Table 44. Reasons of exclusion: Diagnosed onsite TTH volunteers  
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Reasons for exclusion in detail 
 
Number of 
exclusion 
headache attributed to other diseases 1 
had TTH less than 1 year  9 
hospitalized because of the head or neck injury 1 
had MG but unable to distinguish TTH from migraine 5 
had >4 times migraine attacks in the past 4 weeks  2 
had >1 migraine attacks with aura per month  1 
had met more than one exclusion criteria 1 
 
Total number of onsite TTH volunteers:  
n=108 
 
Total excluded:  
n=20 
 
8.4.4  Missing data handling  
A total 47 cases had missing data (Appendix 39). Those cases with missing values were 
mainly from the participants (n=44) who completed the paper-based questionnaires at 
each collaborating site, and the remaining 3 cases were online participants.  
 
One case in this study had a total 70 missing values in CMHQ, which was 36% of the whole 
questions. As a result, this case was removed from data analysis.  
 
The frequencies of missing values on 46 cases were less than 30% (ranged from 1% to 18%) 
of the useable responses. Missing values were reported in Section 8.5 descriptive statistics 
in details. Their prediction and substitution were performed for extracted factors using EM 
imputation (Appendix 40). 
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Finally, of the 171 cases, 46 of 47 participants with missing values were included. Together 
with the other 124 cases without missing data, a total of 170 participants were included for 
data analysis.  
 
 
8.5  Results – Part B: Descriptive Statistics 
8.5.1  Demographic characteristics  
Demographic characteristics of the participants collected from this survey include 
information such as gender, age, ethnicity, marital status and education (Table 45 and 
Table 46). 
 
Of the 170 TTH participants, the majority was young, female, Asian, and married or 
partnered, and had tertiary education. There were more females than males, and the 
average age was 38 (SD=12).  
 
Table 45. Demographic data on gender and age  
 
Gender 
Number of 
participants 
Percent 
Age (years) 
Mean±SD 
Female 120 70.6 38±12 
Male 50 29.4 39±13 
Total 170 100 38±12 
 
Table 46. Other demographic data 
 
Age range 
Number of 
participants 
Percent 
Valid 
Percent 
Valid 
20-29 55 32.4 33.1 
30-39 44 25.9 26.5 
40-49 31 18.2 18.7 
50-59 26 15.3 15.7 
60+ 10 5.9 6.0 
Total 166 97.6 100.0 
Missing 4 2.4 
 
Total 170 100.0 
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Ethnicity distribution 
Number of 
participants 
Percent 
Valid 
Percent 
Valid 
Chinese Asian 79 46.5 48.2 
Australian Peoples 42 24.7 25.6 
British 13 7.6 7.9 
New Zealand Peoples 3 1.8 1.8 
Southern European 3 1.8 1.8 
Irish 3 1.8 1.8 
Western European 3 1.8 1.8 
South Eastern European 1 .6 .6 
Northern European 1 .6 .6 
Eastern European 1 .6 .6 
Maritime South-East Asian 1 .6 .6 
Arab 1 .6 .6 
Central Asian 1 .6 .6 
Mainland South-East Asian 1 .6 .6 
Southern Asian 1 .6 .6 
Other north-east Asian 1 .6 .6 
Other Asian 1 .6 .6 
Had more than one ethnicity 8 4.7 4.9 
Total 164 96.5 100.0 
Missing 6 3.5 
 
Total 170 100.0 
 
Marital status 
Number of 
participants 
Percent 
Valid 
Percent 
Valid 
Single 64 37.6 38.8 
Married 77 45.3 46.7 
Partnered 9 5.3 5.5 
Divorced 13 7.6 7.9 
Separated 2 1.2 1.2 
Total 165 97.1 100.0 
Missing 5 2.9 
 
Total 170 100.0 
 
Level of education 
Number of 
participants 
Percent 
Valid 
Percent 
Valid 
Postgraduate degree level 40 23.5 24.4 
Graduate diploma and 
graduate certificate level 
8 4.7 4.9 
Bachelor degree level 72 42.4 43.9 
Advanced diploma and 
diploma level 
18 10.6 11.0 
TAFE level 10 5.9 6.1 
Secondary education 14 8.2 8.5 
Primary education 2 1.2 1.2 
Total 164 96.5 100.0 
Missing 6 3.5 
 
Total 170 100.0 
 
 
8.5.2  Frequencies of CMHQ items 
There were total 193 items presented in tables of three sections. For each item presented, 
the figures of 0 to 4 indicated their responses to the 5-point Likert scale. Calculation of 
frequency and precent of items were according to the choice from 2 to 4, which indicated 
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the positive responses to “sometimes”, “often”, and 0” almost always”. 
 
8.5.2.1  Part 1: Pain Description 
In this survey, the commonest locations of headache were on the right side of head, left side 
of the head, and forehead. Determination of the bilateral or unilateral headache of the 
participants was based on their response to items 1.1.2 (Left side of the head) and 1.1.3 
(Right side of the head). Since the five-point Likert scale contains value of 0 to 4 (which 
stand for never, seldom, sometimes, often and almost always), the value of 0 was coded as 
a negative response any value 1, 2, 3, or 4 was considered as a positive response.   
 
The scenarios are as follow:  
 
(1). positive responses to both items of 1.1.2 and 1.1.3; - considered as bilateral 
headache  
(2). positive responses to one of the item of 1.1.2 or 1.1.3; - considered as unilateral 
headache  
(3). non-active response to both items; - headache might be in other area  
 
As a result, the majority (n=121; 71%) of participants had bilateral headache, whereas 15% 
(n=26) had headache on either left or right side. Twenty-two (22) (13%) participants 
suffered from headaches in other parts of the head.  
 
Table 47 detailed the frequencies and precents of each section. Headaches mainly affect the 
neck and eyes, with a fixed location, of continuous and intermittent nature, tight and 
pulsating. The majority of participants had frequent headache either being worse at the end 
of the day or with no particular time.  
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Table 47. Frequency analysis of Part 1 items 
 
Headache location Missing 
(n) 
Level of item scaling Frequency  
(n) 
Percent 
(%) 0 1 2 3 4 
1.1.1 Forehead 1 42 38 35 25 29 89 52.7 
1.1.2 Left side of the head 2 31 41 34 40 22 96 57.1 
1.1.3 Right side of the head 1 39 29 35 41 25 101 59.8 
1.1.4 Back of the head 5 59 28 36 25 17 78 47.3 
1.1.5 Top of the head 6 65 39 31 15 14 60 36.5 
1.1.6 Whole head 5 72 45 30 15 3 48 29.1 
1.1.7 No particular location 14 94 35 16 10 1 27 17.3 
Headache affected area Missing 
(n) 
Level of item scaling Frequency 
(n) 
Percent 
(%) 0 1 2 3 4 
1.2.1 Neck 2 43 22 17 38 48 103 61.3 
1.2.2 Shoulders 3 65 22 16 26 38 80 48.0 
1.2.3 Ears 1 112 30 14 9 4 27 16.0 
1.2.4 Eyebrow 2 62 34 29 25 18 72 42.9 
1.2.5 Eyes 2 44 28 39 31 26 96 57.2 
1.2.6 Cheeks 5 107 25 17 10 6 33 20.0 
Quality of headache Missing 
(n) 
Level of item scaling Frequency 
(n) 
Percent 
(%) 0 1 
1.3.1 Pressing  1 99 70 70 41.4 
1.3.2 Explosive 0 154 16 16 9.4 
1.3.3 Burning 0 165 5 5 2.9 
1.3.4 Drilling 0 153 17 17 10.0 
1.3.5 Cutting 0 166 4 4 2.4 
1.3.6 Sharp 0 135 35 35 20.6 
1.3.7 Vague 0 133 37 37 21.8 
1.3.8 Heavy 0 112 58 58 34.1 
1.3.9 Dull 0 118 52 52 30.6 
1.3.10 Throbbing 0 106 64 64 37.6 
1.3.11 Pulling 0 154 16 16 9.4 
1.3.12 Empty 0 166 4 4 2.4 
1.3.13 Tight 0 110 60 60 35.3 
1.3.14 Distending 0 139 31 31 18.2 
1.3.15 Piercing 0 148 22 22 12.9 
1.3.16 Pulsating 0 112 58 58 34.1 
1.3.17 Radiating 0 154 16 16 9.4 
1.3.18 Pounding 0 137 33 33 19.4 
1.3.19 “band-like” sensation  0 131 39 39 22.9 
Nature of headache Missing 
(n) 
Level of item scaling Frequency 
(n) 
Percent 
(%) 0 1 2 3 4 
1.4.1 Fixed location 1 25 19 20 51 54 125 74.0 
1.4.2 Moves around 3 70 48 28 18 3 49 29.4 
1.4.3 Continuous 2 32 24 29 38 45 112 66.7 
1.4.4 Intermittent 3 36 43 42 30 16 88 52.7 
Days on headache per month Missing 
(n) 
Level of item scaling (n/%) 
headache < 
1d 
14d > 
headache > 
1d 
headache > 
15d 
1.5 days on headache per month 0 24 (14%) 107 (63%) 39 (23%) 
Time during the day that headache gets 
worse 
Missing 
(n) 
Level of item scaling Frequency 
(n) 
Percent 
(%) 0 1 
1.6.1 Worse in the morning 0 145 25 25 14.7 
1.6.2 Worse in the afternoon 0 122 48 48 28.2 
1.6.3 Worse at the end of the day 0 117 53 53 31.2 
1.6.4 Worse at night 0 139 31 31 18.2 
1.6.5 All day 0 158 12 12 7.1 
1.6.6 No particular time 0 109 61 61 35.9 
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8.5.2.2  Part 2: Aggravating and Relieving factors  
In this part, overwork, when tired, mental strain, muscular strain (muscle tightness), lack 
of sleep, stress, nervousness, anger or irritability, and anxiety (excessive worry) were 
identified as the commonest aggravating factors of headache (≥50%), whereas sleeping, 
medication, lying-down, pressing or pressure on the pain area and massage were the 
commonest relieving factors of the headaches (≥ 50%) (Table 48).  
 
Table 48. Frequency analysis of Part 2 items 
 
Aggravating factors Missing 
(n) 
Level of item scaling Frequency 
(n) 
Percent 
(%) 0 1 2 3 4 
2.1.1 Overwork 1 23 21 42 54 29 125 74.1 
2.1.2 When tired 1 27 27 53 40 22 115 68.1 
2.1.3 Mental strain 0 22 29 47 46 26 119 70.0 
2.1.4 Eye strain 1 44 42 35 29 19 83 49.1 
2.1.5 Muscular strain 2 54 25 29 30 30 89 53.1 
2.1.6 Physical labour 4 65 54 25 14 8 47 28.3 
2.1.7 Lack of sleep 1 23 31 45 41 29 115 68.1 
2.1.8 Poor posture 3 58 38 33 18 20 71 42.6 
2.1.9 Alcohol 4 75 28 37 15 11 63 37.9 
2.1.10 Coffee 5 109 31 14 7 4 25 15.1 
2.1.11 Dehydration 5 65 25 39 25 11 75 45.5 
2.1.12 Hunger / Being hungry 5 82 33 30 17 3 50 30.3 
2.1.13 Chocolate 6 117 28 11 8 0 19 11.6 
2.1.14 Cigarette smoking 8 140 8 8 5 1 14 8.6 
2.1.15 Soft drink / Sodas 6 139 17 5 0 3 8 4.8 
2.1.16 Tea 6 140 15 3 5 1 9 5.4 
2.1.17 Dairy foods 5 136 12 7 7 3 17 10.2 
2.1.18 Monosodium glutamate 5 125 20 9 4 7 20 12.1 
2.1.19 Sugar / too much sugar 6 124 23 11 3 3 17 10.3 
2.1.20 Spicy food 6 121 26 11 5 1 17 10.3 
2.1.21 Over consumption of oily food 5 121 29 10 5 0 15 9.1 
2.1.22 Irregular diet 5 97 27 24 14 3 41 24.8 
2.1.23 Change of weather 2 94 26 23 18 7 48 28.6 
2.1.24 Change in temperature 2 95 33 16 19 5 40 23.8 
2.1.25 Exposure to bright lights 2 71 27 41 19 10 70 41.7 
2.1.26 Hot weather 1 74 30 30 26 9 65 38.5 
2.1.27 Cold weather 3 105 36 15 9 2 26 15.6 
2.1.28 Windy days 3 97 35 20 9 6 35 21.0 
2.1.29 Damp / Humid weather 3 104 30 24 7 2 33 19.8 
2.1.30 Rainy days 3 126 27 7 6 1 14 8.4 
2.1.31 Stress 0 18 27 37 59 29 125 73.6 
2.1.32 Nervousness 1 40 34 53 27 15 95 56.3 
2.1.33 Anger or irritability 1 26 32 53 42 16 111 65.8 
2.1.34 Anxiety (excessive worry) 2 30 28 47 40 23 110 65.5 
2.1.35 Depression 1 58 36 45 20 10 75 44.3 
2.1.36 Tension or conflict related 0 41 27 46 33 23 102 60.0 
2.1.37 Sneezing 7 123 23 13 3 1 17 10.4 
2.1.38 Teeth grinding 7 122 10 15 9 7 31 19.0 
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Relieving factors Missing 
(n) 
Level of item scaling Frequency 
(n) 
Percent 
(%) 0 1 2 3 4 
2.2.1 Rest 0 21 32 54 40 23 117 68.8 
2.2.2 Lying-down 0 26 38 54 33 19 106 62.4 
2.2.3 Sleeping 0 14 24 50 47 35 132 77.6 
2.2.4 Medication 3 37 22 31 42 35 108 62.7 
2.2.5 Exercise / light exercise 6 73 37 38 13 3 54 32.9 
2.2.6 Massage 3 58 24 47 25 13 85 50.9 
2.2.7 Pressing on the pain area 1 29 35 55 35 15 105 62.1 
2.2.8 Eating 1 89 39 34 7 0 41 24.2 
2.2.9 Warmth 1 71 34 44 14 6 64 37.9 
2.2.10 Coldness 1 104 28 27 8 2 37 21.9 
 
8.5.2.3  Part 3: Accompanying symptoms 
The most frequent rated items of accompanying symptoms with headaches were fatigue, 
neck stiffness, neck pain, irritability, restlessness and increased forgetfulness (Table 49). 
Apart from headaches, neck, shoulder and lower back were mostly complained areas with 
pain (Table 50). Of the female related items, bright, red coloured menstrual blood, dark 
coloured menstrual blood, headache before period and abdominal pain during periods were 
mostly referred items (Table 51). 
 
Table 49. Frequency analysis for Part 3 items of accompanying symptoms 
 
Eye related symptoms Missing 
(n) 
Level of item scaling Frequency 
(n) 
Percent 
(%) 
0 1 2 3 4 
3.1.1 Sensitivity to light  0 64 27 44 19 16 79 46.6 
3.1.2 Dry eyes 0 78 41 30 15 6 51 29.9 
3.1.3 Teary eyes 1 93 43 18 10 5 33 19.6 
3.1.4 Blurred vision 0 73 45 28 17 7 52 30.6 
3.1.5 Sore eyes 0 55 41 41 24 9 74 43.5 
3.1.6 Red eyes 0 94 38 28 9 1 38 22.4 
3.1.7 Swollen eyelids 0 109 39 16 5 1 22 12.9 
3.1.8 Eye twitching 1 79 39 44 6 1 51 30.2 
3.1.9 Floaters in the eyes 1 107 29 20 7 6 33 19.5 
3.1.10 Burning sensation in the eyes 1 124 28 11 6 0 17 10.1 
3.1.11 Itchy sensation in the eyes 1 101 28 29 9 2 40 23.7 
Face (mouth, ear and nose) related 
symptoms 
Missing 
(n) 
Level of item 
presentation 
Frequency 
(n) 
Percent 
(%) 
0 1 2 3 4 
3.1.12 Sensitivity to sound 0 69 27 40 18 16 74 43.5 
3.1.13 Dry mouth 0 76 38 38 15 3 56 33.0 
3.1.14 Thirst 0 62 39 49 17 3 69 40.6 
3.1.15 Bitter taste in the mouth 0 100 33 25 10 2 37 21.8 
3.1.16 Runny nose 0 107 37 15 10 1 26 15.3 
3.1.17 Sore throat 0 104 39 19 7 1 27 15.9 
3.1.18 Ear discharge 1 151 14 4 0 0 4 2.4 
3.1.19 Tinnitus (ringing in the ears) 0 100 37 13 13 7 33 19.3 
3.1.20 Flushed face / hot red face 0 87 39 31 9 4 44 25.9 
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Digestion related symptoms 
 
Missing 
(n) 
Level of item scaling Frequency 
(n) 
Percent 
(%) 0 1 2 3 4 
3.1.21 Nausea 0 70 44 35 16 5 56 32.9 
3.1.22 Vomiting 0 104 38 20 7 1 28 16.5 
3.1.23 Reflux 0 101 40 21 7 1 29 17.1 
3.1.24 Belching 0 106 35 17 10 2 29 17.1 
3.1.25 Bloating / flatulence 0 78 41 35 15 1 51 30.0 
3.1.26 Indigestion 0 88 46 28 6 2 36 21.2 
3.1.27 Poor appetite 0 81 49 28 7 5 40 22.5 
Urine and bowel related symptoms 
 
Missing 
(n) 
Level of item scaling Frequency 
(n) 
Percent 
(%) 0 1 2 3 4 
3.1.28 Yellowish urine 0 58 57 39 14 2 55 32.3 
3.1.29 Frequent urination 1 87 38 24 13 7 44 26.0 
3.1.30 Watery bowel motion 1 93 43 25 6 2 33 19.6 
3.1.31 Loose bowel motion 0 94 47 25 4 0 29 17.1 
3.1.32 Dry stools 1 87 47 22 12 1 35 20.7 
3.1.33 Constipation 0 85 40 33 10 2 45 26.5 
Muscles and joint related symptoms 
 
Missing 
(n) 
Level of item scaling Frequency 
(n) 
Percent 
(%) 0 1 2 3 4 
3.1.34 Joint stiffness 0 57 44 40 21 8 69 40.6 
3.1.35 Neck stiffness 0 28 23 42 50 27 119 70.0 
3.1.36 Muscle twitching 0 79 37 38 8 8 54 31.8 
3.1.37 Weak legs and knees 0 85 40 31 9 5 45 26.4 
3.1.38 Feeling weak in the lower back 0 74 42 36 11 7 54 31.8 
3.1.39 Feeling cold in the lower back 0 94 38 23 6 9 38 22.3 
3.1.40 Cold hands and feet / limbs 0 81 35 25 13 16 54 31.7 
3.1.41 Hot sensation in the palms 0 102 31 24 11 2 37 21.8 
3.1.42 “Pins and needles” in the limbs 0 93 43 25 7 2 34 20.0 
Other symptoms  
 
Missing 
(n) 
Level of item scaling Frequency 
(n) 
Percent 
(%) 0 1 2 3 4 
3.1.43 Increased forgetfulness 0 44 41 51 28 6 85 50.0 
3.1.44 Feeling depressed 0 36 54 49 26 5 80 47.0 
3.1.45 Irritability / Irascibility 0 22 49 55 34 10 99 58.3 
3.1.46 Restlessness 0 23 50 61 24 12 97 57.1 
3.1.47 Fatigue / tiredness 0 18 31 46 55 20 121 71.3 
3.1.48 Faintness 0 99 38 24 7 2 33 19.4 
3.1.49 Heavy sensation in the body 0 64 57 32 13 4 49 28.8 
3.1.50 Insomnia 0 41 51 36 31 11 78 45.9 
3.1.51 Sighing often 0 57 43 39 24 7 70 41.1 
3.1.52 Feverish sensation 0 100 36 20 12 2 34 20.1 
3.1.53 Shortness of breath 0 95 37 25 12 1 38 22.4 
3.1.54 Dizziness 0 66 46 38 15 5 58 34.1 
3.1.55 Excessive phlegm 0 116 34 14 5 1 20 11.7 
3.1.56 Palpitation 0 83 44 29 13 1 43 25.3 
3.1.57 Inability to concentrate 0 42 48 43 28 9 80 47.1 
3.1.58 Night sweating 0 93 36 26 13 2 41 24.1 
3.1.59 Sweating upon mild activity 0 91 51 13 10 5 28 16.4 
3.1.60 Aversion to cold 0 93 21 24 21 11 56 33.0 
3.1.61 Aversion to hot  0 103 35 16 13 3 32 18.8 
3.1.62 Sensitive to temperature changes 0 76 39 24 25 6 55 32.3 
 
Table 50. Frequency analysis for Part 3 items of pain in other parts 
 
Item Missing 
(n) 
Response to items Frequency 
(n) 
Percent 
(%) 
0 1 
3.2.1 Neck 0 68 102 102 60.0 
3.2.2 Shoulder 0 93 77 77 45.3 
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3.2.3 Jaw 0 142 28 28 16.5 
3.2.4 Throat 0 161 9 9 5.3 
3.2.5 Ears 0 158 12 12 7.1 
3.2.6 Eyes 0 126 44 44 25.9 
3.2.7 Chest 0 162 8 8 4.7 
3.2.8 Breasts 0 157 13 13 7.6 
3.2.9 Upper back 0 146 24 24 14.1 
3.2.10 Middle back 0 153 17 17 10.0 
3.2.11 Lower back 0 110 60 60 35.3 
3.2.12 Abdomen 0 162 8 8 4.7 
3.2.13 Arms 0 160 10 10 5.9 
3.2.14 Legs 0 155 15 15 8.8 
3.2.15 Knees 0 148 22 22 12.9 
3.2.16 Heel 0 160 10 10 5.9 
3.2.17 Hips 0 149 21 21 12.4 
3.2.18 Buttocks 0 157 13 13 7.6 
3.2.19 Flank (side of the body) 0 166 4 4 2.4 
3.2.20 Hypochondria (lower abdomen) 0 160 10 10 5.9 
 
Table 51. Frequency analysis for Part 3 items of female related items on 
menstruation 
 
Item Missin
g 
(n) 
Response to items n=93 
1 2 3 4 5 Frequency 
(n) 
Percent 
(%) 
3.3.2.1 Irregular period cycle 0 37 30 15 6 5 26 28.0 
3.3.2.2 Early periods 0 47 30 11 4 1 16 17.2 
3.3.2.3 Delayed periods 0 45 26 10 7 5 22 23.7 
3.3.2.4 Light bleeding 0 32 29 18 11 3 32 34.4 
3.3.2.5 Excessive bleeding 0 42 31 12 5 3 20 21.5 
3.3.2.6 Bleeding with clots 0 28 22 17 15 11 43 46.2 
3.3.2.7 Bright red coloured menstrual blood 0 25 21 17 21 9 47 50.5 
3.3.2.8 Light red coloured menstrual blood 0 39 35 13 5 1 19 20.4 
3.3.2.9 Dark coloured menstrual blood 0 19 16 26 26 6 58 62.4 
3.3.2.10 Excessive watery discharge 0 52 23 12 4 2 18 19.4 
3.3.2.11 Yellow discharge 0 42 31 8 10 2 20 21.5 
3.3.2.12 Headache before period 0 20 25 23 14 11 48 51.6 
3.3.2.13 Headache during period 0 32 16 26 11 8 45 48.4 
3.3.2.14 Headache after period 0 38 24 24 4 3 31 33.3 
3.3.2.15 Abdominal pain before periods 0 21 26 18 19 9 46 49.5 
3.3.2.16 Abdominal pain during periods 0 24 20 19 21 9 49 52.7 
3.3.2.17 Abdominal pain after periods 0 57 22 4 9 1 14 15.1 
3.3.2.18 Lower back pain before periods 0 33 17 15 22 6 43 46.2 
3.3.2.19 Lower back pain during periods 0 32 16 15 17 13 45 48.4 
3.3.2.20 Lower back pain after periods 0 57 23 6 5 2 13 14.0 
 
8.5.2.4  Summary of common headache features  
Overall, in this survey, the commonest headache features were fixed location (74%) and 
continuous pain (66.7%). Headache was aggravated by overwork (74.1%), stress (73.6%), 
and mental strain (70%) and may relieve by sleeping (77.6%). The most common 
accompanying symptoms were fatigue (71.3%) and neck stiffness (70%).  
 250 
 
8.6  Results – Part C: Evaluation of CMHQ reliability and validity  
8.6.1  Test-retest reliability  
Test-retest reliability of CMHQ was measured using Spearman's rank correlation. In the 
paper-based survey, 48 participants were administered with the CMHQ-3 twice with one 
week interval for its test-retest reliability evaluation. Of these 48 participants, 23 were 
collected from Melbourne site and 25 were from Beijing site.  
 
Indicated by the Spearman rank correlation coefficients, which scores ranged from 0.759 to 
0.850 (Table 52), the test-retest reliability of the whole CMHQ was high (0.842). 
 
Table 52. Correlations of the test and retest datasets (n=48) 
 
Dimension Correlation Coefficients 
Part 1 Pain description .847** 
Part 2 Aggravating and relieving 
factors 
.759** 
Part 3 Accompanying symptoms .850** 
CMHQ .842** 
**. Correlation is significant at the 0.01 level (2-tailed). 
 
8.6.2  Internal consistency reliability  
All of the 193 items of the survey were submitted for reliability tests, which was assessed by 
Cronbach‟s alpha coefficient, a corrected item-total coefficient. The tests yielded 
Cronbach‟s alpha values above 0.7 for all parts and the whole CMHQ demonstrated a strong 
internal consistency with an overall alpha value of 0.952 (Table 53). 
 
Table 53. Evaluation of internal consistency reliability (n=170) 
 
Dimension Number of items Cronbach’s α Coefficients 
Part 1 Pain description 43 0.790 
Part 2 Aggravating and relieving factors 48 0.887 
Part 3 Accompanying symptoms 102 0.947 
CMHQ 193 0.952 
 
 251 
 
8.6.3  Construct validity 
In this study, factor analysis was used to establish construct validity of the CMHQ as well as 
performed for the dimensionality reduction when identifying CM patterns. CMHQ data of the 
eleven sections were subjected to PCA using SPSS version 19. As mentioned previously 
(Chapter 5, section 5.9.7.2), the terms of „factor‟ and „component‟ are often interchanged 
used. To avoid confusion, data analyses for the evaluation of construct validity adopted 
„component‟ instead of „factor‟, whereas „factor‟ was specifically used to indicate the 
reduction of CMHQ items. 
 
Visual inspection of the correlation matrix of the dataset (Appendix 41) revealed the 
presence of a substantial number of coefficients of correlation above 0.30. For instance, The 
KMO index value of 0.811 exceeds the recommended cut-point value of 0.5; and the 
Barlett‟s Test of Sphericity yielded Chi2= 478.746 (P<0.001). Both indicated that the 12 
sections (questions) of CMHQ were highly correlated and suitable for the application of 
factor analysis (Table 54).  
 
Table 54. Assessment of the data suitability for factor analysis 
 
KMO and Bartlett's Test 
Kaiser-Meyer-Olkin Measure of Sampling Adequacy .811 
Bartlett's Test of Sphericity Approx. Chi-Square 478.746 
Df 55 
Sig. .000 
 
An initial exploratory factor analysis was executed using an eigenvalue of 1 as a criterion for 
factor extraction. This analysis yielded three components with eigenvalue exceeding 1 
(Table 55), and observation of the scree plot showed an elbow at component 3 (Figure 27). 
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Table 55. Eigenvalues and the Explained Percentage of Variance by the 
components 
 
Total Variance Explained 
Comp
onent 
Initial Eigen values Extraction Sums of 
Squared Loadings 
Rotation Sums of Squared 
Loadings 
Total % of 
Variance 
Cumulative
 % 
Total % of 
Variance 
Cumulative
 % 
Total % of 
Variance 
Cumulative
 % 
1 3.811 34.643 34.643 3.811 34.643 34.643 2.432 22.111 22.111 
2 1.314 11.945 46.588 1.314 11.945 46.588 2.419 21.990 44.101 
3 1.078 9.784 56.371 1.076 9.784 56.371 1.350 12.271 56.371 
4 .981 8.922 65.293       
5 .846 7.692 72.985       
6 .694 6.308 79.291       
7 .573 5.212 84.503       
8 .572 5.198 89.701       
9 .405 3.684 93.385       
10 .381 3.461 96.846       
11 .347 3.154 100.000       
Extraction Method: Principal Component Analysis. 
 
 
Figure 27. Scree plot of the Catell’s scree test 
 
Based on the eigenvalue > 1 rule of Kaiser‟s criteria and the plot of the Catell‟s scree test, 
three components were extracted, with accumulated a total of 56.371 per cent of the 
variance.   
 
Varimax rotation was conducted with these three identified components. As showed in 
Table 56, the analysis yielded an acceptable three-component model. Inspection of the 
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contents in the respective 3 components suggested that the CMHQ can be measured in 3 
different aspects of the CM diagnosis. The first component, which included part 2 and 3, was 
related to the aggravating and relieving factors and accompanying symptoms other than 
headache itself. The second component included headache location, affected area and its 
rhythm, as well as days on headache in a month. The last component was related to the 
specific period of the worst headache and its quality.  
 
External experts agreed that the three-component structure was consistent with the key 
diagnostic information required for CM pattern identification. The three components were 
respectively labelled as:  
 
1).  Symptoms and signs other than headache;  
2).  Headache frequency, rhythm and location; and  
3).  Headache exacerbation period. 
 
Table 56. Component Matrices with VARIMAX rotation (n=170) 
 
 
Dimension 
Components 
1 2 3 
2.1 Aggravating factors .649 .297 .299 
2.2 Relieving factors .655 .002 .077 
3.1 Accompanying .493 .475 -.038 
3.2 Other pain in the body .657 .127 .115 
3.3 Female related items .633 -.001 -.484 
1.1 Headache location .296 .554 .290 
1.2 Headache affected area .490 .557 .291 
1.4 Headache rhythm  .096 .788 .181 
1.5 Days on headache per month -.084 .810 -.215 
1.3 Headache (pain) quality  .397 .440 .498 
1.6 Worst headache during a day .074 .013 .714 
Eigenvalue 3.811 1.314 1.076 
Explained variance 34.643 11.945 9.784 
Extraction Method: Principal Component Analysis.  
Rotation Method: Varimax with Kaiser Normalization.  
a. Rotation converged in 5 iterations. 
-- Factor loadings > 0.50 are highlighted (bolded). 
 
 
 254 
 
8.7  Discussion 
Developing a valid and reliable headache questionnaire may have major impact on headache 
research [411]. Although survey instruments or self-administrated questionnaires will never 
replace clinical assessments, they could be an alternative approach to the face-to-face 
interview for studies with a large number of subjects [411] and provide supplementary 
information to clinical inquiry. More importantly, using questionnaire eliminated interviewer 
bias so as to ensure standarlisation of the measurement, as all participants follow the same 
procedure and asked the same questions [574].  
 
CMHQ is a symptom-based data collection tool which provides parameters of clinical data to 
researchers and practitioners objectively. Reliability is especially important if the measure is 
to be used in clinical observation, and the CHMQ-3 appeared to be excellent in terms of the 
internal consistency of symptoms and signs, which calculated by Cronbach‟s alpha. The 
stability, which measured by test-retest, has showed a high score reflected a high 
correlation and good agreement on both occasions. In testing for construct validity, 
exploratory analytic results revealed the latent structure of CMHQ-3 represent an overall 
headache status and the labelled three components reflected the key diagnostic 
requirement of the CM diagnosis process. 
 
In the present study, by using a valid questionnaire equipped with scaling questions, 
subjectivity of clinical inquiry can be quantified into patient-reported measures by degrees. 
Based on the information collected, the process of clustering using computer software may 
generate objective information for making diagnosis rather than relying on human 
impression.   
 
 
8.8  Chapter summary  
Majority of the 160 TTH participants were Chinese Asian female between age of 20 and 39, 
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and their average was 38. More than two thirds of them experienced fatigue and neck 
stiffness. The commonest aggravating factors were overwork, stress, and mental strain; 
whereas sleeping and rest were the commonest relieving factors. 
 
At this stage, CMHQ-3 was found to be reliable and valid due to its high test-retest reliability, 
high internal consistency, and adequate construct validity. It is suitable to be used for the 
assessment of TTH symptomatic features and could be administrated for the identification of 
CM patterns. 
 
Please refer to Chapter 9, Section 9.8 for discussion of survey results and methodological 
issues for TTH pattern identification.  
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CHAPTER 9  The full-scale survey: Part 2. CM pattern 
identification 
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9.1  Introduction 
In last chapter (Chapter 8), the CMHQ-3 was found to be reliable and valid in terms of its 
content and structure. As mentioned in Literatures Review (Chapter 2), consensus on CM 
pattern identification of TTH to guide the clinical practice or research does not exist. 
Furthermore, the existing CM patterns proposed for TTH are experience-based, and vary 
from paper to paper. Two of the primary aims of this research were to use multivariate 
statistical methods, i.e., cluster analysis and factor analysis, to analyse data obtained from 
CMHQ-3 so as to explore the TTH CM patterns; and to utilise established instruments in 
exploring the differences in and correlations of various outcome measures among the 
identified subtypes of TTH. For example, MIDAS [312] was employed to evaluate the 
severity of disability associated with TTH. PSS [515] was applied to assess self-perceived 
stress among participants, and a comorbidity checklist was added to gather health 
conditions of the participants. Obtaining such information may further help understand the 
profiles of potential subgroups of TTH.  
 
In this chapter (Chapter 9), the results of TTH pattern identification (Part D), comparisons 
of TTH subtypes and demographic data among the clusters (Part E), comparisons of 
comorbidity, disability and perceived stress among the clusters (Part F), and other 
comparisons related to TTH subtypes such as demographic data, MIDAS data, and PSS data 
(Part G) are presented.  
 
The discussion of this chapter focuses on CM patterns of TTH and their differences in various 
dimensions. Methodological issues associated with pattern identification will be discussed in 
the final chapter (Chapter 10).  
 
 
9.2  Specific objectives 
The specific objectives of this part of the research were: 
 258 
 
 
1).  to explore clusters for CM pattern identification of TTH; and, 
2).  to explore if identified CM patterns differed in headache features and other parameters 
such as self-perceived level of stress assessed with PSS, severity of headache-related 
disability assessed with MIDAS and number of comorbidities. 
 
 
9.3  Methods 
9.3.1  Inclusion of other measurements 
As outlined in the method chapter (Chapter 5), MIDAS [514] (Appendix 11, and Appendix 
12), PSS [518] (Appendix 13, and Appendix 14) and a modified comorbidity checklist based 
on CIRS [522] and WMH-CIDI [523](Appendix 15) were included in this survey to evaluate 
TTH in a multidimensional manner. 
 
9.3.2  Data analysis and data mining 
9.3.2.1  Classification of TTH subtypes 
In WM, subtypes of TTH refer to episodic and chronic TTH, and are classified according to 
IHS criterion outlined in ICHD-II, which is number of days on headache per month. 
 
9.3.2.2  Exploration of clusters to enable TTH CM pattern identification 
Cluster is the terminology of cluster analysis indicating the outcome of clustering. In the 
present study, cluster analysis was used to identify TTH CM patterns. In order to obtain 
effective clusters and identify meaningful CM patterns for TTH, factor analysis and cluster 
analysis were applied conjunctively. Factor analysis (using PCA) was firstly used to 
condense diagnostic information obtained from CMHQ-3 items. Such reduction of CMHQ 
items provided convenience for the exploration of clusters. The TwoStep cluster analysis 
was then used for grouping these identified factors into clusters for further evaluation. 
Evaluators consisting of experienced practitioners and experts then discussed each cluster 
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and reached consensus on a CM pattern The process of evaluation and interpretation of data 
extracted from both factor and cluster analyses is described in Section 9.3.3 of this chapter. 
 
9.3.2.3  Comparison of clusters and subtypes of TTH 
ANOVA was used to assess the cluster difference (i.e., the CM patterns) and TTH subtypes 
in MIDAS and PSS. Chi-Square tests were used to examine the difference in categorical 
outcomes, such as disability level (MIDAS level), comorbidity checklist, gender, age range, 
marital status, education level and ethnicity (Appendix 42, and Appendix 43). 
 
9.3.3  Evaluation and interpretation of data for pattern identification 
Figure 28 illustrates the four sequential steps of exploration of TTH patterns. The first step 
was to reduce the items of CMHQ into a smaller datasets using factor analysis; the second 
step was to assess the factors extracted and labelling those factors in a clinical meaningful 
manner; the third step was to group (clinical meaningful) factors into clusters using cluster 
analysis; the final step was the identification of TTH patterns, that is to label the clusters 
into clinically meaningful CM patterns. 
 
Internal group discussion and CM experts‟ opinion were employed in the 2nd and 3 rd steps to 
ensure that the labels assigned to factors and clusters were of clinical relevance and 
significance. Only the labels reached 70% agreement among 16 evaluators were retained. 
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Figure 28. Process of CM pattern identification 
 
 
9.4  Results – Part D: TTH pattern identification 
9.4.1  Reduction of CMHQ items 
The CMHQ had a relative large number of 193 items. For item reduction, PCA was used to 
extract factors from CMHQ Part 1, Section 1 to Part 3, Section 3, which were the major 
sections related to CM diagnosis of CMHQ. In SPSS, each section of CMHQ data was subject 
to factor analysis. There were 6 sections in Part 1, 2 sections in Part 2, and 3 sections in Part 
3. The analysis was computed on each of section separately by following the factor analysis 
process (listed in Section 5.9.8, Chapter 5). Reduction of items of each section of CMHQ was 
majorly relied on the process of factor extraction and factor rotation. The principles of the 
factor extraction were based on the eigenvalue of 1 criterion and the factor being clinically 
meaningful. 
 
The reduction process resulted in 60 factors, i.e., 19 of them were from CHMQ Part 1, 13 
from Part 2, and 28 from Part 3. Details of these factors are in Tables 57, 58, and 59. For 
instance, in Section 1 of Part 1, three factors were identified in section 1.1 about the 
location of headache. Three factors could be considered as describing the location of 
headache in the sagital plane, in the cornal plane or with no fixed location.  
Reduction of CMHQ items 
Evaluation and labeling of 
factors 
 
Grouping factors into 
clusters 
 
Interpretation of clusters and determination of CM patterns 
 
Step 1 
Step 3 
Step 2 
Step 4 
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A detailed structure and components of CMHQ item reduction procedure is shown in 
Appendices 44 to 53.  
 
Table 57. CMHQ-3 part 1 factor extraction 
 
Part 1 Factors 
(FAC) 
extracted 
Items (loadings after rotation) 
Section 1.1 
(Location 1)  
FAC1.1F1  Forehead (0.755) 
 Back of the head (0.731) 
 Top of the head; (0.673) 
FAC1.1F2  Whole head (0.718) 
 No particular location (0.915) 
FAC1.1F3  Left side of the head(0.830) 
 Right side of the head (0.814) 
Section 1.2 
(Location 2) 
FAC1.2F1  Neck (0.937) 
 Shoulders (0.928) 
FAC1.2F2  Eyebrow (0.723) 
 Eyes (0.610) 
 Cheeks (0.759) 
Section 1.3  
(Quality)  
FAC1.3F1  Throbbing (0.789) 
 Pulsating (0.674) 
 Pounding (0.744) 
FAC1.3F2  Explosive (0.734) 
 Dull (-0.584) 
FAC1.3F3  Sharp (0.577) 
 Piercing (0.800) 
FAC1.3F4  Tight (0.636) 
 A “band-like” sensation around the head (0.803) 
FAC1.3F5  Pressing (0.555) 
 Burning (0.746) 
 Radiating (0.640) 
FAC1.3F6  Cutting (0.804) 
 Heavy (0.627) 
FAC1.3F7  Pulling (0.768) 
 Distending (-0.570) 
FAC1.3F8  Empty (0.882) 
Section 1.4 
(Spatial- 
Temperate  
factor)  
FAC1.4F1  Fixed location (0.855) 
 Continuous (0.828) 
FAC1.4F2  Moves around the head (0.967) 
FAC1.4F3  Intermittent (0.975) 
Section 1.6  
(Time of the 
day)  
FAC1.6F1  Worse in the afternoon (0.774) 
 Worse at the end of the day (0.706) 
 No particular time (-0.765) 
FAC1.6F2  Worse in the morning (0.811) 
 Worse at night (0.627) 
FAC1.6F3  All day (0.984) 
Total extracted factors: n=19 
-- Labelling the extracted factors was in line with the SPSS datasheet and the outputs. 
-- In this table, “FAC” is the abbreviation of “factor”, whereas the numbers 1.X after it indicate their 
section number. For instance, FAC1.6F1 denotes the extracted first factor of Section 1.6, which 
summarised items of Forehead, Back of the head, and Top of the head.  
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Table 58. CMHQ-3 part 2 factor extraction 
 
Part 2 Factors 
(FAC) 
extracted 
Items (loadings after rotation) 
Section 2.1 
(Aggravaiting 
factors)  
 
FAC2.1F1  Stress (0.742) 
 Nervousness (0.808) 
 Anger or irritability (0.828) 
 Anxiety (excessive worry) (0.808) 
 Depression (0.682) 
 Tension or conflict related factors (0.796) 
FAC2.1F2  Coffee (0.595) 
 Chocolate (0.564) 
 Soft drink or sodas (0.585) 
 Tea (0.604) 
 Dairy foods (0.792) 
 Sugar or too much sugar (0.794) 
FAC2.1F3  Change of weather (0.827) 
 Change in temperature (0.838) 
 Hot weather (0.607) 
 Cold weather (0.620). 
FAC2.1F4  Dehydration (0.771) 
 Hunger or being hungry (0.758) 
 Chocolate (0.511) 
FAC2.1F5  Overwork (0.816) 
 When tired (0.688) 
 Mental strain (0.689) 
FAC2.1F6  Muscular strain (muscle tightness) (0.719) 
 Poor posture in sitting, standing or sleeping (0.769) 
 Teeth grinding (0.507) 
FAC2.1F7  Spicy food (0.698) 
 Over consumption of oily food (0.703) 
 Irregular diet (0.695) 
FAC2.1F8  Windy days (0.552) 
 Damp or humid weather (0.592) 
 Rainy days (0.782) 
FAC2.1F9  Physical labour (0.723)  
 Lack of sleep (0.607) 
FAC2.1F10  Alcohol (0.606) 
 Cigarette smoking (0.793) 
Section 2.2 
(Relieving 
factors)  
FAC2.2F1  Rest (0.872) 
 Lying-down (0.900) 
 Sleeping (0.799) 
FAC2.2F2  Exercise or light exercise (0.692) 
 Massage (0.736) 
 Pressing or pressure on the pain area (0.681) 
 Warmth (0.602) 
 Coldness (0.567) 
FAC2.2F3 
 
 Medication (0.772) 
 Eating (0.655) 
Total extracted factors: n=13 
-- Labelling the extracted factors was in line with the SPSS datasheet and the outputs. 
-- In this table, “FAC” is the abbreviation of “factor”, whereas the numbers 2.X after it indicate their 
section number. For instance, FAC2.2F3 denotes the extracted third factor of Section 2.2, which 
summarised items of Medication and Eating.   
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Table 59. CMHQ-3 part 3 factor extraction 
 
Part 3 Factors 
(FAC) 
extracted 
Items  
(loadings after rotation) 
Section 3.1 
(Accompanying 
symptoms)  
FAC3.1F1  Feeling depressed (0.673) 
 Irritability or irascibility (0.700) 
 Restlessness (0.798) 
 Fatigue or tiredness (0.566) 
 Heavy sensation in the body (0.510) 
 Sighing often (0.584) 
 Shortness of breath (0.509) 
 Inability to concentrate (0.562). 
FAC3.1F2  Dry eyes (0.573) 
 Teary eyes (0.675) 
 Blurred vision (0.654) 
 Sore eyes (0.636) 
 Red eyes (0.679) 
 Swollen eyelids (0.548) 
FAC3.1F3  Joint stiffness (0.750) 
 Neck stiffness (0.694) 
 Muscle twitching (0.704) 
 Feeling weak in the lower back (0.506) 
 Feeling cold in the lower back (0.509) 
FAC3.1F4  Belching (0.727) 
 Bloating or flatulence (0.748) 
 Indigestion (0.748) 
FAC3.1F5  Dry mouth (0.855) 
 Thirst (0.744) 
 Bitter taste in the mouth (0.745) 
FAC3.1F6  Frequent urination (0.697) 
 Night sweating (0.545) 
 Sweating upon mild activity (0.724) 
FAC3.1F7  Nausea (0.704) 
 Vomiting (0.863) 
 Reflux (0.517) 
FAC3.1F8  Runny nose (0.605) 
 Sore throat (0.723) 
 Ear discharge (0.546) 
 Excessive phlegm (0.537) 
FAC3.1F9  Sensitivity to light (or to bright lights) (0.679) 
 Sensitivity to sound (0.718) 
FAC3.1F10  Aversion to hot or fear of being hot (0.735) 
 Sensitive to temperature changes (.0661) 
FAC3.1F11  Dry stools (0.788)  
 Constipation (0.793) 
FAC3.1F12  “Pins and needles” or numbness in the hands and / or 
feet (0.676) 
 Faintness (0.614) 
 Dizziness (0.608) 
FAC3.1F13  Cold hands and feet / cold limbs (0.724) 
 Aversion to cold or fear of being cold (0.731) 
FAC3.1F14  Watery bowel motion (0.813)  
 Loose bowel motion (0.743) 
FAC3.1F15  Floaters in the eyes (0.776) 
FAC3.1F16  Tinnitus (ringing in the ears) (0.724) 
FAC3.1F17  Dry eyes (0.528)  
 Insomnia (0.540) 
Section 3.2 
(Other pains)  
FAC3.2F1  Neck (0.743) 
 Shoulder (0.792) 
 Lower back (0.584) 
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FAC3.2F2  Arms (0.700)  
 legs (0.778) 
FAC3.2F3  Jaw (0.650) 
 Ears (0.589) 
 Heel (0.639) 
FAC3.2F4  Flank (side of the body) (0.664) 
 Hypochondria (lower abdomen) (0.744) 
FAC3.2F5  Breasts (0.766) 
 Abdomen (0.665) 
FAC3.2F6  Eyes (0.805) 
Section 3.3 
(female 
items) 
FAC3.3F1  Bleeding with clots (0.638) 
 Dark coloured menstrual blood (0.521) 
 Abdominal pain before periods (0.782) 
 Abdominal pain during periods (0.735) 
FAC3.3F2  Excessive bleeding (0.675) 
 Light red coloured menstrual blood (0.629) 
 Excessive watery discharge (0.805) 
 Yellow discharge (0.763) 
FAC3.3F3  Abdominal pain after periods (0.801) 
 Lower back pain before periods (0.660) 
 Lower back pain during periods (0.662) 
 Lower back pain after periods (0.870) 
FAC3.3F4  Early periods(0.548) 
 Headache before period (0.624) 
 Headache during period (0.791) 
 Headache after periods (0.699) 
FAC3.3F5  Irregular period cycle (0.753) 
 Delayed periods (0.810) 
 Light bleeding (0.591) 
Total extracted factors: n=28 
-- Labelling the extracted factors was in line with the SPSS datasheet and the outputs. 
-- In this table, “FAC” is the abbreviation of “factor”, whereas the numbers 3.X after it indicate their 
section number. For instance, FAC3.2F2 denotes the extracted second factor of Section 3.2, which 
summarised items of Excessive bleeding, Light red coloured menstrual blood, Excessive watery 
discharge, and Yellow discharge. 
 
9.4.2  Evaluation and naming of factors 
Meaningful dimensionality of the data is important for cluster analysis. The evaluations of 
extracted factors therefore should meet the agreements on their being clinically meaningful 
as judged by the evaluators. 
 
Prior to the TwoStep clustering, the 60 extracted factors (Table 60) of clinical relevance 
were firstly discussed among internal members and then consulted with external experts. 
Based on CM theory, only 41 clinical meaningful factors, including 12 factors from CMHQ 
part 1, 13 from part 2, and 16 from part 3, were labelled and retained for TTH pattern 
identification.  
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Table 60. Extraction of factors 
 
CMHQ PART1  
Pain description 
CMHQ PART2  
Aggravating & relieving 
factors 
CMHQ PART3  
Accompanying symptoms 
FAC1.1F1CentralHead FAC 2.1F1Mental FAC 3.1F1LiverQi&Fire 
FAC 1.1F2WholeHead FAC 2.1F2Food FAC 3.1F2Eye 
FAC 1.1F3LateralHead FAC 2.1F3WeatherChange FAC 3.1F3BoneJointWind 
FAC 1.3F1RhythmHeadache FAC 2.1F4NoFood&Drink FAC 3.1F4PoorDigestion 
FAC 1.3F2ExplosiveNotDull FAC 2.1F5MentalStrain FAC 3.1F5LiverSpleenFire 
FAC 1.3F3SharpHeadache FAC 2.1F6MuscularStrain FAC 3.1F6YinDeficiency 
FAC 1.3F4TightHeadache FAC 2.1F7Oil&Spicy FAC 3.1F7LiverAttackStomach 
FAC 1.3F7DistendingHeadache FAC 2.1F8WindDamp FAC 3.1F8ENT 
FAC 1.3F8EmptyHeadache FAC 2.1F9PhysicalStrain FAC 3.1F9LightSound 
FAC 1.5F1LateOfDay FAC 2.1F10Alcohol-DragCigar FAC 3.1F10TemperatureSensitivity 
FAC 1.5F2BothEnd FAC 2.2F1Rest FAC 3.1F11Constipation 
FAC 1.5F3AllDay FAC 2.2F2PhysicalStimulation FAC 3.1F12BloodDeficiency 
 FAC 2.2F3EatingRelated FAC 3.1F13YangDeficiency 
  FAC 3.1F14SpleenDeficienyOfBowel 
  FAC 3.1F16Tinnitus 
  FAC 3.1F17Insomnia 
Included: n=12 Included: n=13 Included: n=16 
 
9.4.3  Grouping the factors and exploring TTH patterns 
In the third step, the TwoStep cluster analysis was used to analyse the 41 retained factors 
to explore TTH patterns. Four distinct cluster groups were identified with nearly one quarter 
of TTH participants in each cluster (Figure 29).  
 
 
Figure 29. Cluster analysis results 
 
n=46  
(27%) 
n=34 
(20%) 
n=46 
(27%) 
n=44 
(26%) 
Cluster Sizes 
(n=170) 
Cluster 1
Cluster 2
Cluster 3
Cluster 4
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The results of TwoStep analysis including the mean scores of each factor were presented in 
Appendix 54. 
 
9.4.4  Naming of clusters and interpretation TTH patterns  
The last step of TTH pattern exploration was to name and interpret the identified clusters. 
In TwoStep cluster analyses, the mean scores reflected as within-cluster weightings. As 
some of the factors may be shared across the different clusters, the mean scores thus were 
used to discriminate one cluster from another quantitatively. However, in determining and 
interpreting the TwoStep cluster analysis results, the current literatures does not provide 
clear guiding rules for the cut-off mean score. Hence, interpretations of clusters have to rely 
on the theoretical framework and clinical knowledge.  
 
Similar to labelling factors, labelling clusters is a subjective process. In the present study, to 
ensure each cluster was clinically relevant, external experts‟ opinions were consulted. 
Expert‟s opinions and agreements were applied to determine the cut-off mean score among 
clusters. Experts were asked to evaluate the symptoms from the point of clinical practice. 
Consequently the following guide was developed to determine and interpret clusters. For 
those clusters with a large number of symptoms and signs decomposed from factors, a 
cut-off mean score of positive 0.4 for each factor was applied for the interpretation and 
labelling of clusters; for those clusters involved few number of symptoms and signs 
decomposed from factors, interpretation and naming of clusters were based on all 
symptoms. This method has been used in other studies exploring CM patterns [94, 575, 
576].  
 
Table 61 reports the results of the TwoStep cluster analyses. Computed from the TwoStep 
cluster algorithm, mean scores of extracted factors that exceeded value 0.4 are listed for 
Clusters 1, 2, and 3. The cut-off of 0.4 was determined as those clusters being considered 
to be clinically relevant. 
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Table 61. Results of the cluster analysis 
 
Clusters  Factors (mean in SD)  
CMHQ Part 1 factors CMHQ Part 2 factors CMHQ Part 3 factors 
Cluster 1 -  
Ascendant 
hyperactivity of Liver 
yang 
 1.3F4TightHeadache 
(0.68) 
 1.3F1RhythmHeadache 
(0.53) 
 1.1F1CentralHead (0.51) 
 2.1F4NoFood&Drink (0.69) 
 2.1F6MuscularStrain 
(0.42) 
 3.1F9LightSound (0.61) 
Cluster 2 -  
Dual Qi and Blood 
deficiency 
 1.6F2BothEnd (0.72) 
 1.1F3LateralHead (0.66) 
 1.6F3AllDay (0.65) 
 1.3F1RhythmHeadache 
(0.56) 
 1.1F1CentralHead (0.51) 
 2.2F2PhysicalStimulation 
(0.65) 
 2.1F3WeatherChange(0.5
5) 
 2.2F3EatingRelated (0.44) 
 2.1F4NoFood&Drink (0.42) 
 3.1F14SpleenDeficienyOfB
owel (0.71) 
 3.1F12BloodDeficiency 
(0.49) 
 
Cluster 3 -  
Liver depression 
forming fire 
 1.1F2WholeHead (0.66) 
 
 2.1F1Mental (0.42) 
 
 
 3.1F5LiverStomachFire 
(0.51) 
Cluster 4 -  
Nonspecific cluster 
 1.3F2ExplosiveNotDull 
(0.29) 
 1.3F3SharpHeadache 
(0.04) 
 2.1F8WindDamp (0.08) 
 
 3.1F4PoorDigestion (0.07) 
 3.1F10TemperatureSensiti
vity (0.09) 
 3.1F11Constipation (0.04) 
 
The proposed guide was found to be operational and clusters could then be discriminated 
from each other. Based on the theory of CM and clinical characteristics of each cluster, three 
of the four clusters were able to be labelled accordingly. Assessed by internal and external 
experts, the four clusters were Ascendant hyperactivity of Liver-Yang, Dual 
deficiency of Qi and Blood, Liver depression forming Fire and a nonspecific cluster. 
The three clusters/patterns of TTH identified are common clinical presentations of TTH. The 
fourth cluster was nonspecific as there were insufficient characteristics of the symptoms 
and signs. 
 
 
9.5  Results – Part E: Cluster comparisons of TTH subtypes and 
demographic data 
9.5.1  TTH clusters and TTH subtypes  
Indicated by the Chi-Square test results, a statistically significant cluster difference was 
found on subtypes of TTH (Table 62). Over three quarters of participants in Clusters 1 and 
2 had frequent ETTH and about one fifth had CTTH, whereas one third in Cluster 3 had CTTH, 
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and half had frequent ETTH. All three clusters had very few participants with infrequent 
ETTH, whereas one third of Cluster 4 was with infrequent ETTH (< 1 day). 
 
Table 62. Comparisons of TTH groups and subtypes (Chi-Square Tests) 
 
TTH 
cluster 
 
TTH subtypes  n (%)  
N  
(total) 
Chi-Square 
Infrequent 
ETTH 
(headache 
≤1d)  
 
Frequent 
ETTH 
(headache 
> 1d 
≤14d)  
CTTH 
(headache 
≥15d) 
 
Value df 
Asymp.Sig
(2-sided) 
1 1(2%) 36(78%) 9(20%) 46 
29.299a 6 .000* 
2 1(3%) 26(76%) 7(21%) 34 
3 7(15%) 23(50%) 16(35%) 46 
4 15(34%) 22(50%) 7(16%) 44 
Total 24(14%) 107(63%) 39(23%) 170 
*. The mean difference is significant at the 0.0125 level. 
 
9.5.2  TTH clusters and demographic data 
ANOVA results indicated a statistically significant difference in age (Table 63). Post-hoc 
t-tests with Bonferroni correction was use to compare group means (Appendix 55). 
Participants in Cluster 1 were older than those in Clusters 3 and 4; whereas those in Cluster 
2 were older than those in Cluster 4 (Appendix 56). 
 
Table 63. Comparisons of demographic data (ANOVA) 
 
Age 
TTH 
cluster 
N Mean 
Std. 
Deviation 
ANOVA 
F df Sig 
1v.34 44 45.23 12.445 
10.759 3,139 0.000* 
2 v.4 33 38.70 10.987 
3 v.1 37 36.84 11.999 
4 v.12 29 30.07 8.8848 
Total 143 38.48 12.462 
*. The mean difference is significant at the 0.05 level. 
“v.” denotes the cluster being different from other specified cluster or clusters, whereas the “x(figure)” after “v.” 
indicates specific cluster or clusters. 
 
Other demographic information such as gender, marriage status, and education level and 
ethnicity distribution of participants were analysed using Chi-Square tests (Table 64). Due 
to multiple comparison, the P-value was divided by 4 (number of comparisons), the 
statistically significant level was set at 0.0125. Statistically significant cluster differences 
were found in ethnicity distribution, whereas no group differences were detected in 
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marriage status or education levels. Over three quarters of participants in Clusters 3 and 4 
were of Asian origin, but over three quarters of those in Clusters 1 and 2 were of Oceania 
and European origin. 
 
Table 64. Comparisons of demographic data (Chi-Square Tests) 
 
 
TTH 
cluster 
 
Gender  
N  
(total) 
Chi-Square 
Female Male Value df Asymp.Sig 
(2-sided) 
Gender 
1 35 11 46 
3.608 3 .307 
2 27 7 34 
3 30 16 46 
4 28 16 44 
Total 120 50 170 
Age 
range 
TTH 
cluster 
 
Age range  
N  
(total) 
Chi-Square 
20-2
9 
30-39 40-4
9 
50-59 60+ Value df Asymp.Sig 
(2-sided) 
1 6 10 10 14 5 45 
33.213 12 .001* 
2 8 12 8 4 2 34 
3 17 10 6 8 2 43 
4 24 12 7 0 1 44 
Total 55 44 31 26 10 166 
Marriage 
TTH 
cluster 
 
Marriage status  
N  
(total) 
Chi-Square 
Single Marri
ed 
Partner
ed 
Divor
ced 
Separat
ed 
Value df Asymp.Sig 
(2-sided) 
1 13 22 3 6 0 45 
21.250 12 .047 
2 10 15 4 4 1 34 
3 16 25 0 1 0 42 
4 25 14 2 2 1 44 
Total 64 77 9 13 2 165 
Education 
TTH 
cluster 
 
 
 
Education level  
N  
(total) 
Chi-Square 
Post
grad
uate  
Gra
dua
te 
Bac
helo
r 
Dipl
oma  
TAF
E  
Sec
ond
ary 
Edu 
Prim
ary 
Edu  
Value df Asymp.Sig 
(2-sided) 
1 13 3 17 4 4 4 0 45 
8.607 18 .968 
2 8 2 14 5 1 4 0 34 
3 8 1 21 3 3 4 1 41 
4 11 2 20 6 2 2 1 44 
Total 40 8 72 19 10 14 2 164 
Ethnicity 
TTH 
cluster 
 
Ethnicity  
N  
(total) 
Chi-Square 
Oceania Europe
an 
Arab Asian had > 1 
ethnicity Value df 
Asymp.Sig 
(2-sided) 
1 19 14 0 7 5 45 
87.308 12 .000* 
2 18 7 0 5 3 33 
3 4 2 1 35 0 42 
4 4 2 0 38 0 44 
Total 45 25 1 85 8 164 
*. The mean difference is significant at the 0.0125 level. 
Note: Australia is a county of immigraintion. In section of ethenicity, the categlory of “had more than 1 ethenicity” 
indicated a group of participants in this coutry share more than one ethenicity. For example, an Australian 
person may have his/her mother of Irish ethenicity and father of Greek. In such case, thess participants may 
tick two options and in data analysis, he/she was classified as participant had more than one ethenicity. 
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9.6  Results – Part F: Cluster comparisons in comorbidity, disability 
and perceived stress  
9.6.1  Frequency of comorbidity checklist of all participants  
All participants had low frequency of comorbidity. Of the somatic comorbidity, the body 
systems of upper gastrointestinal and phthalmological & otorhinolaryngology had a higher 
response (9.4% and 8.8% respectively) than others. In regard to the mental comorbidity, 
Anxiety disorders and mood disorders were reported by 12 participants each (7.1%) (Table 
65). 
 
Table 65. Summary of comorbidity checklist results 
 
Item Missing 
(n) 
Frequency 
(n) 
Percent 
(%) 
CIRS checklist 
1 Cardiac 0 6  3.5 
2 Vascular 0 11  6.5 
3 Ematological 0 2  1.2 
4 Respiratory 0 13  7.6 
5 Phthalmological & 
otorhinolaryngology 
0 
15  8.8 
6 Upper gastrointestinal 0 16  9.4 
7 Lower gastrointestinal 0 4  2.4 
8 Hepatic & pancreatic 0 3  1.8 
9 Renal 0 3  1.8 
10 Genito-urinary 0 3  1.8 
11 Musculo-skeletal-integumentary 0 13  7.6 
12 Neurological 0 4  2.4 
13 Endocrine-metabolic 0 6  3.5 
14 Psychiatric 0 13  7.6 
15 Female hormonal & reproductive 0 10  5.9 
Mental comorbidity checklist 
1 Anxiety disorders 0 12  7.1 
2 Mood disorders 0 12  7.1 
3 Substance use disorders 0 2  1.2 
 
9.6.2  TTH clusters and comorbidity  
Comorbidities of TTH participants were calculated by counting total number of somatic 
comorbidity and mental comorbidity separately. Indicated by the Chi-Square test results, 
there were no significant differences in somatic comorbidity among the identified four TTH 
clusters (Table 66). Although there was no statistically significant difference in mental 
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comorbidity among clusters, cluster 4 participants suffered no mental comorbidity at all 
(Table 67). 
 
Table 66. Comorbidity checklist: somatic comorbidity 
 
 
TTH 
cluster 
 
4.1 somatic comorbidity  
(number of  items) 
Total Chi-Square 
0 1 2 3 4 5 6 Frequency Percent 
Value df 
Asymp. 
Sig(2-sided) 
1 26 9 8 2 1 0 0 46 43.40% 13.181 15 .588 
2 15 11 5 3 0 0 0 34 55.90% 
3 27 9 5 3 1 0 1 46 41.30% 
4 29 12 2 1 0 0 0 44 34.10% 
Total  97 41 20 9 2 0 1 170 42.90% 
 
Table 67. Comorbidity checklist: mental comorbidity 
 
 
TTH 
cluster 
4.2 mental comorbidity 
(number of  items) 
Total Chi-Square  
0 1 2 3 frequency percent 
Value df 
Asymp. 
Sig(2-sided) 
1 38 7 1 0 8 17.40% 16.325 9 .060 
2 25 7 1 1 9 26.50% 
3 41 5 0 0 5 10.90% 
4 44 0 0 0 0 0.00% 
Total  148 19 2 1 22 12.90% 
 
9.6.3  MIDAS results of all participants  
Disability level was classified based on the MIDAS scores. The disability level ranged from 
level 1 to level 4. The mean MIDAS score of the current sample was 22.64 lost days, at a 
severe disability level (≥21 lost days due to headache over the last three months) (Table 
68). 
 
Table 68. Summary of MIDAS results 
 
Item Missing 
(n) 
Minimum Maximum Mean Std. 
Deviation  
Q1 On how many days in the last 3 months 
did you miss work or school because of 
your headaches? 
6 0 66 2.51 7.771 
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Q2 How many days in the last 3 months 
was your productivity at work or school 
reduced by half or more because of 
your headaches?  
6 0 90 7.43 12.131 
Q3 On how many days in the last 3 months 
did you not do household work because 
of your headaches? 
6 0 50 4.35 7.686 
Q4 How many days in the last 3 months 
was your productivity in household 
work reduced by half or more because 
of your headaches? 
6 0 50 5.19 8.312 
Q5 On how many days in the last 3 months 
did you miss family, social or leisure 
activities because of your headaches? 
6 0 90 3.17 7.817 
A On how many days in the last 3 months 
did you have a headache? 
6 0 100 20.49 23.595 
B 
 
On a scale of 0–10, on average how 
painful were these headaches? 
6 0 10 5.41 2.204 
 
 
 
MIDAS score(total ofQ1-Q5) 
 
6 0 240 22.64 31.757 
 
Disability level 
 
Level 4 (severe disability) 
 
9.6.4  TTH clusters and MIDAS scores 
One-way ANOVA results (Table 69) indicated no cluster differences in the overall MIDAS 
scores. However there were significant cluster group differences in MIDAS items 4 (days 
reduced in household work) and MIDAS B (degree of headache intensity). Post-hoc t-tests 
with Bonferroni correction found clusters 2 and 4 were statistically different, as Cluster 2 
having a higher non-productive days at home (8.2 days) due to headache and more severe 
headache (6.3) than cluster 4 (mean: 3 days, mean intensity: 4.7) (Appendix 57). 
 
Table 69. Analysis of variance data for MIDAS 
 
MIDAS 
Item 
TTH 
cluster 
N Mean 
Std. 
Deviation 
Minimum Maximum 
ANOVA 
F df Sig. 
Sum of 
MIDAS 
scores 
1 44 18.59 23.689 0 144 1.205 
 
3,160 .310 
2 33 31.18 33.478 1 141 
3 43 23.56 27.037 0 130 
4 44 19.39 40.362 0 240 
Total 164 22.64 31.757 0 240 
MIDAS 
Q1 
1 44 1.07 2.491 0 15 .970 
 
3,160 .408 
2 33 2.30 3.331 0 15 
3 43 2.74 6.048 0 30 
4 44 3.86 13.215 0 66 
Total 164 2.51 7.771 0 66 
MIDAS 
Q2 
1 44 5.34 7.061 0 33 1.758 3,160 .157 
2 33 9.67 14.916 0 80 
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3 43 9.81 15.426 0 90  
4 44 5.50 9.600 0 50 
Total 164 7.43 12.131 0 90 
MIDAS 
Q3 
1 44 3.95 6.577 0 40 1.531 
 
3,160 .209 
2 33 6.82 8.480 0 40 
3 43 4.00 6.939 0 40 
4 44 3.23 8.597 0 50 
Total 164 4.35 7.686 0 50 
MIDAS 
Q4 
1 44 6.05 7.205 0 40 2.877 
 
3,160 .038* 
2 v.4 33 8.15 10.038 0 40 
3 43 4.35 7.761 0 40 
4 v.2 44 2.93 7.922 0 50 
Total 164 5.19 8.312 0 50 
MIDAS 
Q5 
1 44 2.18 2.998 0 16 .616 
 
3,160 .606 
2 33 4.24 5.500 0 20 
3 43 2.65 3.484 0 10 
4 44 3.86 13.624 0 90 
Total 164 3.17 7.817 0 90 
MIDAS A 1 44 20.45 17.632 0 70 1.352 
 
3,160 .259 
2 33 26.73 27.636 2 92 
3 43 20.53 25.018 0 100 
4 44 15.82 23.824 0 90 
Total 164 20.49 23.595 0 100 
MIDAS B 1 44 5.45 1.771 3 10 3.576 
 
3,160 .015* 
2 v.4 33 6.30 2.158 2 10 
3 43 5.42 2.061 0 9 
4 v.2 44 4.68 2.550 0 10 
Total 164 5.41 2.204 0 10 
“*”indicate significant cluster difference; significant level is at the 0.05 level. 
“v” means the two clusters differed with post-hoc Bonferroni correction, whereas the “x(figure)” after “v.” indicates 
specific cluster or clusters. 
 
9.6.5  TTH clusters and level of disability  
Indicated by the Chi-Square test results, there was a statistically significant cluster 
difference in the disability level (P=0.017) (Table 70). This is largely due to that about 50% 
the participants in Clusters 2 and 3 had a higher level of disability (levels 3 and 4) whereas 
50% of Cluster 4 had the lowest level of disability (level 1).   
 
Table 70. Comparisons of TTH clusters and disability level (Chi-Square Tests) 
 
 
 
 
 
 
 
 
Disability 
level  
(by 
summing 
of MIDAS 
TTH 
cluster 
 
MIDAS disability level  
n(%) 
 
N 
(total) 
Chi-Square 
Level 1 Level 2 Level 3 Level 4 
Value df 
Asymp.Sig 
(2-sided) 
1 12 
(27%) 
5 
(11%) 
14 
(32%) 
13 
(30%) 
44 20.231 9 .017* 
2 3 
(1%) 
7 
(21%) 
8 
(24%) 
15 
(45%) 
33 
3 14 
(33%) 
3 
(7%) 
8 
(19%) 
18 
(42%) 
43 
4 22 4 7 11 44 
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scores) (50%) (9%) (16%) (25%) 
Total 51 19 37 57 164 
*. The mean difference is significant at the 0.05 level. 
 
9.6.6  PSS results of all participants  
The PSS scores were calculated by summing each item, an average score of 16.72 was 
found (Table 71). A mean score of PSS-10 around 13 is considered to be the average of 
2387 healthy respondents in the United States [517, 577], with the normative data ranging 
from 12.1 to 14.7. Comparing with the norm, the existing sample had a relatively higher 
perceived stress than normal people. Although PSS does not have a cut-point to quantify 
the level of stress, it has been suggested that a score around 20 or higher is considered to 
be of a high stress level. 
 
Table 71. Summary of PSS results  
 
Item Missing 
(n) 
Minim
um 
Maxim
um 
Mean Std. 
Deviation 
(S.D) 
Q1 In the last month, how often have you 
been upset because of something 
that happened unexpectedly? 
10 0 4  1.73 1.109  
Q2 In the last month, how often have you 
felt that you were unable to control 
the important things in your life? 
10 0 4  1.51 1.022  
Q3 In the last month, how often have you 
felt nervous and “stressed”? 
10 0 4  2.03 1.066  
Q4 In the last month, how often have you 
felt confident about your ability to 
handle your personal problems? 
10 0 4  1.42  0.955 
Q5 In the last month, how often have you 
felt that things were going your way? 
10 0 4  1.81 1.015  
Q6 In the last month, how often have you 
found that you could not cope with all 
the things that you had to do? 
10 0 4  1.60 1.041  
Q7 In the last month, how often have you 
been able to control irritations in your 
life? 
10 0 4  1.71  1.001 
Q8 
 
In the last month, how often have you 
felt that you were on top of things? 
10 0 4 1.86 1.027 
Q9 In the last month, how often have you 
been angered because of things that 
were outside your control? 
0 0 4  1.71 0.994  
Q10 In the last month, how often have you 
felt difficulties were piling up so high 
that you could not overcome them? 
10 0 4 1.39 1.099 
 Sum of PSS scores (PSS item 1-10) 
 
10 2 36 16.72 6.925 
Perceived Distress 0 0 22 9.39 5.420 
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(item 1, 2, 3, 6, 9, 10) 
Perceived Coping 
(item 4,5,7,8) 
0 2 16 6.35 3.579 
 
In addition, the average scores for factors of “Perceived Distress” and “Perceived Coping” 
were 9.39 and 6.35 respectively. Based on a higher PSS score correspond to a higher level 
of perceived stress, a higher score in factor of “Perceived Distress” indicates a higher degree 
of general distress. It is also necessary to aware that a lower score in “Perceived Coping” 
factor reflects better coping ability since the four positively stated items (4,5,7,8) in this 
factor are reversed scoring (e.g., 0 = 4, 1 = 3, 2 = 2, 3 = 1 and, 4 = 0) and then summing 
across all items when calculating the overall score of PSS-10. Like the PSS overall score, 
there are no cut-offs for the two factors either. However, it may be helpful in providing 
group comparisons between people in a specific sample. 
 
9.6.7  TTH clusters and PSS scores 
One-way ANOVA results indicated there was a statistically significant cluster difference 
observed on PSS items of 3, 5, 8 (Appendix 58) and “Perceived Coping” factor (Table 72). 
However, there were neither statistically significant differences among the 4 clusters of 
their overall PSS scores nor perceived distress sub-scale. Detected by the post-hoc t-tests 
with Bonferroni correction, significant differences between Cluster 1 and Clusters 3 and 4; 
Cluster 2 and Clusters 3 and 4 were found (Appendix 59). Participants in Clusters 1 and 2 
seemed to cope stress better than the other two clusters.  
 
Table 72. Mean and SD of PSS data of the three clusters and results of ANOVA 
 
Item 
TTH 
cluster 
N Mean 
Std. 
Deviation 
Minimu
m 
Maximu
m 
ANOVA 
F df Sig. 
Sum of PSS 
scores 
1 41 16.68 6.259 7 34 2.182 
 
3,156 .092 
2 32 16.19 7.744 4 32 
3 43 18.79 7.963 4 36 
4 44 15.11 5.345 2 29 
Total 160 16.72 6.925 2 36 
Perceived 
Distress 
(1,2,3,6,9,
10) 
1 46 9.85 5.249 0 20 2.441 3,166 .066 
2 34 10.06 5.888 0 21 
3 46 10.22 6.066 0 22 
4 44 7.52 4.078 0 19 
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Total 170 9.39 5.420 0 22 
Perceived 
Coping 
(4,5,7,8) 
 
 
1 v.3,4 46 5.04 3.025 0 14 6.864 3,166 .000* 
2 v.3,4 34 5.18 3.070 0 12 
3 v.1,2 46 7.35* 4.018 0 16 
4 v.1,2 44 7.59* 3.329 2 16 
Total 170 6.35 3.579 0 16 
*. The mean difference is significant at the 0.17 (0.05/3) level. 
“v.” denotes the cluster being different from other specified cluster or clusters, whereas the “x(figure)” after “v.” 
indicates specific cluster or clusters. 
 
 
9.7  Results – Part G: Other comparisons related to TTH subtypes 
9.7.1  TTH subtype comparisons of demographic data 
Unlike the result of comparison between TTH cluster and demographic data of age, there 
was no statistically significant group difference found on age with TTH subtypes (Table 73). 
 
Table 73. Comparisons of TTH subtypes with demographic data 
 
Age 
TTH subtypes 
n (mean±SD) 
ANOVA 
Infrequent ETTH 
(1) 
Frequent ETTH 
(2) 
Chronic TTH 
(3) 
Total 
n (mean±SD) 
F df Sig. 
23 
(35.43±11.731) 
105 
(37.32±12.963) 
38 
(41.82±10.828) 
166 
(38.09±12.454) 
2.465 2,163 0.088 
*. The mean difference is significant at the 0.05 level. 
 
9.7.2  TTH subtype comparisons of MIDAS data 
Overall, there were significant differences among the three TTH subtypes on all MIDAS items 
except item 5 (Table 74). Of the three TTH subtypes defined by the headache days 
(Appendix 60), the infrequent ETTH reported much lower headache intensity and disability 
when compared with frequent ETTH and CTTH sufferers. Despite reporting the similar level 
of pain intensity, CTTH participants reported twice of day loss due to TTH (MIDAS days in 
total) than those having frequent ETTH. Indicated by the Bonferroni corrected post-hoc 
analysis (Appendix 61), each subtype differed from others by their days on headache 
(MIDAS A), and Sum of MIDAS scores (total MIDAS days). 
 
Table 74. Comparisons of TTH subtypes with MIDAS data (ANOVA results) 
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 TTH subtypes   
n (mean±SD) 
ANOVA 
Infrequent 
ETTH (1) 
Frequent ETTH 
(2) 
Chronic TTH 
(3) 
Total 
n (mean±SD) 
Between Groups 
F df Sig. 
MIDAS days 
(MIDAS 
item1-5) 
23 
(3.83±6.177) 
104 
(20.95±24.007) 
37 
(39.08±48.803) 
164 
(22.64±31.757) 10.171 2,161 0.000* 
Days on 
headache 
(MIDAS A) 
23 
(1.87±1.914) 
104 
(15.16±13.019) 
37 
(47.05±31.700) 
164 
(20.49±23.595) 55.502 2,161 0.000* 
Headache 
intensity 
(MIDAS B) 
23 
(2.78±1.930) 
104 
(5.85±1.889) 
37 
(5.81±2.093) 
164 
(5.41±2.204) 24.643 2,161 0.000* 
*. The mean difference is significant at the 0.17 (0.05/3) level. 
 
In addition, there were also significant differences among the disability level calculated 
from MIDAS days (Table 75). In subtype of Infrequent ETTH, majority of participants were 
detected minor disability, whereas more than half CTTH participants were of severe 
disability. Furthermore, participants of Frequent ETTH had more precent in locating 
moderate level of disability, such as level 2 and level 3. Such trends may suggest that 
CTTH participants suffer more disability than ETTH participants, and frequent ETTH may 
have more impact on disability levels than that of Infrequent ETTH. 
 
Table 75. Comparisons of TTH subtypes with disability level (Chi-Square results) 
 
Disability 
level by 
MIDAS 
scores 
 
Level TTH subtypes 
days(percent) 
Total 
days(percent) 
Chi-Square 
Value df Sig 
1 16 (69.5%) 25 (24.0%) 10 (27.0%) 51 (31.1%) 
33.304 6 0.000* 
2 5 (21.7%) 12 (11.5%) 2 (5.4%) 19 (11.6%) 
3 1 (4.3%) 31 (29.8%) 5 (13.5%) 37 (22.6%) 
4 1 (4.3%) 36 (34.6%) 20 (54.0%) 57 (34.8%) 
Total  23 104 37 164 
*. The mean difference is significant at the 0.05 level. 
 
9.7.3  TTH subtype comparisons of PSS data 
One-way ANOVA results (Table 76, and Appendix 62) suggested there were significant 
differences among three subtypes on PSS items 3 and 9. Significant differences were 
detected by Bonferroni's post-hoc test (Appendix 63) between Infrequent ETTH and other 
two subtypes. However, there were no significant differences detected between subtypes 
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of Frequent ETTH and CTTH on other PSS items.  
 
Table 76. Comparisons of TTH subtypes with PSS data 
 
 TTH subtypes   
n (mean±SD) 
ANOVA 
Infrequent 
ETTH (1) 
Frequent ETTH 
(2)  
Chronic TTH  
(3) 
Total 
n (mean±SD) 
Between Groups 
F df Sig. 
Sum of PSS 
scores 
23 
(16.09±6.259) 
101 
(17.23±6.918) 
36 
(15.69±7.375) 
160 
(16.72±6.925) 
0.760 2,157 0.469 
Perceived 
Distress 
24 
(7.46±4.952) 
107 
(10.05±5.290) 
39 
(8.77±5.810) 
170 
(9.39±5.420) 
2.615 2,167 0.076 
Perceived 
Coping 
24 
(7.96±3.445) 
107 
(6.23±3.477) 
39 
(5.69±3.736) 
170 
(6.35±3.579) 
3.221 2,167 0.042 
*. The mean difference is significant at the 0.17 (0.05/3) level. 
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9.8  Discussion  
9.8.1  Summary: characteristics of the identified clusters 
Four clusters were identified based on symptoms and signs using cluster analysis and 
expert opinion, i.e., Ascendant hyperactivity of Liver-Yang (Cluster 1), Dual 
deficiency of Qi and Blood (Cluster 2), Liver depression forming Fire (Cluster 3) and 
a nonspecific cluster (Cluster 4). Among them, three subtypes, i.e., infrequent ETTH, 
frequent ETTH, and CTTH, were presented in all clusters. In this sample, more than half of 
participants had frequent ETTH. 
 
Based on the ANOVA results on MIDAS, PSS and comorbidity checklist, the characteristics 
of the identified four clusters of TTH participants are summarised in Table 77. The four 
clusters were not only distinguishable in CM patterns, they also differed in aspects of 
subtypes of TTH, stress level, pain intensity (indicated by MIDAS item B), and disability 
level (indicated by MIDAS). 
 
The pattern of Ascendant hyperactivity of Liver-Yang (Cluster 1) has moderate pain 
level, moderate level of disability, and moderate distribution in both physical and mental 
comorbidity. Participants in this pattern may have more emotional changes than others, 
such as nervous and “stressed” (Item 3). However, comparing with others, they mostly 
often felt that things were going their way(Item 5) and tended to perform best in coping 
ability (PSS “Perceived Coping” factor). 
 
The pattern of Dual deficiency of Qi and Blood (Cluster 2) pattern not only has the 
overall highest pain intensity and severest disability among all four patterns, it also has 
the largest number of participants having physical comorbidity. Nevertheless, participants 
in this pattern mostly often felt on top of things (Item 8).  
 
The pattern of Liver depression forming Fire (Cluster 3) has a moderate headache 
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intensity and severe disability, which is similar to Cluster 2. However, participants in this 
type of TTH pattern seemed to be impacted greatly by their headache. They could hardly 
feel on top of things (item 8) which were opposite to that in Cluster 2, nor could feel that 
things were going their way (Item 5) when compared with Cluster 1. 
 
The nonspecific cluster (Cluster 4) may be the least affected cluster not only because it has 
the lowest level (mild) of pain among the four clusters but also have no mental 
comorbidity. Although participants in this cluster have the least emotional problems as 
they rarely felt nervous and “stressed” (item 3), they were likely not to perform well in 
coping as they had the highest score of “Perceived Coping” factor, as in this section, the 
higher the score indicated the poor performance in coping ability. 
 
In summary, among the clusters identified, participants in Cluster 2 experienced the 
most severe headache and had the highest disability level. In contrast, Cluster 4 
presented mild headache intensity, moderate disability and was free from mental 
comorbidity.  
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Table 77. Relationship between patterns and other outcome measures 
 
Clusters  Corresponding  
TTH subtypes 
(n)(data sourced from 
Table 62) 
Outcome measures 
MIDAS PSS (mean±SD) (data sourced from table 9.5.3) Comorbidity(%) 
Intensity 
(0-10) 
Disability 
level 
By PSS items 
(scores of item 3: the higher the worse) 
(reversed scoring of item 5 and 8: the lower the better) 
By “Perceived 
Coping” 
(the lower the 
better in coping) 
Physical Mental  
Cluster 1 -  
Ascendant 
hyperactivi
ty of 
Liver-Yang  
 
(n=46) 
 
 
Moderate 
pain (5.5) 
Moderate 
disability 
(grade 3; 
19 days) 
 
Item 3: (2.46±0.925) MOSTLY often 
„In the last month, how often have you felt nervous and 
“stressed”?‟ 
Item 5: (1.39±0.755) MOSTLY often 
„In the last month, how often have you felt that things 
were going your way?‟ 
 
(5.04±3.025) 
Best 
performance in 
Perceived 
Coping 
43.40% 17.40% 
Cluster 2 -  
Dual Qi and 
Blood 
deficiency  
 
(n=34) 
 
 
 
Moderate 
pain (6.3) 
Severe 
disability 
(grade 4; 
31 days) 
 
Item 8: (1.44±0.982) MOSTLY often 
„In the last month, how often have you felt that you were 
on top of things?‟ 
 55.90% 26.50% 
Cluster 3 -  
Liver 
depression 
forming 
fire 
 
(n=46) 
 
Moderate 
pain (5.4) 
Severe 
disability 
(grade 4; 
24 days) 
 
Item 5: (2.14±1.104) LEASTLY often 
„In the last month, how often have you felt that things 
were going your way?‟ 
Item 8: (2.26±1.049) LEASTLY often 
„In the last month, how often have you felt that you were 
on top of things?‟ 
 41.30% 10.90% 
1 
36 
9 
iETTH fETTH CTTH
1 
26 
7 
iETTH fETTH CTTH
7 
23 
16 
iETTH fETTH CTTH
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Cluster 4 -  
Nonspecific 
cluster 
 
(n=44) 
 
Mild pain 
(4.7) 
Moderate 
disability 
(grade 3 
19 days) 
Item 3: (1.39±0.868) LEASTLY often 
In the last month, how often have you felt nervous and 
“stressed”? 
 
(7.59±3.329)  
Poorest 
performance in 
Perceived 
coping 
 
34.10% 0.00% 
 
 
15 
22 
7 
iETTH fETTH CTTH
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9.8.2  Comparing with the existing literature: TTH symptomatology 
The common TTH characteristics and associated symptoms identified in the present study 
were consistent with the findings of other studies [71, 85, 331, 342, 423, 569]. The main 
similarities are the precipitating factors such as physical activity, stress/tension, when 
tired, lack of sleep, specific foods/drinks, alcohol, and skipping meals, and some 
accompanying symptoms such as fatigue, insomnia, and irritability. 
 
An epidemiology study [423] investigated college students (aged 17-21) in Turkey and 
concluded mild (67.5%) headache was commonest, followed by moderate headache 
(29.4%). Forehead (47.4%) (present study: 52.7%) was the most complained location of 
TTH, followed by other areas (22.7%), top of head (17.8%) and whole head (12.1%). 
Throbbing (49.7%) (present study: 37.6%) and pressing (26.3%) (present study: 41.4%) 
were of the most common qualities, followed by tightening (15%) (present study: 35.3%), 
dull (30.6%) and other sensations (12.1%). In terms of the associated symptoms, none of 
those students reported nausea but nearly a half of them experienced phonophobia 
(45.1%) (present study: Sensitivity to sound 43.5%) whereas less than one tenth 
reported photophobia (7.1%) (present study: Sensitivity to light 46.6%). In addition, a 
series of aggravating factors were identified, including stress (52.5%) (present study: 
73.6%), sunlight exposure (25.8%) (present study: 41.7%), hunger (24.5%) (present 
study: 30.3%), tiredness (21.9%) (present study: 68.1%), and weather changes (15.9%) 
(present study: 28.6%), and travelling (11.7%) were also reported [423]. 
 
One clinic-based study [569] interviewed patients with migraine (n=38) and TTH (n=17) 
via telephone [569]. Stress/tension (82%), not eating on time (76%), lack of sleep (71%) 
and fatigue (65%) (present study: when tired 68.1%) were the most rated precipitating 
factors of TTH whereas stress/tension (88%) (present study: stress 73.6%), lack of sleep 
(76%) (present study: 68.1%), not eating on time (71%) (present study: Irregular diet 
24.8%), light (65%), noise (65%), reading (65%), driving (59%) and physical activity 
(53%) (present study: Physical labour 28.3%) were the most common aggravating 
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factors. Another population-based survey [71] in Croatia using a „face-to-face 
door-to-door‟ interview method and identified stress (49.4%), sleep disturbances (36%) 
and eating habits (30.1%), menstrual cycle (45.7%) and changes in weather and 
temperature (44.7%), frequent travelling (52.5%) and physical activity (36.7%) were 
commonly precipitating factors associated with TTH sufferers (n=1319) [71].  
 
One recent hospital-based study [85] explored characteristics of 399 TTH patients by 
applying a headache questionnaire. In that cross-sectional study, clinical characteristics 
including bilateral pain (79.9%) with other frequently reported location such as frontal 
(34.1%), parietal (26.8%), occipital (25.6%) and temporal regions (22.1%) were 
identified. Swelling (63.7%) as the leading sensation among patients was observed, 
followed by pulsating (23.8%) and tightening (22.6%). Emotional stress (23.8%) and 
change in weather (18.3%) were reported as most common trigger factors for TTH. The 
most commonly reported symptom was phonophobia (25.3%). In addition, half of TTH 
patients complained of sleep disorders (50.4%) in their previous month, other 
accompanying symptoms nausea (4.5%) and photophobia (2.0%) were identified [85].  
 
One study observed a “band-like” sensation of TTH and considered this type of headache 
being associated with inadequate sleep, insomnia, mental stress, stress response, 
excessive fatigue, and depression [331]. In the study, accompanying symptoms of 
depression, anxiety, panic, upset, irritability, fatigue, insomnia were observed from 329 
patients suffered from tension headache. Moreover, a controlled trial [342] observed 
symptoms and signs of hyperalgesia (56%), persistent distending sensation (62%), 
blurred vision and/or sore eyes (21%) (present study: 30.6%/43.5%) insomnia (40%) 
(present study: 45.9%) and palpitation (38%) (present study: 25.3%) from a total 146 
patients suffered from tension headache [342]. 
 
Although the present study was not designed to identify the relationships between mental 
comorbidity and TTH, a small percentage of anxiety disorders and mood disorders were 
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detected (7.1% respectively). This is probably due to more than three quarters of the 
respondents were ETTH sufferers. It has been shown that psychiatric comorbidities were 
more common in CTTH patients [59, 126] whereas those having less frequent TTH tending 
to having a lesser degree of psychiatric comorbidity [51]. 
 
Nevertheless, emotion related factors may have impacted on the presence of TTH. The 
present study found that stress and/or tension (73.6%) was the leading precipitating 
factors, and the finding is consistent with others (49.4% [71], 74.5% [578], 63% in men 
and 77% in women [77], 52.5% [423], and 82% [569]). 
 
In summary, a considerable similarity of reported features and associated symptoms on 
TTH were observed between the present study and studies investigating factors and 
symptoms associated with TTH from western medical aspects. Inevitably, due to the 
differences in sampling, methods of studies, and the time points when each study took 
place, there are some discrepancies in the results reported by the above-mentioned 
studies and the present studies. For example, specific foods/drinks, as an aggravating 
factor, varied from 2% to 35%, skipping meals from 24.8% to 52.9%, smoke from 8.6 to 
38%. In addition, the present study observed that bilateral headache was the most 
common location of TTH (71%) and followed by forehead (52.7%). Although the study by 
Li et al [85] also listed bilateral and forehead headache being the commonest headache, 
and the finding was bilateral headache being of 79.9% whereas forehead 34.1%. The 
present study also collected a series of accompanying symptoms that are seldom 
mentioned by others. For instance, sore eyes (43.5%), thirst (40.6%), bloating (30.0%), 
joint stiffness (40.6%), muscle twitching (31.8%), increased forgetfulness (50.0%), 
sighing often (41.1%), and, inability to concentrate (47.1%) were common symptoms 
experienced by TTH suffers in this sample. 
 
In WM, due to TTH being lack of objective markers and positive, specific clinical symptoms, 
the existing diagnostic criteria of TTH are based on negative findings [48], by excluding 
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other primary or secondary headache syndromes [51]. However, a more scientifically 
based and precise picture of the symptomatology of TTH (in either ETTHs [579] or CTTH 
[580]) is important for both diagnosis and identifying subtypes of TTH. So far no 
systematic attempt has been made to precisely define the clinical characteristics of such 
ill-defined syndrome [581]. Among the above-mentioned range of symptoms associated 
TTH, only nausea, vomiting, photophobia, and phonophobia are regarded as specific 
evaluators as they may differentiate migraine from TTH. In other words, other observed, 
associated symptoms presented by TTH sufferers could be considered as part of its 
symptomatology or TTH accompanying symptoms, but not necessarily used for diagnosis. 
Furthermore, it is unknown at this stage, how significant symptomatology is for TTH 
subgroup identification. In CM, on the contrary, all such symptoms and signs are grouped 
into patterns in order to make proper diagnosis and treatment.  
 
9.8.3  TTH subtypes: ETTH and CTTH  
The IHS committee divided primary headaches into two broad groups. „Episodic‟ 
headaches which refers to the frequency of headache with low to moderate (<15 
headache days per month); whereas „chronic‟ headaches indicates a high frequency (≥15 
headache days per month) [103]. Therefore in WM, identification of subtypes of TTH under 
ICHD-II is mainly distinguished by the frequency of headache attacks on the basis of 
epidemiological studies [47]. That is ETTH and CTTH. Within ETTH, its infrequent subtype 
occur on lower frequency (<1 day a month) than the frequent subtype (≥1 day a month). 
 
Very few studies examined the differences between ETTH and CTTH beyond headache 
days. One study selected six factors of headache to examine the differences between TTH 
subtypes, and the factors were severity of headache measured with VAS, upset 
(irritability), cardiopalmus (palpitation), agrypnia (insomnia), the rigidity of cervical 
muscle (cervical muscle tightness), and pale (complexion) [582]. Among them, headache 
intensity, irritability, palpitation and insomnia in CTTH group were found significantly 
higher than ETTH group. In ETTH group, insomnia and cervical muscle tightness were 
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found to be positively correlated with headache intensity. In CTTH group, factors of 
irritability, palpitation and degree of insomnia were found to be positively correlated with 
headache intensity. In addition, stress was found to be associated with TTH. ETTH patients 
were reported to have a relevant high level of stress even their headaches were not 
present; and furthermore, the stress level was significantly higher during a headache 
when compared with no headache. 
 
The present study found that the three subtypes of TTH not only differ in headache 
frequency, but also in headache intensity and disability. The infrequent ETTH reported 
much lower headache intensity (mild, mean of 2.78) than other two (moderate, mean of 
5.85 and 5.81 respectively) and showed the lowest level of disability. This is in line with 
the description of ICHD-II that such infrequent subtype has very little impact on the 
individual, hence does not require much attention from the medical consultation [18]. In 
contrast, like the ICHD-II description, the chronic subtype in the present study is 
associated with a high level of disability, and can be considered a serious disease on its 
own [18]. Therefore, treatment of different types of TTH may differ. As recommended by 
the IHS, acute (symptomatic) drugs are often effective in patients with ETTH [18]. 
However, analgesics may not suitable for those on CTTH. In addition, prophylactic 
treatment should be considered in CTTH patients and patients with very frequent ETTH 
[583]. 
 
In summary, ETTH and CTTH differ in the level of disability and some symptomatology. 
However, research in this area is few and further information is required. Furthermore, the 
existing treatment for TTH is for acute and prophylactic purposes, and is not determined 
by a diagnosis of ETTH and CTTH. It is possible with better understanding of 
symptomology of ETTH and more targeted treatments can be developed. The IHS 
classification of ICHD-II has been criticised for not addressing the heterogeneity among 
subtypes of TTH [338, 411]. Specifically, these differences in clinical practice may include 
the cause or triggers of symptoms; the nature, severity, location, or duration of symptoms; 
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associated symptoms; and exacerbating factors; and/or response to various therapeutic. 
Nevertheless, the existing literatures did not provide a comprehensive picture on these 
aspects for its management. 
 
9.8.4  CM patterns of TTH   
The present study attempted to identify subgroups of TTH by using CM understanding of 
TTH clinical features. Different from WM classification of TTH, CM diagnosis and treatment 
on TTH is based on multifaceted information, including quality and location of pain, the 
corresponding areas or meridians, internal/external factors and multiple body function 
states. All of those are taken into consideration to arrive at the final CM diagnosis [319, 
325, 338].  
 
In this full-scale study, not all five patterns recommended by the text-book information 
and those used in the pilot study (previously listed in Table 8) were identified with the 
explorative analysis. Only patterns of Ascendant Hyperactivity of Liver Yang, and Dual 
Deficiency of Qi and Blood have been detected. A third, additional pattern “Liver Qi 
Depression transforming into Fire” was not previously included in the pilot study. However, 
this pattern has been proposed and discussed by several modern journal articles about 
TTH in recent years [330, 331, 584]. The other three patterns recommended by the 
textbooks, i.e., patterns of Liver Qi Depression, Phlegm Rises to Cloud the Mind, and 
Stagnation of blood were absent. It is likely they are uncommon in TTH. However it is also 
likely that the current sample size is not large enough to identify those patterns.  
 
In the present study, two patterns corresponding to the „Liver‟ have been detected, i.e., 
Ascendant hyperactivity of Liver-Yang pattern (Cluster 1) and Liver depression forming 
Fire (Cluster 3). People with either of the two clusters, as shown with results of PSS items, 
tended to have negative state of emotions than the other 2 clusters. Based on CM theory 
both have the same aetiology, which is mainly emotional depression and / or irritability. In 
CM, the Liver regulates and modulates emotions, such as “anger” and “depression” [337, 
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565]. which can represent resentment, frustration, and irritability [567]. Studies from WM 
perspective also identify that emotion is one of the main factors closely associated with the 
onset of TTH. CM recognises a bi-directional impact between the Liver and emotion. 
Dysfunction of the Liver causes emotional upset, whereas emotional upsets leads to the 
Liver dysfunction.  
 
As a result, a series of abnormality closely associated with Liver function, such as anxiety, 
depression, belching, sighing, or stuffy sensation in the chest, emerge [585]. Other 
symptoms and signs associated with the Liver, such as restlessness of the mind, 
irascibility, dizziness, may also be observed [585]. 
 
The pattern of „Liver depression forming Fire‟ has been regarded to be the next stage of 
„Liver qi depression‟, as prolonged stagnation of „Liver qi‟ may transform into „Liver Heat‟, 
or „Liver Fire‟ [586, 587]. In clinical practice, if patients have such Fire-syndrome in 
addition to Liver-Qi depression, they may cause heat in the related internal organs, which 
causing symptoms and signs of heat, such as red eyes, stinging or burning in the eyes, 
sensitive to light, blurred vision, flushed face, bitter taste in the mouth, short-tempered, 
or having outbursts of anger were giving rise to. However, the heat in these two patterns 
differs. In Ascendant hyperactivity of Liver Yang, the heat symptoms and signs are often 
due to deficient heat or „solid‟ fire drying up the body fluids, resulted from the deficiency 
of Liver-Yin and/or Kidney-Yin, therefore presenting “Sensitivity to light” (or to bright 
lights) and “Sensitivity to sound”; whereas in Liver depression forming Fire‟, the heat 
symptoms and signs are mainly due to excessive heat, such as thirst and bitter taste in the 
mouth [319].  
 
9.8.5  Explorative analysis methods for CM pattern identification  
The essence of cluster analysis, which is to classify a set of observations into groups, could 
be a suitable technique in supporting and verifying the CM syndrome research. Indeed, 
cluster analysis has been used to explore and study CM patterns in order to understand a 
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series of diseases and conditions defined by mmodern medicine [95, 577, 583]. Those 
studies covers a range of topics such as metabolic syndrome [588], chronic fatigue 
syndrome [589, 590], diabetic nephropathy [591], acquired immune deficiency syndrome 
(AIDS) [100, 592], lung cancer [514], preoperative colorectal cancer [593], stroke [97, 
99], diabetes mellitus [575], diabetic retinopathy [98], excessive menstruation [96], 
functional constipation [594], uterus myoma [575], acute myocardial infraction [576], 
acute pancreatitis [595], posthepatitic cirrhosis [95], and coronary heart disease [94, 322, 
596]. Generally, those studies identified explainable CM patterns and interpreted those 
modern illness/diseases in a reasonable fashion. 
 
Although the explorative analysis based on data mining could be valuable method for the 
study of CM syndrome research, without integration with the theory, the results of data 
mining could not contribute to either research or clinical practice. Hence, it is suggested to 
combine the results with knowledge of experts‟ opinions and clinical experiences in order 
to ensure its nature of accuracy, and being consistent with clinical observation [597] 
 
By conducting explorative analytic methods of cluster analysis and factor analysis, the 
four-cluster solution was regarded to be meaningful and reflecting the clinical practice. In 
addition, determination and naming of the identified patterns were also based on the 
consultation of expert opinion, and such process was used to construct 
evidence-supported as well as theory-justifiable patterns of CM identification. Hence, 
explorative analytic methods may be an appropriate solution in providing/identifying 
relatively objective classification of CM patterns. 
 
9.8.6  Implications of the pattern exploration 
The present study indicates that it is possible to subcategorise TTH from a 
multi-dimensional perspective, but not just limited to the frequency of headache. As 
shown in the present study, the four CM patterns differed from the current TTH subtypes. 
A CM pattern includes all three subtypes, yet within one subtype one may have different 
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CM patterns. The CM pattern identification goes beyond the headache frequency as it 
focuses on symptoms and signs that TTH sufferers experience in addition to their 
headache. In CM, clinically specific treatment strategy is developed for each pattern to 
address headache as well as symptoms and signs. This classification method is perhaps 
more clinically orientated and relevant than subtyping TTH based on headache days only.  
 
Also importantly, the four patterns differ on PSS score. This needs to be acknowledged by 
CM practitioners. Whether CM treatment modalities are adequate for addressing those 
emotional difficulties is yet to be examined. In the West, psychological interventions are 
often used to specifically address those problems. The two patterns (Ascendant 
hyperactivity of Liver-Yang, Liver depression forming Fire) may require additional 
psychological interventions to bring out the best therapeutic effects. 
 
 
9.9  Chapter summary  
The reliability and validity of the CMHQ-3 was examined through a series of tests. Cluster 
analysis was found to be appropriate for pattern identification. Expert interpretation was 
required to identify the patterns. Three main TTH patterns were identified. They not only 
differed on accompanying symptoms and signs, but also on level of disability and stress. 
The results highlight the CM knowledge gaps between clinical practice and textbook 
information. The results also provide a guide to future studies on identifying subtypes of 
TTH. For the subtype of TTH, it is perhaps important to look beyond frequency of headache. 
The present study indicates that accompanying symptoms and signs could assist in 
subtype classification.  
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10.1  Summary of the thesis project 
Research for the standardisation of CM diagnostic criteria (CM patterns) was initiated in 
1950s [598]. TTH, as an entity of WM, does not have standardised criteria in CM diagnosis. 
In 1990s, patterns were proposed by the Group of Encephalopathy Emergency of State 
Administration of TCM of the People's Republic of China and the patterns included all types 
of headaches [599, 600]. In later years, those criteria were considered to be impractical 
[324], as those patterns were not consistent with clinical observations [332-335].  
 
This thesis project aimed to use evidence-based approaches to develop and validate the 
CMHQ for TTH; and to explore CM patterns of TTH and understand TTH associated signs 
and symptoms by administering CMHQ to the clinical population. 
 
This project had four specific aims and findings to each objective are summarised as 
follows.  
 
10.1.1  A systematic review of acupuncture for TTH (Chapter 3) 
Objective: “to identify the factors contributed to the conflicting outcomes among efficacy 
studies of acupuncture for TTH through systematically reviewing randomised controlled 
trials” 
 
Outcomes and conclusions 
The systematic review using meta-analyses and subgroup analyses identified factors that 
might have contributed to inconsistent findings among acupuncture RCTs of TTH. Five (5) 
sham-acupuncture controlled RCTs for TTH were reviewed. No statistically significant 
differences between real and sham acupuncture on headache days were found. 
Heterogeneity among the studies was high and its source was identified through subgroup 
analyses. Electro-acupuncture, longer needle retention and twice a week treatment were 
reported to be associated with better outcomes than manual acupuncture, no needle 
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retention and once a week treatment, respectively. This review also identified deficiencies 
in current acupuncture research on TTH, such as a lack of standardised CM patterns, 
adequacy and quality treatment, and monitoring of adherence to the trial protocol. 
 
10.1.2  Development and validation of the CMHQ (Chapters 6,7, and 8)   
Objective: “to develop and validate the CMHQ to assist CM pattern identification” 
 
Outcomes and conclusions 
The development and validation of the CM theory-based CMHQ followed the conventional 
methodology of questionnaire development process (Figure 30). Methods used for its 
development included literature review, item generation, piloting of questionnaire, 
internal group discussion, and external expert consultation. Three versions of CMHQ were 
developed and amended to fulfill a psychometrically sound questionnaire. Both reliability 
and validity of CMHQ were evaluated. The questionnaire had good face validity, 
considerable content validity, high internal consistency validity, high test-retest reliability 
and adequate construct validity.  
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Figure 30. Summary of development and validation process of CMHQ 
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10.1.3  Identification of TTH patterns using explorative statistical 
analytic methods (Chapter 9)   
Objectives: “to understand TTH associated symptoms and signs, and identify CM 
patterns using factor analysis and cluster analysis” 
 
Outcomes and conclusions 
The CMHQ is found to be reliable and valid in capturing essential clinical indicators for 
making CM diagnosis. Two hundred and seventy-eight (278) people with TTH took part in 
this project over three phases. A large quantity of information related to TTH and 
accompanying symptoms were identified systematically using CMHQ. The commonest 
headache features were continuous pain (64%) and fixed location (74%). Headache was 
aggravated by overwork (74%), stress (74%), and mental strain (70%) and relieved by 
sleeping (78%). The commonest accompanying symptoms were fatigue (71%) and neck 
stiffness (70%). Four clusters were identified with 46, 34, 46 and 44 participants in 
Clusters 1-4, respectively. These results expanded the common understanding of TTH 
symptomatology in terms of its pain description, trigger factors, and accompanying 
symptoms. 
 
The methods of factor and cluster analysis were helpful in exploring unknown TTH groups. 
Four CM patterns were Ascendant hyperactivity of Liver-Yang (Cluster 1), Dual Qi and 
Blood deficiency (Cluster 2), Liver depression forming Fire (Cluster 3) and a nonspecific 
cluster (Cluster 4). Three of them were clinically meaningful thus may guide the clinical 
practice for TTH management in CM. 
 
10.1.4  Exploration of correlations between CM patterns and other 
instruments (Chapter 9)   
Objective: “to further differentiate TTH patterns and better understand their differences 
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in the perceived level of stress, disability and comorbidity” 
 
Outcomes and conclusions 
PSS, MIDAS, and a comorbidity checklist were applied to assess the self-perceived stress 
(using PSS), severity of disability (using MIDAS) due to headache and comorbidity. The 
identified four clusters not only differed in symptoms and signs, but also in level of 
disability and stress. Among them, Cluster 2 had the most severe headache and highest 
disability level, whereas Cluster 4 had mildest headache intensity, moderate disability and 
was free from mental comorbidity. 
 
 
10.2 Strengths and limitations 
10.2.1  Strengths of the project 
The entire PHD project was performed following a logical flow and systematic sequence. It 
was important because theoretically grounded research advances science for 
evidence-based research.  
 
To the best of author‟s knowledge, the present survey investigation is among the first 
studies using explorative statistical method to research TTH related symptoms as well as 
identifying CM patterns of TTH. The entire process is of explorative nature. The method 
applied, that is using CM questionnaire and objective explorative analytic approaches, 
provides an alternative to current WM approaches in understanding the symptoms 
associated with TTH and subgroups of TTH. Conduction of the survey is both 
hospital-based and general population-based. As a result, it should be applicable to the 
majority of TTH population. In summary, the findings of this thesis expand the existing 
understanding of TTH symptomatology and TTH patterns. It provides essential 
information for future research on subgroups of TTH. 
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10.2.2  Limitations of the project 
There are some limitations of this study. 
 
Firstly, a larger sample size would be desirable in both validating the CMHQ and exploring 
the CM patterns. Although the patterns identified reflect clinical practice and observation, 
the present results could be limited due to its sample size. Some other possible patterns 
may not be observed in this study, for instance, Liver-Qi depression, Phlegm rises to cloud 
the Mind, or Stagnation of Bloods. Future studies with a large sample size will enable 
identification of those patterns.  
 
Secondly, relying on explorative analysis has its drawbacks, since statistically determined 
clusters can be affected by many factors. For example, what types of symptoms to be 
included in the analysis? How to measure those symptoms? Literature suggests that 
explorative analysis should be used in conjunction with experts‟ opinions, such as when 
interpreting the generated factors and labelling the grouped symptoms and signs. Only 
through the empirical confirmation from experts, factors and patterns generated through 
explorative analysis could be clinical relevant.  However expert opinions are subjective. 
The present study minimised the limitation by a combined approach of explorative 
analysis and expert opinions. For the latter, both internal and external experts were 
consulted during the processes of evaluation, determination and labelling of clusters.  
 
Thirdly, this study is a cross-sectional study, which only analysed the symptom 
distribution collected at a specific duration over the last 3 months. The presence and the 
severity of symptoms observed may change over time.  
 
Future studies may use longitudinal cohort approaches to evaluate the stability of the 
identified CM patterns over time, and to assess the effect of interventions.  
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10.3  Identifying subgroups of diseases, health conditions or 
disorders 
10.3.1  Symptom cluster research 
In biomedicine, the research of symptoms cluster is a method used to subgroup patients 
with a specific disease based on their clinical presentation of symptoms. A symptom 
cluster may be defined as two or more concurrent symptoms occurring with a high degree 
of predictability. Symptoms in a cluster may or may not share the same aetiology, but 
relationships among the symptoms within a cluster should have a stronger association 
with each other than with symptoms in different clusters [601]. For example, a review of 
13 studies on women with breast cancer during and after cancer treatment found majority 
of them reported two or three symptoms which consistently occurred together [602]. 
These symptoms include fatigue, pain, sleep, depression, mood changes, cognitive 
impairment, and /or menopausal symptoms. Some studies supported fatigue and sleep as 
a symptom cluster [603-606], some found fatigue, sleep, and depression being a 
symptom cluster [607, 608], whereas others detected a cluster of fatigue, mood changes, 
and cognitive impairment [609], a cluster of fatigue and menopausal symptoms [610], 
and a cluster of fatigue, pain, depression, insomnia, and menopausal symptoms [611].  
 
Methods 
Grouping symptoms to create clusters is currently the most common conceptual method 
used in cancer research [602, 612]. A multi-symptom assessment tools are used to collect 
symptoms and explorative analytic methods are then used to identify symptom clusters 
[602, 613]. For example, in determining the number and types of symptom clusters, a 
symptom assessment tool could be administered to a sample of oncology patients. 
Patients are invited to describe the symptoms they experienced. The tool may include the 
types of symptoms as well ratings of frequency, severity and impact of each symptom. 
Using multivariate methods of either factor analysis or cluster analysis, one or more 
symptom clusters could be derived empirically based on the results of statistical analyses. 
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Finally, various symptom clusters can be labelled by clinicians based on the specific 
symptoms included in the cluster [614]. In this example, five clusters, represented a 
pooled 18 symptoms were identified from explorative statistical methods. Each of them 
consisted of three to five correlated symptoms and labelled by experts accordingly to 
possible pathological dimensions, such as “psychological”, “pain”, “respiratory”, and 
“sleep/fatigue”. Under the assumption that the correlations among symptoms are due to 
a common etiology or a shared biologic mechanism, EFA is the most commonly applied 
data analysis method to symptom cluster for classification and diagnosis purposes [513, 
601].  
 
Theory frameworks 
Theoretical foundation is needed when clustering symptoms. Clusters generated using 
statistical methods need to be clinical meaningful and relevant. Only a few theory models, 
such as the Theory of Unpleasant Symptoms [615], Model of Symptom Management 
[616], the Symptoms Experience Model [617], and the Symptom Interaction Framework 
[618] are available to guide researches to the clustering of symptoms in cancer research. 
These models may provide a shared understanding of the complexities of the symptom 
experience, propose appropriate symptom assessment and management strategies, help 
assess the effectiveness of interventions for symptom relief and improve outcomes for 
patients [619].  
 
Clinical relevance and implications 
Understanding of the cause and mechanisms of symptom cluster may lead to the 
opportunities for interventions [619]. WM recognises the theoretical possibility that 
treating one symptom in a cluster may relieve other related symptoms in the cluster when 
common mechanisms exist [40, 620-622] . In general medicine, the use of symptom 
clusters is helpful in the diagnostic process of disease [601]. For instance, syndromes 
often have unexplainable pathology, and diagnosis and treatment may rely solely upon 
symptom patterns. To date, symptom clusters have been used to subgroup and monitor 
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diseases such as chronic hepatitis C infection [623, 624], acute bipolar mania [625], 
diabetes mellitus [626], congestive heart failure [627], end stage renal disease [628], 
fibromyalgia [629], functional dyspepsia and irritable bowel syndrome [630], HIV disease 
[631], premenstrual syndrome [631], psychomotor seizures of temporal lob [632], and 
syndrome Z [633], and various forms of cancers [513, 601, 634-636].  
 
10.3.2  Subgrouping of TTH  
TTH has been shown to be associated with a number of symptoms [71, 85, 331, 342, 423, 
569], including fatigue, insomnia, irritability, hyperalgesia, persistent distending 
sensation, blurred vision and/or sore eyes, insomnia, and palpitation. It is unknown that 
how many of those symptoms and signs are specific to TTH and how many are associated 
with TTH. In ICHD-II, only four symptoms, nausea, vomiting, photophobia, and 
phonophobia, are outlined for TTH differential diagnosis, while other symptoms and signs 
are not mentioned. The current study and other studies (Chapter 9, Section 9.8.2) found 
that TTH patients may suffer from a series of common symptoms and signs, which may be 
associated to their headache, emotional changes, and impact of headache. The present 
study is not designed to identify which symptoms and signs are specific to TTH and which 
are associated with TTH. However over 40% of TTH patients suffer 14 accompanying 
symptoms (Chapter 8, Section 8.5.2.4). In symptom cluster research, only two or three 
symptoms are allowed to form a symptom cluster. Clearly, such a definition limits the 
application of symptom cluster in TTH. Further complicating this is a lack of theoretic 
framework to explain the multiple symptoms of TTH. 
 
10.3.3  Pattern identification of TTH subgroups  
Pattern identification and symptom cluster are two approaches utilising explorative 
analytic methods under different system structures of CM and WM, respectively, to 
subgroup patients with a specific illness or disease. In identifying patterns or clusters, 
both approaches rely on the evaluation of multiple symptoms.  
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Both approaches reply on experts‟ interpretation and labelling of clinical data and their 
judgements. Comparing with symptom cluster, pattern identification used in the present 
study has several advantages, including: 1) existing CM theory provides the framework to 
make sense of different symptom patterns which may help subgrouping TTH, 2) in CM 
diagnosis, a pattern may have five to 10 symptoms and signs, unlike in symptom cluster 
only allowing up to three symptoms in one cluster; and 3) CM already has a systematic 
diagnosis roadmap including associated treatment principles that can be used to guide the 
follow-up management and treatment of different types of patterns. 
 
Using factor analysis, researchers of a RCT analysed the most important 8 symptoms and 
signs (thirst, vexation, hot feeling in the joints, turbid, yellow urine, cold feeling in the 
whole body, cold feeling in the limbs, and cold feeling in the joints) experienced by patients 
with rheumatoid arthritis (RA). Cold, hot, and indefinable patterns were found among a 
total of 194 patients (60 in cold pattern, 55 in hot pattern, and 79 in undefined pattern). 
The study found that patients with the cold pattern responded better to the combination 
therapy of diclofenac, methotrexate, and sulfasalazine than those with hot pattern did. 
Those findings suggest subsets of patients identified through pattern identification may 
respond to biomedical therapies differently [637]. 
 
In summary, pattern identification entails the comprehensive analysis of symptoms and 
signs. Such an approach may finally help advance biomedical understanding of individual 
presentations of diseases and develop targeted treatment for individuals with the same 
disease but of different patterns of presentation [637].  
 
 
10.4  CMHQ: further research plans  
So far, the initial development of CMHQ has been accomplished. As mentioned, its relative 
large number of items may limit its application in clinical setting. Future tests are 
necessarily to evaluate the stability of the identified patterns. To CM clinical practice, a 
 303 
 
questionnaire that can help clinicians identify TTH patterns quickly will be beneficial. 
Several steps are needed. 
 
The first step is to evaluate CMHQ with a larger sample size to validate the existing 
patterns as well as to detect other potential patterns. In this step, methods used in the 
present study will be replicated, and significant clinical indicators and typical markers of 
each pattern will be identified using EFA. 
 
The second step is to confirm the dimensionality of CMHQ. Confirmatory factor analysis 
(CFA) will be used as a subsequent testing on the obtained patterns. Such process may 
yield sufficient evidence for specific and nonspecific factors underlying diagnostic 
indicators, which may provide evidence to test, evaluate, refine and confirm the model of 
CMHQ. 
 
The third step is to further reduce items and determine item weighting within each pattern 
based on the results of above mentioned tests. A series of advanced statistical analytic 
methods, such as factor analysis, cluster analysis, experts scoring method, stepwise 
regression analysis, Cronbach‟s alpha coefficient method, and discrimination analysis, are 
common approaches for item reduction. Stability of items within each pattern will be 
evaluated. 
 
The last step is model validation. Another patient-based investigation will be conducted to 
test the proposed model in a group of TTH patients to identify and differentiate primary, 
secondary, and tertiary clinical indicator and diagnostic markers based on each TTH 
pattern. Structural formula modelling, which is often used to confirm models of hypothesis 
constructed, will be applied.  
 
The four proposed steps for the further development of the CMHQ will improve consensus 
on the diagnosis of CM patterns in both research and clinical application. The further 
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amended instrument should be incorporated into future clinical applications. 
 
 
10.5  Significance and implications 
10.5.1  Filling the knowledge gap 
From the review of literature, several gaps in the research of TTH emerge. On one hand, 
the IHS diagnostic criteria on TTH are designed to distinguish TTH from other types of 
headaches to some degree, and to classify TTH into three subtypes based upon attack 
frequency only. There is, however, a lack of understanding of non-headache symptoms 
associated with TTH. On the other hand, despite several epidemiological studies observed 
a series of aggravating and relieving factors and accompanying symptoms of TTH, clinical 
practice to date has not given adequate attention to the TTH symptom research. The 
current study fills those gaps by further understanding non-headache symptoms in TTH 
and using knowledge of pattern identification and advanced statistical methods to identify 
three clinically-meaningful subgroups of TTH.  
 
10.5.2  Implications for clinical practice  
The current version of CMHQ could not be used to directly identify patterns by counting the 
number of items. CM practitioners could use it to collect patients‟ TTH-related symptoms, 
assist in identifying CM patterns and help develop treatment plans for TTH. This tool may 
be used by WM practitioners to recognise the multiple symptoms of TTH, which may lead 
to better WM treatment options. CM and WM practitioners should not only aim at reducing 
the intensity and frequency of headaches, but also need to identify and manage 
underlying trigger factors and symptoms other than headaches. Such an approach might 
improve the treatment efficacy, as well as improving patients‟ quality of life. For instance 
TTH patients suffering from severe fatigue perhaps should be treated differently from 
those without fatigue. For those with considerable levels of self-perceived stress and 
disability, appropriate psychological supports should be also considered. 
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10.5.3  Implications for research 
Acknowledging the reality that a series of accompanying symptoms and signs exist in TTH 
patients will help better understand the complex symptomatology of such a disorder. This 
study presents a unique contribution to existing knowledge of TTH and may have the 
potential to influence the clinical practice of TTH as well as its research. The findings 
indicate that future research in TTH should be multidimensional, not only focusing on 
features of headache, such as the attack frequency, severity, and quality, but also other 
non-headache symptoms, such as fatigue and insomnia, and the level of perceived stress 
and disability. Research into pattern identification may provide a new diection for clinical 
assessment and management of TTH and improves furtuer research in clinical assessment 
and intervention. 
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APPENDICES  
 
Appendix 1. A summary of excluded studies (n=50) 
 
Study  (21 English studies) Reason for exclusion Final reason 
Johansson 
1976 
Effect of acupuncture in 
tension headache and 
brainstem reflexes 
outcome measure: invalid 
outcome measure 
invalid outcome 
measure 
Ahonen 1983 Acupuncture and 
physiotherapy in the treatment 
of myogenic headache 
patients: pain relief and EMG 
activity 
patients: no diagnostic 
criteria  
intervention: invalid control 
had more than 
one items not 
met criteria 
Ahonen 1984 Effectiveness of acupuncture 
and physiotherapy on myogenic 
headache: a comparative study 
patients: no diagnostic 
criteria  
intervention: invalid control 
had more than 
one items not 
met criteria 
Hansen 1985 Acupuncture treatment of 
chronic tension headache--a 
controlled cross-over trial 
outcome measure: invalid 
outcome measure 
invalid outcome 
measure 
Carlsson 
1990 
Muscle tenderness in tension 
headache treated with 
acupuncture or physiotherapy 
intervention: invalid control invalid control 
Carlsson 
1990 
Oculomotor disturbances in 
patients with tension headache 
treated with acupuncture or 
physiotherapy 
intervention: invalid control invalid control 
Carlsson 
1990 
Tension headache and signs 
and symptoms of 
craniomandibular disorders 
treated with acupuncture or 
physiotherapy 
intervention: invalid control invalid control 
Hamp 1999 The effect of acupuncture and 
relaxation training of children 
and youths with tension-type 
headache - a pilot study 
intervention: invalid control 
patients: children and 
teenagers 
had more than 
one items not 
met criteria 
Vincent 1990 The treatment of tension 
headache by acupuncture: A 
controlled single case design 
with time series analysis 
outcome measure: statistic 
data not available to extract 
invalid outcome 
measure 
Tavola 1992 Traditional Chinese 
acupuncture in tension-type 
headache: A controlled study 
outcome measure: invalid 
outcome measure 
invalid outcome 
measure 
Zwolfer 1994 Treatment of the tension type 
headache with acupuncture 
patients: not using IHS 
criteria 
not using IHS 
criteria 
White 1996 A pilot study of acupuncture for 
tension headache, using a 
novel placebo 
outcome measure: statistic 
data not available to extract 
invalid outcome 
measure 
Karst 2000 Pressure pain threshold and 
needle acupuncture in chronic 
tension-type headache--a 
double-blind 
placebo-controlled study 
outcome measure: 
duplicated outcome 
duplicated 
outcome 
Karakurum 
2001 
 
The 'dry-needle technique': 
intramuscular stimulation in 
tension-type headache 
 
intervention: invalid active 
outcome measure: invalid 
outcome measure 
had more than 
one items not 
met criteria 
Soderberg 
2006 
Chronic tension-type headache 
treated with acupuncture, 
physical training and 
relaxation training 
intervention: invalid control invalid control 
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Wang 2007 Effect of acupuncture-like 
electrical stimulation on 
chronic tension-type 
headache: a randomized, 
double-blinded, 
placebo-controlled trial 
intervention: invalid active invalid 
intervention 
Jena 2008 Acupuncture in patients with 
headache 
intervention: invalid control invalid control 
Bijak 2011 Female patient with tension 
type headache and previously 
unsuccessful acupuncture 
therapy 
patients: case report 
intervention: invalid control 
had more than 
one items not 
met criteria 
Guerreiro da 
Silva 2012 
Acupuncture for tension-type 
headache in pregnancy: A 
prospective, randomized, 
controlled study 
intervention: invalid control invalid control 
Ohlsen 2012 Combination of acupuncture 
and spinal manipulative 
therapy: management of a 
32-year-old patient with 
chronic tension-type headache 
and migraine 
intervention: invalid control 
patients: case report 
had more than 
one items not 
met criteria 
Ferro 2012 The combined effect of 
acupuncture and Tanacetum 
parthenium on quality of life in 
women with headache: 
randomised study on quality of 
life in women with headache: 
randomised study 
intervention: invalid control invalid control 
Study   (29 Chinese studies) Reason for exclusion Final reason 
孟冬祥 1996 传统针刺与安慰针刺治疗紧张性头
痛的初步比较研究 
intervention: no diagnostic 
criteria 
unexplainable result;  
lacking data and inconsistent 
outcomes 
had more than 
one items not 
met criteria 
赵静 1996 印百电为主治疗肌紧张性头痛64例 patients: not using IHS 
criteria 
not using IHS 
criteria 
魏福良 1998 电针治疗紧张性头痛 80 例 patients: no diagnostic 
criteria  
intervention: invalid control 
had more than 
one items not 
met criteria 
郭学军 2000 电针加简易精神疗法治疗紧张性头
痛 
intervention: invalid control invalid control 
徐天舒 2000 针刺与西药对照治疗颈肌紧张性头
痛疗效观察 
intervention: invalid active; 
invalid control 
had more than 
one items not 
met criteria 
黄学军 2001 针刺和安定单用或合用治疗肌肉收缩
性头痛的比较 
patients: no diagnostic 
criteria  
intervention: invalid active; 
invalid control 
had more than 
one items not 
met criteria 
彭建民 2002 电针加拔罐治疗紧张性头痛 82 例
临床观察 
intervention: invalid active;  
invalid control 
had more than 
one items not 
met criteria 
王尚臣 2002 小针刀与针刺治疗发作性紧张型头
痛疗效观察 
intervention: invalid control invalid control 
江勇 2003 针刺推拿治疗紧张性头痛临床研究 patients: no diagnostic 
criteria  
intervention: invalid active;  
invalid control 
had more than 
one items not 
met criteria 
康瑞珍 2003 养阴疏肝法配合针刺治疗紧张性头
痛 58 例 
intervention: invalid control invalid control 
谢菊英 2003 针刺加推拿治疗发作性紧张性头痛
37 例总结 
intervention: invalid control invalid control 
陈玉玲 2004 针刺配合刮痧治疗紧张性头痛 intervention: invalid control invalid control 
老锦雄 2004 针刺醒脑法治疗紧张性头痛的临床
疗效观察 
intervention: invalid control invalid control 
李俐 2004 腕踝针治疗紧张性头痛 30 例 intervention: invalid control invalid control 
陈晓斌 2006 针刺治疗发作性紧张型头痛的效果 intervention: invalid control invalid control 
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评估 
毛芝芳 2006 电针配合按摩治疗紧张性头痛 71
例 
intervention: invalid active;  
invalid control 
had more than 
one items not 
met criteria 
苏志伟 2006 刺血通经法治疗伴有抑郁和/ 或焦
虑症状的紧张性头痛的临床研究 
intervention: invalid control invalid control 
沈红强 2008 针灸调心治疗紧张型头痛临床研究 outcome measure: invalid 
outcome measure 
invalid outcome 
measure 
彭建民 2009 针刺治疗紧张性头痛的临床研究 intervention: invalid control 
outcome measure: invalid 
outcome measure 
had more than 
one items not 
met criteria 
张路 2009 针刺治疗慢性紧张型头痛随机对照
研究 
intervention: invalid control invalid control 
杨城 2010 针刀治疗紧张型头痛疗效观察 intervention: invalid active invalid 
intervention 
王兴旺 2010 电针治疗紧张性头痛验案 3 则 intervention: no diagnostic 
criteria 
intervention: invalid active;  
invalid control 
outcome measure: invalid 
outcome measure 
had more than 
one items not 
met criteria 
黄翠立 2011 电针结合走罐治疗紧张性头痛 60
例疗效观察 
intervention: invalid active;  
invalid control 
outcome measure: invalid 
outcome measure 
had more than 
one items not 
met criteria 
罗平 2011 刃针配合穴位放血治疗颈肌紧张性
头痛 132 例 
intervention: no diagnostic 
criteria 
invalid control 
outcome measure: invalid 
outcome measure 
had more than 
one items not 
met criteria 
李国辉 2012 
 
针刺治疗紧张性头痛 40 例 intervention: invalid control 
outcome measure: invalid 
outcome measure 
had more than 
one items not 
met criteria 
颜武 2013 针灸康复结合中药治疗紧张性头痛
分析 
intervention: invalid control  invalid control 
莫晓枫 2013 腹针治疗紧张型头痛临床观察 intervention: invalid control  invalid control 
陈日含 2013 
 
针刺帽状腱膜筋结点治疗慢性紧张
型头痛疗效观察 
intervention: invalid control  
 
invalid control 
李华 2013 
 
中药联合针灸治疗紧张性头痛的疗
效 
intervention: no diagnostic 
criteria 
intervention: invalid control 
had more than 
one items not 
met criteria 
刘昊 2014 调督安神针刺法治疗青年紧张型头
痛临床观察 
intervention: invalid control invalid control 
刘昊 2014 调督安神针法治疗紧张性头痛临床
观察 
intervention: invalid control invalid control 
宣雅波 2014 帽状腱膜下针刺法治疗慢性紧张性
头痛 26 例临床观察 
intervention: invalid control invalid control 
庞然 2014 针刀疗法为主综合治疗肌紧张型头
痛临床观察 
intervention: invalid active;  
invalid control 
had more than 
one items not 
met criteria 
Note: In total, 50 studies were excluded, 6 were excluded due to Invalid outcome measure; 20 for 
having invalid control; 2 had invalid acupuncture treatment, 2 due to not using IHS criteria; 1 being 
a duplicate publication; and 19 for having more than one items not meeting the selection criteria.  
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Appendix 2. Ethical approval (NHMRC trial) 
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Appendix 3. Ethical approval (Melbourne centre - A) 
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Appendix 4. Ethical approval (Melbourne centre - B) 
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Appendix 5. Ethical approval (Beijing site) 
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Appendix 6. Ethical approval (Chengdu site) 
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Appendix 7. Plain language statement for the clinical trial 
 
 
 
School of Health Sciences 
RMIT University 
 
 
Invitation to Participate in a Research Project 
Plain Language Statement 
 
This is an invitation to participate in a clinical trial investigating the effects of 
electroacupuncture and cognitive behavioural therapy (CBT) for tension-type 
headache. 
 
 
Chief Investigator 
 
Professor Ken Greenwood PhD       
School of Health Sciences 
RMIT University, Bundoora Campus                                                                          
Other Investigators 
 
Professor Charlie Xue PhD 
Division of Chinese Medicine                               
School of Medical Sciences 
RMIT University, Bundoora Campus 
Other Investigators                                                           
 
Doctor Zhen Zheng PhD 
Division of Chinese Medicine  
School of Health Sciences 
RMIT University, Bundoora Campus 
Other Investigators
 
Mr Alan Hao BMed 
Division of Chinese Medicine  
School of Health Sciences 
RMIT University, Bundoora Campus 
Other Investigators 
 
Professor Paul Martin PhD                                          
School of Psychology, Psychiatry and 
Psychological Medicine  
Monash University 
Other Investigators                                                           
 
Professor Robert Helme PhD 
Department of Neurology 
Western Health, Melbourne 
Other Investigators 
 
Associate Professor Stephen Gibson 
PhD                                          
National Ageing Research Institute   
University of Melbourne 
Other Investigators                                                           
 
Professor Kai Lo PhD 
Faculty of Health, Medicine, Nursing and 
Behavioural Sciences  
Deakin University 
Other Investigators 
 
Professor Marc Cohen PhD  
School of Health Sciences 
RMIT University, Bundoora Campus    
 
Other Investigators        
 
Dr Yanyi Wang PhD 
Division of Chinese Medicine  
School of Health Sciences 
RMIT University, Bundoora Campus 
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Dear Volunteers,  
 
You are invited to participate in a research project being conducted by RMIT 
University. This information sheet describes the project in straightforward language, 
or „plain English‟. Please read this sheet carefully and be confident that you 
understand its contents before deciding whether to participate. If you have any 
questions about the project, please ask one of the investigators.   
 
Why is it being conducted? Who is involved in this research project? 
Tension-type headache (TTH) affects up to three-quarters of the world population 
and more than one-third of Australians. Apart from pain, the majority of patients 
experience reduced quality of life and reduced effectiveness at work, school and 
home for up to one month each year. The direct and indirect costs to individuals and 
societies due to TTH are significant. Commonly used medications, including simple 
pain killers and anti-depressants, have been shown to be effective for short-term 
management. Their effectiveness for long-term management is yet to be 
established. Furthermore, some medications are not tolerated by a small portion of 
patients due to side-effects. 
 
Acupuncture is commonly used in Chinese medicine practice worldwide and is 
regularly used in everyday practice. In this clinical trial, electroacupuncture (EA, see 
below for details) is used either alone or in conjunction with cognitive 
behavioural-therapy for the treatment of TTH. The study will be conducted by the 
investigators mentioned above and be supervised by Professors Ken Greenwood 
and Charlie Xue and Doctor Zhen Zheng. This study has been approved by the RMIT 
Human Research Ethics Committee, and is funded by National Health and Medical 
Research Council and the School of Health Sciences, RMITUniversity.  
 
Why have you been approached? 
You have been invited because you answered our advertisement, and partially met 
the inclusion criteria.   
 
What is the project about? What are the questions being addressed? 
Results of a few clinical trials indicate that either acupuncture or CBT alone is an 
effective treatment for chronic headache, including TTH and migraine. Given that 
the two therapies possibly address different aspects of TTH, pain and coping of 
stress, a combined therapy of EA and CBT likely provides a better and longer-lasting 
effect for TTH, with respect to reduction of the intensity and frequency of headache, 
reduced used of analgesics and improved quality of life. This hypothesis will be 
tested by this clinical trial, which will involve 225 participants.   
 
If I agree to participate, what will I be required to do? 
If you would like to take part in the study, you must have TTH attacks once or more 
a month for at least one year, be age between 18 and 65 years and be able to read 
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and converse in English. If you meet one of the following criteria, you must let the 
investigators know. 1) Take analgesic on more than 15 days per month; 2) have 
migraine without aura attacks more than four times per month; 3) have migraine 
with aura more than once per month; 4)TTH onsets after 50 years old; 5) have a 
history of drug or alcohol abuse; 6) have whiplash or a history of significant head 
injury that required hospital stay; 7) have severe unstable arrthymia or heart failure, 
pregnancy or intent to get pregnant, epilepsy, brain tumour, cancer, haemophiliac 
or wearing cardiac pacemakers; 8) had eight or more sessions of acupuncture or 
CBT for TTH in the last six months; 9) having intellectual disability, or 10) having 
been diagnosed psychosis.It will be in your benefit to fully disclose any known 
current or previous medical condition/s. This is to minimise risk to you and because 
you will be insured for any adverse effects as a result of this study, based on known 
or provided information. 
 
If you agree to participate, you will be asked to record your symptoms of headache 
and medications consumed for headache daily in provided diaries for four weeks so 
that we can establish your current status of headache. If you meet all the inclusion 
criteria, you will then be randomly allocated to one of the three groups, EA alone, 
CBT alone or EA + CBT.  
 
The trial will be conducted at the RMIT Bundoora and Melbourne CBD campuses. If 
you are in the EA alone group, you will be required to one of the campus to receive 
EA twice per week for four weeks, and then once a week for another eight weeks. 
Each session will last for 30 minutes. If you are in the CBT alone group, you will have 
fifty-minute CBT consultations once a week for twelve weeks. If you are in the EA + 
CBT group, you will have EA treatment twice per week for four weeks followed by 
once per week for two weeks, then weekly fifty-minute CBT consultations for 
another six weeks. If you are in the either CBT group, you will be asked to do given 
CBT assignments at home. A manual will be provided to you. You will receive a total 
of ten hours of therapy or therapies.  
 
During the treatment period, you will be asked to complete the diaries daily for 12 
weeks. In order to identify whether the treatment has a long-term effect, you will be 
required to complete diaries for four weeks in the third and sixth months after the 
completion of the treatment. In between, one of the research assistants will phone 
you for 5 minutes fortnightly. In total, the study will last for 40 weeks. 
 
Electroacupuncture is widely used in everyday practice with. Disposable needles will 
be used and they are much thinner than needles used for injections. Pre-defined 
points on the scalp, neck, arms or legs will be selected. After insertion, two pairs of 
needles on the hand and / or legs will be connected to a battery operated 
acupuncture stimulator manufactured by the Tens Plus Industrial Company, China. 
Electrical pulses will be delivered via stimulator leads. The electrical stimulation 
time is 20 minutes for each session. In general, vibration or pressure sensation is 
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felt during EA and small muscle contraction might occur. Generally there is no pain 
or discomfort involved in acupuncture. 
 
What are the risks or disadvantages associated with participation? 
Electroacupuncture procedure has an excellent safety profile, and has been 
reported to be associated, in a very few cases, with minor risks, such as fainting, 
infection, small bleeding and bruises. There are few known adverse events of CBT. 
In this clinical trial, the acupuncturists and psychologists who deliver EA treatments 
and CBT consultations, respectively, are experienced and registered with relevant 
registration boards. Precaution will be taken to minimise any possible unpleasant 
adverse effect. Furthermore, they are qualified to give First Aid (level II training) 
and will manage minor risks as appropriate. Matters that are beyond the first aid 
training, such as infection, will be referred to your general practitioners or assessed 
by our trial physicians.      
 
Some people may experience minor pricking sensations upon needle insertion. This 
normally is reduced in later treatment.  
 
Some people are not suitable to have EA or CBT treatment. If you have conditions 
listed in “What is the project about? What are the questions being addressed?”, 
please inform the investigators who will withdraw you from the study. The effects of 
electroacupuncture on the unborn child and on the newborn baby are not known. 
Because of this, it is important that study participants are not pregnant or 
breast-feeding and do not become pregnant during the treatment stage of the study. 
You must not participate in the study if you are pregnant or trying to become 
pregnant, or breast-feeding. If you do become pregnant whilst participating in the 
study you should advise the chief investigator immediately. He will withdraw you 
from the study.  
 
What are the benefits associated with participation? 
One of the benefits of participating in the study is that your TTH symptoms and 
well-being will be monitored closely. In addition, previous clinical trials indicate that 
either EA or CBT alone can reduce the frequency of TTH by 50% on average. The 
treatment might help you reduce the symptoms and improve your wellbeing.  
 
The results of the clinical trial will contribute towards a growing body of scientific 
knowledge about the effective treatments for TTH. Your involvement will help to 
determine whether EA alone or the combined therapy of EA + CBT might be used as 
an alternative drug-free treatment to the debilitating TTH condition. All findings will 
be made available to all participants in a summary format.  
 
What will happen to the information I provide? 
All information provided by you and the data collected through this study will be 
stored in a password protected computer program. All files are kept securely in a 
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locked filling cabinet. Only investigators of this study have the access to the records. 
All data will be kept securely at RMIT for a period of 5 years before being destroyed.   
In any form of publication, only group data, but not personal information, will be 
presented. Should it be necessary to present individual data, data will be coded so 
that they are not identifiable. You have the right to view or request a copy of your 
personal data. 
 
Any information that you provide can be disclosed only if (1) it is to protect you or 
others from harm, (2) a court order is produced, or (3) you provide the researchers 
with written permission.  
 
What are my rights as a participant? 
Your involvement in this study is voluntary. It is your right as a participant in this 
study to withdraw from the study at any time; to withdraw any unprocessed data 
and to have any questions about the study being answered. You will receive no 
prejudicial treatment from the investigating group or RMITUniversity. Should you 
want to withdraw the unprocessed data, the data will be destroyed provided this 
action does not increase your risk.  Withdrawn data will be not used in any 
publication.  
 
Whom should I contact if I have any questions? 
If you require any clarification of the procedures of the study, please do not hesitate 
to contact Dr. Yanyi Wang on 03 9925 7396, or send email to 
headache@rmit.edu.au. 
 
Thank you for taking the time to read this invitation, and for considering being a 
participant in this project.  
 
Yours sincerely 
 
Prof. Ken Greenwood  
Prof. Charlie Xue 
Dr. Zhen Zheng 
Mr. Alan Hao  
Prof. Paul Martin 
Prof. Robert Helme 
A/Prof. Stephen Gibson  
Prof. Kai Lo 
Prof. Marc Cohen 
Dr. Yanyi Wang  
 
 
Any complaints about your participation in this project may be directed to the Executive Officer, RMIT Human Research 
Ethics Committee, Research & Innovation, RMIT, GPO Box 2476V, Melbourne, 3001.    
Details of the complaints procedure are available at:  http://www.rmit.edu.au/rd/hrec_complaints  
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Appendix 8. Inform consent form for the clinical trial 
 
Prescribed Consent Form For Persons Participating In Research 
Projects Involving Interviews, Questionnaires or Disclosure of 
Personal Information 
 
 
Portfolio  SET 
School of Health Sciences  
Name of participant:  
Project Title: Combined therapy of electroacupuncture and cognitive behavioural 
therapy for tension-type headache: a randomised controlled trial  
Name(s) of investigators:   (1) Prof Ken Greenwood Phone: 03 9925 7360 
(2) Prof Charlie Xue Phone: 03 9925 7745 
(3) Dr Zhen Zheng Phone: 03 9925 7167 
(4)  Mr Alan Hao  Phone:  03 9925 7177  
(5) Prof Paul Marin  Phone: 03 9594 1468 
(6) Prof Robert Helme Phone: 03 9740 5363 
(7) A/Prof Stephen Gibson  Phone: 03 8387 2329 
(8) Prof Kai Lo   Phone: 03 9251 7314 
(9) Prof Marc Cohen  Phone: 03 9925 7440 
(10) Dr Yanyi Wang Phone: 03 9925 7396 
 
1. I have received a statement explaining the interview/questionnaire involved in this project. 
2. I consent to participate in the above project, the particulars of which - including details of the 
interviews or questionnaires - have been explained to me. 
3. I authorise the investigator or his or her assistant to interview me or administer a questionnaire. 
4. I acknowledge that: 
 
(a) Having read Plain Language Statement, I agree to the general purpose, methods and 
demands of the study. 
(b) I have been informed that I am free to withdraw from the project at any time and to 
withdraw any unprocessed data previously supplied. 
(c) The project is for the purpose of research and/or teaching. It may not be of direct benefit to 
me. 
(d) The privacy of the personal information I provide will be safeguarded and only disclosed 
where I have consented to the disclosure or as required by law. 
(e) The security of the research data is assured during and after completion of the study.  
The data collected during the study may be published, and a report of the project 
outcomes will be provided to__me__(researcher to specify).   Any information which will 
identify me will not be used. 
 
Participant’s Consent 
 
Participant:  Date:  
(Signature) 
Witness:  Date:  
(Signature) 
Participants should be given a photocopy of this consent form after it has been signed. 
 
 
 
 
Any complaints about your participation in this project may be directed to the Executive Officer, RMIT Human Research 
Ethics Committee, Research & Innovation, RMIT, GPO Box 2476V, Melbourne, 3001.   
The telephone number is (03) 9925 2251.   
Details of the complaints procedure are available from the above address.   
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Appendix 9. Inform consent form for the clinical trial 
 
Prescribed Consent Form For Persons Participating In Research 
Projects Involving Tests and/or Medical Procedures 
 
 
Portfolio  SET 
School of Health Sciences  
Name of participant:  
Project Title: Combined therapy of electroacupuncture and cognitive behavioural 
therapy for tension-type headache: a randomised controlled trial  
  
Name(s) of investigators:  (1) Prof Ken Greenwood Phone: 03 9925 7360 
(2) Prof Charlie Xue Phone: 03 9925 7745 
(3) Dr Zhen Zheng Phone: 03 9925 7167 
(4)  Mr Alan Hao  Phone:  03 9925 7177  
(5) Prof Paul Marin  Phone: 03 9594 1468 
(6) Prof Robert Helme Phone: 03 9740 5363 
(7) A/Prof Stephen Gibson  Phone: 03 8387 2329 
(8) Prof Kai Lo   Phone: 03 9251 7314 
(9) Prof Marc Cohen  Phone: 03 9925 7440 
(10) Dr Yanyi Wang Phone: 03 9925 7396 
 
 
1. I have received a statement explaining the tests/procedures involved in this project. 
2. I consent to participate in the above project, the particulars of which - including details of tests or 
procedures - have been explained to me. 
3. I authorise the investigator or his or her assistant to use with me the tests or procedures referred 
to in 1 above. 
4. I acknowledge that: 
 
(a) The possible effects of the tests or procedures have been explained to me to my 
satisfaction. 
(b) I have been informed that I am free to withdraw from the project at any time and to 
withdraw any unprocessed data previously supplied (unless follow-up is needed for 
safety). 
(c) The project is for the purpose of research and/or teaching.  It may not be of direct benefit 
to me. 
(d) The privacy of the personal information I provide will be safeguarded and only disclosed 
where I have consented to the disclosure or as required by law. 
(e) The security of the research data is assured during and after completion of the study.  
The data collected during the study may be published, and a report of the project 
outcomes will be provided to …me……….. (researcher to specify).   Any information 
which will identify me will not be used. 
 
Participant’s Consent 
 
 
Participant:  Date:  
(Signature) 
 
 
Witness:  Date:  
(Signature) 
 
Participants should be given a photocopy of this consent form after it has been signed. 
 
 
Any complaints about your participation in this project may be directed to the Executive Officer, RMIT Human Research 
Ethics Committee, Research & Innovation, RMIT, GPO Box 2476V, Melbourne, 3001.   
The telephone number is (03) 9925 2251.   
Details of the complaints procedure are available from the above address.  . 
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Appendix 10. Plain language statement for the full-scale survey 
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Appendix 11. Migraine Disability Assessment (MIDAS) Questionnaire (English 
Version) 
 
 
 
MIDAS QUESTIONNAIRE 
 
INSTRUCTIONS:  
 
 Please answer the following questions about ALL your headaches 
you have had over the last 3 months.  
 Write your answer in the box next to each question.  
 Write zero if you did not do the activity in the last 3 months. 
 
1.  On how many days in the last 3 months did you miss work or school 
because of your headaches? 
 
[      ] days 
2.  How many days in the last 3 months was your productivity at work or 
school reduced by half or more because of your headaches?                    
(Do not include days you counted in question 1 where you missed work 
or school)  
 
[     ] days 
3.  On how many days in the last 3 months did you not do household work 
because of your headaches? 
 
[      ] days 
4.  How many days in the last 3 months was your productivity in household 
work reduced by half or more because of your headaches?   
(Do not include days you counted in question 3 where you did not do 
household work) 
 
[      ] days 
5.  On how many days in the last 3 months did you miss family, social or 
leisure activities because of your headaches? 
 
[      ] days 
TOTAL ____ days 
A   On how many days in the last 3 months did you have a headache?  
(If a headache lasted more than 1 day, count each day) 
 
[      ] days 
B    On a scale of 0–10, on average how painful were these headaches?  
(where 0 = no pain at all, and 10 = pain as bad as it can be) 
————————————————————————— 
0    1    2    3    4    5    6    7    8    9   10 
 
 
[      ] (score) 
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Appendix 12. Migraine Disability Assessment (MIDAS) Questionnaire (Chinese 
Version) 
 
 
 
MIDAS 头痛问卷 
 
填写说明:  
 
 请回答近 3 个月来有关您头痛的下列问题 
 请在每个问题后的方框内作答 
 如果您在近 3 个月内根本没有没有以下情况请以“0”作答  
 
 
1.  最近 3 个月您有多少天因为头痛而误工或缺课？  
 
[    ] 天    
2.  最近 3 个月您有多少天因为头痛而使学习或工作效率降低一半以上？                    
(不包括在第 1 问里已算的天数)   [     
[    ] 天 
3.  最近 3 个月您有多少天因为头痛而没做家务？  
 
[    ] 天 
4.  最近 3 个月您有多少天因为头痛而没做家务的效率降低一半以上？ 
(不包括在第 3 问里已算的天数) 
 
 
 
[    ] 天 
5.  最近 3 个月您有多少天因为头痛而使您放弃家庭、社会及娱乐活动？  
 
[    ] 天 
 
 
共计  ____   天 
A   最近 3 个月里您有多少天出现了头痛？ 
(如果一次头痛超过一天, 则其每一天均算为一天) 
 
 
[    ] 天 
B   用 0 – 10 级来表示头痛的剧烈程度， 您的头痛平均来说算几级？   
( 0 表示根本不痛， 10 表示难以忍受的痛) 
————————————————————————— 
0    1    2    3    4    5    6    7    8    9   10 
 
 
 
 
[    ] 分 
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Appendix 13. PSS-10 (English Version) 
 
 
 
Perceived Stress Scale (PSS-10) 
 
INSTRUCTIONS: 
 
The questions in this scale ask you about your feelings and thoughts during THE LAST MONTH. In 
each case, you will be asked to indicate your response by placing an “X” over the circle representing 
HOW OFTEN you felt or thought a certain way. Although some of the questions are similar, there are 
differences between them and you should treat each one as a separate question. The best approach 
is to answer fairly quickly. That is, don‟t try to count up the number of times you felt a particular way, 
but rather indicate the alternative that seems like a reasonable estimate. 
 
 
 
 
1. In the last month, how often have you been 
upset because of something that happened 
unexpectedly? 
 
2. In the last month, how often have you felt that 
you were unable to control the important things 
in your life? 
 
3. In the last month, how often have you felt 
nervous and “stressed”? 
 
4. In the last month, how often have you felt 
confident about your ability to handle your 
personal problems? 
 
5. In the last month, how often have you felt that 
things were going your way? 
 
6. In the last month, how often have you found 
that you could not cope with all the things that 
you had to do? 
 
7. In the last month, how often have you been 
able to control irritations in your life? 
 
8. In the last month, how often have you felt that 
you were on top of things? 
 
9. In the last month, how often have you been 
angered because of things that were outside of 
your control? 
 
10.In the last month, how often have you felt 
difficulties were piling up so high that you could 
not overcome them? 
Almost Fairly Very 
Never Never Sometimes Often Often 
 1         2      3   4        5  
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Appendix 14. PSS-10 (Chinese Version) 
 
 
压力知觉量表 (PSS-10) 
填写说明： 
这份量表询问在最近一个月来，您个人的感受和想法。这份量表一共包含 10项问题，每一
项题目都对应有以下五种可能：□从不；□偶尔；□有时；□经常；□总是 
 
请您在各项问题后勾选一个最符合您自身感受和想法的答案。虽然有些问题比较相似，但仍
有细微的差别，所以每一项问题均需作答。回答题目时请尽量以快速、不假思索的方式给出
选择以真实反映您真实的感受。 
请您回忆最近一个月来发生下列状况的频率 从不   偶尔  有时 经常 总是 
1. 对一些无法预料事情的发生而感到心烦意乱 □ □ □ □ □ 
2. 感觉无法掌控生活中重要的事情 □ □ □ □ □ 
3. 感到紧张不安或压力 □ □ □ □ □ 
4. 对处理自己私人问题的能力感到有信心 □ □ □ □ □ 
5. 感到事情发展顺心如意 □ □ □ □ □ 
6. 发现自己难以应付那些必须去做的事情 □ □ □ □ □ 
7. 能够控制日常生活中烦躁的情绪 □ □ □ □ □ 
8. 感觉事情都在自己的掌控之中 □ □ □ □ □ 
9. 因为不能控制某些超出自己能力范围的事情
而愤怒 
□ □ □ □ □ 
10. 感到困难堆积如山而无法克服 □ □ □ □ □ 
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Appendix 15. Cumulative Illness Rating Scale 
 
 
Cumulative Illness Rating Scale 0 1 2 3 4 Score 
1 Cardiac (heart only)       
2 Hypertension (rating is based on severity)       
3 Vascular (arteries, veins, lymphatics)       
4 Respiratory (lungs, bronchi, trachea)       
5 EENT (eye, ear, nose, throat, larynx)       
6 Upper GI (esophagus, stomach, duodenum, biliary and 
pancreatic trees) 
      
7 Lower GI (intestines, hernias)       
8 Hepatic (liver only)       
9 Renal (kidneys only)       
10 Other GU (ureters, bladder, urethra, prostate, genitals)       
11 Musculo-skeletal-integumentary (muscles, bone, skin)       
12 Neurological (brain, spinal cord, nerves)       
13 Endocrine-metabolic (including diabetes, hyperlipidemia, 
infections, toxicity) 
      
14 Psychiatric (dementia, depression, anxiety, agitation, 
psychosis) 
      
TOTAL SCORE       
Instructions 
0  None No impairment to that organ/ system 
1 
 
Mild Impairment does not interfere with normal activity; treatment may or may not be 
required; prognosis is excellent  
2  
 
Moderate Impairment interferes with normal activity; treatment is needed; prognosis is good 
(Examples could be gallstones, diabetes, or fractures) 
3  Severe Impairment is disabling; treatment is urgently needed; prognosis is guarded.  
4  Extremely 
Severe 
Impairment is life threatening; treatment is urgent or of no avail; prognosis is 
grave. 
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Appendix 16. List of literatures and publications included for review 
 
Textbook 
 
Author Year Publisher 
中医诊断学 邓铁涛, 郭振球 1987 人民卫生出版社 
针灸学 杨甲三 1989 人民卫生出版社 
针灸学 邱茂良, 张善忱 1985 上海科学技术出版社 
针灸学 石学敏 2002 中国中医药出版社 
针灸治疗学 杨长森, 何树槐 1985 上海科学技术出版社 
中医内科学 张伯臾, 董建华, 周仲瑛 1985 上海科学技术出版社 
中医内科学 周仲瑛 2003 中国中医药出版社 
Monograph 
 
Author Year Publisher 
中西医临床神经病学 王玉来, 高颖 1998. 中国中医药出版社 
中医治法与方剂 陈潮祖 2009 人民卫生出版社 
当代名医临证精华头痛眩晕专辑 史宇广 单书健 1997 中医古籍出版社 
中国针灸配穴疗法 王庆文, 陈德成 1995 贵州科技出版社 
头痛诊疗学 蔡日初 2006 北京科学技术出版社 
头痛辨治精华 肖国士 2007 湖南科学技术出版社  
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Appendix 17. List of journal articles from electronic databases 
 
Author 
 
Year Title  Journal 
Jensen L.B.; Jensen S.B.; 
陈钢 
1986 针刺对紧张性头痛的作用 成都中医学院学报 
刘世超 1993 慢性头痛的中医疗法 日本医学介绍 
王秀英,罗秋玲,李魁英 1993 肌收缩性头痛治验 中医药信息 
张宾辉 1994 头痛分型的临床观察与体会 浙江中医学院学报 
刘新生 1994 缓急拈痛饮治疗肌肉收缩性头痛52例 湖南中医药导报 
雍履平 1995 天王补心丹治疗紧张性头痛的体会 中医杂志 
蔡朗 1995 针罐并用治疗颈肌紧张性头痛64例 针灸临床杂志 
赵英贤; 戴宗海; 孙仲篪 1995 按摩治疗肌紧张性头痛42例 陕西中医 
谢炜; 赵云燕; 陈宝田 1996 头痛的中医治疗概况 新中医 
于万海; 成晓棉 1996 龙胆泻肝汤为主治疗肌收缩性头痛49例观察 青海医药杂志 
吴心芳 1996 中药治疗紧张性头痛48例分析 宁夏医学院学报 
孟冬祥; 樊碧发; 周书元; 郝
双林 
1996 传统针刺与安慰针刺治疗紧张性头痛的初步比较
研究 
疼痛学杂志 
吴心芳 1996 中药治疗紧张性头痛48例分析 宁夏医学院学报 
马朱红; 王荣春; 张晓燕 1997 针灸治疗紧张性头痛64例临床观察 浙江中医学院学报 
苏善候 1998 逍遥散化裁治疗紧张性头痛17例 广西中医药 
胡九东; 王嘉敏 1998 头风散治疗头痛临床疗效观察 中国中医基础医学杂志 
王芳 1998 顽固性头痛从肝论治45例临床观察 光明中医 
魏福良 1998 电针治疗紧张性头痛80例 上海针灸杂志 
王东霞 1998 低年级大学生紧张性头痛患病调查 中国校医 
林小武 1999 从肝论治紧张性头痛43例 右江民族医学院学报 
郑军 2000 紧张性头痛分型治验 天津中医学院学报 
张春光; 朱家鹏; 许晓霞 2000 黄连阿胶汤治疗紧张性头痛23例 中医药信息 
胡明 2000 中药治疗紧张性头痛40例 实用中医内科杂志 
郑军 2000 紧张性头痛分型治验 天津中医学院学报 
刘秀红; 邱建成 2001 灸囟会为主治疗紧张性头痛22例 山东中医杂志 
李劲松 2001 舒缓汤治疗肌收缩性头痛136例 湖北中医杂志 
赵世珂; 郭立华; 李春红 2001 疏肝柔肝法治疗紧张性头痛42例 山东中医杂志 
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楼仲新 2002 慢性紧张性头痛的临床观察 第四次全国中西医结合神经
系统疾病学术研讨会论文集 
张盛之 2002 综合针法治疗紧张性头痛50例 中国针灸 
吴春节; 李建 2002 针灸加中药治疗头风115例临床报告 北京中医 
靳淼 2002 疏肝益肾法治疗紧张性头痛42例 浙江中医杂志 
陆永辉 2002 齐刺法治疗紧张性头痛42例 河南中医 
彭建民 2002 电针加拔罐治疗紧张性头痛82例临床观察 河北中医 
郭万刚; 于戈; 徐钟 2003 紧张性头痛的针灸康复治疗 中国临床医生 
谢菊英, 李志 2003 针刺加推拿治疗发作性紧张性头痛37例总结 湖南中医杂志 
康瑞珍 2003 养阴疏肝法配合针刺治疗紧张性头痛58例 陕西中医 
江勇, 王敏华, 王敏, 华启海, 
李震宇, 孙涛 
2003 针刺推拿治疗紧张性头痛临床研究 针灸临床杂志  
刘济跃 2003 紧张性头痛329例舌象分析 山东中医杂志 
高建忠; 朱桂玲 2003 项针为主治疗紧张性头痛46例 针灸临床杂志 
高天宇; 杨煜飞; 段文清 2003 头风宁胶囊治疗肌性收缩性头痛62例 中医药学刊 
袁保丰 2004 针刺为主治疗紧张性头痛109例 河北中医 
李俐; 吴明霞; 郭毅坚 2004 腕踝针治疗紧张性头痛30例 福建中医学院学报 
老锦雄; 李子勇 2004 针刺醒脑法治疗紧张性头痛的临床疗效观察 广东省针灸学会第九次学术
交流会暨“针灸治疗痛症及
特种针法”专题讲座论文汇
编 
陈玉玲; 莫穗林; 温明; 胡跃
华; 饶忠东 
2004 针刺配合刮痧治疗紧张性头痛 广东省针灸学会第九次学术
交流会暨“针灸治疗痛症及
特种针法”专题讲座论文汇
编 
黄焕新 2004 紧张性头痛的心理社会因素分析 中华医学会第七次全国神经
病学学术会议论文汇编 
梅运伟 2004 温胆汤加减治疗中学生紧张性头痛46例 河南中医学院学报 
李达云; 叶子 2004 中西医结合治疗紧张型头痛107例疗效观察 浙江中西医结合杂志 
林飞英; 钟秀丹 2004 紧张性头痛的原因分析及心理护理 海南医学 
黄赫; 孟小娜; 杨媛 2004 129例士兵肌收缩性头痛病因分析 华南国防医学杂志 
田伟; 孔祥玉 2004 非急性头痛113例病因诊断体会 现代实用医学 
管荫槐 2004 平肝疏风化痰汤治疗紧张性头痛疗效观察 广西中医药 
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黄年斌; 邱联群 2004 逍遥散治疗紧张性头痛28例观察 实用中医药杂志 
聂伟 2004 柴胡疏肝散治疗紧张性头痛60例 辽宁中医学院学报 
黄文溪 2004 清肝通络汤治疗紧张性头痛 中国中医急症 
李漾; 罗纯 2005 针刺治疗紧张性头痛疗效的系统评价 中国循证医学杂志 
黄粤; 丁元庆 2005 中药治疗紧张性头痛的近况与用药规律分析 2005全国中医脑病学术研
讨会论文汇编 
阎英杰; 朱建贵 2005 朱建贵主任医师从肝论治头痛经验介绍 新中医 
高洁 2005 针刺治疗肌收缩性头痛41例 辽宁中医学院学报 
仇祝江; 张涛; 仇鞠娜 2005 头痛灵方治疗紧张性头痛38例 中国民间疗法 
衡向阳 2005 血府逐瘀汤治疗紧张性头痛56例 中国民间疗法 
李日行; 古剑雄 2005 紧张性头痛患者的病因和认知障碍分析 上海预防医学杂志 
倪瑞军; 路瑶 2005 组穴多向透刺法治疗紧张性头痛75例 针灸临床杂志 
黄粤; 丁元庆 2005 紧张性头痛病因病机探讨 山东中医药大学学报 
黄粤; 丁元庆 2005 中药治疗紧张性头痛的近况与用药规律分析 2005全国中医脑病学术研
讨会论文汇编 
黄粤 2005 紧张性头痛从络病论治探讨 2005全国中医脑病学术研
讨会论文汇编 
徐恩 2005 紧张型头痛的诊断与治疗 继续医学教育  
李晟 闫肃 2005 头痛方治疗慢性紧张型头痛68 例 陕西中医 
李超英 2006 中西医结合治疗紧张性头痛34例疗效观察 重庆医学 
甘露 2006 针灸治疗紧张性头痛的临床设计构想 中国针灸 
陈晓斌, 郭伟, 章浩军 2006 针刺治疗发作性紧张型头痛的效果评估 中国临床康复  
苏志伟, 方明星, 刘焕荣 2006 刺血通经法治疗伴有抑郁和／或焦虑症状的紧张
性头痛的临床研究 
四川中医  
熊安保 2006 针刺配合中药治疗紧张性头痛65例 实用中医药杂志 
黄粤; 丁元庆; 王志程 2006 中医药治疗紧张性头痛的近况与用药规律分析 四川中医 
颜红; 汪瑜菡; 陈立伟 2006 理气活血汤治疗慢性紧张性头痛的临床对照研究 中华医学会精神病学分会第
七届学术年会论文摘要集 
李立红; 王永武; 李生棣 2006 李生棣主任自拟通窍安神汤治疗血管紧张性头痛
54例体会 
甘肃省中医药学会第五次会
员代表大会、甘肃省针灸学
会第三次会员代表大会暨学
术研讨会论文汇编 
王金贵 2006 通脉调气腹部辨证推拿法治疗紧张性头痛75例 新中医 
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疗效观察 
李开洲; 雪强 2006 加味柴芩温胆汤治疗紧张性头痛86例 陕西中医学院学报 
毛芝芳,王晋荣 2006 电针配合按摩治疗紧张性头痛71例 浙江中西医结合杂志 
凌方明 2006
- 
紧张性头痛研究现状与治疗新思路 中医药学刊 
宋立群,赵大鹏 2006 辨证论治紧张性头痛验案 中医药信息 
何世民,蒋健 2006 偏头痛与紧张型头痛的中医治疗综述 中医药学刊 
陈秀慧,黄坚红,黄德弘,许幸仪 2006 中药内服配合穴注治疗紧张型头痛临床观察 辽宁中医药大学学报 
黄焕新 2006 紧张型头痛 52 例心理社会因素分析 南通大学学报 
施慧芬 2006 头痛 2 号方配合放松疗法治疗紧张型头痛疗效观察 上海中医药杂志 
雍胜海 2006 自拟头风灵煎剂治疗血虚和肝阳上亢型紧张性头痛
疗效研究 
《华夏医学》  
陈秀慧,黄坚红,黄德弘,许幸仪 2006 中药内服配合穴注治疗紧张型头痛临床观察 辽宁中医药大学学报 
黄坚红, 钟嘉熙 2007 钟嘉熙治疗头痛经验 实用中医药杂志 
谭涛,王金贵,孙庆,石玉生 2007 通脉调气辨证推拿法治疗紧张性头痛 150 例临床研
究 
中医杂志 
胡志强 2007 紧张型头痛临床研究进展 山东中医药大学学报 
许玲,侯东强,许坤,郭军 2007 紧张型头痛患者的生活质量与应对方式以及社会支
持的相关性研究 
中国健康心理学杂志 
孙岩,陈眉 2007 紧张型头痛中医治法刍议 中华中医药学刊 
秦燕 2007 消痛汤治疗紧张性头痛 46 例 河南中医 
郭红 2007 针刺通络法治疗紧张性头痛的临床研究 中国医药指南 
凌玲 2007 紧张性头痛中医治疗之我见 贵阳中医学院学报 
刘东敏 2007 舒窍汤治疗紧张性头痛 46 例 陕西中医 
孟庆莉 2007 正清汤治疗紧张性头痛 78 例 陕西中医 
张安生 陈志新 2007 中西医结合治疗频繁发作性紧张型头痛 62 例 武警医学 
谭涛; 王金贵; 孙庆; 石玉生 2007 通脉调气辨证推拿法治疗紧张性头痛 150 例临床研
究 
中医杂志 
沈红强 2008 针灸调心治疗紧张型头痛临床研究 实用中医药杂志 
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Appendix 18. CMHQ-1 
 
 
 
 
School of Health Sciences 
Chinese Medicine Research Group 
 
Headache Questionnaire 
 
 
Please tick the following items applied to you. (patients to complete) 
 
 
Part I. Pain description  
 
1. Pain rhythm     Continuous         Intermittent 
 
2. Please mark/shade the location of your headache 
 
 
 
3.  Please tick the following descriptions relevant to your headache   
 Pressing  Explosive  Burning  Drilling  Stabbing 
 Pounding  Vague  Pulling  Empty  Distending 
 Piercing  Dull    Throbbing   Heavy  Pulsating 
 Radiating  Tightness  Cutting or sharp  
 Others (please specify) :  
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 Part II. Aggravating and relieving factors 
4. Please tick the relevant aggravating factors of your headache 
Exercise or overwork 
 Overwork  Exercise  Cough  When tired 
 Laughing  Thinking  Swallowing  Sitting straight 
 Opening mouth  Brushing teeth  
Neck exercise 
 Turning head  Neck flexion  Washing face  Yawning     
 Eating  Sticking out tongue  Computer or reading long time 
Diet 
 Alcohol  Chocolate  Milk  Coffee 
 Ice cream  Exertion  Spicy food  MSG 
 Over consumption of oily food   
Weather 
 Change of weather   Cold weather  Windy days 
 Warm or hot weather  Humid weather or rainy days  
 Change in temperature,  
from hot to cold 
 Change in temperature,  
from cold to hot 
Menstruation 
 Before onset of menstruation bleeding 
 During menstruation bleeding  
 After the end of the menstruation bleeding 
Emotion and other factors 
Stress               Nervous   Irritability 
 Anxiety  Pregnancy   Menopause     
Others   
Please specify: 
 
5. Please tick the relevant relieving factors of your headache 
 Pressing    Rest  Sleep    Lying 
 With medications  (please specify: ……………………) 
Others Please specify: 
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Part III．Accompaning symptoms 
6. Please tick the symptoms accompanied your headache  
 Sensitive to sounds  Sensitive to light  Nausea 
 Vomiting  Dizziness  Blurred vision 
 Double vision  Neck stiffness  Fainting 
 Black out  Fatigue or tired  Cold hands and feet    
 Twitching  Weight loss  Sweating 
 Palpitations  Swollen painful eyes  Dripping eyelid 
 Tinnitus or deafness  Runny nose  Poor memory 
 Poor concentration  Diarrhoea  Weight loss 
 Poor appetite      Irritability  Chronic illness 
 Neck pain  Shoulder pain  Lower back pain 
 Weak knees  Heavy sensation in the head 
 Bitter taste in the mouth  Short-tempered, or having outbursts of anger 
 
 Others (Please specify): 
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Appendix 19. CMHQ-2 
 
Headache Questionnaire 
Please tick the listeditems or phrases to best describe your headache.  
PARTI. PAIN DESCRIPTION 
1.1  Where is your headache? (you may select as many items as applicable) 
 Front of the head  Sides of the head  Back of the head  Top of the head 
 Whole head  No particular location   
 others (pleas e specify) 
 
 
1.2  When you have headache, do you also have pain in the following areas?  
(you may select as many items as applicable) 
 Neck  Shoulder  Ears  Eyebrow  Eyes 
 Face  Cheeks  Jaw  Nose / Bridge of nose 
 others (pleas e specify) 
 
1.3What is the qualityof your headache?  (you may select as many items as applicable) 
Pressing Explosive Burning Drilling Cutting  Sharp 
Vague Distending Dull Heaviness Pulling Emptiness 
Throbbing Piercing Tightness Pulsating Radiating Pounding 
A “band-like” sensation around the head    
Others (please specify) 
 
 
 
1.4How frequent are your headaches?  (please select one only) 
Continuous (that is constant, persistent, non-stop, unceasing or uninterrupted) 
Intermittent (this is coming and going at intervals, occasional, on-and-off orperiodicallyoccurring) 
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1.5  In the past 3 months, on average, in how many days did you have a headache 
per month?  (please select one only) 
 Less than one day   Between 1 to 14 days   15 days or more  
 
1.6During the course of the day, when would you most likely have headache? 
(you may select as many items as applicable) 
 Worse in the morning  Worse in the afternoon  Worse at the end of the day 
 Worse at night  All day  
 
 
PART II. AGGRAVATING AND RELIEVING FACTORS 
2.1  What worsens your headache?(you may select as many items as applicable) 
Exercise or 
overwork 
 Overwork  Exercise  When tired 
 Physical exertion  Muscle tightness  Lack of sleep 
 Eyestrain 
(e.g., reading, computer or TV) 
  Mental strain  
(e.g., concentration, over-thinking) 
Diet  Alcohol   Coffee   Hunger / Being hungry 
 Chocolate  MSG  Cheese 
 Tea   
Weather   Change of weather  Hot weather  Cold weather 
 Windy days   Humid weather or rainy days  Change in temperature 
Emotional 
changes 
 Nervousness  Anger or irritability  Anxiety 
 Depression  Stress  Tension or conflict at 
work / or at home  
For female 
patients 
 Before period  During period  After period 
 Menopause   
Other factors  Sneezing  Teeth grinding  
Others (please specify) 
 
 
 
2.2  What relieves your headache?  (you may select as many items as applicable) 
 Rest  Lying-down  Sleeping 
 Cold drink  Gentle exercise  Eating  
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 Medication  Pressing/ pressure on the 
pain area 
 Warmth ( warm environment, 
hot shower or hot pack ) 
Others (please specify) 
 
 
 
 
PART III. ACCOMPANYING SYMPTOMS  
3.1  Do you have any of these symptoms?  (you may select as many items as applicable) 
Eye related   Dry eyes  Sore eyes  Muscle or eye twitching 
 Blurred vision  Swollen eyelids  Sensitive to light 
Mouth, ear 
and nose 
related  
 Dry mouth  Thirst  Bitter taste in the mouth 
 Sore throat  Runny nose  Sensitive to sound 
 Tinnitus (Ringing in the ears) 
Digestion 
related  
 Nausea  Vomiting  Reflux 
 Belching  Indigestion  Poor appetite 
Urine and 
bowel 
related  
 Yellowish urine  Frequent urination 
(especially at night) 
 Watery bowel motion 
 Loose bowel motion  Dry stools  Constipation 
Neck, 
shoulder 
back and 
limb related  
 Neck stiffness  Cold lower back  Knee weakness 
 Cold hands and feet/ 
Cold limbs 
 Hot sensation in the 
palms 
 
 
 
 
 
Other 
symptoms  
 Forgetfulness or poor 
memory 
 Dizziness  Fainting 
 Fatigue or feeling tired 
easily 
 Palpitation 
 
 Insomnia (difficult to fall 
asleep or maintain sleep) 
 Poor concentration  Heavy sensation in the 
body 
 Feverish sensation 
 Feeling depressed  Short of breath  Sigh often 
 Sweating upon mild 
activity 
 Night sweating  Excessive phlegm 
 Irritability 
(short-tempered) 
 
 Feeling hot easily  Feeling cold easily 
(Sensitive to low 
temperature / Catch cold 
easily) 
Others (please specify) 
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For female 
participants  
 
 Early periods  Irregular periods  Delayed periods 
 Light bleeding  Excessive bleeding  Bleeding with clots 
 Bright red menstrual 
bleeding 
 Dark menstrual 
bleeding 
 Light red menstrual 
bleeding 
 Abdominal pain during 
or before periods 
 Lower back pain during  
or before periods 
 Excessive watery 
discharge 
 Yellow discharge  
Others (please specify) 
 
 
 
 
3.2  Do you have pain in other parts of the body?  
(you may select as many items as applicable) 
 Jaw pain  Ear ache  Neck pain 
 Pain in the shoulders 
 
 Flank pain (pain in the 
lower rib area) 
 Pain in the abdominal 
 
 Pain in the upper back  Pain in the middle back  Pain in the lower back 
 Pain in the arm/hands 
 
 Pain in the leg/feet 
 
 Pain in everywhere of 
the body 
 Pain in the hips  Pain in the buttocks  
Others(please specify) 
 
 
 
 
 
 
 
 
 
  
Appendix 20. Headache brochure for TTH clinical trial 
 
 
 
  
Appendix 21. Screening questionnaire for TTH clinical trial 
 
 
 
 
 
Electroacupuncture and Cognitive-Behavioural Therapy for Tension-Type 
Headache -Expression of Interest 
 
(To be completed by the patient) 
 
Dear Participants,  
 
Thank you for your interest in participating in the study of tension-type headache. 
Please find enclosed information about the study. 
 
This questionnaire contains a number of questions to be completed. Your answers will 
help us assess whether you are suitable to participate in our study. 
 
In order to provide accurate information for this initial assessment, please read the 
information carefully prior to completing the form.  
 
Please return the completed Expression of Interest form in the enclosed prepaid 
envelope. Upon receipt of your information I will contact you to arrange an 
appointment for further assessment to confirm your suitability for this research. 
 
I look forward to your participation and thank you for taking time to fill in this form. 
 
Yours Sincerely 
 
Dr Zhen Zheng  
 
Tel:  03 9925 7167  Fax:  03 9925 7178  or  email: zhen.zheng@rmit.edu.au 
            
1. Title:       
 Mr       
 M r s       
 Miss     
 
2. Family Name: ______________       First name: _______________________ 
 
3. Date of birth: _______________    Gender     Male      Female 
 
4. Address:  Street_____________________________________________________ 
 
Suburb________________________    postcode: ______________ 
 
Email: ____________________________________________________ 
 
  
5. Telephone No: (home) __________________    (work): __________________   
    
     (mobile) ______________________________________________       
 
Best time to call you ______________________________                   
Which one do you prefer to contact with:  
 Home phone          Work phone          Mobile 
6. Emergency Contact: 
 
Name: ____________________________________________________________ 
 
Address: __________________________________________________________ 
 
Telephone No: (home) ___________________    (work) ________________ 
 
(mobile) _____________________________________________ 
 
7. Currently married/ partnered?        Yes          No 
 
8. Occupation (current): ________________________________________________ 
 
9. Education attained: __________________________________________________    
 
10. Nationality: _________________     Country of Birth: ___________________ 
 
11. Are you of Aboriginal and/or Torres Strait Island descent?  
 
   Yes                    No 
If Yes, please tick one :     Aboriginal and Torres Strait 
  Aboriginal not Torres Strait 
  Torres Strait 
 
12. How long have you suffered from headache?  _________________________ 
     
13. When did you first have tension-type headache? ________________________ 
 
14. Do you use any pain medication for headache control?   
 
    Yes                     No 
If Yes, please list the medication that you have used 
Name of 
Medication 
Dosage Frequency ( times/day 
or week) 
How long have you 
been taking it? 
    
    
  
15. Please tick () how many times you usually have a headache per month. 
  1-2 times/month 
  3-4 times/month 
  5-6 times/month 
  7-8 times/month 
  ≥ 8 times/month 
 
16. Please tick () the symptoms that happen while you have headache. 
           on both siders of the head 
  pressing and/or tightening in quality 
  NOT aggravated by routine physical activity, such as walking 
or climbing stairs 
  mild or moderate in intensity 
  Vomiting            Nausea 
  Light Sensitive       Sound Sensitive 
  Other _____________________________ 
 
17. Have you had acupuncture treatment previously? 
 
  Yes                   No 
If yes, what was the acupuncture treatment for and when? ___________ 
 
18. Have you had cognitive behavioural therapy (CBT) previously? 
 
  Yes                   No 
If yes, what was the CBT for and when? _______________ 
 
19. Can you visit the clinic 14 times in the future 3 months?     
 
      Yes                   No                   Not sure   
 
20. Do you plan to move to other city during the next 9 months? 
 
  Yes                   No  
 
21. Are you willing and able to participate in the study? 
 
  Yes                   No                    Not sure 
 
  
22. Are you currently participating in any other clinical trial research? 
 
          Yes                   No 
 
23. If you have any of the condition listed, please tick (). The researchers might ask 
more questions about your answer.   
 had head injury or whiplash before 
 suffer from migraine 
 
Please specify how often you have migraine attacks per month? ______________  
  being haemophiliac 
  Take anti-coagulants, such as aspirin or waferine  
  being pregnant (if you are female)  
  currently breast-feeding (if you are female) 
  wear a cardiac pacemaker 
  suffer from any heart arrhythmia 
 
If yes, please specify: ______________________________________________ 
  suffer from any heart disease 
 
If yes, Please specify: ______________________________________________ 
  being diagnosed with a malignancy 
 
If yes, please specify: ______________________________________________ 
  being diagnosed with a brain tumour or epilepsy 
  have any infectious diseases 
 
If yes, please specify: _______________________________________________ 
  abuse drugs or alcohol or have had a history of drug or alcohol abuse  
  take antipsychotic medications 
 
If yes, what are they and what are they for? _______________ 
  have an intellectual disability  
  Yes                                No 
 
24. Do you have any other diseases? 
 
  Yes                                No 
 
If yes, please specify: _______________________________________________ 
 
  
  
Appendix 22. Headache diary 
 
 
 
 
 
 
Headache Diary 
 
 
Date ____ to _____ 
Week No. ___ 
 
 
Trial title: 
Combined therapy of electroacupuncture and cognitive behavioural therapy for 
tension-type headache: a randomised controlled trial – a pilot study 
 
 
Contact persons: 
Dr Zhen Zheng          Mr Alan Xinyu Hao 
9925 7167               9925 7177 
 
 
 
RMIT HREC protocol number: 21/07 
TGA registration number: CTN Number 064/2008 
ANZCTR registration number: ACTRN12608000239369 
 
 
 
 
 
 
Patient Initial:         Patient No.:      Date:         
  
Headache Diary                     Baseline  
 
 
1. Do you have tension-type headache today?   
 Yes               No 
      
If yes, please indicate the headache period today. 
 
 
6am   8    10    12pm  2     4    6     8     10   12am   2   4am   6am 
 
 
2. What is the highest level of your headache today 
(0 means “no pain”;       10 means “pain as bad as it could be”) 
 
0   10 
 
 
3. What is the average level of your headache pain intensity today? 
(0 means “no pain”;       10 means “pain as bad as it could be”) 
 
       0  10 
 
 
4.  Please tick (√) the symptoms that are associated with your headache today. 
 Only headache, no other symptoms  
 Sound sensitive    Light sensitive  Nausea      
 Fatigue         Dizziness    Low back pain   
 Neck pain      Others. Please specify___________  
           
 
5. Do you have any of the following consultation today for your headache? 
 Yes              No 
If yes, please select 
  Medical doctors   Physiotherapist  Chiropractor  
  Osteopathic practitioner        Massage therapist  
  Other treatments      please specify:_____________ 
 
 
            
  
 
6. Did you take any medication for your headache today?  
 
  Yes              No         
 
If Yes, please fill in the name of the medication, how many tablets you take at one time, 
how often you take the medication and whether the medication is effective or not. Please 
give a score between 1 and 5 where 1 means the medication is not effective and 5 means the 
medication is most effective.  
(Please indicate with “*” if it is for migraine)   
 
1 means: not effective           5 means: most effective 
 
 
7. Likert Scale of Headache Severity 
 
Please tick (√) only one answer in the table below, which corresponds to the headache of 
today. 
 
   0: No headache 
   1: I notice the headache only when I pay attention to it 
   2: Mild headache that can be ignored at times 
   3: Headache is painful, but I can do my job or usual tasks 
 4: Very severe headache: I find it difficult to concentrate and can do only 
undemanding tasks 
 5: Intense, incapacitating headache 
 
 
8. Do you have migraine headache today?   
 
 Yes               No 
 
If yes, how long does it last?    _________                        
  
Medication      
Amount      
Effectiveness Scale (in each box, enter the number that best reflects the effectiveness of your 
relief) from 1(not effective) to 5 (most effective) 
 
Score 
     
  
Appendix 23. Demographic checklist for TTH clinical trial 
 
Demographic information 
 
1. Your gender:  Male      Female     
2. Your date of birth： __________________  
3. Your age range:   
 18-29    30-39   40-55   56-64   65 + 
4. Your ethnicity (please tick one): 
1. Oceanian 
 Australian Peoples 
 New Zealand Peoples 
 Melanesian and Papuan 
 Micronesian 
 Polynesian 
2. North-west European 
 British 
 Irish 
 Western European 
 Northern European 
 
3. Southern and eastern European 
 Southern European 
 South Eastern European 
 Eastern European 
 
4. Arab 
 Arab 
 Jewish 
 Other North African and Middle Eastern 
 
5. South-east Asian 
 Mainland South-East Asian 
 Maritime South-East Asian 
 
6. North-east Asian 
 Chinese Asian 
 Other North-East Asian 
 
7. Southern and central Asian 
 Southern Asian 
  
 Central Asian 
 
8. People of the Americas 
 North American 
 South American 
 Central American 
 Caribbean Islander 
 
9. Sub-Saharan African 
 Central and West African 
 Southern and East African 
 
10. Others 
  (Please specify):___________ 
 
 
5. What is your marital status? (please tick one) 
 Single  
 Married  
 Partnered / De facto 
 Divorced  
 Separated  
 Widowed 
 
6. What is your highest level of education? (please tick one) 
 Postgraduate degree level 
 Graduate diploma and graduate certificate level 
 Bachelor degree level 
 Advanced diploma and diploma level 
    (advanced deploma, deploma level and associate degree level) 
 Certificate level (certificate I-IV) 
 Secondary education (year 7-12) 
 Primary education (year 1-7) 
 Other education  (please specify:                   ) 
 
 
 
  
  
Appendix 24. Invitation email letter to experts 
 
 
                                                                    School of Health Sciences / 
 Discipline of Chinese Medicine 
 
PO Box 71 
Bundoora    VIC   3083 
Australia 
Tel. +61 3 9925 7746 
Fax +61 3 9925 7178 
 
 
Dear Professor _________ , 
 
 
Re: Invitation to provide expert opinions on a questionnaire - Chinese Medicine Diagnostic 
Questionnaire for Tension-type Headache (TTH) 
 
 
I would like to invite you to be on the advisory panel for our recently developed Chinese 
medicine Diagnostic Questionnaire for Tension-Type Headache (TTH). The development and 
validation of this questionnaire is part of my PhD project. The proposed research aims to 
establish Chinese medicine differential diagnostic criteria for TTH and identify its accompanying 
non-pain symptoms. My PhD supervisors are Dr Zhen Zheng and Prof Charlie Xue. Prof Ken 
Greenwood, a psychologist, is the consultant.  
 
As you know TTH is a Western medical diagnosis and its Chinese medicine syndrome 
differentiation is mainly based on expert opinions. To build an evidence base for TTH Chinese 
medicine diagnosis, we have developed the questionnaire based on information from textbooks 
and research papers, and have tested it a small group of TTH patients. Our next step is to test it 
with a large sample. Prior to that, we will appreciate your comments on the questionnaire.  
 
You are approached because of your academic reputation in the area of acupuncture research 
on headache, and also because of you are the external experts of our NHMRC funded clinical 
trial (Combined therapy of electroacupuncture and cognitive behavioural therapy for 
tension-type headache: a randomised controlled trial).  
 
If you agree to take part in the study, I will email you the questionnaire and our questions. Once 
completed, you can email your answers back. It will take you 30-40 minutes.  
 
I thank you in advance. I believe your expertise in the area of Chinese medicine and headache 
research will be valuable to the further development of this questionnaire.  
 
If you are willing to comment on our questionnaire, could you please reply this email either to 
me on alan.hao@rmit.edu.au, or Dr Zheng, zhen.zheng@rmit.edu.au. 
 
 
Sincerely yours,  
  
 
Alan Hao (PhD candidate; BMed)  
 
PhD supervisors 
Dr. Zhen Zheng (BMed, PhD); Prof. Charlie Xue (BMed, PhD) 
 
Consultants 
Prof. Ken Greenwood (BBehavSc, PhD) 
 
 
 
  
  
Appendix 25. Follow-up email to CM experts and detailed questions 
 
 
School of Health Sciences / 
 Discipline of Chinese Medicine 
 
PO Box 71 
Bundoora    VIC   3083 
Australia 
Tel. +61 3 9925 7746 
Fax +61 3 9925 7178 
 
 
Dear Professor _________ , 
 
 
Thank you for agreeing to comment on the 2
nd
 version of the Chinese Medicine Headache 
Questionnaire.  
 
 
Background about Chinese Medicine Headache Questionnaire 
 
This questionnaire was developed from textbook information and published papers, and 
has been revised after being tested in 16 patients with tension type of headache (TTH). 
This questionnaire is designed to identify subgroups of TTH according to Chinese 
medicine understanding of headache and accompanying symptoms.  We hope this 
questionnaire will eventually provide an evidence base for the Chinese medicine 
syndrome differential diagnosis of TTH. 
 
To develop and validate this questionnaire is part of my PhD project. The advisory expert 
panel consists of Chinese medicine and western medicine doctors and psychologists who 
specialise in treating headaches. Once we have collected the comments from you and 
other experts, we will amend the questionnaire and test its validity in a larger patient 
sample.   
 
 
What do I need to do?  
 
We appreciate your comments on the following aspects:  
1)   Completeness of the items; 
2)   Relevance of each sign and symptom; and  
3)   The format of the questionnaire.  
 
Specifically we are interested in your views on the questions as follows. 
1. Part I, PAIN DESCRIPTION: do the items listed reflect the nature of TTH? 
2. Part II, AGGRAVATING AND RELIEVING FACTORS:  Are these common 
factors reported by TTH sufferers? 
3. Part III, ACCOMPANYING SYMPTOMS:   
  
a. Chinese medicine experts: Are these items comprehensive and appropriate 
for Chinese medicine diagnoses of TTH?   
b. Non-Chinese Medicine experts: Are these symptoms commonly experienced 
by TTH sufferers?  Please comment and add additional items when 
appropriate.  
4. Part IV. Item 4.1 is the CUMULATIVE ILLNESS RATING SCALE (CIRS) with 
minor modification, aiming to assess physical comorbidity of TTH. Item 4.2 has 
been developed from WHO ICD-10 classification system to assess mental 
comorbidity of TTH. Are both items appropriate and necessary for assessing the 
comorbidity of TTH?  
  
5. Other comments  
Are the wordings clear and accurate? Please feel free to add items and 
comment on the items that can be removed.  
Do you have any other comments or suggestions? We appreciate your expert advice. Could 
you please send your reply to me within two to three weeks?  
 
If you have further questions, please feel free to contact us. 
 
 
Yours sincerely, 
 
Alan Hao 
 
PhD supervisors 
Dr. Zhen Zheng (BMed, PhD); Prof. Charlie Xue (BMed, PhD) 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
  
Appendix 26. Group comparisons of part 1 items 
 
Item Groups (frequency & percent) Chi-Square  
Ascendant 
hyperactivity of 
Liver-Yang 
Liver-Qi depression Asymp. Sig. (2-sided) 
1.1.1 Front of the head 26(60.5) 22(64.7)  
1.1.2 Sides of the head 31(72.1) 24(70.6)  
1.1.3 Back of the head 18(41.9) 20(58.8) .139 
1.1.4 Top of the head 10(23.3) 3(8.8) .093 
1.1.5 Whole head 4(9.3) 9(26.5) .046 
1.1.6 No particular location 1(2.3) 2(5.9)  
1.2.1 Neck 33(76.7) 28(82.4)  
1.2.2 Shoulder 25(58.1) 22(64.7)  
1.2.3 Ears  7(16.3) 3(8.8)  
1.2.4 Eyebrow 14(32.6) 12(35.3)  
1.2.5 Eyes 24(55.8) 15(44.1) .308 
1.2.6 Face 8(18.6) 4(11.8) . 
1.2.7 Cheeks 2(4.7) 2(5.9)  
1.2.8 Jaw 12(27.9) 7(20.6)  
1.2.9 Nose / Bridge of nose 14(32.6) 5(14.7) .071 
1.3.1 Pressing 25(58.1) 18(52.9)  
1.3.2 Explosive 2(4.7) 1(2.9)  
1.3.3 Burning 2(4.7) 1(2.9)  
1.3.4 Drilling 6(14) 5(14.7)  
1.3.5 Cutting 1(2.3) 1(2.9)  
1.3.6 Sharp  10(23.3) 14(41.2) .092 
1.3.7 Vague 8(18.6) 6(17.6)  
1.3.8 Distending 1(2.3) 1(2.9)  
1.3.9 Dull  13(30.2) 16(47.1) .130 
1.3.10 Heaviness 16(37.2) 16(47.1)  
1.3.11 Pulling 4(9.3) 2(5.9)  
1.3.12 Emptiness 2(4.7) 1(2.9)  
1.3.13 Throbbing 21(48.8) 13(38.2)  
1.3.14 Piercing 4(9.3) 2(5.9)  
1.3.15 Tightness 26(60.5) 18(52.9) .508 
1.3.16 Pulsating 13(30.2) 9(26.5) .113 
1.3.17 Radiating 8(18.6) 7(20.6) .827 
1.3.18 Pounding 16(37.2) 10(29.4) .472 
1.3.19 A “band-like” sensation around 
the head  13(30.2) 7(20.6) 
.338 
1.6.1 Worse in the morning 13(30.2) 6(17.6) .445 
1.6.2 Worse in the afternoon 19(44.2) 12(35.3) .730 
1.6.3 Worse at the end of the day 15(34.9) 8(23.5) .557 
1.6.4 Worse at night 4(9.3) 2(5.9) .848 
1.6.5 All day 13(30.2) 15(44.1) .430 
 
 
  
  
Appendix 27. Group comparisons of part 2 items 
 
Item Groups (frequency & percent) Chi-Square 
Ascendant 
hyperactivity of 
Liver-Yang 
Liver Qi depression Asymp. Sig. (2-sided) 
2.1.1 Overwork 19(44.2) 12(35.3) .429 
2.1.2 Exercise  5(11.6) 8(23.5) .166 
2.1.3 When tired  23(53.5) 16(47.1) .575 
2.1.4 Physical exertion 5(11.6) 7(20.6) .282 
2.1.5 Muscle tightness 24(55.8) 22(64.7) .429 
2.1.6 Lack of sleep 25(58.1) 13(38.2) .083 
2.1.7 Eye strain  19(44.2) 13(38.2) .599 
2.1.8 Mental strain  24(55.8) 18(52.9) .802 
2.1.9 Alcohol  14(32.6) 7(20.6) .242 
2.1.10 Coffee  7(16.3) 3(8.8) .334 
2.1.11 Hunger / Being hungry 17(39.5) 19(55.9) .153 
2.1.12 Chocolate 8(18.6) 5(14.7) .650 
2.1.13 MSG 6(14) 5(14.7) .925 
2.1.14 Cheese 0 2(5.9) .107 
2.1.15 Tea 2(4.7) 2(5.9) .809 
2.1.16 Change of weather 11(25.6) 5(14.7) .243 
2.1.17 Hot weather 16(37.2) 9(26.5) .318 
2.1.18 Cold weather 4(9.3) 5(14.7) .464 
2.1.19 Windy days 7(16.3) 3(8.8) .334 
2.1.20 Humid weather or rainy days 6(14) 2(5.9) .249 
2.1.21 Change in temperature 13(30.2) 5(14.7) .110 
2.1.22 Nervousness 19(44.2) 12(35.3) .429 
2.1.23 Anger or irritability 28(65.1) 16(47.1) .112 
2.1.24 Anxiety 29(67.4) 21(61.8) .604 
2.1.25 Depression 13(30.2) 8(23.5) .512 
2.1.26 Stress 39(90.7) 29(85.3) .464 
2.1.27 Tension or conflict at work / or 
at home 25(58.1) 21(61.8) 
.747 
2.1.28 
Before period 
10(33.3%) in 30 
Female 14(58.3) in 24 Female 
.052 
2.1.29 During period 9(30%) in 30 Female 11(45.8) in 24 Female .160 
2.1.30 After period 3(10%) in 30 Female 4(16.7) in 24 Female .468 
2.1.31 Menopause 6(20%) in 30 Female 0 in 24 Female .023 
2.1.32 Sneezing 2(4.7) 1(2.9) .700 
2.1.33 Teeth grinding 16(32.6) 4(11.8) .032 
2.2.1 Rest 25(58.1) 19(55.9) .842 
2.2.2 Lying-down 19(44.2) 15(44.1) .995 
2.2.3 Sleeping 28(65.1) 23(67.6) .816 
2.2.4 Cold drink 5(11.6) 1(2.9) .158 
2.2.5 Gentle exercise 11(25.6) 4(11.8) .128 
2.2.6 Eating  9(20.9) 5(14.7) .482 
2.2.7 Medication 28(65.1) 23(67.6) .816 
2.2.8 Pressing/ pressure on the pain 
area 22(51.2) 13(38.2) 
.258 
2.2.9 Warmth ( warm environment, 
hot shower or hot pack ) 14(32.6) 12(35.3) 
.801 
 
  
  
Appendix 28. Group comparisons of part 3 items 
 
Item Groups (frequency & percent) Chi-Square  
Ascendant 
hyperactivity of 
Liver-Yang 
Liver Qi depression Asymp. Sig. (2-sided) 
3.1.1 Dry eyes 10(23.3) 6(17.6) .547 
3.1.2 Sore eyes 17(39.5) 11(32.4) .515 
3.1.3 Muscle or eye twitching 12(27.9) 8(23.5) .664 
3.1.4 Blurred vision 9(20.9) 5(14.7) .482 
3.1.5 Swollen eyelids 3(7) 2(5.9) .847 
3.1.6 Sensitive to light 29(67.4) 10(29.4) 0.001 
3.1.7 Dry mouth 11(25.6) 3(8.8) .058 
3.1.8 Thirst 14(32.6) 3(8.8) 0.013 
3.1.9 Bitter taste in the mouth 5(11.6) 3(8.8) .689 
3.1.10 Sore throat 3(7) 3(8.8) .764 
3.1.11 Runny nose  1(2.3) 5(14.7) .044 
3.1.12 Sensitive to sound 23(53.5) 8(23.5) 0.008 
3.1.13 Tinnitus (Ringing in the ears) 8(18.6) 5(14.7) .650 
3.1.14 Nausea 22(51.2) 15(44.1) .539 
3.1.15 Vomiting 6(14) 5(14.7) .925 
3.1.16 Reflux 3(7) 4(11.8) .468 
3.1.17 Belching 1(2.3) 2(5.9) .423 
3.1.18 Indigestion 5(11.6) 4(11.8) .985 
3.1.19 Poor appetite 11(25.6) 4(11.8) .128 
3.1.20 Yellowish urine 6(14) 2(5.9) .249 
3.1.21 Frequent urination  8(18.6) 6(17.6) .914 
3.1.22 Watery bowel motion 3(7) 3(8.8) .764 
3.1.23 Loose bowel motion 6(14) 2(5.9) .249 
3.1.24 Dry stools 2(4.7) 2(5.9) .809 
3.1.25 Constipation 11(25.6) 4(11.8) .128 
3.1.26 Neck stiffness  34(79.1) 31(91.2) .146 
3.1.27 Cold lower back  2(4.7) 5(14.7) .128 
3.1.28 Knee weakness 5(11.6) 2(5.9) .384 
3.1.29 Cold hands and feet/ Cold limbs 11(25.6) 14(42.1) .147 
3.1.30 Hot sensation in the palms 5(11.6) 0 .040 
3.1.31 Forgetfulness or poor memory 20(46.5) 12(35.3) .321 
3.1.32 Dizziness 14(32.6) 11(32.4) .985 
3.1.33 Fainting 0 0 -- 
3.1.34 Fatigue or feeling tired easily 32(74.4) 20(58.8) .147 
3.1.35 Palpitation 3(7) 1(2.9) .428 
3.1.36 Insomnia (difficult to fall asleep 
or maintain sleep) 18(41.9) 10(29.4) 
.259 
3.1.37 Poor concentration 28(65.1) 21(61.8) .761 
3.1.38 Heavy sensation in the body 6(14) 3(8.8) .487 
3.1.39 Feverish sensation 7(16.3) 3(8.8) .334 
3.1.40 Feeling depressed 16(37.2) 12(35.3) .862 
3.1.41 Short of breath 1(2.3) 6(17.6) .020 
3.1.42 Sigh often 10(23.3) 9(26.5) .745 
3.1.43 Sweating upon mild activity 7(16.3) 2(5.9) .159 
3.1.44 Night sweating 3(7.0) 3(8.8) .764 
3.1.45 Excessive phlegm 2(4.7) 3(8.8) .461 
3.1.46 Irritability  28(65.1) 10(29.4) 0.002 
3.1.47 Feeling hot easily  8(18.6) 6(17.6) .914 
3.1.48 Feeling cold easily (Sensitive to 
low temperature / Catch cold 
easily) 10(23.3) 8(23.5) 
.978 
3.1.49 Early periods  2(6.7) in 30 Female 1(4.2) in 24 Female .700 
3.1.50 Irregular periods  0 in Female 1(4.2) in Female .258 
3.1.51 Delayed periods  0 in Female 1(4.2) in Female .258 
  
3.1.52 Light bleeding 4(13.3) in Female 3(12.5) in Female .942 
3.1.53 Excessive bleeding 6(20%) in Female 2(8.3) in Female .249 
3.1.54 Bleeding with clots 9(30%) in Female 6(25) in Female .718 
3.1.55 Bright red menstrual bleeding 4(13.3%) in Female 3(12.5) in Female .942 
3.1.56 Dark menstrual bleeding 8(26.7%) in Female 5(21) in Female .650 
3.1.57 Light red menstrual bleeding  3(10%) in Female 1(4.2) in Female .428 
3.1.58 Abdominal pain during or 
before periods 14(46.7%) in Female 10(42) in Female 
.767 
3.1.59 Lower back pain during or 
before periods 10(33.3%) in Female 9(37.5) in Female 
.745 
3.1.60 Excessive watery discharge 2(6.7%) in Female 2(8.3) in Female .809 
3.1.61 Yellow discharge 2(6.7%) in Female 3(12.5) in Female .461 
3.2.1 Jaw pain 13(30.2) 7(20.6) .338 
3.2.2 Ear ache 9(20.9) 3(8.8) .146 
3.2.3 Neck pain 28(65.1) 26(76.5) .280 
3.2.4 Pain in the shoulders 21(48.8) 22(64.7) .164 
2.2.5 Flank pain (pain in the lower rib 
area) 2(4.7) 2(5.9) 
.809 
3.2.6 Pain in the abdominal 5(11.6) 1(2.9) .158 
3.2.7 Pain in the upper back 11(25.6) 5(14.7) .243 
3.2.8 Pain in the middle back 3(7) 5(14.7) .270 
3.2.9 Pain in the lower back 14(32.6) 9(26.5) .562 
3.2.10 Pain in the arm/hands  4(9.3) 3(8.8) .942 
3.2.11 Pain in the leg/feet 6(14) 4(11.8) .777 
3.2.12 Pain in everywhere of the body 0 0 --- 
3.2.13 Pain in the hips 6(14) 5(14.7) .925 
3.2.14 Pain in the buttocks 1(2.3) 1(2.9) .866 
 
  
  
Appendix 29. CMHQ-3 (English version) 
 
 
Chinese Medicine Headache Questionnaire 
 
 
Please tick the listed items that best describe your headache and other symptoms you experienced 
over the last 3 months. 
 
PART I. PAIN DESCRIPTION 
1.1  In which areas does your headache mostly occur and how often?  
 (Please tick () one box for each item) 
Location of headache Never Seldom Sometimes Often Almost always 
Forehead(front of the head)      
Side of the head(left side)      
Side of the head(right side)      
Back of the head      
Top of the head      
Whole head      
No particular location      
Other(Please specify) 
 
 
 
 
1.2  When you have a headache, do you ever have discomfort (pain, tensionor tenderness) in the 
following areas? 
(Please tick () one box for each item) 
Affected area Never Seldom Sometimes Often Almost always 
Neck      
Shoulders      
Ears      
Eyebrow      
Eyes      
Face      
Cheeks      
Jaw      
Nose / bridge of nose      
Other(Please specify) 
 
 
  
1.3  What is the sensation of your headache?   
(Please tick ()as many items as applicable) 
 Pressing  Explosive  Burning  Drilling  Cutting 
 Sharp  Vague  Heavy  Dull  Throbbing 
 Pulling  Empty  Tight  Distending  Piercing 
 Pulsating  Radiating  Pounding  A “band-like” sensation around the head 
Other(Please specify) 
 
 
 
 
1.4  When you have a headache, what is the nature of the headache?   
(Please tick () one box for each item) 
 Never Seldom Sometimes Often Almost always 
Fixed  
(headache with fixed location)      
Moves 
(headache moves around the head 
or shifting from side to side) 
     
Continuous  
(constant, persistent, non-stop 
headache) 
     
Intermittent 
(headache comes and goes,occasional, 
orperiodicallyoccurring) 
     
 
 
1.5  Over the last 3 months, on average, how many days per month did you have a headache?  
(Please tick () one of the three options)  
 Less than one day   Between 1 and 14 days   15 days or more  
 
 
1.6  During the course of the day, when does your headache get worse? 
(Please tick ()as many items as applicable) 
 Worse in the morning  Worse in the afternoon  Worse at the end of the day 
 Worse at night  All day  No particular time 
 
  
PART II. AGGRAVATING AND RELIEVING FACTORS 
2.1  What aggravates your headache?(Please tick () one box for each item) 
Increased tension Don’t 
know 
Never Seldom Sometimes Often Almost always 
Overwork  
(e.g., prolonged working hours, 
long periods of studying / typing) 
      
When tired       
Mental strain (e.g., 
over-thinking or other 
concentration) 
      
Eyestrain 
(e.g., reading, computer or TV)       
Muscular strain  
(muscle tightness)       
Physical labour       
Lack of sleep       
Poor posture in sitting, 
standing or sleeping 
      
Diet Don’t 
know 
Never Seldom Sometimes Often Almost always 
Alcohol       
Coffee       
Dehydration       
Hunger / being hungry       
Chocolate       
Cigarette smoking       
Soft drink / sodas       
Tea       
Cheese       
Dairy foods  
(e.g., milk, ice cream, etc.)       
Monosodium 
glutamate(MSG) 
      
Sugar / too much sugar       
Spicy food        
Over consumption of oily 
food 
      
Irregular diet 
(e.g., eating on the run, skip 
meals) 
      
Weather Don’t 
know 
Never Seldom Sometimes Often Almost always 
Change of weather       
Change in temperature       
Exposure to bright lights or 
sunshine 
      
Hot weather       
  
Cold weather       
Windy days       
Damp weather / Humid 
weather 
      
Rainy days       
Stress and emotional 
changes 
Don’t 
know 
Never Seldom Sometimes Often Almost always 
Stress       
Nervousness       
Anger or irritability       
Anxiety (excessive worry)       
Depression  
(feeling unhappy or depressed)       
Tension or conflict related  
(e.g., from financial constraints, 
family, relationship and / or work) 
      
Other factors Don’t 
know 
Never Seldom Sometimes Often Almost always 
Sneezing       
Teeth grinding       
Other(Please specify) 
 
 
 
 
 
2.2  What relieves your headache?  (Please tick () one box for each item) 
 Don’t 
know 
Never Seldom Sometimes Often Almost always 
Rest       
Lying-down       
Sleeping       
Medication       
Exercise / light exercise       
Massage       
Pressing/ applying pressure 
on the pain area 
      
Eating       
Warmth  
(e.g., warm environment, hot 
drink, hot pack, hot shower, etc.) 
      
Coldness  
(e.g., cold environment, cold drink, 
cold pack, cold shower, etc.) 
      
Other(Please specify) 
 
  
PART III. ACCOMPANYING SYMPTOMS 
 
3.1  Do you have any of the following symptoms that may or may not be related to your headache? 
(Please tick () one box for each item) 
Eye related  Never Seldom Sometimes Often Almost always 
Sensitivity to light (or to bright lights)      
Dry eyes      
Teary eyes      
Blurred vision      
Sore eyes      
Red eyes      
Swollen eyelids      
Eye twitching      
Floaters in the eyes      
Burning sensation in the eyes      
Itchy sensation in the eyes      
Face related (mouth, ear and nose)  Never Seldom Sometimes Often Almost always 
Sensitivity to sound (or to loud noises)      
Dry mouth       
Thirst      
Bitter taste in the mouth      
Runny nose      
Sore throat / feeling of foreign body in 
the throat 
     
Ear discharge      
Tinnitus (ringing in the ears)      
Flushed face / hot red face      
Digestion related Never Seldom Sometimes Often Almost always 
Nausea      
Vomiting      
Reflux      
Belching      
Bloating / flatulence       
Indigestion      
Poor appetite / loss of appetite      
Urine and bowel related Never Seldom Sometimes Often Almost always 
Yellowish urine      
Frequent urination (especially at night)      
Watery bowel motion      
Loose bowel motion      
Dry stools      
Constipation      
  
Muscles and joints related Never Seldom Sometimes Often Almost always 
Joint stiffness      
Neck stiffness       
Muscle twitching      
Weak legs and knees      
Feeling weak in the lower back      
Feeling cold in the lower back, or 
lower back pain worsened by coldness  
     
Cold hands and feet/ cold limbs      
Hot sensation in the palms      
“Pins and needles” or numbness in 
the hands and / or feet 
     
Other symptoms Never Seldom Sometimes Often Almost always 
Increased forgetfulness or poor 
memory      
Feeling depressed      
Irritability / Irascibility 
(short-tempered, easily angered) 
     
Restlessness       
Fatigue / tiredness      
Faintness      
Heavy sensation in the body      
Insomnia (difficulty falling asleep or 
staying asleep) 
     
Sighing often      
Feverish sensation      
Shortness of breath      
Dizziness      
Excessive phlegm      
Palpitation (feeling the heart beats 
quickly or unusually) 
     
Inability to concentrate      
Night sweating      
Sweating upon mild activity      
Aversionto cold or fear of being cold      
Aversionto hot or fear of being hot      
Sensitive to temperature changes      
Other(Please specify) 
 
 
  
3.2  Apart from headache, do you experience pain in any other parts of your body?  
(Please tick () as many items as applicable) 
 Neck    Shoulder    Jaw   Throat 
 Ears   Eyes   Chest  Breasts 
 Upper back    Middle back  Lower back  Abdomen 
 Arms    Legs   Knees  Heel 
 Hips  Buttocks  Flank  
(side of the body) 
 Hypochondria 
(lower abdomen) 
Other(Please specify) 
 
 
3.3  Information related to women’s health (Only female participants need to fill in this section. This 
section is about women’s health which may relate to your headache.) 
3.3.1  Do you still have periods? 
 
 NO 
If NO, please ignore section (3.3.2) and tick the following reasons 
 Menopause 
 Hysterectomy 
 Contraceptive pill 
 Other medication 
 Other underlying diseases 
 Pregnancy 
 Others  (please specify:                                              ) 
 YES If YES, please complete the next section (3.3.2) 
 
3.3.2  Information related to women’s health (continued)(Please tick () one box for each item) 
 Never Seldom Sometimes Often Almost always 
Irregular period cycle      
Early periods  
(shortened menstrual cycle)      
Delayed periods  
(prolonged menstrual cycle)      
Light bleeding 
(bleeding less than normal) 
     
Excessive bleeding      
Bleeding with clots      
Bright red coloured menstrual blood      
Light red coloured menstrual blood      
Dark coloured menstrual blood      
Excessive watery discharge      
Yellow discharge      
  
3.3.2continued Never Seldom Sometimes Often Almost always 
Headache before period      
Headache during period      
Headache after period      
Abdominal pain before periods      
Abdominal pain during periods      
Abdominal pain after periods      
Lower back pain before periods      
Lower back pain during periods      
Lower back pain after periods      
Other(Please specify) 
 
 
 
 
PART IV.  OTHER CONDITIONS 
 
4.1  Do you have any other diseases or health conditions diagnosed by your medical doctor? 
NO  
  YES If YES, please tick the following listed conditions that apply to you. 
(Please tick () as many items as applicable) 
  Cardiac Heart problem(such ascardiopathy, pericarditis, coronary heart 
disease,myocarditis, angina, myocardial infarction,arrhythmia, valve problems) 
  Vascular Circulatory problem (such as peripheral atheroscleroticdisease, aneurysm of 
the abdominal aorta),hypertension or cholesterol problem. 
  Hematological Blood problem (Anemia, leukemia, hypercoagulabilityor any other problem 
affecting the blood, theblood cells, the spleen or the lymphatic system) 
  Respiratory 
 
Respiratory problem (such asasthma, emphysema,bronchitis, pulmonary 
embolismor any problems related to the lungs, bronchi, trachea.) 
  Ophthalmological and 
otorhinolaryngology 
Problems of the eyes (such as glaucoma, cataract, loss of vision); ears (such as 
important hearingimpairment, otitis media); nose (such as sinusitis, rhinitis); 
throat (pharyngitis),and voice. 
  Upper gastrointestinal(does 
not include diabetes) 
Problems of thestomach or digestion(such asproblems of the esophagus, 
stomach, andduodenum (such as gastritis, peptic ulcer, duodenal ulcer, etc.).  
  Lower gastrointestinal Intestinal problems (such as intestinal hernias,enteritis,intestinal tuberculosis, 
chronic diarrhea, colitis, constipation, anal problems andbowel incontinence.) 
  Hepatic and pancreatic 
 
Problems of the liver (impairment in function,liver infection, etc.), pancreas 
(such as pancreatitis), gallbladder (such as cholecystitis).  
  Renal 
 
Problems of the kidneys (Impairment in function,kidney infection, etc.) 
  Genito-urinary Problems of the urination system, such as ureters, bladder, urethra, prostate 
and genitals (such askidney stone, urinary incontinence, bladder infection, 
  
prostate diseases, sexual dysfunction, etc.). 
  Musculo-skeletal-integu
mentary 
Problems of the muscles, joints, bones, connective tissue and skin. (such as 
fibromyalgia,rheumatoid arthritis,osteoarthritis, osteoporosis, other forms of 
arthritis, carpal tunnel syndrome,Sjogren’s syndrome, systemic lupus 
erythematosus,polymyositis etc.)and any skin (such as atopic dermatitis, 
eczema, herpes, etc.) or other musculoskeletal problems. 
  Neurological Neurological (brain, spinal cord, nerves) problem (such ascerebrovascular 
accident,peripheral neuropathy, facial neuritis, polyneuropathy, Gearan-Kaizer 
syndrome, myelitis,myasthenia gravis, multiple sclerosis, etc.) 
  Endocrine-metabolic Problems of the thyroid gland, obesity, diabetes, orany other hormonal 
problems. 
  Psychiatric 
 
Problems of depression, anxiety, alcohol, drugabuse, or other problems. 
 Female hormonal and 
reproductive  
(for females only) 
Problems of reproductive system (such asthe uterus, ovary, fallopian tubes etc.) 
and other gynaecologicalproblems (such as premenstrual syndrome, polycystic 
ovary syndrome, pelvic inflammatory disease, etc.) 
  Other(Please specify) 
 
 
4.2  Have you been diagnosed by a medical doctor with any of the following mental health conditions? 
  NO       
  YES        If YES, please tick the following listed conditions that apply to you. 
 Anxiety disorders 
 
Includes Anxiety, Panic Disorder, Obsessive-Compulsive Disorder, 
Post-Traumatic Stress Disorder, Agoraphobia, Social Phobia, etc. 
 Mood disorders 
 
Includes Depression, Mania, Bipolar (Affective) Disorder, etc. 
 Substance use disorders Includes dependence or harmful use of alcohol, or drugs (opioids, sedatives, 
stimulants,cannabinoids, petrol, glue, etc).  
 Other (Please specify) 
 
 
Thank you for completing this questionnaire. 
Wishing you all the best in health and happiness! 
  
  
Appendix 30. CMHQ-3 (Chinese version) 
中医头痛问卷 
 
这份头痛问卷旨在收集您对最近 3個月來的头痛及身体其他症状的感受。请逐项回答，并从下列五种程度
中勾选最适合的一项： 
从不 偶尔 有时 经常 总是   
 
第一部分  疼痛描述 
1.1 请选择您的头痛部位并给出相应程度  
头痛部位 从不 偶尔 有时 经常 总是 
前额痛      
侧头痛（左侧）      
侧头痛（右侧）      
后头痛      
头顶痛      
整个头部疼痛      
头痛无特定区域      
其他部位（请描述） 
 
 
 
 
1.2 当您头痛发作的时候，下列部位也会有疼痛或不适的感觉吗？ 
累及部位 从不 偶尔 有时 经常 总是 
颈项      
肩      
耳朵      
眉弓      
眼睛      
脸      
面颊      
下巴      
鼻/鼻梁      
其他部位（请描述） 
 
 
  
 
 
1.3 请在下列条目中勾选您头痛的性质（可选多项） 
 压迫性疼痛  爆炸性疼痛  烧灼样疼痛  钻孔样疼痛  刀割样疼痛 
 尖锐性疼痛    头痛隐隐  疼痛伴有沉重感  钝痛  抽搐痛（颤痛,跳痛） 
 牵拉样疼痛  头脑空痛  紧箍样疼痛  胀痛  刺痛（锥刺,戳刺） 
 搏动性疼痛  扩散性疼痛  打击或撞击样疼痛  头痛如裹（头痛如有如布包裹般） 
其他性质的疼痛（请描述） 
 
 
 
 
1.4 请勾选您每次头痛发生的性质 
 从不 偶尔 有时 经常 总是 
头痛固定不移 
     
头痛游走不定 
     
连续性疼痛 
(头痛不停歇，持久，不断，
不减轻或无间隔) 
     
间歇性疼痛 
(头痛时去时来，或来或止)      
 
 
 
1.5 在过去的 3个月里，平均每个月您有多少天头痛？（仅选一项） 
 每月少于一天   每月 1天至 14天   每月多于 15天  
 
 
 
1.6 在一天中的什么时候，您的头痛会加重？（可选多项） 
 清晨  下午  傍晚 
 夜间 全天  无特定时间 
 
  
第二部分  头痛加重及减缓因素 
2.1 以下哪些因素会使您头痛程度加重？ 
疲劳和紧张 不知道 从不 偶尔 有时 经常 总是 
过度操劳 
(例如长时间学习,工作) 
      
困倦时       
精神疲倦  
(例如过度专注或思虑过度) 
      
眼部疲劳 
(用眼过度，例如久视书报、
电视或电脑屏幕) 
 
 
 
 
 
 
 
 
 
 
 
 
肌肉紧张       
体力劳动       
睡眠不足       
不良姿势 
(站姿,坐姿,睡姿等)  
      
饮食 不知道 从不 偶尔 有时 经常 总是 
酒类       
咖啡       
身体水分不足 
(饮水不足，脱水等) 
      
饥饿       
巧克力       
抽烟       
碳酸饮料/苏打水       
茶       
奶酪/芝士       
奶制品(如牛奶冰激凌等)       
味精       
糖       
辛辣食物        
油腻食物       
不良饮食习惯       
天气 不知道 从不 偶尔 有时 经常 总是 
天气变化       
温度变化       
阳光或日晒       
炎热天       
寒冷天       
多风天气       
潮湿气候       
下雨天       
  
压力和情致变化 不知道 从不 偶尔 有时 经常 总是 
压力 
(各种情况导致的心理压力) 
      
紧张不安       
心烦易怒(急躁易怒)       
焦虑(过度担忧)       
抑郁(情绪低落,不快）       
来自工作或家庭的紧张或
冲突(如财务困扰,家庭/人际
关系等) 
 
 
 
 
 
 
 
 
 
 
 
 
其他原因 不知道 从不 偶尔 有时 经常 总是 
因打喷嚏头痛加重       
因夜间磨牙头痛加重       
其他诱发因素（请描述） 
 
 
 
 
 
 
 
2.2 以下哪些因素会使您头痛程度减轻？ 
减缓因素 不知道 从不 偶尔 有时 经常 总是 
休息       
平躺或卧床       
睡眠       
西药(如止痛片)       
运动锻炼 
(如跑步,游泳,太极,瑜伽等) 
      
推拿       
压迫或按摩痛处       
吃饭，进食       
头痛得热则减  
(如处于温暖的环境中，或靠
近热源,洗热水澡,热敷等,热
饮等) 
 
 
 
 
 
 
 
 
 
 
 
 
头痛遇寒则减  
(寒凉的环境如乘凉,冷敷,冷
饮,洗凉水澡等) 
      
其他缓解因素（请描述） 
 
 
  
第三部分  伴随症状及体征 
3.1 您平时是否伴有下列症状? 
眼部  从不 偶尔 有时 经常 总是 
畏光，羞明（对光线敏感）      
眼睛干涩      
流眼泪，迎风流泪      
视力模糊      
眼睛酸胀      
目赤或眼睛常伴有血丝      
眼睑肿胀      
眼部周围肌肉跳动，抽搐      
飞蚊症（眼前时常出现小斑小点飞舞）      
眼睛有烧灼感      
眼睛发痒      
颜面，耳，鼻，喉  从不 偶尔 有时 经常 总是 
畏声（对声音敏感）      
口干      
口渴      
口苦      
流鼻涕      
咽喉不适（干、痒、酸、胀）      
耳内流脓，耳道流溢黄水      
耳鸣或耳聋      
面红（脸颊潮红）      
消化 从不 偶尔 有时 经常 总是 
恶心      
呕吐      
反胃      
嗳气吞酸       
腹胀      
消化不良      
食欲不振                                                                                         
大小便 从不 偶尔 有时 经常 总是 
小便黄      
小便频多（夜间尤甚）      
便溏（大便稀溏或水样大便）      
腹泻（大便不成形，一日多于 3 次或伴
有腹痛） 
     
大便干结      
便秘（大便每 2～3 天或更长时间一次）      
  
肌肉关节 从不 偶尔 有时 经常 总是 
关节拘紧僵硬      
颈项拘紧僵硬      
肌肉不自觉跳动或颤动      
两膝酸软无力      
腰背酸软无力      
腰背部易觉寒冷      
手足冰凉易觉寒冷      
掌心发热（手足心发热或发烫）      
手足，四肢麻木或针刺样疼痛      
其他症状 从不 偶尔 有时 经常 总是 
健忘      
情绪低落      
急躁易怒       
烦躁不安      
倦怠乏力，容易疲倦      
晕厥      
自感身体困重       
失眠（难以入眠或易醒）      
善叹息（经常不自觉或不经意的叹气)      
烦热（自觉低热）      
胸闷气紧      
眩晕      
平素多痰      
心悸（自觉心脏跳动加速或心跳异常）      
注意力难集中      
夜间汗出（盗汗）      
容易出汗（自汗）      
怕热，不耐热      
畏寒，怕风寒      
对温度变化敏感      
其他伴随症状（请说明） 
 
 
 
  
3.2 您平时是否还有其他部位的疼痛？ 
颈项 肩部 下颌 喉咙 
耳朵（耳轮耳廓） 眼睛 胸部 乳房 
上背部  中背 下背，后腰 腹部 
手臂 腿脚 膝盖 足后跟 
髋部，胯部 臀部 躯干两侧 胸胁(肋骨下方) 
其他（请说明） 
 
 
3.3 女性患者相关信息（女性患者填写） 
3.3.1 您停经了吗？ 
 
是的，我已经停经了 
如果您已停经，请勾选下列原因并忽略本节条目 3.3.2 
 绝经期 
 子宫切除 
 由于服用避孕药停经 
 由于服用其他药物停经 
 其他疾病导致停经 
 怀孕 
 其他原因 （请说明                               ） 
不是，我还有月经 如果您还有月经，请完成本节条目 3.3.2 
 
3.3.2 月经相关信息 
 从不 偶尔 有时 经常 总是 
月经不调，月经先后无定期 
(月经周期或前或后 1-2 周) 
     
月经先期(月经周期提前七天以上)      
月经后期(月经周期延后七天以上)       
月经量少      
月经过多      
月经伴瘀块      
经血颜色鲜红      
经血颜色淡红      
经血颜色黯红      
白带过多或呈水样      
白带偏黄      
  
 从不 偶尔 有时 经常 总是 
头痛发作于月经前      
头痛发作于月经期间      
头痛发作于月经结束后      
月经前腹痛      
月经期间腹痛      
月经结束后腹痛      
月经前期腰痛      
月经期间腰痛      
月经结束后腰痛      
其他（请说明） 
 
 
 
第四部分  其他疾患 
4.1 您是否还被明确诊断患有其他疾病? 
否  
 是      如是，请勾选以下相应类别条目（可选多项） 
   心脏相关 心脏方面的疾患，如心脏病，心包炎，冠状动脉疾病，心肌炎，心绞痛，
心肌梗塞，心律不齐等 
   血管相关 血液循环方面的疾患，如周边动脉粥样硬化疾病，腹主动脉瘤，高血压及
胆固醇相关疾病 
   血液相关 血液相关的疾患， 如贫血，白血病，血液高凝状态等，及其他与血液细
胞，脾脏及淋巴系统相关的疾病 
   呼吸系统相关 
 
呼吸系统相关的疾患，如哮喘，肺气肿，支气管炎，肺栓塞及其他与肺，
气管、支气管相关的疾病 
   五官相关 
（眼,耳,鼻,咽喉） 
五官科疾患（如青光眼，白内障等；听力受损，中耳炎；鼻炎，鼻窦炎；
咽炎等） 
   上消化道相关 
 
胃及十二指肠疾病等消化方面疾患如胃炎，消化性溃疡，十二指肠溃疡等 
   下消化道相关 肠道，肛门等部位的疾患如小肠疝，肠炎，肠结核，慢性腹泻，结肠炎，
便秘，肠道失禁等 
   肝脏相关 肝脏，胆囊，胰腺相关的疾患。如肝功能损伤，肝脏感染；胰腺炎；胆囊
炎等 
   肾脏相关 
 
肾脏疾患。如肾功能损伤，肾脏感染等 
   生殖-泌尿系统相关 尿道，膀胱，输尿管，前列腺相关等生殖泌尿相关的疾患。如肾结石，
  
尿失禁，膀胱感染，前列腺炎，性功能障碍等 
   肌肉-骨骼-皮肤系统相关 肌肉，骨骼，关节，结缔组织及皮肤的疾患。如纤维肌痛，骨质疏松症，
风湿性关节炎，骨关节病及其他形式的关节炎；腕管综合征，干燥综合症
（修格兰氏症），系统性红斑狼疮，多发性肌炎；过敏性皮炎，湿疹，疱
疹；或其他肌肉骨骼疾病 
   神经系统相关 神经系统（大脑，脊髓，神经等）疾患，如脑血管意外，周围性神经疾
患，面部神经炎，多发性神经炎，格林-巴利综合征，脊髓炎，重症肌无
力，多发性硬化等 
   内分泌-代谢相关 
 
代谢相关疾患，甲状腺病变，肥胖，糖尿病或其他激素相关疾病 
   精神心理相关 
 
精神科相关疾患如抑郁，焦虑，药物滥用等 
  妇科相关 
 
子宫，卵巢，输卵管等生殖相关及其他妇科疾患如经前期综合症，多囊
卵巢综合症，盆腔炎等 
   其他（请说明）  
 
 
4.2  您有无确诊的精神疾患？ 
 无       
 有      如有，请勾选以下相应类别条目（可选多项） 
焦虑性障碍（焦虑症） 如恐慌症，焦虑症，创伤后压力心理障碍症，强迫症，广场恐惧症，社
交恐惧症等。 
心境障碍（情感性障碍） 
 
如抑郁症,狂躁症, 双相（情感）障碍等。 
 应用精神作用物质所致精
神障碍 
如滥用或依赖酒精，精神药物（如阿片类药物，镇静剂，兴奋剂等）或
其他有害物品（如大麻，强力胶，汽油，有机溶剂等）。 
 其他 （请说明） 
 
 
 
  
Appendix 31. Screening questionnaire (English version used in Melbourne site) 
 
 
Screening questionnaire 
(to complete by the practitioners) 
 
Participants will be asked to complete a screening questionnaire before taking part in the 
survey. The following questions will help the investigators to understand how their 
headaches are related to tension-type headache. 
(* All participants will be included after the completion of this screening questionnaire. If the 
headaches reported by participants do not meet the selection criteria, their data will be 
excluded from the Tension-type Headache (TTH) group and treated separately as OTHER 
TYPES OF HEADACHE.) 
 
1. Has your headache been diagnosed as tension-type headache?  
YES  □ Go to Question 2 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
NO   
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
1. On average, do you have 1 or more headache 
attack(s) per month? 
YES  □ NO  □ 
2. Is your headache on both sides of your head? YES  □ NO  □ 
3. Is your headache pressing or tightening in quality?   YES  □ NO  □ 
4. Is your headache mild to moderate in intensity? YES  □ NO  □ 
5. Is your headache aggravated by routine physical 
activity, such as walking or climbing stairs? 
YES  □ NO  □ 
6. Do you feel nausea when you have a headache? YES  □ NO  □ 
7. Do you suffer from vomiting when you have a 
headache? 
YES  □ NO  □ 
8. Are you sensitive to sound when you have a 
headache? 
YES  □ NO  □ 
9. Are you sensitive to light when you have a headache? 
YES  □ NO  □ 
10. Have you been told by your doctor that your 
headache is caused by one or more of the 
disorders listed below?  
 Neck problems  
 High blood pressure 
 Temporomandibular joint (TMJ) disorder or jaw 
disorder  
 Eye diseases 
 Ear diseases 
 Nose diseases 
 Throat diseases 
 Oral cavity diseases  
 Brain tumours 
 Pituitary lesions 
 Meningoencephalitis 
 Giant cell arteritis; Temporal arteritis 
 Intracranial infection 
 Epilepsy  
Others (please specify):  ________ 
 
YES  □ NO  □ 
  
 11. Is your headache excruciating AND accompanied by the 
following features? 
 red eyes 
 tearing of the eyes 
 nasal congestion 
 runny nose  
 forehead/facial sweating 
 constriction of pupil  
 (drooping of eyelid)  
 eyelid swelling 
YES  □ NO  □ 
12. Is your headache triggered or worsened by neck 
movement, including active or passive neck movement?  
YES  □ NO  □ 
13. Do you have restricted neck movement or range of 
motion? YES  □ NO  □ 
 
 
2. How long have you been suffering from tension-type headache? 
2.1  Less than one year  □ 2.2  More than one year  □ 
 
 
3. Do you have a history of head or neck injury? 
3.1  NO  □ Go to Question 4 
3.2  YES   
Have you been hospitalized because of 
the injury? 
YES  □ NO  □ 
 
 
4. Do you suffer from migraine?  
4.1  NO   □ Go to Question 5 
4.2  YES  
1. Are you able to distinguish your 
tension-type headache from migraine? 
YES  □ NO  □ 
2. For how many times did you suffer from 
the migraine attacks in the past 4 weeks? 
Less than 4 
days    □ 
More than 4 
days   □ 
3. Does your migraine come with aura? 
(any accompanying visual or sensory 
symptoms, or speech disturbance)?  
 visual symptoms 
(include flashing lights and zig zags and/or 
lights, spots or lines and/or loss of vision, etc.)  
 sensory symptoms  
(include pins and needles and/or numbness 
feeling) 
NO  □  Go to Question 5 
YES 
1 or less than 1 attack 
per month    □ 
More than 1 attack per 
month   □ 
 
  
  
5. In the past 3 months, did you have headache on more than 15 days per month? 
a) No  Screening finished 
b) If YES 1. Have you been regularly taking simple 
analgesics (e.g., aspirin; paracetamol, 
panadol; etc.) for ≥ 15 days per month in the 
past 3 months? 
 
2. Have you been regularly taking any of the 
following medication for ≥ 10 days per month 
in the last 3 months? 
 Ergotamine / Dihydroergotamine 
 5HT1 agonists (‘Triptans’)  
(e.g., Naramig; Imigran, Suvalan; Zomig) 
 Opioid  
(e.g., Fentanyl, Duragesic, Actiq; Morphine, 
Kapanol, Astramorph, Avinza; OxyContin, 
Endodan,Percocet; Norco, Vicodin; 
Demerol,Meperitab; Ultram; etc.)  
 Combination analgesic  
(e.g., Aspalgin, Codiphen, Codis, Codral Forte, 
Disprin Forte, Veganin; Nurofen Plus; Codalgin, 
Codapane, Codral Pain Relief, Dolaforte, 
Dymadon, Febricod, Hexal Comfarol Plus, 
Mersyndol Day Strength, Painstop, Panadeine, 
Panamax Co, Prodeine, Panadeine Forte; 
Codalgin Plus, Fiorinal, Mersyndol, Panalgesic; 
etc.)  
 
If NO, screening finished. 
If YES to either one. Data 
will be excluded for 
analysis. 
  
  
Screening flow-chart (for reviewers only) 
1. Has your headache been diagnosed as tension-type headache?  
 
 
 
 
 
 
 
 
2. How long have you been suffering from tension-type headache? 
 
 
 
 
 
3. Do you have a history of head or neck injury? 
 
 
 
 
 
4. Do you suffer from migraine?  
 
 
 
 
 
 
 
5. In the past 3 months, did you have headache on more than 15 days per month? 
 
 
 
 
 
 
 
 
Screening finished 
(start to continue with the questionnaire) 
 
  
Yes No 
Less than 1 year More than 1 year 
Go through 1.1-1.13 for detailed assessment 
To
 exclu
d
e 
No 
No 
Yes 
 
Yes 
 
No Yes 
 
  
Appendix 32. Screening questionnaire (Chinese version used in Chinese sites) 
 
紧张性头痛诊断辅助问卷 
（医务工作者填写） 
凡头痛患者均可参与此项调研。调查问卷虽为紧张性头痛而设，但其涉及内容同样
也适用于其他类型的头痛患者。完成所列筛选条目能更好地协助科研人员对紧张性头痛
诊断的研究。请辅助患者依次作答（勾选各条目相对应的方框 √）后再发放其他问卷。 
 
1. 患者的头痛是否已被诊断为紧张性头痛？ 
□是，已有诊断 （请回答第 2 题） 
 
 
 
 
 
 
 
 
 
 
 
□还没有被诊断过 
 
 
 
 
 
 
 
 
1. 头痛部位为头部双侧？ □是 □不是 
2. 头痛的性质为压迫感或紧箍感？ □是 □不是 
3. 头痛的程度为轻度或中度？ □是 □不是 
4. 日常活动（如行走或爬楼梯）会加重头痛？ □是 □不是 
5. 头痛时伴有恶心？ □是 □不是 
6. 头痛时伴有呕吐？ □是 □不是 
7. 头痛的时候对声音敏感（畏声）？ □是 □不是 
8. 头痛的时候对光线敏感（畏光）？ □是 □不是 
9. 平均而言，患者是否每月会有一次或以上的头
痛？ 
□是 □不是 
10. 患者的头痛是否和其他疾病有关？ 
如高血压；颞下颌关节疾病；五官科疾病
（眼、耳、鼻、喉、口腔）；头部肿瘤；垂
体病变；脑膜脑炎；巨细胞性动脉炎；颅内
感染；癫痫等 
 
□是 
 
□不是 
11.患者的头痛是否属于丛集性头痛？ 
患者的头痛程度极其严重，疼痛部位多见于
一侧眼眶或额颞部。且头痛时伴有下列特
征：眼结膜充血、流泪、眼睑水肿或鼻塞、
流涕；有时出现瞳孔缩小、垂睑、脸红、颊
肿等症状 
 
 
□是 
 
 
□不是 
  
12.患者的头痛是否属于颈源性头痛？ 
患者头痛因颈部运动而更剧烈或颈部运动
范围受限 
 
□是 
 
□不是 
 
2. 患者患有紧张性头痛多长时间了？ 
□不到一年 □一年或以上 
 
3. 患者头部或颈项有无外伤史？ 
□没有 （请回答第 4 题） 
□有 
 
如有外伤史，患者是否因头部或颈项外伤而住院治疗过？ □是   □否 
 
4. 患者是否还患有偏头痛？ 
□没有 （请回答第 5 题） 
 
 
 
□有 
1. 患者能否辨别其偏头痛和紧张性头痛？ □能 □不能 
2. 在过去的 4周内，患者的偏头痛有几次发作？ □少于 4 次 □多于 4 次 
3. 患者的偏头痛发作是否伴有先兆症状？ 
 
先兆包括视觉（如视物模糊视野中有盲点或
偏盲等）；触觉（针刺或麻木感）或语言障碍。 
 
□无先兆偏头痛 
□有先兆偏头痛 
如为先兆偏头痛，请确认患者的
偏头痛每月发作次数： 
□每月多于 1 次 
□每月不多于 1 次（含 1 次） 
 
  
  
5. 在过去的 3 个月中，平均每月患者的头痛发作次数是否多于每月 15 天？ 
□每月发作少于 15 天 
（评估完成） 
 
□每月发作 15 天或更多 
在过去的3个月中，是否每月有规律地服
用单纯类止痛药（如阿司匹林，扑热息痛
等）≥15天 
□是   □否 
在过去的3个月中，是否每月有规律地服
用麦角胺，曲坦类，阿片类或复合止痛药
物≥10天 
□是   □否 
 
  
  
筛选流程 (供医务工作者参考) 
1. 患者的头痛是否已被诊断为紧张性头痛？ 
 
 
 
 
 
 
 
 
2. 患者患有紧张性头痛多长时间了？ 
 
 
 
 
 
3. 患者头部或颈项有无外伤史？ 
 
 
 
 
 
4. 患者是否患有偏头痛？ 
 
 
 
 
 
 
 
5. 在过去的 3 个月中，平均每月患者的头痛发作次数是否多于每月 15 天？ 
 
 
 
 
 
 
 
筛选完毕 
 
  
是 否 
不到一年 一年或以上 
完成条目 1.1-1.12 具体评估  
剔
除
 
否 
 
否 
是 
 
是 
 
否 
 
是 
 
  
Appendix 33. Screening questionnaire (English online version) 
 
Screening questionnaire (for online survey) 
1. Has your headache been diagnosed as tension-type headache?  
YES  Go to Question 2 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
NO 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
1. On average, do you have 1 or more headache 
attack(s) per month? 
Multiple choice in 
SurveyMonkey® 
2. Is your headache on both sides of your head? 
3. Is your headache pressing or tightening in quality?   
4. Is your headache mild to moderate in intensity? 
5. Is your headache aggravated by routine physical 
activity, such as walking or climbing stairs? 
6. Do you feel nausea when you have a headache? 
7. Do you suffer from vomiting when you have a 
headache? 
8. Are you sensitive to sound when you have a 
headache? 
9. Are you sensitive to light when you have a 
headache? 
10. Have you been told by your doctor that your 
headache is caused by one or more of the 
disorders listed below?  
 Neck problems  
 High blood pressure 
 Temporomandibular joint (TMJ) disorder or jaw disorder  
 Eye diseases 
 Ear diseases 
 Nose diseases 
 Throat diseases 
 Oral cavity diseases  
 Brain tumours 
 Pituitary lesions 
 Meningoencephalitis 
 Giant cell arteritis; Temporal arteritis 
 Intracranial infection 
 Epilepsy  
Others (please specify):  ________ 
 
If NO: Go to 
Question 2 
If YES or OTHERS: 
Data will be 
excluded for 
analysis. 
11. Is your headache excruciating AND accompanied by 
the following features? 
If NO, please ignore this question. 
If YES, please tick as many as applicable. 
 red eyes 
 tearing of the eyes 
 nasal congestion 
 runny nose  
 forehead/facial sweating 
 constriction of pupil  
Multiple choice in 
SurveyMonkey® 
  
 (drooping of eyelid)  
 eyelid swelling 
12. Is your headache triggered or worsened by neck 
movement, including active or passive neck 
movement?  (YES; NO) 
 
13. Do you have restricted neck movement or range of 
motion? (YES; NO) 
Multiple choice in 
SurveyMonkey® 
 
 
2. How long have you been suffering from tension-type headache? 
(to answer 2.1 Less than one year, or 2.2 More than one year) 
2.1  Less than one year  Data will be excluded for analysis. 
2.2  More than one year  Go to Question 3 
 
 
3. Do you have a history of head or neck injury? 
(to answer 3.1 NO or 3.2 YES) 
3.1  NO Go to Question 4 
3.2  YES Have you been hospitalized 
because of the injury? 
IF YES: Data will be excluded for analysis. 
If NO: go to Question 4 
 
 
4. Do you suffer from migraine?  
(to answer 4.1 NO or 4.2 YES) 
4.1  NO  Go to Question 5 
 
 
4.2  YES  
1. Are you able to 
distinguish your 
tension-type headache 
from migraine? 
YES  
 
Go to Question 4.2.2 
No  Data will be excluded for 
analysis. 
2. For how many times did 
you suffer from the 
migraine attacks in the 
past 4 weeks? 
Less than 4 days  
 
Go to Question 4.2.3 
More than 4 days  Data will be excluded for 
analysis. 
3. Does your migraine 
come with aura? 
(any accompanying 
visual or sensory 
symptoms, or speech 
disturbance)?  
 visual symptoms 
(include flashing lights 
and zig zags and/or 
lights, spots or lines 
and/or loss of vision, 
etc.)  
No  
 
 
 
Go to Question 5 
 
 
 
Yes More than 1 
attack per 
month 
Data will be 
excluded for 
analysis. 
Less than 1 Go to 
  
 sensory symptoms  
(include pins and needles 
and/or numbness feeling) 
attack per 
month 
Question 5 
 
 
5. In the past 3 months, did you have headache on more than 15 days per month? 
(to answer 5.1 NO or 5.2 YES) 
5.1  No  Screening finished 
5.2  YES 1. Have you been regularly taking simple 
analgesics (e.g., aspirin; paracetamol, 
panadol; etc.) for ≥ 15 days per month in the 
past 3 months? 
 
2. Have you been regularly taking any of the 
following medication for ≥ 10 days per month 
in the last 3 months? 
 Ergotamine / Dihydroergotamine 
 5HT1 agonists (‘Triptans’)  
(e.g., Naramig; Imigran, Suvalan; Zomig) 
 Opioid  
(e.g., Fentanyl, Duragesic, Actiq; Morphine, 
Kapanol, Astramorph, Avinza; OxyContin, 
Endodan,Percocet; Norco, Vicodin; 
Demerol,Meperitab; Ultram; etc.)  
 Combination analgesic  
(e.g., Aspalgin, Codiphen, Codis, Codral Forte, 
Disprin Forte, Veganin; Nurofen Plus; Codalgin, 
Codapane, Codral Pain Relief, Dolaforte, 
Dymadon, Febricod, Hexal Comfarol Plus, 
Mersyndol Day Strength, Painstop, Panadeine, 
Panamax Co, Prodeine, Panadeine Forte; 
Codalgin Plus, Fiorinal, Mersyndol, Panalgesic; 
etc.)  
If NO, screening finished. 
If YES to either one. Data 
will be excluded for 
analysis. 
 
 
  
  
Appendix 34. Screening questionnaire (Chinese online version) 
 
紧张性头痛诊断筛查问卷 
（供网络问卷使用） 
 
1. 您的头痛是否已被诊断为紧张性头痛？ 
□是的，我的头痛已
经被诊断为紧张性
头痛 
（跳转至第 2 题） 
不是，我还不确定我
的头痛是紧张性头
痛 
1. 头痛部位为头部单侧？ 
多项选择供勾选 
2. 头痛部位为头部双侧？ 
3. 头痛的性质为压迫感或紧箍感？ 
4. 头痛的程度为轻度或中度？ 
5. 日常活动（如行走或爬楼梯）会加重头痛？ 
6. 头痛时伴有恶心？ 
7. 头痛时伴有呕吐？ 
8. 头痛的时候对声音敏感（畏声）？ 
9. 头痛的时候对光线敏感（畏光）？ 
10.其他 （请描述） 
11. 平均而言，您是否每月会有一次或以上的头痛？ □  一次或更多 
□  不足一次 
12. 您的头痛是否和以下疾病有关？ 
如高血压；颞下颌关节疾病；五官科疾病（眼、
耳、鼻、喉、口腔）；头部肿瘤；垂体病变；脑
膜脑炎；巨细胞性动脉炎；颅内感染；癫痫等 
□  是 
□  不是 
13. 您头痛发作时的程度是否极其严重（难以忍受的剧
痛），疼痛部位多见于一侧眼眶附近，并且还伴有下
列特征： 
□ 眼结膜充血  
□ 流泪 
□ 眼睑水肿 
□ 鼻塞、流涕 
□ 有时出现瞳孔缩小 
□ 垂睑 
□ 面颊红肿 
是（勾选相应条目） 
□ 不是，头痛不伴
有所列症状 
  
14. 
您的头痛是否因颈部运动（例如前倾或后仰的
动作）而更剧烈？ 
□  是 
□  不是 
当您头痛的时候，您颈项部的运动范围是否因
头痛而受限？ 
□  是 
□  不是 
 
2. 您患有头痛多长时间了？ 
□ 不到一年 □ 一年以上 
 
3. 您的头部或颈项曾经是否受过伤？ 
□ 不是，未曾受伤 
（跳转至第 4 题） 
是，有外伤史 您是否因你头部或颈项的外伤住院过？ 
□  是 
□  不是 
 
4. 您患有偏头痛吗？ 
□ 没有，我的头痛不是
偏头痛 
（跳转至第 5 题） 
 有，有医生诊断我患
有偏头痛 
您能否辨别你的偏头痛和一般
的头痛？ 
□ 能 □ 不能 
在过去的 4 周内您有几次偏头痛
发作？ 
□ 少于 4 次 □ 多于 4 次 
您的偏头痛是否伴有先兆症
状？ □ 无先兆 
  
先兆症状包括 
a. 眼部征兆如视物模糊，视觉缺
失，视野中出现光斑，或有盲
点或偏盲等； 
b. 触觉征兆如肢体疼痛或伴针
刺麻木感等； 
c. 语言障碍 
有先兆，且
这种先兆性
偏头痛平均
到每月，会
发生几次？ 
□ 多于 1 次 
□ 不多于 1 次
（含 1 次） 
□ 不清楚，还没有医生为我诊断过 
 
5. 在过去的 3 个月中，您头痛发作次数是否多于平均每月 15 天？ 
□ 每月发作少于 15 天 
（评估完成） 
每月发作 15 天或更多 
在过去的3个月中，您是否每月有规律地
服用单纯类止痛药（如阿司匹林，扑热息
痛等）≥15天 
□  是    
□  不是 
在过去的3个月中，您是否每月有规律地
服用麦角胺，曲坦类，阿片类或复合止痛
药物≥10天 
□  是    
□  不是 
  
  
Appendix 35. Advertisement for the full-scale survey  
 
 
 
 
 
  
  
Appendix 36. BASH link (screen shot) 
 
  
  
Appendix 37. Online survey screen shots (English version) 
 
 
Screen shot 1 
 
  
 
Screen shot 2 
 
 
Screen shot 3 
 
  
 
Screen shot 4 
 
 
  
  
Appendix 38. Online survey screen shots (Chinese version) 
 
Screen shot 1 
 
 
Screen shot 2 
  
 
 
Screen shot 3 
 
Screen shot 4 
 
  
Appendix 39. Patterns of missing data in CMHQ by case 
 
Cases (c) 
with missing 
value 
Missing Data inTotal Sections where Missing Data located  
number percent  1.1 1.2 1.3 1.4 1.5 1.6 2.1 2.2 3.1 3.2 3.3 
c1 1 1         1   
c2 1 1 1           
c3 2 1 1   1        
c4 1 1  1          
c5 2 1       2     
c6 1 1        1    
c7 6 3 4   2        
c8 3 2 3           
c9 11 6 6 3  2        
c10 1 1 1           
c11 2 1 1      1     
c12 1 1 1           
c13 2 1    2        
c14 3 2 3           
c15 1 1 1           
c16 2 1 1 1          
c17 1 1       1     
c18 4 2         4   
c19 3 2 1   2        
c20 1 1       1     
c21 1 1    1        
c22 2 1    2        
c23 1 1         1   
c24 12 6        4 8   
c25 8 4 4 4          
c26 1 1         1   
c27 12 6 5 5  1     1   
c28 1 1 1           
c29 3 2       3     
c30 1 1       1     
c31 15 8    2   13     
c32 3 2       3     
c33 18 9       17 1    
c34 35 18       28 7    
c35 29 15       27 2    
c36 17 9       15 1 1   
c37 3 2       2 1    
c38 1 1       1     
c39 2 1       2     
c40 5 3       4 1    
c41 1 1       1     
c42 7 4       5 2    
c43 4 2       4     
c44 1 1         1   
c45 1 1         1   
c46 1 1         1   
c47 70 36 4      2  30 21 13 
 
  
  
Appendix 40. Univariate Statistics of Missing Data imputation for Factors  
(N=170, F=41) 
 
Extracted 
factors 
N Mean
a
 Std. Deviation Missing No. of 
Extremes
a
 
EM  
Means
b
 
Count Percent Low High 
FAC1.1F1 155 -.0413829 1.00203440 15 8.8 0 0 -0.02560148 
FAC1.1F2 155 -.0026633 1.00049216 15 8.8 0 5 0.015020194 
FAC1.1F3 155 -.0340391 1.00095009 15 8.8 0 0 -0.02646084 
FAC1.2F1 164 -.0269371 .99226551 6 3.5 0 0 0.000291338 
FAC1.2F2 164 -.0001274 1.00810371 6 3.5 0 4 0.011372147 
FAC1.3F1 169 -.0004362 1.00293527 1 .6 0 0 -0.00432739 
FAC1.3F2 169 .0017001 1.00273143 1 .6 2 16 0.001360446 
FAC1.3F3 169 .0035184 1.00182979 1 .6 0 15 0.005967721 
FAC1.3F4 169 .0030069 1.00184724 1 .6 0 0 -0.00144781 
FAC1.3F5 169 .0026722 1.00173466 1 .6 0 15 -0.00011854 
FAC1.3F6 169 -.0047117 1.00105947 1 .6 0 4 0.00094296 
FAC1.3F7 169 -.0001818 1.00290988 1 .6 1 14 -0.00039974 
FAC1.3F8 169 -.0042221 1.00143646 1 .6 0 5 -0.00191325 
FAC1.4F1 165 -.0065835 1.00384617 5 2.9 0 0 0.003375096 
FAC1.4F2 165 .0015345 .99839428 5 2.9 0 0 -0.0064158 
FAC1.4F3 165 -.0193841 1.00471160 5 2.9 0 0 -0.012903 
FAC1.4F4 165 -.0129873 1.00279423 5 2.9 0 0 0.00156585 
FAC1.6F1 170 0E-7 1.00000000 0 .0 0 0 1.33574E-16 
FAC1.6F2 170 0E-7 1.00000000 0 .0 0 7 -3.5562E-17 
FAC1.6F3 170 0E-7 1.00000000 0 .0 0 12 -4.8139E-17 
FAC2.1F1 152 .0034386 .99097418 18 10.6 0 0 -0.01116483 
FAC2.1F2 152 .0172238 1.01259241 18 10.6 0 10 0.002278402 
FAC2.1F3 152 .0012716 1.01422844 18 10.6 0 2 -0.00950514 
FAC2.1F4 152 .0344915 .99824210 18 10.6 0 1 0.017955861 
FAC2.1F5 152 -.0227145 .98842621 18 10.6 0 1 -0.00917489 
FAC2.1F6 152 .0077017 .99321666 18 10.6 0 3 -0.01220781 
FAC2.1F7 152 -.0002975 .99716256 18 10.6 1 9 0.018780111 
FAC2.1F8 152 -.0158464 .97130803 18 10.6 1 7 0.00767233 
FAC2.1F9 152 -.0424401 .97355101 18 10.6 0 2 -0.03286376 
FAC2.1F10 152 -.0330730 .93504870 18 10.6 4 13 -0.03150178 
FAC2.2F1 162 .0144667 1.01282699 8 4.7 0 0 0.014078378 
FAC2.2F2 162 .0238561 .99788699 8 4.7 0 2 0.013060998 
FAC2.2F3 162 .0094448 .98981273 8 4.7 0 0 0.010760647 
FAC3.1F1 164 .007021 1.0038117 6 3.5 0 3 -0.00319207 
FAC3.1F2 164 -.0167965 1.00327158 6 3.5 0 3 -0.01027748 
FAC3.1F3 164 -.0250263 .95896230 6 3.5 0 5 -0.03686569 
FAC3.1F4 164 .0129801 1.01227986 6 3.5 0 1 0.018825543 
FAC3.1F5 164 .0014226 1.01447008 6 3.5 0 2 0.015390533 
FAC3.1F6 164 -.0063434 1.00546640 6 3.5 0 5 -0.00665487 
FAC3.1F7 164 .0159624 .99622120 6 3.5 0 6 0.018823813 
FAC3.1F8 164 .0107643 1.00259647 6 3.5 1 4 0.00052158 
FAC3.1F9 164 .0091866 1.01167585 6 3.5 0 0 0.003838502 
FAC3.1F10 164 .0118686 1.01185364 6 3.5 1 7 0.014619267 
FAC3.1F11 164 -.0193993 .98636466 6 3.5 0 6 -0.02171821 
FAC3.1F12 164 .0204879 .98489647 6 3.5 1 0 0.005955924 
FAC3.1F13 164 -.0170762 .97192520 6 3.5 0 3 -0.02963283 
FAC3.1F14 164 .0059629 1.01246375 6 3.5 0 2 0.006522845 
FAC3.1F15 164 .0028117 1.01356171 6 3.5 2 3 0.002616225 
FAC3.1F16 164 .0091568 1.01048563 6 3.5 1 13 0.005717915 
FAC3.1F17 164 -.0032104 .99872220 6 3.5 4 2 0.001621123 
a. Number of cases outside the range (Q1 - 1.5*IQR, Q3 + 1.5*IQR). 
b. Little's MCAR test: Chi-Square = 585.173, DF = 557, Sig. = .198 
 
  
Appendix 41. Correlation Matrix for detecting construct validity 
 
Correlation Matrix 
C
o
r
r
e
la
ti
o
n
 
 1.1 1.2 1.3 1.4 1.5 1.6 2.1 2.2 3.1 3.2 3.3 
1.1 1.000 .484 .358 .440 .298 .190 .411 .297 .274 .210 .086 
1.2 .484 1.000 .558 .472 .291 .144 .501 .257 .400 .474 .131 
1.3 .358 .558 1.000 .450 .197 .226 .443 .221 .342 .434 .020 
1.4 .440 .472 .450 1.000 .428 .147 .350 .157 .349 .107 .056 
1.5 .298 .291 .197 .428 1.000 .026 .106 .055 .272 .090 .058 
1.6 .190 .144 .226 .147 .026 1.000 .173 .097 .118 .042 -.010 
2.1 .411 .501 .443 .350 .106 .173 1.000 .401 .479 .342 .179 
2.2 .297 .257 .221 .157 .055 .097 .401 1.000 .144 .230 .281 
3.1 .274 .400 .342 .349 .272 .118 .479 .144 1.000 .344 .255 
3.2 .210 .474 .434 .107 .090 .042 .342 .230 .344 1.000 .205 
3.3 .086 .131 .020 .056 .058 -.010 .179 .281 .255 .205 1.000 
 
  
  
Appendix 42. Demographic checklist (English version) 
Demographic information 
 
 
 
7. Your gender:MaleFemale 
 
8. In what year were you born?________ 
 
9. Your ethnicity:  
11. Oceanian 
 Australian Peoples 
 New Zealand Peoples 
 Melanesian and Papuan 
 Micronesian 
 Polynesian 
12. North-west European 
 British 
 Irish 
 Western European 
 Northern European 
13. Southern and eastern European 
 Southern European 
 South Eastern European 
 Eastern European 
14. Arab 
 Arab 
 Jewish 
 Other North African and Middle Eastern 
15. South-east Asian 
 Mainland South-East Asian 
 Maritime South-East Asian 
16. North-east Asian 
 Chinese Asian 
 Other North-East Asian 
17. Southern and central Asian 
 Southern Asian 
 Central Asian 
  
18. People of the Americas 
 North American 
 South American 
 Central American 
 Caribbean Islander 
19. Sub-Saharan African 
 Central and West African 
 Southern and East African 
20. Others 
 Please specify:___________ 
 
 
10. What is your marital status? (please tick one) 
 Single 
 Married  
 Partnered / De facto 
 Divorced  
 Separated  
 Widowed 
 
11. What is your highest level of education? (please tick one) 
 Postgraduate degree level 
 Graduate diploma and graduate certificate level 
 Bachelor degree level 
 Advanced diploma and diploma level 
    (advanced deploma, deploma level and associate degree level) 
 TAFE level (certificate I-IV) 
 Secondary education (year 7-12) 
 Primary education (year 1-7) 
 Other education  (please specify:                   ) 
 
 
 
  
  
Appendix 43. Demographic checklist (Chinese version) 
 
患者基本信息 
 
1. 性别：   男      女 
 
2． 出生年份：___________ 
 
3.  民族 
 汉族        壮族     满族       回族       苗族    
 维吾尔族    彝族     土家族     蒙古族     藏族  
其他（请说明）：___________ 
 
4. 婚姻状况 
  单身 
  已婚 
  离婚 
  同居 
  分居 
  孤寡独居 
 
5. 文化程度 (请勾选您的最高学历) 
 
 硕士研究生或更高 
 （本科结束后的）专业继续教育或行业证书 
 本科 
 专科 
 中专、技校、高职 
 初中或高中 
 小学 
 其他（请说明）：___________ 
  
  
Appendix 44. Factor extraction for Part 1, Section 1 
 
Total Variance Explained 
Comp
onent 
Initial Eigenvalues Extraction Sums of Squared 
Loadings 
Rotation Sums of Squared 
Loadings 
Total % of 
Variance 
Cumulative 
% 
Total % of 
Variance 
Cumulative 
% 
Total % of 
Variance 
Cumulative
 % 
1 2.169 30.991 30.991 2.169 30.991 30.991 1.728 24.685 24.685 
2 1.346 19.225 50.215 1.346 19.225 50.215 1.428 20.402 45.087 
3 1.011 14.443 64.658 1.011 14.443 64.658 1.370 19.571 64.658 
4 .743 10.621 75.279       
5 .730 10.426 85.705       
6 .560 7.995 93.700       
7 .441 6.300 100.000       
Extraction Method: Principal Component Analysis. 
 
 
Rotated Component Matrix
a
 
Item Component 
1 2 3 
1.1.1 Forehead .755   
1.1.2 Left side of the head   .830 
1.1.3 Right side of the head   .814 
1.1.4 Back of the head .731   
1.1.5 Top of the head .673   
1.1.6 Whole head  .718  
1.1.7 No particular location  .915  
Extraction Method: Principal Component Analysis.  
Rotation Method: Varimax with Kaiser Normalization. 
a. Rotation converged in 4 iterations. 
 
 
Appendix 45. Factor extraction for Part 1, Section 2 
 
Total Variance Explained 
Comp
onent 
Initial Eigenvalues Extraction Sums of Squared 
Loadings 
Rotation Sums of Squared 
Loadings 
Total % of 
Variance 
Cumulative 
% 
Total % of 
Variance 
Cumulative 
% 
Total % of 
Variance 
Cumulative
 % 
1 2.404 40.072 40.072 2.404 40.072 40.072 1.871 31.180 31.180 
2 1.219 20.323 60.394 1.219 20.323 60.394 1.753 29.214 60.394 
3 .949 15.821 76.215       
4 .699 11.643 87.858       
5 .535 8.924 96.782       
6 .193 3.218 100.000       
Extraction Method: Principal Component Analysis. 
 
 
Rotated Component Matrix
a
 
Item Component 
1 2 
Neck .937  
Shoulders .928  
Ears   
Eyebrow  .723 
Eyes  .610 
Cheeks  .759 
Extraction Method: Principal Component Analysis.  
Rotation Method: Varimax with Kaiser Normalization. 
a. Rotation converged in 3 iterations. 
  
Appendix 46. Factor extraction for Part 1, Section 3  
 
Total Variance Explained 
Comp
onent 
Initial Eigenvalues Extraction Sums of Squared 
Loadings 
Rotation Sums of Squared 
Loadings 
Total % of 
Variance 
Cumulative 
% 
Total % of 
Variance 
Cumulative 
% 
Total % of 
Variance 
Cumulative
 % 
1 2.281 12.008 12.008 2.281 12.008 12.008 1.803 9.491 9.491 
2 2.010 10.579 22.586 2.010 10.579 22.586 1.562 8.220 17.711 
3 1.594 8.391 30.978 1.594 8.391 30.978 1.558 8.202 25.912 
4 1.403 7.383 38.360 1.403 7.383 38.360 1.549 8.152 34.064 
5 1.224 6.443 44.803 1.224 6.443 44.803 1.430 7.524 41.588 
6 1.128 5.939 50.742 1.128 5.939 50.742 1.339 7.048 48.636 
7 1.061 5.585 56.328 1.061 5.585 56.328 1.337 7.035 55.671 
8 1.023 5.384 61.712 1.023 5.384 61.712 1.148 6.041 61.712 
9 .910 4.791 66.503       
10 .869 4.573 71.076       
11 .835 4.394 75.470       
12 .728 3.832 79.302       
13 .713 3.754 83.056       
14 .675 3.552 86.607       
15 .637 3.354 89.962       
16 .581 3.057 93.019       
17 .530 2.792 95.810       
18 .477 2.511 98.321       
19 .319 1.679 100.000       
Extraction Method: Principal Component Analysis. 
 
 
Rotated Component Matrix
a
 
Item  Component 
1 2 3 4 5 6 7 8 
Pressing     .555    
Explosive  .734       
Burning     .746    
Drilling         
Cutting      .804   
Sharp   .577      
Vague         
Heavy      .627   
Dull  -.584       
Throbbing .789        
Pulling       .768  
Empty        .882 
Tight    .636     
Distending       -.570  
Piercing   .800      
Pulsating .674        
Radiating     .640    
Pounding .744        
A “band-like” 
sensation around the 
head 
   .803     
Extraction Method: Principal Component Analysis.  
Rotation Method: Varimax with Kaiser Normalization. 
a. Rotation converged in 13 iterations. 
 
 
 
 
  
Appendix 47. Factor extraction for Part 1, Section 4 
 
Total Variance Explained 
Comp
onent 
Initial Eigenvalues Extraction Sums of Squared 
Loadings 
Rotation Sums of Squared 
Loadings 
Total % of 
Variance 
Cumulative 
% 
Total % of 
Variance 
Cumulative 
% 
Total % of 
Variance 
Cumulative
 % 
1 1.456 36.412 36.412 1.456 36.412 36.412 1.419 35.463 35.463 
2 1.102 27.559 63.971 1.102 27.559 63.971 1.104 27.599 63.062 
3 1.040 25.998 89.969 1.040 25.998 89.969 1.076 26.907 89.969 
4 .401 10.031 100.000       
Extraction Method: Principal Component Analysis. 
 
 
Rotated Component Matrix
a
 
Item  Component 
1 2 3 
Fixed location .855   
Moves around the head  .967  
Continuous .828   
Intermittent   .975 
Extraction Method: Principal Component Analysis.  
Rotation Method: Varimax with Kaiser Normalization. 
a. Rotation converged in 5 iterations. 
 
 
 
Appendix 48. Factor extraction for Part 1, Section 6  
 
Total Variance Explained 
Comp
onent 
Initial Eigenvalues Extraction Sums of Squared 
Loadings 
Rotation Sums of Squared 
Loadings 
Total % of 
Variance 
Cumulative 
% 
Total % of 
Variance 
Cumulative 
% 
Total % of 
Variance 
Cumulative
 % 
1 1.857 30.951 30.951 1.857 30.951 30.951 1.714 28.564 28.564 
2 1.157 19.287 50.238 1.157 19.287 50.238 1.296 21.603 50.167 
3 1.036 17.267 67.505 1.036 17.267 67.505 1.040 17.338 67.505 
4 .888 14.797 82.302       
5 .790 13.162 95.464       
6 .272 4.536 100.000       
Extraction Method: Principal Component Analysis. 
 
 
Rotated Component Matrix
a
 
Item  Component 
1 2 3 
Worse in the morning  .811  
Worse in the afternoon .774   
Worse at the end of the day .706   
Worse at night  .627  
All day   .984 
No particular time -.765   
Extraction Method: Principal Component Analysis.  
Rotation Method: Varimax with Kaiser Normalization. 
a. Rotation converged in 4 iterations. 
  
Appendix 49. Factor extraction for Part 2, Section 1 
 
Total Variance Explained 
Comp
onent 
Initial Eigenvalues Extraction Sums of Squared 
Loadings 
Rotation Sums of Squared 
Loadings 
Total % of 
Variance 
Cumulative 
% 
Total % of 
Variance 
Cumulative 
% 
Total % of 
Variance 
Cumulative
 % 
1 8.029 21.129 21.129 8.029 21.129 21.129 4.496 11.832 11.832 
2 4.110 10.815 31.944 4.110 10.815 31.944 3.230 8.501 20.333 
3 3.028 7.969 39.914 3.028 7.969 39.914 3.109 8.181 28.514 
4 2.358 6.206 46.119 2.358 6.206 46.119 2.695 7.092 35.606 
5 1.772 4.664 50.783 1.772 4.664 50.783 2.472 6.505 42.111 
6 1.567 4.124 54.907 1.567 4.124 54.907 2.161 5.687 47.798 
7 1.415 3.723 58.630 1.415 3.723 58.630 2.100 5.527 53.325 
8 1.240 3.262 61.892 1.240 3.262 61.892 2.085 5.486 58.811 
9 1.097 2.886 64.779 1.097 2.886 64.779 1.729 4.551 63.362 
10 1.024 2.694 67.473 1.024 2.694 67.473 1.562 4.111 67.473 
11 .948 2.494 69.967       
12 .923 2.429 72.396       
13 .849 2.233 74.629       
14 .824 2.168 76.797       
15 .775 2.040 78.837       
16 .721 1.897 80.734       
17 .656 1.726 82.461       
18 .573 1.509 83.969       
19 .537 1.413 85.382       
20 .524 1.378 86.760       
21 .490 1.290 88.050       
22 .467 1.228 89.279       
23 .417 1.097 90.376       
24 .375 .988 91.364       
25 .374 .984 92.348       
26 .358 .942 93.290       
27 .337 .887 94.178       
28 .291 .766 94.944       
29 .286 .754 95.698       
30 .255 .671 96.368       
31 .239 .629 96.997       
32 .205 .539 97.536       
33 .195 .513 98.049       
34 .168 .441 98.490       
35 .158 .415 98.905       
36 .151 .399 99.304       
37 .146 .385 99.689       
38 .118 .311 100.000       
Extraction Method: Principal Component Analysis. 
 
 
Rotated Component Matrix
a
 
Item  Component 
1 2 3 4 5 6 7 8 9 10 
Overwork     .816      
When tired     .688      
Mental strain     .689      
Eye strain           
Muscular 
strain(muscle 
tightness) 
     .719     
Physical labour         .723  
Lack of sleep         .607  
Poor posture in 
sitting, standing or 
sleeping 
     .769     
  
Alcohol          .606 
Coffee  .595         
Dehydration    .771       
Hunger / Being 
hungry 
   .758       
Chocolate  .564  .511       
Cigarette smoking          .793 
Soft drink / Sodas  .585         
Tea  .604         
Dairy foods  .792         
Monosodium 
glutamate 
          
Sugar / too much 
sugar 
 .794         
Spicy food       .698    
Over consumption 
of oily food 
      .703    
Irregular diet       .695    
Change of 
weather 
  .827        
Change in 
temperature 
  .838        
Exposure to bright 
lights or sunshine 
          
Hot weather   .607        
Cold weather   .620        
Windy days        .552   
Damp weather / 
Humid weather 
       .592   
Rainy days        .782   
Stress .742          
Nervousness .808          
Anger or irritability .828          
Anxiety 
(excessive worry) 
.808          
Depression .682          
Tension or conflict 
related 
.796          
Sneezing           
Teeth grinding      .507     
Extraction Method: Principal Component Analysis.  
Rotation Method: Varimax with Kaiser Normalization. 
a. Rotation converged in 15 iterations. 
 
 
Appendix 50. Factor extraction for Part 2, Section 2 
 
Total Variance Explained 
Comp
onent 
Initial Eigenvalues Extraction Sums of Squared 
Loadings 
Rotation Sums of Squared 
Loadings 
Total % of 
Variance 
Cumulative 
% 
Total % of 
Variance 
Cumulative 
% 
Total % of 
Variance 
Cumulative
 % 
1 2.887 28.874 28.874 2.887 28.874 28.874 2.312 23.120 23.120 
2 1.983 19.834 48.708 1.983 19.834 48.708 2.296 22.963 46.083 
3 1.100 10.998 59.706 1.100 10.998 59.706 1.362 13.623 59.706 
4 .883 8.827 68.533       
5 .809 8.094 76.626       
6 .701 7.014 83.640       
7 .543 5.426 89.067       
8 .473 4.733 93.800       
9 .399 3.989 97.789       
10 .221 2.211 100.000       
Extraction Method: Principal Component Analysis. 
  
 
 
Rotated Component Matrix
a
 
Item  Component 
1 2 3 
Rest .872   
Lying-down .900   
Sleeping .799   
Medication   .772 
Exercise / light excercise  .692  
Massage  .736  
Pressing/ pressure on the 
pain area 
 .681  
Eating   .655 
Warmth  .602  
Coldness  .567  
Extraction Method: Principal Component Analysis.  
Rotation Method: Varimax with Kaiser Normalization. 
a. Rotation converged in 4 iterations. 
 
 
 
Appendix 51. Factor extraction for Part 3, Section 1 
 
Total Variance Explained 
Comp
onent 
Initial Eigenvalues Extraction Sums of Squared 
Loadings 
Rotation Sums of Squared 
Loadings 
Total % of 
Variance 
Cumulative 
% 
Total % of 
Variance 
Cumulative 
% 
Total % of 
Variance 
Cumulative
 % 
1 13.662 22.035 22.035 13.662 22.035 22.035 4.916 7.929 7.929 
2 4.145 6.685 28.720 4.145 6.685 28.720 3.666 5.913 13.842 
3 2.960 4.774 33.494 2.960 4.774 33.494 3.090 4.984 18.825 
4 2.557 4.125 37.619 2.557 4.125 37.619 2.996 4.833 23.658 
5 2.362 3.810 41.430 2.362 3.810 41.430 2.873 4.634 28.292 
6 2.111 3.405 44.835 2.111 3.405 44.835 2.775 4.475 32.767 
7 2.037 3.286 48.121 2.037 3.286 48.121 2.682 4.325 37.092 
8 1.715 2.766 50.887 1.715 2.766 50.887 2.573 4.151 41.243 
9 1.633 2.634 53.521 1.633 2.634 53.521 2.325 3.749 44.992 
10 1.588 2.561 56.081 1.588 2.561 56.081 2.312 3.729 48.721 
11 1.505 2.428 58.509 1.505 2.428 58.509 2.233 3.601 52.322 
12 1.366 2.204 60.713 1.366 2.204 60.713 2.196 3.541 55.864 
13 1.204 1.942 62.655 1.204 1.942 62.655 2.008 3.239 59.103 
14 1.190 1.920 64.575 1.190 1.920 64.575 1.988 3.206 62.309 
15 1.118 1.803 66.378 1.118 1.803 66.378 1.815 2.928 65.237 
16 1.073 1.730 68.108 1.073 1.730 68.108 1.406 2.268 67.505 
17 1.001 1.614 69.722 1.001 1.614 69.722 1.374 2.216 69.722 
18 .975 1.573 71.295       
19 .947 1.527 72.822       
20 .884 1.427 74.248       
21 .844 1.361 75.609       
22 .793 1.279 76.888       
23 .769 1.241 78.129       
24 .716 1.155 79.284       
25 .700 1.128 80.412       
26 .672 1.083 81.496       
27 .638 1.030 82.525       
28 .616 .994 83.519       
29 .587 .947 84.466       
30 .573 .924 85.390       
31 .547 .883 86.273       
  
32 .542 .875 87.147       
33 .511 .824 87.972       
34 .497 .802 88.773       
35 .462 .745 89.518       
36 .439 .708 90.226       
37 .423 .682 90.909       
38 .396 .639 91.547       
39 .381 .615 92.162       
40 .365 .589 92.751       
41 .357 .576 93.327       
42 .337 .543 93.870       
43 .312 .503 94.373       
44 .308 .497 94.870       
45 .302 .488 95.358       
46 .287 .463 95.821       
47 .267 .430 96.251       
48 .247 .398 96.649       
49 .236 .380 97.029       
50 .216 .349 97.378       
51 .202 .326 97.704       
52 .195 .314 98.018       
53 .177 .285 98.303       
54 .164 .265 98.568       
55 .143 .231 98.799       
56 .139 .224 99.023       
57 .129 .209 99.231       
58 .116 .188 99.419       
59 .103 .166 99.585       
60 .100 .162 99.747       
61 .091 .146 99.893       
62 .066 .107 100.000       
Extraction Method: Principal Component Analysis. 
 
 
 
  
Rotated Component Matrix
a
 
Item  Component 
1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 
Sensitivity to light 
(or to bright lights) 
        .679         
Dry eyes  .573               .528 
Teary eyes  .675                
Blurred vision  .654                
Sore eyes  .636                
Red eyes  .679                
Swollen eyelids  .548                
Eye twitching                  
Floaters in the eyes               .776   
Burning sensation 
in the eyes 
                 
Itchy sensation in 
the eyes 
                 
Sensitivity to sound         .718         
Dry mouth     .855             
Thirst     .744             
Bitter taste in the 
mouth 
    .745             
Runny nose        .605          
Sore throat        .723          
Ear discharge        .546          
Tinnitus (ringing in 
the ears) 
               .724  
Flushed face / hot 
red face 
                 
Nausea       .704           
Vomiting       .863           
Reflux       .517           
Belching    .727              
Bloating / flatulence    .748              
Indigestion    .748              
Poor appetite / loss 
of appetite 
                 
Yellowish urine                  
Frequent urination      .697            
  
Watery bowel 
motion 
             .813    
Loose bowel 
motion 
             .743    
Dry stools           .788       
Constipation           .793       
Joint stiffness   .750               
Neck stiffness   .694               
Muscle twitching   .704               
Weak legs and 
knees 
                 
Feeling weak in the 
lower back 
  .506               
Feeling cold in the 
lower back 
  .509               
Cold hands and 
feet / cold limbs 
            .724     
Hot sensation in the 
palms 
                 
“Pins and needles” 
or numbness in the 
hands and / or feet 
           .676      
Increased 
forgetfulness or 
poor memory 
                 
Feeling depressed .673                 
Irritability / 
Irascibility 
.700                 
Restlessness .798                 
Fatigue / tiredness .566                 
Faintness            .614      
Heavy sensation in 
the body 
.510                 
Insomnia                 .540 
Sighing often .584                 
Feverish sensation                  
Shortness of breath .509                 
Dizziness            .608      
Excessive phlegm        .537          
Palpitation                  
  
Inability to 
concentrate 
.562                 
Night sweating      .545            
Sweating upon mild 
activity 
     .724            
Aversion to cold or 
fear of being cold 
            .731     
Aversion to hot or 
fear of being hot 
         .735        
Sensitive to 
temperature 
changes 
         .661        
Extraction Method: Principal Component Analysis.  
Rotation Method: Varimax with Kaiser Normalization. 
a. Rotation converged in 18 iterations. 
  
Appendix 52. Factor extraction for Part 3. Section 3.2 
 
Total Variance Explained 
Comp
onent 
Initial Eigenvalues Extraction Sums of Squared 
Loadings 
Rotation Sums of Squared Loadings 
Total % of 
Variance 
Cumulative % Total % of 
Variance 
Cumulative % Total % of Variance Cumulative 
% 
1 4.337 21.685 21.685 4.337 21.685 21.685 2.361 11.806 11.806 
2 1.636 8.179 29.864 1.636 8.179 29.864 2.258 11.291 23.096 
3 1.534 7.672 37.535 1.534 7.672 37.535 2.042 10.208 33.304 
4 1.303 6.513 44.049 1.303 6.513 44.049 1.588 7.942 41.246 
5 1.183 5.915 49.964 1.183 5.915 49.964 1.509 7.544 48.790 
6 1.093 5.467 55.431 1.093 5.467 55.431 1.328 6.641 55.431 
7 .989 4.944 60.375       
8 .974 4.870 65.245       
9 .843 4.214 69.459       
10 .838 4.190 73.649       
11 .832 4.161 77.811       
12 .722 3.610 81.420       
13 .653 3.265 84.686       
14 .569 2.844 87.530       
15 .510 2.548 90.078       
16 .450 2.251 92.329       
17 .424 2.119 94.448       
18 .411 2.053 96.501       
19 .377 1.883 98.384       
20 .323 1.616 100.000       
Extraction Method: Principal Component Analysis. 
 
 
Rotated Component Matrix
a
 
Item  Component 
1 2 3 4 5 6 
Neck .743      
Shoulder .792      
Jaw   .650    
Throat       
Ears   .589    
Eyes      .805 
Chest       
Breasts     .766  
Upper back       
Middle back       
Lower back .584      
Abdomen     .665  
Arms  .700     
Legs  .778     
Knees       
Heel   .639    
Hips       
Buttocks       
Flank (side of the body)    .664   
Hypochondria (lower 
abdomen) 
   .744   
Extraction Method: Principal Component Analysis.  
Rotation Method: Varimax with Kaiser Normalization. 
a. Rotation converged in 11 iterations. 
  
Appendix 53. Factor extraction for Part 3. Section 3.3 
 
Total Variance Explained 
Comp
onent 
Initial Eigenvalues Extraction Sums of Squared 
Loadings 
Rotation Sums of Squared Loadings 
Total % of 
Variance 
Cumulative 
% 
Total % of 
Variance 
Cumulative % Total % of Variance Cumulative 
% 
1 9.145 45.724 45.724 9.145 45.724 45.724 3.313 16.564 16.564 
2 1.760 8.800 54.524 1.760 8.800 54.524 3.037 15.184 31.748 
3 1.287 6.434 60.958 1.287 6.434 60.958 2.829 14.147 45.895 
4 1.133 5.664 66.622 1.133 5.664 66.622 2.796 13.979 59.874 
5 1.031 5.154 71.776 1.031 5.154 71.776 2.380 11.902 71.776 
6 .872 4.359 76.136       
7 .777 3.885 80.021       
8 .597 2.986 83.007       
9 .569 2.847 85.854       
10 .510 2.549 88.403       
11 .406 2.030 90.433       
12 .348 1.739 92.171       
13 .288 1.440 93.612       
14 .274 1.369 94.981       
15 .264 1.322 96.303       
16 .209 1.044 97.347       
17 .169 .843 98.189       
18 .150 .752 98.942       
19 .129 .644 99.585       
20 .083 .415 100.000       
Extraction Method: Principal Component Analysis. 
 
 
Rotated Component Matrix
a
 
Item  Component 
1 2 3 4 5 
Irregular period cycle     .753 
Early periods    .548  
Delayed periods     .810 
Light bleeding     .591 
Excessive bleeding  .675    
Bleeding with clots .638     
Bright red coloured 
menstrual blood 
     
Light red coloured 
menstrual blood 
 .629    
Dark coloured menstrual 
blood 
.521     
Excessive watery discharge  .805    
Yellow discharge  .763    
Headache before period .558   .624  
Headache during period    .791  
Headache after period    .699  
Abdominal pain before 
periods 
.782     
Abdominal pain during 
periods 
.735     
Abdominal pain after 
periods 
  .801   
Lower back pain before 
periods 
  .660   
Lower back pain during 
periods 
  .622   
  
Lower back pain after 
periods 
  .870   
Extraction Method: Principal Component Analysis.  
Rotation Method: Varimax with Kaiser Normalization. 
a. Rotation converged in 7 iterations. 
 
 
 
Appendix 54. Extracted Factors in TwoStep analysis 
 
Extracted factors  Clusters 
1 2 3 4 
FAC1.1F1CentralHead 0.51 0.51 -0.05 -0.97 
FAC1.1F2LateralHead -0.33 0.11 0.66 -0.37 
FAC1.1F3WholeHead -0.12 0.66 -0.33 -.015 
FAC1.3F1RhythmHeadache 0.53 0.56 -0.49 -0.50 
FAC1.3F2ExplosiveNotDull -0.32 0.25 -0.13 0.29 
FAC1.3F3SharpHeadache 0.18 0.31 -0.42 0.04 
FAC1.3F4TightHeadache 0.68 0.20 -0.15 -0.71 
FAC1.3F7DistendingHeadache 0.05 0.32 -0.23 -0.06 
FAC1.3F8EmptyHeadache -0.17 0.28 -0.01 -0.03 
FAC 1.5F1LateOfDay 0.26 0.26 0.08 -0.15 
FAC 1.5F2BothEnd -0.18 0.72 -0.11 -0.25 
FAC 1.5F3AllDay -0.29 0.65 0.06 -0.25 
FAC 2.1F1Mental 0.25 -0.07 0.42 -0.69 
FAC 2.1F2Food -0.33 0.15 0.24 -0.01 
FAC 2.1F3WeatherChange -0.08 0.55 -0.29 -0.08 
FAC 2.1F4NoFood&Drink 0.69 0.42 -0.48 -0.47 
FAC 2.1F5MentalStrain 0.25 -0.10 0.02 -0.25 
FAC 2.1F6MuscularStrain 0.42 0.24 -0.25 -0.41 
FAC 2.1F7Oil&Spicy 0.09 -0.28 0.29 -0.12 
FAC 2.1F8WindDamp -0.35 -0.04 0.34 0.08 
FAC 2.1F9PhysicalStrain -0.21 0.21 -0.03 -0.03 
FAC 2.1F10Alcohol-DragCigar -0.16 0.23 -0.08 -0.04 
FAC 2.2F1Rest 0.29 -0.23 0.18 -0.26 
FAC 2.2F2PhysicalStimulation -0.12 0.65 -0.09 -0.23 
FAC 2.2F3EatingRelated 0.38 0.44 -0.15 -0.54 
FAC 3.1F1LiverQi&Fire 0.07 -0.15 0.33 -0.32 
FAC 3.1F2Eye -0.22 0.02 0.31 -0.14 
FAC 3.1F3BoneJointWind 0.13 0.29 0.09 -0.59 
FAC 3.1F4PoorDigestion -0.07 -0.06 0.12 0.07 
FAC 3.1F5LiverSpleenFire -0.08 -0.26 0.51 -0.19 
FAC 3.1F6YinDeficiency -0.08 0.38 -0.09 -0.14 
FAC 3.1F7LiverAttackStomach 0.07 0.25 0.08 -0.28 
FAC 3.1F8ENT -0.18 0.28 0.12 -0.15 
FAC 3.1F9LightSound 0.61 0.38 -0.39 -0.51 
FAC 3.1F10TemperatureSensitivity -0.20 -0.11 0.25 0.09 
FAC 3.1F11Constipation -0.14 0.28 -0.19 0.04 
FAC 3.1F12BloodDeficiency 0.21 0.49 -0.33 -0.23 
FAC 3.1F13YangDeficiency -0.08 0.15 0.04 -0.20 
FAC 3.1F14SpleenDeficienyOfBowel -0.27 0.71 -0.16 -0.08 
FAC 3.1F16Tinnitus 0.00 0.03 0.09 -0.10 
FAC 3.1F17Insomnia 0.03 -0.18 0.15 -0.04 
 * mean scores of each factor calculated in cluster analysis 
 
  
  
Appendix 55. Multiple comparisons by Bonferroni correction on demographic data 
 
Dependent 
Variable 
(I) TwoStep 
Cluster 
NumberF41_4 
(J) TwoStep 
Cluster 
NumberF41_4 
Mean 
Difference 
(I-J) 
Std. 
Error 
Sig. 95% Confidence 
Interval 
Lower 
Bound 
Upper 
Bound 
Gender 
1 
2 .033 .103 1.000 -.24 .31 
3 -.109 .095 1.000 -.36 .15 
4 -.125 .096 1.000 -.38 .13 
2 
1 -.033 .103 1.000 -.31 .24 
3 -.142 .103 1.000 -.42 .13 
4 -.158 .104 .791 -.44 .12 
3 
1 .109 .095 1.000 -.15 .36 
2 .142 .103 1.000 -.13 .42 
4 -.016 .096 1.000 -.27 .24 
4 
1 .125 .096 1.000 -.13 .38 
2 .158 .104 .791 -.12 .44 
3 .016 .096 1.000 -.24 .27 
Age range 
1 
2 .633 .264 .105 -.07 1.34 
3 .789* .247 .010 .13 1.45 
4 1.363* .246 .000 .71 2.02 
2 
1 -.633 .264 .105 -1.34 .07 
3 .156 .266 1.000 -.55 .87 
4 .730* .265 .039 .02 1.44 
3 
1 -.789* .247 .010 -1.45 -.13 
2 -.156 .266 1.000 -.87 .55 
4 .574 .249 .134 -.09 1.24 
4 
1 -1.363* .246 .000 -2.02 -.71 
2 -.730* .265 .039 -1.44 -.02 
3 -.574 .249 .134 -1.24 .09 
Marriage 
1 
2 -.103 .206 1.000 -.65 .45 
3 .378 .194 .320 -.14 .90 
4 .408 .192 .209 -.10 .92 
2 
1 .103 .206 1.000 -.45 .65 
3 .480 .209 .136 -.08 1.04 
4 .511 .207 .087 -.04 1.06 
3 
1 -.378 .194 .320 -.90 .14 
2 -.480 .209 .136 -1.04 .08 
4 .030 .195 1.000 -.49 .55 
4 
1 -.408 .192 .209 -.92 .10 
2 -.511 .207 .087 -1.06 .04 
3 -.030 .195 1.000 -.55 .49 
Edu-level 
1 
2 -.141 .351 1.000 -1.08 .80 
3 -.306 .333 1.000 -1.20 .58 
4 -.020 .327 1.000 -.89 .85 
2 
1 .141 .351 1.000 -.80 1.08 
3 -.166 .358 1.000 -1.12 .79 
4 .120 .353 1.000 -.82 1.06 
3 
1 .306 .333 1.000 -.58 1.20 
2 .166 .358 1.000 -.79 1.12 
4 .286 .335 1.000 -.61 1.18 
4 
1 .020 .327 1.000 -.85 .89 
2 -.120 .353 1.000 -1.06 .82 
3 -.286 .335 1.000 -1.18 .61 
Ethenicity 
1 
2 .192 .275 1.000 -.54 .93 
3 -1.373* .258 .000 -2.06 -.68 
4 -1.414* .255 .000 -2.09 -.73 
2 
1 -.192 .275 1.000 -.93 .54 
3 -1.565* .280 .000 -2.31 -.82 
4 -1.606* .277 .000 -2.35 -.87 
3 
1 1.373* .258 .000 .68 2.06 
2 1.565* .280 .000 .82 2.31 
4 -.041 .259 1.000 -.73 .65 
  
4 
1 1.414* .255 .000 .73 2.09 
2 1.606* .277 .000 .87 2.35 
3 .041 .259 1.000 -.65 .73 
*. The mean difference is significant at the 0.05 level. 
 
 
 
Appendix 56. Bonferroni correction of multiple comparisons age with TTH subtypes 
 
Dependent 
Variable 
(I) TwoStep Cluster 
NumberF41_4 
(J) TwoStep 
Cluster 
NumberF41_4 
Mean 
Difference 
(I-J) 
Std. 
Error 
Sig. 95% Confidence 
Interval 
Lower 
Bound 
Upper 
Bound 
Age 
1 
2 6.530 2.613 .082 -.46 13.52 
3 8.389* 2.531 .007 1.61 15.16 
4 15.158* 2.714 .000 7.89 22.42 
2 
1 -6.530 2.613 .082 -13.52 .46 
3 1.859 2.717 1.000 -5.41 9.13 
4 8.628* 2.888 .020 .90 16.36 
3 
1 -8.389* 2.531 .007 -15.16 -1.61 
2 -1.859 2.717 1.000 -9.13 5.41 
4 6.769 2.814 .105 -.76 14.30 
4 
1 -15.158* 2.714 .000 -22.42 -7.89 
2 -8.628* 2.888 .020 -16.36 -.90 
3 -6.769 2.814 .105 -14.30 .76 
*. The mean difference is significant at the 0.05 level. 
 
 
 
Appendix 57. Bonferroni correction of multiple comparisons of MIDAS with TTH clusters 
 
Dependent 
Variable 
(I) TwoStep Cluster 
NumberF41_4 
(J) TwoStep Cluster 
NumberF41_4 
Mean 
Difference 
(I-J) 
Std. 
Error 
Sig. 95% Confidence 
Interval 
Lower 
Bound 
Upper 
Bound 
MIDAS Q1 
1 
2 -1.235 1.790 1.000 -6.02 3.55 
3 -1.676 1.667 1.000 -6.13 2.78 
4 -2.795 1.657 .561 -7.22 1.63 
2 
1 1.235 1.790 1.000 -3.55 6.02 
3 -.441 1.799 1.000 -5.25 4.36 
4 -1.561 1.790 1.000 -6.34 3.22 
3 
1 1.676 1.667 1.000 -2.78 6.13 
2 .441 1.799 1.000 -4.36 5.25 
4 -1.119 1.667 1.000 -5.57 3.33 
4 
1 2.795 1.657 .561 -1.63 7.22 
2 1.561 1.790 1.000 -3.22 6.34 
3 1.119 1.667 1.000 -3.33 5.57 
MIDAS Q2 
1 
2 -4.326 2.774 .725 -11.74 3.09 
3 -4.473 2.583 .512 -11.37 2.43 
4 -.159 2.568 1.000 -7.02 6.70 
2 
1 4.326 2.774 .725 -3.09 11.74 
3 -.147 2.788 1.000 -7.60 7.30 
4 4.167 2.774 .811 -3.24 11.58 
3 
1 4.473 2.583 .512 -2.43 11.37 
2 .147 2.788 1.000 -7.30 7.60 
  
4 4.314 2.583 .581 -2.59 11.22 
4 
1 .159 2.568 1.000 -6.70 7.02 
2 -4.167 2.774 .811 -11.58 3.24 
3 -4.314 2.583 .581 -11.22 2.59 
MIDAS Q3 
1 
2 -2.864 1.761 .636 -7.57 1.84 
3 -.045 1.640 1.000 -4.43 4.34 
4 .727 1.631 1.000 -3.63 5.08 
2 
1 2.864 1.761 .636 -1.84 7.57 
3 2.818 1.770 .680 -1.91 7.55 
4 3.591 1.761 .259 -1.11 8.30 
3 
1 .045 1.640 1.000 -4.34 4.43 
2 -2.818 1.770 .680 -7.55 1.91 
4 .773 1.640 1.000 -3.61 5.15 
4 
1 -.727 1.631 1.000 -5.08 3.63 
2 -3.591 1.761 .259 -8.30 1.11 
3 -.773 1.640 1.000 -5.15 3.61 
MIDAS Q4 
1 
2 -2.106 1.882 1.000 -7.13 2.92 
3 1.697 1.752 1.000 -2.98 6.38 
4 3.114 1.742 .455 -1.54 7.77 
2 
1 2.106 1.882 1.000 -2.92 7.13 
3 3.803 1.891 .276 -1.25 8.85 
4 5.220* 1.882 .037 .19 10.25 
3 
1 -1.697 1.752 1.000 -6.38 2.98 
2 -3.803 1.891 .276 -8.85 1.25 
4 1.417 1.752 1.000 -3.26 6.10 
4 
1 -3.114 1.742 .455 -7.77 1.54 
2 -5.220* 1.882 .037 -10.25 -.19 
3 -1.417 1.752 1.000 -6.10 3.26 
MIDAS Q5 
1 
2 -2.061 1.806 1.000 -6.89 2.77 
3 -.469 1.682 1.000 -4.96 4.02 
4 -1.682 1.672 1.000 -6.15 2.79 
2 
1 2.061 1.806 1.000 -2.77 6.89 
3 1.591 1.815 1.000 -3.26 6.44 
4 .379 1.806 1.000 -4.45 5.20 
3 
1 .469 1.682 1.000 -4.02 4.96 
2 -1.591 1.815 1.000 -6.44 3.26 
4 -1.212 1.682 1.000 -5.71 3.28 
4 
1 1.682 1.672 1.000 -2.79 6.15 
2 -.379 1.806 1.000 -5.20 4.45 
3 1.212 1.682 1.000 -3.28 5.71 
MIDAS A 
1 
2 -6.273 5.416 1.000 -20.74 8.20 
3 -.080 5.043 1.000 -13.55 13.39 
4 4.636 5.014 1.000 -8.76 18.03 
2 
1 6.273 5.416 1.000 -8.20 20.74 
3 6.192 5.443 1.000 -8.35 20.73 
4 10.909 5.416 .274 -3.56 25.38 
3 
1 .080 5.043 1.000 -13.39 13.55 
2 -6.192 5.443 1.000 -20.73 8.35 
4 4.717 5.043 1.000 -8.76 18.19 
4 
1 -4.636 5.014 1.000 -18.03 8.76 
2 -10.909 5.416 .274 -25.38 3.56 
3 -4.717 5.043 1.000 -18.19 8.76 
MIDAS B 
1 
2 -.848 .496 .534 -2.17 .48 
3 .036 .462 1.000 -1.20 1.27 
4 .773 .459 .566 -.45 2.00 
2 
1 .848 .496 .534 -.48 2.17 
3 .884 .498 .467 -.45 2.22 
4 1.621* .496 .008 .30 2.95 
3 
1 -.036 .462 1.000 -1.27 1.20 
2 -.884 .498 .467 -2.22 .45 
4 .737 .462 .675 -.50 1.97 
4 
1 -.773 .459 .566 -2.00 .45 
2 -1.621* .496 .008 -2.95 -.30 
3 -.737 .462 .675 -1.97 .50 
  
 
Sum of MIDAS 
scores 
 
 
1 
2 -12.591 7.299 .519 -32.09 6.91 
3 -4.967 6.797 1.000 -23.13 13.19 
4 -.795 6.758 1.000 -18.85 17.26 
2 
1 12.591 7.299 .519 -6.91 32.09 
3 7.624 7.336 1.000 -11.97 27.22 
4 11.795 7.299 .648 -7.70 31.30 
3 
1 4.967 6.797 1.000 -13.19 23.13 
2 -7.624 7.336 1.000 -27.22 11.97 
4 4.172 6.797 1.000 -13.99 22.33 
4 
1 .795 6.758 1.000 -17.26 18.85 
2 -11.795 7.299 .648 -31.30 7.70 
3 -4.172 6.797 1.000 -22.33 13.99 
*. The mean difference is significant at the 0.05 level. 
 
 
 
Appendix 58. Analysis of variance data for PSS among TTH clusters 
 
Item 
 
 
TTH 
Cluster 
 
N 
 
 
Mean 
 
 
Std. 
Deviation 
 
Minimum 
 
 
Maximum 
 
 
ANOVA 
(Between Groups) 
F df Sig. 
PSS Q1 1 41 1.63 1.019 0 4 2.816 3,156 .041 
2 32 1.78 1.070 0 4 
3
v.4
 43 2.09 1.360 0 4 
4
v.3
 44 1.43 .846 0 3 
Total 160 1.73 1.109 0 4 
PSS Q2 1
 v.4
 41 1.73 .923 0 4 3.017 3,156 .032 
2 32 1.56 1.105 0 4 
3 43 1.65 1.193 0 4 
4
 v.1
 44 1.14 .765 0 3 
Total 160 1.51 1.022 0 4 
PSS Q3 1
 v.4
 41 2.46 .925 0 4 9.360 3,156 .000* 
2
 v.4
 32 2.22 1.008 0 4 
3
 v.4
 43 2.14 1.146 0 4 
4
 v.123
 44 1.39 .868 0 4 
Total 160 2.03 1.066 0 4 
PSS Q4 1 41 1.24 .830 0 4 3.457 3,156 .018 
2
 v.3
 32 1.09 .995 0 4 
3
 v.2
 43 1.72 .984 0 4 
4 44 1.52 .927 0 4 
Total 160 1.42 .955 0 4 
PSS Q5 1
 v.3,4
 38 1.39 .755 0 3 6.436 3,156 .000* 
2
 v.3,4
 31 1.48 .962 0 4 
3
 v.1,2
 43 2.14 1.104 0 4 
4
 v.1,2
 44 2.09 .984 0 4 
Total 156 1.81 1.015 0 4 
PSS Q6 1 41 1.76 1.090 0 4 2.638 3,156 .052 
2 32 1.84 1.167 0 4 
3 43 1.63 .976 0 4 
4 44 1.25 .892 0 4 
Total 160 1.60 1.041 0 4 
PSS Q7 1 41 1.56 .808 0 4 1.390 3,156 .248 
2 32 1.53 .915 0 3 
3 43 1.74 1.071 0 4 
4 44 1.93 1.129 0 4 
Total 160 1.71 1.001 0 4 
PSS Q8 
 
 
 
1
 v.3
 41 1.56 .867 0 3 6.108 3,156 .001* 
2
 v.3
 32 1.44 .982 0 4 
3
 v1,2
 43 2.26 1.049 0 4 
4 44 2.05 1.011 0 4 
  
 Total 160 1.86 1.027 0 4 
PSS Q9 
 
 
 
 
1
 v,4
 41 1.98 .935 0 4 3.228 3,156 .024 
2 32 1.78 .832 0 3 
3 43 1.77 1.130 0 4 
4
 v.1
 44 1.34 .939 0 4 
Total 160 1.71 .994 0 4 
PSS Q10 
 
 
 
 
1 41 1.46 1.142 0 4 3.171 3,156 .026 
2 32 1.50 1.191 0 4 
3
 v.4
 43 1.65 1.251 0 4 
4
 v.3
 44 .98 .664 0 2 
Total 160 1.39 1.099 0 4 
“*” indicates significant cluster difference, significant level at p< 0.01 (0.05/10)  
“
v.
” means the cluster being different from other specified cluster or clusters, whereas the “
x(figure)
” after “
v.
” indicates specific 
cluster or clusters. 
 
 
 
Appendix 59. Bonferroni correction of multiple comparisons of PSS-10 with TTH clusters 
 
Dependent 
Variable 
(I) TwoStep Cluster 
NumberF41_4 
(J) TwoStep 
Cluster 
NumberF41_4 
Mean 
Difference 
(I-J) 
Std. 
Error 
Sig. 95% Confidence 
Interval 
Lower 
Bound 
Upper 
Bound 
PSS1 
1 
2 -.147 .257 1.000 -.83 .54 
3 -.459 .238 .334 -1.09 .18 
4 .202 .237 1.000 -.43 .83 
2 
1 .147 .257 1.000 -.54 .83 
3 -.312 .255 1.000 -.99 .37 
4 .349 .253 1.000 -.33 1.03 
3 
1 .459 .238 .334 -.18 1.09 
2 .312 .255 1.000 -.37 .99 
4 .661* .234 .032 .04 1.29 
4 
1 -.202 .237 1.000 -.83 .43 
2 -.349 .253 1.000 -1.03 .33 
3 -.661* .234 .032 -1.29 -.04 
PSS2 
1 
2 .169 .237 1.000 -.46 .80 
3 .081 .219 1.000 -.50 .67 
4 .595* .218 .042 .01 1.18 
2 
1 -.169 .237 1.000 -.80 .46 
3 -.089 .234 1.000 -.71 .54 
4 .426 .233 .416 -.20 1.05 
3 
1 -.081 .219 1.000 -.67 .50 
2 .089 .234 1.000 -.54 .71 
4 .515 .215 .107 -.06 1.09 
4 
1 -.595* .218 .042 -1.18 -.01 
2 -.426 .233 .416 -1.05 .20 
3 -.515 .215 .107 -1.09 .06 
PSS3 
1 
2 .245 .234 1.000 -.38 .87 
3 .324 .216 .818 -.25 .90 
4 1.077* .215 .000 .50 1.65 
2 
1 -.245 .234 1.000 -.87 .38 
3 .079 .231 1.000 -.54 .70 
4 .832* .230 .002 .22 1.45 
3 
1 -.324 .216 .818 -.90 .25 
2 -.079 .231 1.000 -.70 .54 
4 .753* .213 .003 .19 1.32 
4 
1 -1.077* .215 .000 -1.65 -.50 
2 -.832* .230 .002 -1.45 -.22 
3 -.753* .213 .003 -1.32 -.19 
PSS4 1 
2 .150 .220 1.000 -.44 .74 
3 -.477 .204 .123 -1.02 .07 
  
4 -.279 .203 1.000 -.82 .26 
2 
1 -.150 .220 1.000 -.74 .44 
3 -.627* .218 .027 -1.21 -.04 
4 -.429 .217 .298 -1.01 .15 
3 
1 .477 .204 .123 -.07 1.02 
2 .627* .218 .027 .04 1.21 
4 .198 .200 1.000 -.34 .73 
4 
1 .279 .203 1.000 -.26 .82 
2 .429 .217 .298 -.15 1.01 
3 -.198 .200 1.000 -.73 .34 
PSS5 
1 
2 -.089 .234 1.000 -.71 .54 
3 -.745* .215 .004 -1.32 -.17 
4 -.696* .214 .008 -1.27 -.12 
2 
1 .089 .234 1.000 -.54 .71 
3 -.656* .227 .027 -1.26 -.05 
4 -.607* .226 .049 -1.21 .00 
3 
1 .745* .215 .004 .17 1.32 
2 .656* .227 .027 .05 1.26 
4 .049 .207 1.000 -.50 .60 
4 
1 .696* .214 .008 .12 1.27 
2 .607* .226 .049 .00 1.21 
3 -.049 .207 1.000 -.60 .50 
PSS6 
1 
2 -.088 .242 1.000 -.73 .56 
3 .128 .224 1.000 -.47 .73 
4 .506 .223 .146 -.09 1.10 
2 
1 .088 .242 1.000 -.56 .73 
3 .216 .239 1.000 -.42 .86 
4 .594 .238 .083 -.04 1.23 
3 
1 -.128 .224 1.000 -.73 .47 
2 -.216 .239 1.000 -.86 .42 
4 .378 .220 .526 -.21 .97 
4 
1 -.506 .223 .146 -1.10 .09 
2 -.594 .238 .083 -1.23 .04 
3 -.378 .220 .526 -.97 .21 
PSS7 
1 
2 .030 .235 1.000 -.60 .66 
3 -.183 .218 1.000 -.76 .40 
4 -.371 .216 .531 -.95 .21 
2 
1 -.030 .235 1.000 -.66 .60 
3 -.213 .233 1.000 -.83 .41 
4 -.401 .232 .514 -1.02 .22 
3 
1 .183 .218 1.000 -.40 .76 
2 .213 .233 1.000 -.41 .83 
4 -.188 .214 1.000 -.76 .38 
4 
1 .371 .216 .531 -.21 .95 
2 .401 .232 .514 -.22 1.02 
3 .188 .214 1.000 -.38 .76 
PSS8 
1 
2 .123 .231 1.000 -.49 .74 
3 -.695* .214 .009 -1.27 -.12 
4 -.484 .213 .145 -1.05 .08 
2 
1 -.123 .231 1.000 -.74 .49 
3 -.818* .229 .003 -1.43 -.21 
4 -.608 .228 .051 -1.22 .00 
3 
1 .695* .214 .009 .12 1.27 
2 .818* .229 .003 .21 1.43 
4 .210 .210 1.000 -.35 .77 
4 
1 .484 .213 .145 -.08 1.05 
2 .608 .228 .051 .00 1.22 
3 -.210 .210 1.000 -.77 .35 
PSS9 
1 
2 .194 .230 1.000 -.42 .81 
3 .208 .213 1.000 -.36 .78 
4 .635* .211 .019 .07 1.20 
2 
1 -.194 .230 1.000 -.81 .42 
3 .014 .227 1.000 -.59 .62 
4 .440 .226 .321 -.16 1.05 
  
3 
1 -.208 .213 1.000 -.78 .36 
2 -.014 .227 1.000 -.62 .59 
4 .427 .209 .257 -.13 .98 
4 
1 -.635* .211 .019 -1.20 -.07 
2 -.440 .226 .321 -1.05 .16 
3 -.427 .209 .257 -.98 .13 
PSS10 
1 
2 -.037 .254 1.000 -.72 .64 
3 -.188 .235 1.000 -.82 .44 
4 .486 .234 .235 -.14 1.11 
2 
1 .037 .254 1.000 -.64 .72 
3 -.151 .251 1.000 -.82 .52 
4 .523 .250 .230 -.15 1.19 
3 
1 .188 .235 1.000 -.44 .82 
2 .151 .251 1.000 -.52 .82 
4 .674* .231 .024 .06 1.29 
4 
1 -.486 .234 .235 -1.11 .14 
2 -.523 .250 .230 -1.19 .15 
3 -.674* .231 .024 -1.29 -.06 
Sum of 
PSSscores 
 
1 
2 .495 1.616 1.000 -3.82 4.81 
3 -2.108 1.495 .963 -6.10 1.89 
4 1.569 1.487 1.000 -2.40 5.54 
2 
1 -.495 1.616 1.000 -4.81 3.82 
3 -2.603 1.599 .633 -6.88 1.67 
4 1.074 1.591 1.000 -3.18 5.33 
3 
1 2.108 1.495 .963 -1.89 6.10 
2 2.603 1.599 .633 -1.67 6.88 
4 3.677 1.469 .080 -.25 7.60 
4 
1 -1.569 1.487 1.000 -5.54 2.40 
2 -1.074 1.591 1.000 -5.33 3.18 
3 -3.677 1.469 .080 -7.60 .25 
PerceivedDistres
s(1,2,3,6,9,10) 
1 
2 -.211 1.210 1.000 -3.44 3.02 
3 -.370 1.116 1.000 -3.35 2.61 
4 2.325 1.129 .246 -.69 5.34 
2 
1 .211 1.210 1.000 -3.02 3.44 
3 -.159 1.210 1.000 -3.39 3.07 
4 2.536 1.222 .237 -.73 5.80 
3 
1 .370 1.116 1.000 -2.61 3.35 
2 .159 1.210 1.000 -3.07 3.39 
4 2.695 1.129 .108 -.32 5.71 
4 
1 -2.325 1.129 .246 -5.34 .69 
2 -2.536 1.222 .237 -5.80 .73 
3 -2.695 1.129 .108 -5.71 .32 
PerceivedCopin
g(4,5,7,8) 
1 
2 -.133 .770 1.000 -2.19 1.92 
3 -2.304* .710 .009 -4.20 -.41 
4 -2.547* .718 .003 -4.47 -.63 
2 
1 .133 .770 1.000 -1.92 2.19 
3 -2.171* .770 .032 -4.23 -.11 
4 -2.414* .778 .013 -4.49 -.34 
3 
1 2.304* .710 .009 .41 4.20 
2 2.171* .770 .032 .11 4.23 
4 -.243 .718 1.000 -2.16 1.67 
4 
1 2.547* .718 .003 .63 4.47 
2 2.414* .778 .013 .34 4.49 
3 .243 .718 1.000 -1.67 2.16 
*. The mean difference is significant at the 0.05 level. 
 
  
  
Appendix 60. Analysis of variance data for MIDAS items among TTH subtypes 
 
 TTH subtypes   
n (mean±SD) 
ANOVA 
Infrequent 
ETTH (1) 
Frequent 
ETTH (2) 
Chronic TTH 
(3) 
Total 
n (mean±SD) 
Between Groups 
F df Sig. 
MIDAS Q1 23  
(0.22±0.671) 
104 
(1.85±3.276) 
37 
(5.78±15.059) 
164 
(2.51±7.771) 
4.886 
2, 
161 
0.009* 
MIDAS Q2 13 
(1.57±3.409) 
104 
(6.67±8.165) 
37 
(13.19±20.266) 
164 
(7.43±12.131) 
7.635 
2, 
161 
0.001* 
MIDAS Q3 23 
(0.65±1.265) 
104 
(4.24±6.581) 
37 
(6.95±11.264) 
164 
(4.35±7.686) 
5.019 
2, 
161 
0.008* 
MIDAS Q4 23 
(0.78±1.783) 
104 
(5.19±7.502) 
37 
(7.92±11.393) 
164 
(5.19±8.312) 
5.517 
2, 
161 
0.005* 
MIDAS Q5 23 
(0.61±1.196) 
104 
(3.00±3.872) 
37 
(5.24±14.973) 
164 
(3.17±7.817) 2.611 
2, 
161 0.077 
*. The mean difference is significant at the 0.01 (0.05/5) level. 
 
 
 
Appendix 61. Bonferroni correction of multiple comparisons of MIDAS with TTH 
subtypes 
 
Dependent 
Variable 
(I) days per month 
on headache 
(J) days per month 
on headache 
Mean 
Difference 
(I-J) 
Std. 
Error 
Sig. 95% Confidence 
Interval 
Lower 
Bound 
Upper 
Bound 
MIDAS Q1 
1 
2 -1.629 1.749 1.000 -5.86 2.60 
3 -5.566* 2.016 .019 -10.44 -.69 
2 
1 1.629 1.749 1.000 -2.60 5.86 
3 -3.938* 1.453 .022 -7.45 -.42 
3 
1 5.566* 2.016 .019 .69 10.44 
2 3.938* 1.453 .022 .42 7.45 
MIDAS Q2 
1 
2 -5.108 2.688 .178 -11.61 1.39 
3 -11.624* 3.097 .001 -19.12 -4.13 
2 
1 5.108 2.688 .178 -1.39 11.61 
3 -6.516* 2.233 .012 -11.92 -1.11 
3 
1 11.624* 3.097 .001 4.13 19.12 
2 6.516* 2.233 .012 1.11 11.92 
MIDAS Q3 
1 
2 -3.588 1.729 .119 -7.77 .59 
3 -6.294* 1.992 .006 -11.11 -1.47 
2 
1 3.588 1.729 .119 -.59 7.77 
3 -2.706 1.436 .184 -6.18 .77 
3 
1 6.294* 1.992 .006 1.47 11.11 
2 2.706 1.436 .184 -.77 6.18 
MIDAS Q4 
1 
2 -4.410 1.864 .058 -8.92 .10 
3 -7.136* 2.148 .003 -12.33 -1.94 
2 
1 4.410 1.864 .058 -.10 8.92 
3 -2.727 1.549 .241 -6.47 1.02 
3 
1 7.136* 2.148 .003 1.94 12.33 
2 2.727 1.549 .241 -1.02 6.47 
MIDAS Q5 
1 
2 -2.391 1.784 .546 -6.71 1.92 
3 -4.635 2.055 .076 -9.61 .34 
2 
1 2.391 1.784 .546 -1.92 6.71 
3 -2.243 1.482 .396 -5.83 1.34 
3 
1 4.635 2.055 .076 -.34 9.61 
2 2.243 1.482 .396 -1.34 5.83 
  
MIDAS A 
1 
2 -13.294* 4.209 .006 -23.48 -3.11 
3 -45.184* 4.850 .000 -56.92 -33.45 
2 
1 13.294* 4.209 .006 3.11 23.48 
3 -31.891* 3.496 .000 -40.35 -23.43 
3 
1 45.184* 4.850 .000 33.45 56.92 
2 31.891* 3.496 .000 23.43 40.35 
MIDAS B 
1 
2 -3.064* .447 .000 -4.15 -1.98 
3 -3.028* .516 .000 -4.28 -1.78 
2 
1 3.064* .447 .000 1.98 4.15 
3 .035 .372 1.000 -.86 .93 
3 
1 3.028* .516 .000 1.78 4.28 
2 -.035 .372 1.000 -.93 .86 
 
Sum of MIDAS 
scores 
 
 
1 
2 -17.126* 6.937 .044 -33.91 -.34 
3 -35.255* 7.994 .000 -54.60 -15.91 
2 
1 17.126* 6.937 .044 .34 33.91 
3 -18.129* 5.763 .006 -32.07 -4.19 
3 
1 35.255* 7.994 .000 15.91 54.60 
2 18.129* 5.763 .006 4.19 32.07 
*. The mean difference is significant at the 0.05 level. 
 
 
 
Appendix 62. Analysis of variance data for PSS among TTH subtypes 
 
Item  TTH subtypes   
n (mean±SD) 
ANOVA 
Infrequent ETTH 
(1) 
Frequent ETTH 
(2)  
Chronic TTH  
(3) 
Total 
n (mean±SD) 
Between Groups 
F df Sig. 
PSS Q1 23 
(1.35±.935) 
101 
(1.78±1.110) 
36 
(1.83±1.183) 
160 
(1.73±1.109) 
1.648 2,157 0.196 
PSS Q2 23 
(1.17±.887) 
101 
(1.60±.991) 
36 
(1.47±1.158) 
160 
(1.51±1.022) 
1.711 2,157 0.184 
PSS Q3 23 
(1.35±1.027) 
101 
(2.13±1.016) 
36 
(2.19±1.091) 
160 
(2.03±1.066) 
5.909 2,157 0.003 
PSS Q4 23 
(1.83±.984) 
101 
(1.37±.924) 
36 
(1.31±.980) 
160 
(1.42±.955) 
2.547 2,157 0.082 
PSS Q5 22 
(2.32±.839) 
99 
(1.78±1.016) 
35 
(1.60±1.035) 
156 
(1.81±1.015) 
3.680 2,153 0.027 
PSS Q6 23 
(1.43±.945) 
101 
(1.69±1.046) 
36 
(1.44±1.081) 
160 
(1.60±1.041) 
1.096 2,157 0.337 
PSS Q7 23 
(1.91±.996) 
101 
(1.71±.973) 
36 
(1.56±1.081) 
160 
(1.71±1.001) 
.901 2,157 0.408 
PSS Q8 23 
(2.35±1.071) 
101 
(1.78±.976) 
36 
(1.75±1.079) 
160 
(1.86±1.027) 
3.175 2,157 0.044 
PSS Q9 23 
(1.09±.848) 
101 
(1.92±.997) 
36 
(1.50±.878) 
160 
(1.71±.994) 
8.282 2,157 0.000 
PSS Q10 23 
(1.39±.988) 
101 
(1.50±1.074) 
36 
(1.08±1.204) 
160 
(1.39±1.099) 
1.884 2,157 0.155 
*. The mean difference is significant at the 0.01 (0.05/5) level. 
 
  
  
Appendix 63. Bonferroni correction of multiple comparisons of PSS-10 with TTH 
subtypes 
 
Dependent 
Variable 
(I) days per 
month on 
headache 
(J) days per 
month on 
headache 
Mean 
Difference 
(I-J) 
Std. 
Error 
Sig. 95% Confidence 
Interval 
Lower 
Bound 
Upper 
Bound 
PSS1 
1 
2 -.434 .255 .272 -1.05 .18 
3 -.486 .295 .305 -1.20 .23 
2 
1 .434 .255 .272 -.18 1.05 
3 -.051 .214 1.000 -.57 .47 
3 
1 .486 .295 .305 -.23 1.20 
2 .051 .214 1.000 -.47 .57 
PSS2 
1 
2 -.430 .235 .207 -1.00 .14 
3 -.298 .272 .821 -.96 .36 
2 
1 .430 .235 .207 -.14 1.00 
3 .132 .197 1.000 -.35 .61 
3 
1 .298 .272 .821 -.36 .96 
2 -.132 .197 1.000 -.61 .35 
PSS3 
1 
2 -.781* .239 .004 -1.36 -.20 
3 -.847* .276 .008 -1.52 -.18 
2 
1 .781* .239 .004 .20 1.36 
3 -.066 .201 1.000 -.55 .42 
3 
1 .847* .276 .008 .18 1.52 
2 .066 .201 1.000 -.42 .55 
PSS4 
1 
2 .460 .218 .111 -.07 .99 
3 .521 .252 .123 -.09 1.13 
2 
1 -.460 .218 .111 -.99 .07 
3 .061 .184 1.000 -.38 .50 
3 
1 -.521 .252 .123 -1.13 .09 
2 -.061 .184 1.000 -.50 .38 
PSS5 
1 
2 .540 .235 .069 -.03 1.11 
3 .718* .271 .027 .06 1.38 
2 
1 -.540 .235 .069 -1.11 .03 
3 .178 .196 1.000 -.30 .65 
3 
1 -.718* .271 .027 -1.38 -.06 
2 -.178 .196 1.000 -.65 .30 
PSS6 
1 
2 -.258 .240 .853 -.84 .32 
3 -.010 .278 1.000 -.68 .66 
2 
1 .258 .240 .853 -.32 .84 
3 .249 .202 .661 -.24 .74 
3 
1 .010 .278 1.000 -.66 .68 
2 -.249 .202 .661 -.74 .24 
PSS7 
1 
2 .200 .231 1.000 -.36 .76 
3 .357 .267 .549 -.29 1.00 
2 
1 -.200 .231 1.000 -.76 .36 
3 .157 .194 1.000 -.31 .63 
3 
1 -.357 .267 .549 -1.00 .29 
2 -.157 .194 1.000 -.63 .31 
PSS8 
1 
2 .566 .234 .050 .00 1.13 
3 .598 .270 .086 -.06 1.25 
2 
1 -.566 .234 .050 -1.13 .00 
3 .032 .197 1.000 -.44 .51 
3 
1 -.598 .270 .086 -1.25 .06 
2 -.032 .197 1.000 -.51 .44 
PSS9 
1 
2 -.834* .220 .001 -1.37 -.30 
3 -.413 .254 .318 -1.03 .20 
2 
1 .834* .220 .001 .30 1.37 
3 .421 .185 .072 -.03 .87 
3 
1 .413 .254 .318 -.20 1.03 
2 -.421 .185 .072 -.87 .03 
PSS10 1 2 -.104 .252 1.000 -.71 .51 
  
3 .308 .292 .878 -.40 1.01 
2 
1 .104 .252 1.000 -.51 .71 
3 .412 .212 .162 -.10 .93 
3 
1 -.308 .292 .878 -1.01 .40 
2 -.412 .212 .162 -.93 .10 
PSS SUM 
1 
2 -1.141 1.602 1.000 -5.02 2.74 
3 .393 1.851 1.000 -4.09 4.87 
2 
1 1.141 1.602 1.000 -2.74 5.02 
3 1.533 1.346 .769 -1.72 4.79 
3 
1 -.393 1.851 1.000 -4.87 4.09 
2 -1.533 1.346 .769 -4.79 1.72 
PerceivedDist
ress(123690) 
1 
2 -2.588 1.213 .103 -5.52 .34 
3 -1.311 1.393 1.000 -4.68 2.06 
2 
1 2.588 1.213 .103 -.34 5.52 
3 1.277 1.004 .615 -1.15 3.71 
3 
1 1.311 1.393 1.000 -2.06 4.68 
2 -1.277 1.004 .615 -3.71 1.15 
PerceivedCop
ingAbility(457
8) 
1 
2 1.725 .798 .096 -.21 3.65 
3 2.266* .917 .043 .05 4.48 
2 
1 -1.725 .798 .096 -3.65 .21 
3 .541 .661 1.000 -1.06 2.14 
3 
1 -2.266* .917 .043 -4.48 -.05 
2 -.541 .661 1.000 -2.14 1.06 
*. The mean difference is significant at the 0.01 (0.05/5) level. 
 
